data_6ryq_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6ryq _Structure_validation_residue.Date_analyzed 2020-07-10 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.4 tptp . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.931 0.396 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.6 mt -136.28 -43.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.659 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.706 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.2 mt -92.29 -94.69 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.95 -5.97 2.51 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 108.131 -1.987 . . . . 0.0 108.131 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.706 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.48 -48.26 5.09 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 113.099 -1.551 . . . . 0.0 109.708 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.44 25.91 1.15 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.12 48.01 0.1 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.681 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.3 mt 60.93 29.28 18.92 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.104 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 53.7 61.69 2.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.436 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 49.19 45.75 23.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.697 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 7.4 mp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.139 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ILE . 81.7 tttt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.586 0.231 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' ALA . 15.8 pt -71.4 7.2 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.504 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.708 ' C ' ' H ' ' A' ' 14' ' ' GLY . 45.3 mm -71.41 -88.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.41 -3.94 3.4 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 107.479 -2.248 . . . . 0.0 107.479 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.708 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.0 -39.08 8.18 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 113.702 -1.249 . . . . 0.0 110.124 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 11' ' ' ILE . . . -90.88 25.94 2.24 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.78 35.4 0.21 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.6 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 53.48 33.33 15.84 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.91 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.5 t0 56.54 -79.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' LEU . 46.5 m-70 -50.2 -63.68 1.04 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.657 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.069 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.3 tttt . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.773 0.32 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.1 mt -117.84 -45.57 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.398 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.666 ' C ' ' H ' ' A' ' 14' ' ' GLY . 68.2 mt -94.97 -97.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.13 -8.42 1.53 Allowed Glycine 0 C--N 1.344 1.01 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.666 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.2 -47.48 5.48 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 113.227 -1.486 . . . . 0.0 110.106 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.46 26.34 0.8 Allowed 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 80.3 39.84 0.08 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.105 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.4 tp 55.76 22.85 5.81 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.335 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 53.72 -85.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.707 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.9 m-70 -49.8 -39.47 38.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.554 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.192 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.7 tttt . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.77 0.319 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.7 mt -137.07 -45.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.218 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.687 ' C ' ' H ' ' A' ' 14' ' ' GLY . 66.3 mt -82.83 -93.97 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.64 -8.27 2.69 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 107.882 -2.087 . . . . 0.0 107.882 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.687 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.52 -48.06 6.49 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 113.099 -1.551 . . . . 0.0 109.946 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.89 30.05 0.77 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 73.54 41.61 0.44 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.573 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.7 tt 66.39 53.57 0.98 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.82 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.9 t0 55.51 -81.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.909 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.644 ' H ' ' HD1' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -150.34 39.24 0.73 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.559 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.434 179.887 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.421 ' N ' ' CD ' ' A' ' 10' ' ' LYS . 3.5 mptp? . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 121.004 0.43 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.39 -36.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.125 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.681 ' C ' ' H ' ' A' ' 14' ' ' GLY . 87.1 mt -77.3 -87.76 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.41 -4.95 5.64 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 107.199 -2.36 . . . . 0.0 107.199 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.91 -45.84 6.53 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 113.102 -1.549 . . . . 0.0 110.092 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.78 30.54 0.82 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 71.78 42.73 0.61 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.484 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 61.28 53.52 3.49 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.31 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.28 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.671 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 1.1 t60 -159.43 52.86 0.37 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 0.0 110.355 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.2 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.109 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.007 0.432 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.9 mt -140.32 -37.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.167 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.675 ' C ' ' H ' ' A' ' 14' ' ' GLY . 39.1 mm -75.57 -87.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.98 -5.24 5.31 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 107.217 -2.353 . . . . 0.0 107.217 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.51 -44.81 7.18 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 113.207 -1.496 . . . . 0.0 110.266 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.51 27.8 1.06 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.69 39.06 0.35 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.573 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 58.66 44.69 17.03 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.259 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 54.64 36.59 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.437 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 13.4 t-80 51.04 46.47 26.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.606 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.477 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.9 tttt . . . . . 0 N--CA 1.464 0.253 0 CA-C-O 120.703 0.287 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.4 mt -119.77 -54.89 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.191 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.683 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.7 mt -77.67 -95.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.691 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.34 -8.19 1.61 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.32 -48.2 6.09 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 112.835 -1.682 . . . . 0.0 110.102 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.98 28.66 1.01 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 73.67 46.98 0.18 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.63 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.7 mt 62.91 41.54 8.5 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 53.07 31.16 10.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.297 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 51.38 62.84 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.479 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.394 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 121.028 0.442 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -118.85 -52.58 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.664 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.695 ' C ' ' H ' ' A' ' 14' ' ' GLY . 42.3 mm -73.84 -98.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.205 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.38 -10.71 0.6 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.695 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.24 -47.65 7.37 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 113.243 -1.479 . . . . 0.0 110.126 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -87.2 27.2 1.08 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.02 39.64 0.16 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.751 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 64.89 17.43 11.03 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.826 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.5 t70 55.35 -82.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.683 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 1.4 t-80 -54.39 -69.78 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.48 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 N--CA 1.464 0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.453 179.881 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.5 tttm . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.834 0.35 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.5 mt -117.5 -52.15 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.675 ' C ' ' H ' ' A' ' 14' ' ' GLY . 34.9 mm -85.76 -99.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.04 -11.15 0.54 Allowed Glycine 0 C--N 1.348 1.201 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.89 -49.88 5.83 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 113.12 -1.54 . . . . 0.0 109.875 177.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -84.86 29.33 0.63 Allowed 'General case' 0 C--N 1.345 0.395 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.82 37.79 0.15 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.478 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 52.49 36.76 21.13 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.213 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 53.51 -84.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.83 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 51.9 m80 -45.61 -63.39 0.97 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.083 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.4 tttm . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 120.554 0.216 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -113.81 -48.21 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.83 0.348 . . . . 0.0 111.481 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.639 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.4 mm -96.56 -101.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.046 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.11 -12.09 0.47 Allowed Glycine 0 C--N 1.345 1.077 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.639 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.19 -48.51 5.66 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 113.504 -1.348 . . . . 0.0 110.055 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -84.15 22.39 1.21 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.509 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 83.22 41.96 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.951 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.8 tp 61.71 6.45 1.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.252 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 16' ' ' ALA . 33.0 t70 53.16 38.11 26.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.61 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 29.4 m170 50.03 55.42 9.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.631 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.227 -179.924 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 121.208 0.528 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 11.9 mt -112.54 -44.85 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.74 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.69 ' C ' ' H ' ' A' ' 14' ' ' GLY . 82.6 mt -73.65 -91.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.154 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.64 -8.61 2.05 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 176.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.69 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.23 -46.14 7.14 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 113.219 -1.491 . . . . 0.0 110.213 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -85.47 31.0 0.59 Allowed 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 73.16 37.68 0.74 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.684 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.7 tt 57.23 50.19 12.12 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.726 -0.789 . . . . 0.0 109.684 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 55.17 -82.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.665 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.573 ' N ' ' HD1' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -163.62 51.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.502 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.578 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 82.5 tttt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.853 0.358 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -127.98 -44.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.772 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.68 ' C ' ' H ' ' A' ' 14' ' ' GLY . 69.0 mt -89.94 -95.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.0 -7.6 2.52 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.68 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.87 -47.0 6.04 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 113.182 -1.509 . . . . 0.0 110.032 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.31 30.27 0.54 Allowed 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.24 37.79 0.44 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.805 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 52.83 46.79 26.05 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.899 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 49.74 47.58 22.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.704 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 50.2 44.54 26.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.588 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 8.4 mp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.089 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 tptp . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.78 0.324 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -134.31 -51.2 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.292 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.679 ' C ' ' H ' ' A' ' 14' ' ' GLY . 73.6 mt -77.05 -94.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 12' ' ' ILE . . . -56.27 -8.38 2.47 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 176.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.95 -47.43 7.12 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 112.853 -1.673 . . . . 0.0 110.047 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -85.72 30.5 0.64 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.15 37.94 0.58 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.634 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 19' ' ' HIS . 1.1 tt 57.22 38.49 28.82 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.848 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.4 t70 60.5 0.48 0.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.081 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.526 ' H ' ' C ' ' A' ' 17' ' ' LEU . 19.4 t-160 -173.43 -72.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.267 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.42 -179.846 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.428 ' H ' ' H ' ' A' ' 11' ' ' ILE . 44.5 tptt . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 120.868 0.366 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.428 ' H ' ' H ' ' A' ' 10' ' ' LYS . 11.9 mt -118.64 -48.66 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.65 ' C ' ' H ' ' A' ' 14' ' ' GLY . 44.0 mm -91.86 -99.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.69 -10.67 0.7 Allowed Glycine 0 C--N 1.347 1.139 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 176.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.65 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.43 -49.03 5.66 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 113.223 -1.488 . . . . 0.0 109.886 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -83.79 27.4 0.64 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 79.68 38.2 0.11 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.229 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.99 31.39 10.92 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.094 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 49.76 53.82 12.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 52.32 57.88 5.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.646 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.225 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.771 0.319 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.5 mt -134.07 -47.28 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.223 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.663 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.1 mt -79.22 -92.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.99 -8.89 2.5 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 176.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.663 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.28 -48.5 6.37 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 112.923 -1.638 . . . . 0.0 110.27 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.68 28.65 0.86 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.74 41.25 0.18 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.876 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.6 tp 61.19 26.43 16.31 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.299 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 t0 58.31 -77.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.949 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.582 ' N ' ' HD1' ' A' ' 19' ' ' HIS . 1.0 OUTLIER -48.58 -62.46 1.49 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.756 0.313 . . . . 0.0 110.824 -179.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.514 -180.0 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm . . . . . 0 N--CA 1.461 0.111 0 CA-C-O 120.985 0.421 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -139.9 -40.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.432 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.698 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.2 mt -76.46 -88.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.08 -5.78 4.79 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 107.271 -2.332 . . . . 0.0 107.271 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.698 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.34 -45.76 6.82 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 113.106 -1.547 . . . . 0.0 110.198 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.64 27.72 0.94 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.91 37.8 0.27 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.802 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.3 tp 58.66 27.15 15.44 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 55.33 -82.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 56.7 t-80 -49.45 -60.72 2.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.739 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.137 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.664 0.269 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 15' ' ' ALA . 16.2 pt -78.3 6.54 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.681 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.693 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.9 mm -70.66 -89.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.22 -4.17 3.39 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 107.488 -2.245 . . . . 0.0 107.488 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.693 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.01 -38.99 8.81 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' ILE . . . -93.91 27.5 2.74 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 75.54 38.52 0.38 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.552 -178.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.4 tt 66.14 44.27 2.65 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.731 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 59.8 t0 55.29 35.35 24.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.493 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.3 m80 52.57 57.61 6.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.532 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 tt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.6 tttp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.901 0.382 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.3 mt -131.07 -46.99 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.366 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.694 ' C ' ' H ' ' A' ' 14' ' ' GLY . 28.3 mt -81.99 -94.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.12 -7.38 1.79 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.694 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.24 -48.16 5.8 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.013 -1.593 . . . . 0.0 110.133 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.69 29.94 1.1 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.26 48.09 0.13 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.785 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.4 mt 64.08 49.83 2.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.8 t0 59.63 -76.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.746 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -162.45 26.95 0.11 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.729 0.299 . . . . 0.0 110.482 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.08 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.2 tttp . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.651 0.262 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -129.3 -44.43 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.095 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.691 ' C ' ' H ' ' A' ' 14' ' ' GLY . 73.7 mt -90.75 -94.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.22 -6.98 3.47 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.691 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.45 -47.57 5.65 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 113.062 -1.569 . . . . 0.0 110.121 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.87 27.21 0.77 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.22 40.4 0.13 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.863 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.5 tp 56.56 23.2 7.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.248 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 57.48 11.62 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.184 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -171.3 -44.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.764 0.316 . . . . 0.0 110.648 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.126 -179.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.1 tttt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.853 0.359 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.4 mt -139.6 -42.9 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.356 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.685 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.7 mt -86.84 -91.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.33 -6.62 4.55 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.685 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.4 -47.63 5.97 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 112.909 -1.645 . . . . 0.0 109.892 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.84 25.88 0.89 Allowed 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.78 43.15 0.18 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.576 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 69.51 51.69 0.47 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.377 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.6 t70 60.61 -76.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.591 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' HD1' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -160.77 50.85 0.27 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 0.0 110.397 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.143 -179.932 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.9 mttp . . . . . 0 N--CA 1.467 0.375 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.4 mt -129.29 -43.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.775 0.321 . . . . 0.0 110.88 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.666 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.3 mt -94.69 -94.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.09 -7.19 3.52 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 176.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.666 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.07 -47.44 5.53 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 113.131 -1.534 . . . . 0.0 109.86 178.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.92 27.67 0.64 Allowed 'General case' 0 C--N 1.341 0.23 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.541 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.75 39.59 0.17 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.004 -179.072 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.2 tt 52.19 39.33 26.66 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.96 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.3 t70 54.57 -83.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.591 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' LEU . 23.9 m80 -52.57 -65.83 0.49 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.632 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.207 -179.936 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.912 0.386 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -133.57 -45.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.358 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.676 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.9 mt -77.26 -91.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.13 -7.53 3.87 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 175.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.676 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.2 -47.16 6.63 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 112.895 -1.653 . . . . 0.0 110.159 178.314 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.35 30.74 0.68 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 73.6 40.07 0.52 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.73 -178.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 58.94 51.9 6.9 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.143 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 65.72 -74.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.03 38.4 0.26 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.795 0.331 . . . . 0.0 110.521 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.412 -179.986 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.5 tttp . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.764 0.316 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.7 mp -119.86 -48.18 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.665 ' C ' ' H ' ' A' ' 14' ' ' GLY . 42.4 mm -91.45 -98.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.66 -179.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.0 -11.95 0.65 Allowed Glycine 0 C--N 1.346 1.11 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 176.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.665 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.89 -50.41 5.57 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 113.309 -1.445 . . . . 0.0 109.997 177.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -85.02 27.94 0.74 Allowed 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.08 44.68 0.13 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.771 -178.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.1 tp 66.75 11.3 8.14 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.19 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.9 t70 58.71 -77.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.5 t60 -77.87 13.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.722 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 9.8 mp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.064 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.0 tttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.784 0.326 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mt -139.12 -44.24 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.12 -179.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.655 ' C ' ' H ' ' A' ' 14' ' ' GLY . 7.7 mm -86.13 -93.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.19 -7.05 3.5 Favored Glycine 0 C--N 1.342 0.908 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 176.027 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.655 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.89 -47.97 6.0 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 113.006 -1.597 . . . . 0.0 110.031 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.74 29.77 0.69 Allowed 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.77 40.75 0.36 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.86 -178.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 58.36 20.91 7.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.695 -179.801 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.2 t0 56.95 -78.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.948 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.553 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 1.5 m-70 -46.83 -59.52 3.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.989 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.198 -179.919 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.2 tptt . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.86 0.362 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.62 -46.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.19 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.651 ' C ' ' H ' ' A' ' 14' ' ' GLY . 30.9 mt -78.3 -92.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.92 -8.72 2.34 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 175.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.651 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.54 -48.24 6.39 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 113.001 -1.599 . . . . 0.0 110.283 178.196 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.74 27.78 1.1 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.51 43.83 0.13 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.82 -178.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 65.62 17.53 10.93 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.447 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 58.53 -77.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.929 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 10.7 m-70 -52.97 -65.08 0.62 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.837 0.351 . . . . 0.0 110.604 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.175 -179.964 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.8 tttp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.723 0.297 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.5 mt -132.59 -50.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.325 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.685 ' C ' ' H ' ' A' ' 14' ' ' GLY . 33.5 mm -78.41 -94.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.413 ' H ' ' HB ' ' A' ' 12' ' ' ILE . . . -54.34 -9.33 1.48 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 176.204 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.685 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.09 -48.63 6.38 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 112.959 -1.62 . . . . 0.0 110.229 178.151 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.96 27.96 0.73 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.53 37.95 0.17 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.014 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.1 tp 57.18 11.64 1.11 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.246 179.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER 58.58 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.92 -179.986 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 17' ' ' LEU . 57.8 t-80 -50.62 -44.4 57.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.838 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.12 -179.858 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.6 tttm . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.672 0.272 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.0 mt -124.04 -54.21 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.364 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.675 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.4 mm -75.06 -98.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.021 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.97 -11.63 0.59 Allowed Glycine 0 C--N 1.347 1.178 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 176.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -77.82 -48.92 7.45 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.048 -1.576 . . . . 0.0 109.966 178.049 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -86.34 28.34 0.85 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.704 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.66 39.35 0.24 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.813 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 62.41 25.37 15.13 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.78 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.3 t70 58.01 -78.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' LEU . 16.2 m80 -51.04 -65.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.606 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.233 179.988 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.9 tttp . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.99 0.424 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.1 mt -111.44 -48.46 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.524 -179.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.665 ' C ' ' H ' ' A' ' 14' ' ' GLY . 40.7 mm -96.16 -101.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.093 -178.62 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.95 -12.08 0.43 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 177.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.665 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.47 -48.59 5.54 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 113.507 -1.347 . . . . 0.0 110.082 177.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -83.08 23.37 0.86 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.002 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 83.94 39.41 0.03 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.196 -179.336 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.4 tp 54.91 18.04 2.05 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.268 179.757 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 52.67 20.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.119 -179.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 m170 57.83 64.12 1.62 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.503 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.336 -179.952 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.716 0.293 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 mt -112.42 -51.08 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.327 -179.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.678 ' C ' ' H ' ' A' ' 14' ' ' GLY . 38.8 mm -89.73 -100.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.177 -179.036 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.63 -11.59 0.52 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 176.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.13 -49.65 5.85 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 113.294 -1.453 . . . . 0.0 109.946 177.737 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -85.26 28.2 0.74 Allowed 'General case' 0 C--N 1.345 0.41 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.747 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.18 41.77 0.15 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.047 -179.1 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 19' ' ' HIS . 4.1 tp 62.3 10.41 3.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.446 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.489 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 33.0 t70 57.63 5.05 0.29 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 55.7 m80 -157.49 -13.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 109.836 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.8 tp . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.313 179.874 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 tttp . . . . . 0 C--O 1.232 0.137 0 CA-C-O 121.054 0.454 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.7 mt -134.42 -35.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.375 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.675 ' C ' ' H ' ' A' ' 14' ' ' GLY . 82.0 mt -74.83 -88.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.07 -4.72 4.85 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 175.407 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.15 -43.62 7.44 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 113.28 -1.46 . . . . 0.0 110.14 178.483 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -88.36 27.86 1.18 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.884 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.26 37.9 0.34 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.614 -178.722 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 55.21 48.67 18.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.898 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 48.62 29.94 2.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.746 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.2 m80 53.18 59.43 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.583 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.069 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.6 tttp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.868 0.366 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.409 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -135.93 -46.38 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.268 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.684 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.4 mt -76.48 -92.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.409 ' H ' ' HB ' ' A' ' 12' ' ' ILE . . . -57.69 -8.04 3.76 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.932 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.684 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.07 -46.67 7.51 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 112.907 -1.646 . . . . 0.0 110.224 178.324 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.68 29.43 0.79 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.526 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.98 41.22 0.51 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.222 -178.448 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 63.15 51.94 2.63 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.05 -179.688 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 t0 59.8 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.579 -179.867 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.532 ' N ' ' HD1' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -167.46 53.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.492 179.884 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.132 179.965 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 tttp . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.793 0.33 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.1 mt -135.47 -47.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.9 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 14' ' ' GLY . 47.5 mm -76.7 -94.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.471 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.3 -9.49 1.53 Allowed Glycine 0 C--N 1.346 1.118 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 176.127 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.02 -47.79 6.89 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 113.175 -1.513 . . . . 0.0 110.203 178.253 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -87.93 28.75 1.0 Allowed 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.819 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.25 42.03 0.19 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.827 -178.954 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.2 tp 63.67 30.16 14.87 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.337 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.0 t0 56.36 -80.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.742 -179.989 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 74.5 m80 -49.29 -65.75 0.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.982 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.888 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 tptp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.913 0.387 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 21.5 mt -138.41 -45.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.69 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.8 mt -77.93 -92.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.68 -5.92 3.14 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 107.819 -2.113 . . . . 0.0 107.819 175.718 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.69 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.65 -47.57 5.9 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 112.893 -1.654 . . . . 0.0 110.172 178.261 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -88.34 29.21 0.99 Allowed 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.683 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 73.21 47.62 0.19 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.382 -178.652 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.1 mt 64.19 39.86 7.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.082 -179.391 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.1 t70 51.72 42.1 29.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.658 179.918 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.0 m170 50.62 36.76 14.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.643 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.17 -179.985 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.9 mttt . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.768 0.318 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.3 mt -129.95 -48.13 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.255 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.69 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.0 mt -76.25 -93.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.859 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.66 -8.79 2.15 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 176.286 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.69 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.22 -47.42 6.99 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 112.873 -1.663 . . . . 0.0 110.167 178.276 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.41 27.96 0.89 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.834 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.43 38.95 0.2 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.892 -178.893 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 57.29 45.38 20.35 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.854 179.92 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 50.46 31.51 5.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.73 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.5 t60 51.41 60.4 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.696 179.845 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.5 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.264 179.87 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.6 tttm . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.763 0.316 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.4 mt -131.45 -46.91 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.386 -179.556 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.669 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.1 mm -87.12 -95.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.865 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.84 -8.84 1.51 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 176.218 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.669 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.61 -49.34 5.48 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 113.063 -1.569 . . . . 0.0 110.087 178.082 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.94 26.57 1.13 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.754 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.65 47.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.736 -178.946 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.6 mt 62.61 11.37 4.73 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.484 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.6 t0 55.87 53.83 8.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.48 -179.592 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 55.32 55.93 6.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.674 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.2 mp . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.343 179.916 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.1 tttt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.939 0.4 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 7.1 mm -132.14 -46.27 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.018 -179.943 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.681 ' C ' ' H ' ' A' ' 14' ' ' GLY . 72.2 mt -77.16 -92.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.47 -7.63 3.13 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 176.04 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.02 -47.24 6.66 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 112.9 -1.65 . . . . 0.0 110.258 178.235 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.49 28.74 0.83 Allowed 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.663 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.68 40.4 0.3 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.691 -178.749 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 60.08 49.36 7.57 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.282 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 58.72 -77.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.843 -179.883 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' LEU . 13.0 t-80 -159.36 56.92 0.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.779 0.323 . . . . 0.0 110.39 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.495 179.951 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.3 tttm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.817 0.341 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.3 mt -132.92 -50.01 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.163 -179.832 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.685 ' C ' ' H ' ' A' ' 14' ' ' GLY . 60.9 mt -76.52 -95.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.827 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.69 -9.66 1.82 Allowed Glycine 0 C--N 1.346 1.1 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 176.419 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.685 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.81 -47.92 7.47 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 112.9 -1.65 . . . . 0.0 110.116 178.098 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.63 28.97 0.82 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.717 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.82 40.19 0.38 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.486 -178.661 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 63.93 49.77 2.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.757 -179.708 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.49 ' CG ' ' HD1' ' A' ' 19' ' ' HIS . 30.3 t0 59.23 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.74 -179.782 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 17' ' ' LEU . 13.9 p-80 -159.26 44.03 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.821 0.344 . . . . 0.0 110.362 179.922 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.509 -179.912 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.665 0.269 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 3.7 mp -120.85 -59.8 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.667 -179.816 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.676 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.0 mt -76.13 -98.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.265 -179.331 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.34 -11.44 0.71 Allowed Glycine 0 C--N 1.347 1.186 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 176.993 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.676 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.09 -48.73 7.41 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.875 -1.662 . . . . 0.0 110.003 178.006 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -86.55 29.9 0.75 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.604 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.85 39.82 0.4 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.728 -178.879 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.5 tt 63.64 47.86 3.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.783 -179.896 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 54.04 -84.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.657 -179.822 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' LEU . 15.1 t-160 -161.17 50.71 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.459 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.411 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.7 mp . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.154 -180.0 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.3 tttm . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.671 0.272 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.7 mt -120.66 -52.43 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.221 -178.847 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.672 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.4 mm -74.32 -97.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.229 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.77 -10.49 0.69 Allowed Glycine 0 C--N 1.346 1.104 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 176.711 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.672 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.8 -47.84 7.52 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 113.218 -1.491 . . . . 0.0 110.02 178.183 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -88.55 31.54 0.83 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.716 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.71 41.93 0.52 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.69 -178.75 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.2 tp 65.12 53.61 1.33 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.103 -179.721 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.0 t0 62.73 -75.49 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.844 -179.821 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.421 ' N ' ' O ' ' A' ' 17' ' ' LEU . 2.7 t60 -152.74 42.13 0.61 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.794 0.33 . . . . 0.0 110.369 -179.892 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.9 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.496 179.954 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 mttp . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.827 0.346 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -129.11 -46.04 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.647 -179.609 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.707 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.2 mt -74.89 -92.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.659 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.08 -6.69 3.11 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 176.029 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.707 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.65 -45.33 7.35 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 113.082 -1.559 . . . . 0.0 110.139 178.327 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.77 29.9 0.77 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.573 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.03 37.46 0.63 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.513 -178.578 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.4 tt 58.24 47.32 14.4 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.878 -179.933 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.486 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 71.0 m-20 54.03 -83.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 17' ' ' LEU . 96.3 m-70 -158.21 52.11 0.43 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.366 179.974 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.081 -179.924 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.7 tttm . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 120.649 0.261 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.7 mt -116.9 -46.59 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.789 0.328 . . . . 0.0 111.573 -179.119 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.668 ' C ' ' H ' ' A' ' 14' ' ' GLY . 63.1 mt -95.78 -97.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.069 -178.564 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.35 -8.29 1.66 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 176.854 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.9 -48.02 5.35 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 113.155 -1.522 . . . . 0.0 109.808 177.999 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.11 27.06 0.41 Allowed 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.604 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.576 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.17 36.45 0.23 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.758 -179.042 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 51.3 32.14 7.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.265 -179.824 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 51.15 10.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.134 179.837 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.498 ' H ' ' C ' ' A' ' 17' ' ' LEU . 20.9 t-160 -168.3 -41.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.611 179.929 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.8 pp . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.584 -179.97 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.9 tttt . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.6 mt -112.07 -46.16 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.277 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.696 ' C ' ' H ' ' A' ' 14' ' ' GLY . 60.5 mt -95.99 -98.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.135 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.95 -6.8 1.41 Allowed Glycine 0 C--N 1.341 0.854 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.393 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.696 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.92 -46.53 5.35 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 113.291 -1.455 . . . . 0.0 110.001 178.332 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.29 28.56 0.72 Allowed 'General case' 0 C--N 1.343 0.292 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.728 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.26 41.47 0.28 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.797 -178.927 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.2 OUTLIER 68.25 37.19 2.89 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.014 -0.675 . . . . 0.0 109.72 -179.762 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.495 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 33.6 t70 55.71 -82.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.716 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' LEU . 96.8 m-70 -158.5 57.61 0.45 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.475 179.98 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.476 -179.943 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.4 mttm . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.911 0.386 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.6 mt -138.95 -39.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.193 -179.567 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.672 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.5 mt -75.83 -89.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.56 -5.52 5.12 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 175.385 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.672 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.36 -45.16 7.09 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 113.105 -1.547 . . . . 0.0 110.161 178.345 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -87.94 29.86 0.89 Allowed 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.653 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.59 40.78 0.61 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.407 -178.502 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.3 tp 63.14 20.4 12.26 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.214 -179.736 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.8 t70 58.83 -77.5 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' LEU . 20.7 m80 -49.25 -61.02 2.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.304 . . . . 0.0 110.711 -179.938 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.029 179.966 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.814 0.34 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.3 mt -133.9 -52.07 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 109.979 -179.936 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.662 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.1 mm -76.51 -96.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.695 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.9 -11.08 0.85 Allowed Glycine 0 C--N 1.347 1.16 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 176.448 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.662 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.56 -48.87 6.99 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 113.053 -1.573 . . . . 0.0 110.28 178.056 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -86.44 27.18 0.97 Allowed 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.877 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.5 40.07 0.13 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.916 -179.086 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.3 tt 62.18 42.69 9.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.828 179.955 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.6 t0 50.9 34.96 11.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.552 -179.858 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.8 t60 53.96 62.06 2.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.483 179.922 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.294 179.974 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.2 mttp . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.9 mm -118.22 -43.36 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.89 0.376 . . . . 0.0 111.415 -179.146 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.692 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.1 mt -98.54 -98.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.873 -178.65 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.67 -8.3 1.26 Allowed Glycine 0 C--N 1.342 0.914 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 176.743 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.692 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.6 -48.2 4.82 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 113.231 -1.485 . . . . 0.0 109.845 177.995 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.23 26.59 1.02 Allowed 'General case' 0 C--N 1.342 0.239 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.865 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.97 48.65 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.754 -178.918 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.0 mt 61.14 14.52 5.55 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.462 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.2 t70 58.67 -77.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 -179.706 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 63.6 t60 -164.9 47.76 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.914 0.388 . . . . 0.0 110.485 179.903 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.116 180.0 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.856 0.36 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.7 mt -136.8 -45.52 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.149 -179.91 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.681 ' C ' ' H ' ' A' ' 14' ' ' GLY . 78.7 mt -84.07 -93.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.958 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.81 -8.34 2.88 Favored Glycine 0 C--N 1.343 0.955 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 175.959 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.8 -48.25 6.27 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 112.945 -1.628 . . . . 0.0 110.117 178.153 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.02 27.53 0.89 Allowed 'General case' 0 C--N 1.343 0.311 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.77 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.57 41.59 0.19 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.627 -178.871 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.6 tt 63.38 48.89 3.37 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.771 -179.786 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.8 t0 50.91 28.97 4.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.404 -179.825 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.8 t60 55.91 68.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.476 -179.796 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.4 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.244 -179.846 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.818 0.342 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.8 mt -130.35 -49.23 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.124 -179.826 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.678 ' C ' ' H ' ' A' ' 14' ' ' GLY . 28.2 mt -75.98 -95.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.886 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.12 -9.73 1.53 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 176.294 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.27 -47.81 7.25 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 113.019 -1.59 . . . . 0.0 110.074 178.036 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.8 29.36 1.03 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.823 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.14 41.71 0.28 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.615 -178.83 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.1 tt 69.33 39.38 1.67 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.893 -179.864 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.9 t0 48.56 49.29 18.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.654 -179.943 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 53.21 60.86 3.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 -179.891 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 7.9 mp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.03 -179.882 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.099 0.476 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.3 mt -131.44 -35.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.514 -179.485 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.692 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.7 mt -75.82 -87.6 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.908 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.08 -4.99 5.13 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 175.2 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.692 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.06 -44.48 7.07 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 113.209 -1.496 . . . . 0.0 110.193 178.471 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -87.51 27.72 1.07 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.953 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.492 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.05 37.34 0.28 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.707 -178.881 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.2 tt 55.97 43.04 27.92 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.052 179.921 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.0 t0 50.94 39.95 24.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.656 -179.994 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 51.53 45.63 27.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.551 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.352 -179.987 . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.9 tttm . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.669 0.271 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.3 mt -132.59 -49.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.86 0.362 . . . . 0.0 110.452 -179.754 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.674 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.1 mm -81.99 -96.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.92 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.43 -8.63 1.26 Allowed Glycine 0 C--N 1.344 0.987 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 176.393 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.674 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.8 -48.97 5.9 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.1 -1.55 . . . . 0.0 110.002 178.015 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.71 29.67 0.99 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.586 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.3 48.84 0.23 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.571 -178.671 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.0 mt 64.53 31.63 12.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.204 -179.493 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.7 t70 53.03 44.68 30.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.957 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 50.56 65.48 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.647 179.948 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.203 -179.859 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.9 tttp . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 120.714 0.292 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.0 mt -131.06 -44.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.868 0.366 . . . . 0.0 110.764 -179.351 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.655 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.0 mt -89.99 -94.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.575 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.77 -7.33 3.26 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 176.215 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.655 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.67 -47.55 5.9 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 113.011 -1.594 . . . . 0.0 109.984 178.154 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.11 29.32 0.57 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.661 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.17 38.33 0.33 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.867 -178.958 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.1 tt 51.73 38.38 22.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.069 -179.946 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.6 t0 52.43 -85.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 17' ' ' LEU . 73.7 m-70 -53.11 -65.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.67 -179.854 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.023 -179.915 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.4 tttm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.848 0.356 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 051 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 18.5 mt -125.27 -55.37 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.172 -179.916 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.677 ' C ' ' H ' ' A' ' 14' ' ' GLY . 34.6 mm -75.46 -98.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.928 -179.911 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.49 -10.99 0.68 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 176.794 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.56 -48.5 7.25 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 113.013 -1.593 . . . . 0.0 110.074 178.046 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -85.85 27.71 0.85 Allowed 'General case' 0 C--N 1.344 0.363 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.652 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.22 39.32 0.2 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.741 -178.923 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tt 58.01 48.8 12.66 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.6 179.945 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 53.97 22.84 3.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.205 -179.593 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.6 t60 56.01 63.14 2.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.635 -179.925 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.184 179.906 . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.7 mt -122.84 -45.63 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.75 0.31 . . . . 0.0 111.129 -179.642 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 14' ' ' GLY . 71.2 mt -95.03 -97.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.069 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.27 -8.48 1.67 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 176.462 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.55 -48.0 5.45 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 113.318 -1.441 . . . . 0.0 109.953 177.997 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.55 28.62 0.74 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.816 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.509 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.5 41.79 0.19 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.931 -179.011 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.0 tp 62.31 30.01 17.41 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.574 -179.996 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t0 55.23 -82.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 179.73 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 17' ' ' LEU . 61.0 m80 -47.75 -64.68 0.72 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.853 -179.812 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.453 -179.991 . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.9 tttm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.76 0.314 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.413 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 11.5 mt -124.97 -51.91 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.542 -179.647 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.668 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.5 mm -74.67 -97.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.898 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.03 -10.24 0.73 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 176.738 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.17 -48.08 7.12 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 113.095 -1.552 . . . . 0.0 110.029 178.061 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -86.2 28.48 0.82 Allowed 'General case' 0 C--N 1.343 0.325 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.67 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.99 38.18 0.25 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.964 -179.055 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.5 tt 55.52 46.39 23.11 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.888 179.801 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 55.69 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.731 -179.903 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.566 ' N ' ' HD1' ' A' ' 19' ' ' HIS . 1.5 p-80 -157.03 44.71 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.418 -179.972 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.155 -179.98 . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.4 tttt . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.621 0.248 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.59 -47.73 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.789 0.328 . . . . 0.0 111.649 -178.946 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.667 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.9 mt -94.86 -98.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.008 -178.681 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.57 -10.96 1.06 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 176.669 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.667 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.88 -49.8 5.2 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 113.199 -1.501 . . . . 0.0 109.936 177.771 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -84.28 25.87 0.82 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.941 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.53 44.51 0.07 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.856 -178.991 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.4 tp 62.78 31.5 16.47 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.305 -179.968 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.4 t0 56.84 -79.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' LEU . 35.6 m80 -54.92 -62.38 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.542 179.994 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.728 179.581 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 tttp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.822 0.344 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.1 mt -131.51 -44.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.068 -179.849 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.683 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.1 mt -75.34 -91.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' H ' ' HB ' ' A' ' 12' ' ' ILE . . . -58.5 -6.66 3.54 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 107.579 -2.208 . . . . 0.0 107.579 176.016 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.46 -45.72 7.25 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 112.98 -1.61 . . . . 0.0 110.035 178.315 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.5 29.96 0.74 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.618 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.11 37.53 0.61 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.5 -178.645 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.6 tt 56.79 46.26 20.23 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.797 -179.884 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 47.56 44.75 17.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.1 m80 54.73 45.77 26.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.597 -179.883 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.339 -179.993 . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.415 ' H ' ' H ' ' A' ' 11' ' ' ILE . 18.3 tptm . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.905 0.383 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.415 ' H ' ' H ' ' A' ' 10' ' ' LYS . 12.4 mt -124.43 -49.76 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.764 -179.819 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.663 ' C ' ' H ' ' A' ' 14' ' ' GLY . 25.9 mt -81.9 -95.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.945 -179.424 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.401 ' H ' ' HB ' ' A' ' 12' ' ' ILE . . . -53.89 -9.96 1.49 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 176.402 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.663 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.04 -49.38 6.01 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 112.994 -1.603 . . . . 0.0 110.247 177.985 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.78 28.24 0.91 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.799 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.69 43.93 0.12 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.841 -179.026 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 64.34 24.8 13.34 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.477 -179.997 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.3 t70 57.47 -78.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 50.0 m80 -49.79 -67.07 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.452 179.873 . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttm . . . . . 0 CA--C 1.522 -0.101 0 CA-C-O 120.604 0.24 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' ALA . 16.6 pt -81.2 4.96 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.647 179.994 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.712 ' C ' ' H ' ' A' ' 14' ' ' GLY . 38.9 mm -70.83 -88.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.301 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.32 -3.76 3.16 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 175.402 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.712 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.08 -38.33 8.61 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 113.77 -1.215 . . . . 0.0 110.137 178.604 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 11' ' ' ILE . . . -94.17 26.03 3.49 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.873 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 79.07 37.29 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.653 -178.886 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 3.7 tp 61.94 11.35 4.13 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.41 179.719 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 60.05 -77.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.469 -179.579 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -55.07 -70.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 110.559 179.797 . . . . . . . . 3 3 . 1 . 057 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.463 0.222 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.479 179.906 . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt . . . . . 0 CA--C 1.53 0.203 0 CA-C-O 120.919 0.39 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.81 -49.47 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.895 -179.05 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 14' ' ' GLY . 23.5 mt -95.54 -99.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.385 -178.24 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.27 -10.83 0.93 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 177.097 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.1 -49.24 5.38 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 113.155 -1.523 . . . . 0.0 109.756 177.877 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -84.48 29.52 0.59 Allowed 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.607 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.17 43.91 0.27 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.74 -178.898 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 61.17 34.47 18.88 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.953 -179.693 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 t70 57.89 -78.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.928 -179.799 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 86.8 m-70 -64.89 -64.29 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.705 -179.77 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.461 -179.786 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.2 tttp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.942 0.401 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -137.98 -43.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.776 -179.953 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.674 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.7 mt -77.37 -90.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.525 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.59 -7.27 4.18 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 175.772 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.674 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.26 -46.7 6.84 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 112.931 -1.635 . . . . 0.0 110.199 178.431 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.14 27.08 0.94 Allowed 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.797 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.61 39.05 0.19 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.683 -178.894 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 57.43 47.17 16.89 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.991 179.931 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 54.33 -83.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 179.966 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.7 t-80 -157.4 40.33 0.3 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.425 179.975 . . . . . . . . 0 0 . 1 . 060 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.5 tttp . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.705 0.288 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 060 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.5 mt -130.7 -46.57 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.624 -179.474 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.693 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.9 mt -84.53 -94.33 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.835 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.57 -7.26 2.02 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 176.074 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.693 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.22 -48.63 5.6 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 112.915 -1.642 . . . . 0.0 109.955 178.031 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.25 29.16 0.98 Allowed 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.588 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.46 49.15 0.21 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.586 -178.572 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 11.1 mt 63.52 6.08 2.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.157 -179.293 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 16' ' ' ALA . 38.3 t70 58.22 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 -179.977 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -158.76 54.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.306 179.941 . . . . . . . . 3 3 . 1 . 060 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.201 -179.857 . . . . . . . . 0 0 . 1 . 061 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.1 tttp . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.716 0.293 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 061 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.8 mt -133.13 -44.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.905 0.383 . . . . 0.0 110.701 -179.548 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.0 mt -90.35 -94.32 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.662 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.48 -8.58 2.75 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 176.306 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.79 -49.07 5.54 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 112.986 -1.607 . . . . 0.0 109.985 178.017 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.86 29.62 0.62 Allowed 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.728 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.95 40.97 0.25 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.113 -179.168 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.7 OUTLIER 56.53 13.9 1.5 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.69 -179.98 . . . . . . . . 3 3 . 1 . 061 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.9 t0 55.57 -82.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.792 -179.942 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 49.6 m80 -58.44 -20.18 42.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.57 -179.987 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 -179.908 . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.5 tptm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.85 0.357 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.5 mt -136.86 -46.25 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.934 0.397 . . . . 0.0 110.367 -179.735 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.692 ' C ' ' H ' ' A' ' 14' ' ' GLY . 71.4 mt -80.16 -93.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.945 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.12 -6.65 3.13 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 176.127 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.692 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.43 -46.54 6.85 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 112.963 -1.619 . . . . 0.0 109.886 178.219 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.43 30.29 0.63 Allowed 'General case' 0 C--N 1.345 0.396 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.506 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 73.46 38.0 0.67 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.441 -178.596 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.6 tt 54.36 52.27 12.79 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.771 -179.738 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER 56.1 -80.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.947 179.927 . . . . . . . . 3 3 . 1 . 062 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -160.95 48.68 0.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.362 -179.939 . . . . . . . . 3 3 . 1 . 062 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.038 -179.896 . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.7 tttp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.862 0.363 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.0 mt -135.72 -50.45 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.831 179.939 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.677 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.6 mm -76.53 -96.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.602 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.6 -10.37 0.93 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 176.387 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.05 -48.56 6.87 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 113.109 -1.545 . . . . 0.0 110.171 178.082 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -86.95 29.1 0.84 Allowed 'General case' 0 C--N 1.344 0.337 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.772 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.52 39.74 0.24 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.991 -178.993 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.2 tt 63.09 43.63 6.35 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.966 179.844 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.1 t0 49.0 32.29 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.559 -179.977 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 54.79 73.92 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.475 -179.865 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.0 tp . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.52 -179.979 . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.955 0.407 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.3 mt -133.15 -38.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.148 -179.789 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.68 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.6 mt -75.58 -89.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.825 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.96 -5.66 4.49 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 107.332 -2.307 . . . . 0.0 107.332 175.385 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.68 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.29 -44.73 7.34 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 113.167 -1.516 . . . . 0.0 110.038 178.379 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.69 28.35 1.16 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.889 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.55 38.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.596 -178.766 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 3.2 tp 63.22 48.99 3.45 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 53.8 -84.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.754 179.822 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 58.4 m80 -150.36 57.17 0.94 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.353 179.993 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.514 -179.966 . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 tttm . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.6 0.238 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.7 mt -120.69 -47.41 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 120.793 0.33 . . . . 0.0 111.26 -179.163 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.69 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.3 mt -91.28 -97.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.128 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.21 -8.93 1.26 Allowed Glycine 0 C--N 1.343 0.933 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 176.524 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.69 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.53 -48.96 5.37 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 113.147 -1.526 . . . . 0.0 109.935 177.984 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.38 28.91 0.91 Allowed 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.723 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 18' ' ' ASP . . . 73.87 48.78 0.13 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.556 -178.724 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.9 mt 65.1 -1.55 0.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.351 -179.427 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 16' ' ' ALA . 26.3 t70 53.9 -83.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.765 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 2.4 t60 -46.98 -37.79 9.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.95 -179.882 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.068 179.973 . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 12' ' ' ILE . 75.3 tttt . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.735 0.302 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 15' ' ' ALA . 19.4 pt -78.02 10.79 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.403 180.0 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.676 ' C ' ' H ' ' A' ' 14' ' ' GLY . 6.8 mm -74.52 -86.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.515 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.405 ' H ' ' HB ' ' A' ' 12' ' ' ILE . . . -62.49 -3.15 5.07 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 175.249 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.676 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.53 -40.77 7.15 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 113.663 -1.269 . . . . 0.0 110.314 178.637 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' ILE . . . -90.49 26.21 2.05 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.873 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 79.43 37.16 0.14 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.876 -178.945 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.1 tp 59.24 17.92 6.14 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.546 179.76 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 56.93 6.95 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.794 179.728 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.477 ' H ' ' C ' ' A' ' 17' ' ' LEU . 54.6 t-80 -170.34 -59.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.522 -179.961 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.204 -179.987 . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.7 tttt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.816 0.341 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.8 mt -139.68 -43.89 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.02 -179.855 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.685 ' C ' ' H ' ' A' ' 14' ' ' GLY . 23.7 mt -84.43 -93.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.771 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.89 -6.25 2.63 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 175.751 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.685 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.38 -47.36 5.75 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 113.066 -1.567 . . . . 0.0 110.158 178.265 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.32 29.03 1.14 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.726 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.63 47.82 0.12 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.721 -178.821 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.4 mt 63.71 17.81 10.7 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.247 0.342 . . . . 0.0 110.137 -179.596 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 59.56 -76.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.766 179.894 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.692 ' H ' ' HD1' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -154.68 52.56 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.82 0.343 . . . . 0.0 110.427 -179.991 . . . . . . . . 3 3 . 1 . 067 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.304 -179.967 . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.927 0.394 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.11 -43.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.332 -179.861 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.681 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.5 mt -88.0 -93.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.94 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.47 -6.66 3.51 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 175.941 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.73 -47.48 5.9 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 113.046 -1.577 . . . . 0.0 109.939 178.152 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.88 29.73 0.61 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.708 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.47 38.68 0.38 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.773 -178.941 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 56.39 33.89 23.21 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.969 -179.973 . . . . . . . . 3 3 . 1 . 068 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.7 t0 58.02 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.781 -179.962 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.574 ' H ' ' HD1' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -155.3 62.24 0.63 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.268 179.875 . . . . . . . . 3 3 . 1 . 068 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.373 -179.771 . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.6 mttm . . . . . 0 N--CA 1.468 0.425 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.8 mt -126.4 -45.2 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.832 0.348 . . . . 0.0 110.97 -179.357 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.677 ' C ' ' H ' ' A' ' 14' ' ' GLY . 66.1 mt -95.97 -96.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.248 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.38 -7.76 2.18 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 176.434 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.0 -48.75 5.04 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 113.053 -1.573 . . . . 0.0 109.557 177.922 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.2 29.15 0.67 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 177.526 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.06 48.03 0.28 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.451 -178.687 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.0 mt 62.54 22.52 13.34 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.366 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.9 t70 55.73 -82.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.625 -179.875 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 31.9 m-70 -53.66 -33.93 56.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.59 179.973 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.163 -179.985 . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.1 tptp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.773 0.321 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.0 mt -132.06 -48.63 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.343 -179.894 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.677 ' C ' ' H ' ' A' ' 14' ' ' GLY . 65.3 mt -78.24 -94.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -179.788 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.11 -8.24 2.25 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 176.241 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.44 -47.53 6.81 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 112.899 -1.651 . . . . 0.0 110.186 178.133 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.82 29.31 0.81 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.757 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.75 39.29 0.33 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.755 -178.928 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 12' ' ' ILE . 0.9 OUTLIER 62.14 27.97 16.83 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.881 179.971 . . . . . . . . 3 3 . 1 . 070 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 t70 50.05 -91.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 179.949 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' LEU . 71.9 m80 -50.19 -25.2 3.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.732 -179.761 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.222 179.994 . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 tttp . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.592 0.234 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.7 mt -123.91 -51.21 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.847 0.356 . . . . 0.0 110.867 -179.563 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.678 ' C ' ' H ' ' A' ' 14' ' ' GLY . 44.3 mm -83.79 -98.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.7 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.68 -10.89 0.73 Allowed Glycine 0 C--N 1.346 1.121 0 N-CA-C 108.544 -1.823 . . . . 0.0 108.544 176.654 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.57 -49.83 5.97 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 113.136 -1.532 . . . . 0.0 110.058 177.919 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -86.09 28.42 0.82 Allowed 'General case' 0 C--N 1.345 0.398 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.833 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.43 42.19 0.13 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.084 -179.16 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 60.87 44.49 10.72 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.633 179.796 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.9 t70 53.58 47.56 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 179.915 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 51.1 53.86 12.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.701 179.818 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 7.6 mp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.261 179.952 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.9 tttp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.775 0.321 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.3 mt -135.41 -44.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.559 -179.486 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.656 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.1 mt -90.34 -95.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.748 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.44 -8.34 1.76 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 175.976 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.656 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.64 -49.15 5.26 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 113.142 -1.529 . . . . 0.0 109.992 177.978 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.94 28.08 0.94 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.808 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.19 48.07 0.1 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.742 -178.877 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.6 mt 64.31 33.97 11.02 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.325 0.391 . . . . 0.0 110.259 -179.773 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 t0 57.0 -78.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.954 179.785 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 17' ' ' LEU . 16.1 p-80 -145.63 51.74 1.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.328 -179.871 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.195 179.986 . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.3 tptm . . . . . 0 CA--C 1.529 0.138 0 CA-C-O 120.959 0.409 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.409 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.3 mt -138.5 -36.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.539 -179.64 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.6 mt -75.03 -88.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.989 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.44 -4.73 5.44 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 175.173 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.07 -43.87 7.35 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 113.197 -1.502 . . . . 0.0 110.258 178.389 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -88.06 28.07 1.11 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.702 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.88 39.25 0.42 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.454 -178.626 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 19' ' ' HIS . 5.0 tp 60.19 41.26 17.07 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.333 -179.778 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.9 0.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.492 ' H ' ' C ' ' A' ' 17' ' ' LEU . 6.7 t60 -170.79 -65.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 110.65 179.946 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 16' ' ' ALA . 16.7 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.759 0.314 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 074 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 6.8 mm -131.52 -51.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.863 -179.981 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.668 ' C ' ' H ' ' A' ' 14' ' ' GLY . 42.6 mm -76.0 -97.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.841 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.01 -11.05 0.88 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 176.766 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.34 -48.93 7.09 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 113.029 -1.585 . . . . 0.0 110.128 178.024 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -85.19 28.8 0.69 Allowed 'General case' 0 C--N 1.343 0.323 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.597 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.93 38.47 0.25 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.899 -179.019 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tt 55.63 45.64 24.34 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.671 179.924 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 54.55 33.19 18.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.379 -179.703 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.0 m80 58.59 45.88 15.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.547 -179.987 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.137 179.912 . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.2 tttt . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.586 0.231 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.2 mp -132.46 -48.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 121.058 0.456 . . . . 0.0 110.341 179.569 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.661 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.1 mt -83.67 -94.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.667 -179.66 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.03 -8.59 2.38 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 176.1 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.661 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.52 -48.74 6.13 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 113.004 -1.598 . . . . 0.0 109.863 178.025 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.69 30.55 0.72 Allowed 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.553 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.21 44.15 0.46 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.527 -178.702 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.7 tp 65.27 21.67 12.04 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.279 -179.711 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.8 t70 56.14 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.998 179.853 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' LEU . 12.5 t-80 -49.32 -29.87 6.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.885 -179.687 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 tt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.15 179.985 . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.823 0.344 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.2 mt -137.44 -44.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.416 -179.483 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.686 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.0 mt -87.67 -94.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.849 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.79 -6.23 2.51 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 175.992 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.686 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.1 -47.71 5.69 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 113.182 -1.509 . . . . 0.0 109.755 177.987 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.76 27.37 1.15 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.484 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.9 48.19 0.19 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.408 -178.607 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 19' ' ' HIS . 9.6 mt 61.95 35.88 15.98 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.176 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 55.77 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.716 -179.669 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 17' ' ' LEU . 3.8 p-80 -162.27 46.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.472 -179.995 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.323 179.974 . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.908 0.385 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 14.9 mt -131.71 -50.47 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.898 179.912 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.658 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.1 mm -76.68 -96.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.705 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.39 -9.66 1.1 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 108.379 -1.889 . . . . 0.0 108.379 176.425 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.658 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.97 -47.87 6.86 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 113.005 -1.597 . . . . 0.0 110.252 178.249 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.27 27.92 0.88 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.865 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.43 38.6 0.16 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.988 -179.083 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 58.21 42.36 22.09 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.691 179.836 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 54.61 -83.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.576 -179.849 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -163.01 52.97 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.36 179.954 . . . . . . . . 3 3 . 1 . 077 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.187 -179.999 . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.926 0.393 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.7 mm -110.03 -46.83 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.83 -178.959 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.644 ' C ' ' H ' ' A' ' 14' ' ' GLY . 47.2 mm -98.36 -101.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.139 -178.695 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.47 -11.45 0.47 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 177.252 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.644 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.37 -48.09 5.47 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 177.824 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -82.97 27.13 0.56 Allowed 'General case' 0 C--N 1.342 0.265 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.642 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.35 39.99 0.14 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.968 -179.12 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 55.17 22.26 4.52 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.078 -179.983 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 53.56 -86.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.454 -179.742 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -50.21 -37.21 34.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.542 179.94 . . . . . . . . 3 3 . 1 . 078 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.165 179.921 . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.985 0.421 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 14.1 mt -138.35 -37.9 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.034 -179.565 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.683 ' C ' ' H ' ' A' ' 14' ' ' GLY . 86.3 mt -73.96 -88.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.788 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.97 -5.19 5.23 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 175.585 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.02 -43.28 7.66 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 113.091 -1.555 . . . . 0.0 110.189 178.504 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -88.1 28.4 1.07 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.845 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.49 37.06 0.45 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.509 -178.639 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.4 tt 54.2 49.59 18.31 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.838 -179.934 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 49.87 23.8 1.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.609 -179.989 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 54.08 57.59 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.468 -179.912 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.4 tp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.13 -179.838 . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.6 tttp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.867 0.365 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.3 mt -139.71 -46.99 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.039 179.937 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.672 ' C ' ' H ' ' A' ' 14' ' ' GLY . 37.5 mt -78.14 -92.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.789 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.01 -8.19 2.95 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 176.121 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.672 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.25 -47.67 6.83 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 112.93 -1.635 . . . . 0.0 110.13 178.131 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.96 28.68 0.78 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.642 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.51 39.45 0.35 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.715 -178.848 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.1 tt 60.25 39.14 19.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.945 179.979 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 38.5 t70 47.88 61.38 3.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.5 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 27.0 p80 41.16 51.28 3.41 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.261 -179.98 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 7.7 mp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.187 179.975 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.7 tttt . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.771 0.319 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.9 mm -133.69 -47.39 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.988 -179.924 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.685 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.8 mt -80.0 -93.39 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.862 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.6 -7.62 3.29 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 176.171 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.685 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.64 -47.38 6.79 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 112.799 -1.7 . . . . 0.0 110.008 178.165 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.67 29.35 0.61 Allowed 'General case' 0 C--N 1.343 0.319 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.467 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.5 38.46 0.5 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.444 -178.734 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.6 tt 54.76 50.86 14.85 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.632 -179.746 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t0 55.43 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.695 -179.796 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' LEU . 8.7 t60 -164.39 44.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.524 179.873 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.123 -179.97 . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.3 tttm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.715 0.293 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -125.96 -52.62 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.391 -179.672 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.697 ' C ' ' H ' ' A' ' 14' ' ' GLY . 39.8 mm -75.58 -97.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.921 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.23 -10.28 0.8 Allowed Glycine 0 C--N 1.346 1.133 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 176.648 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.697 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.28 -48.08 7.07 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.144 -1.528 . . . . 0.0 110.258 178.053 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -88.34 30.36 0.89 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.797 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.44 42.81 0.29 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.802 -178.852 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.6 tp 63.82 51.52 2.36 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.25 -179.827 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 t0 69.91 -70.55 0.14 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.591 -179.758 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -159.88 19.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.457 179.934 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.248 179.876 . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 tttm . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 120.714 0.292 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -114.4 -49.1 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.411 -179.207 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.662 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.6 mt -91.8 -99.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.687 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.58 -10.74 1.01 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 176.931 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.662 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.83 -49.14 5.81 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.126 -1.537 . . . . 0.0 109.764 177.881 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -85.73 29.49 0.7 Allowed 'General case' 0 C--N 1.344 0.342 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.597 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.16 43.48 0.29 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.647 -178.853 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.6 tp 65.7 -1.19 1.09 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.231 -179.725 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 16' ' ' ALA . 19.5 t70 51.35 -85.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.08 179.647 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 84.5 m-70 -49.02 -17.96 0.25 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.931 -179.708 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.341 -179.976 . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 72.3 tttt . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.885 0.374 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.0 mm -119.38 -43.73 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.569 -178.946 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 14' ' ' GLY . 58.4 mt -96.73 -97.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.645 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.18 -7.44 1.87 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 176.493 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.05 -46.77 5.51 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 113.306 -1.447 . . . . 0.0 109.845 178.124 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.93 29.06 0.47 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.62 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.548 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.91 38.38 0.35 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.779 -178.91 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.4 tp 53.2 41.31 32.14 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.234 -179.731 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 55.48 31.46 17.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.321 -179.76 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.3 m80 53.23 69.02 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.378 -179.877 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.18 -179.849 . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 tttm . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.596 0.236 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -122.39 -44.69 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.737 0.303 . . . . 0.0 111.301 -179.189 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.67 ' C ' ' H ' ' A' ' 14' ' ' GLY . 69.9 mt -95.0 -95.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.935 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.95 -7.72 2.57 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 176.367 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.67 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.11 -48.02 5.29 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 113.08 -1.56 . . . . 0.0 110.001 178.193 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.25 27.86 0.56 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.834 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.77 39.88 0.16 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.936 -179.005 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.2 tp 54.22 39.46 30.81 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.255 -179.939 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 57.14 -79.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.752 179.996 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' LEU . 38.6 t-80 -63.58 -60.94 2.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 0.0 110.583 -179.999 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.206 -179.969 . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -131.57 -38.86 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.434 -179.542 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.691 ' C ' ' H ' ' A' ' 14' ' ' GLY . 86.5 mt -76.36 -88.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.8 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.25 -4.06 4.45 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 175.343 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.691 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.69 -45.35 6.45 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 113.092 -1.554 . . . . 0.0 110.0 178.357 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.22 27.94 1.32 Allowed 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.755 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.458 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 73.28 45.73 0.26 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.437 -178.582 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.8 mt 63.91 28.7 14.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.297 -179.42 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 48.97 27.31 1.61 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.629 -179.905 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.0 m80 53.57 48.46 21.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.332 -179.782 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.279 -179.924 . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 tptm . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.684 0.278 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -135.99 -47.89 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.8 0.333 . . . . 0.0 110.58 -179.731 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.661 ' C ' ' H ' ' A' ' 14' ' ' GLY . 25.2 mt -84.09 -94.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.986 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.21 -9.42 2.08 Favored Glycine 0 C--N 1.345 1.033 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 176.201 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.661 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.98 -49.41 6.02 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 112.922 -1.639 . . . . 0.0 110.0 177.956 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.51 29.17 0.79 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.679 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.48 44.01 0.24 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.652 -178.917 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.5 tp 65.58 22.35 11.74 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.286 -179.908 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.2 t0 55.77 25.24 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.286 -179.817 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 53.58 70.25 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.438 -179.8 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.366 -179.902 . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.967 0.413 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.402 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.7 mt -139.92 -39.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.134 -179.532 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.689 ' C ' ' H ' ' A' ' 14' ' ' GLY . 70.0 mt -75.75 -88.83 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.948 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.44 -5.53 4.98 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 175.427 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.689 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.93 -44.65 7.04 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.147 -1.526 . . . . 0.0 110.342 178.498 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -87.37 27.04 1.13 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.849 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.05 37.77 0.2 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.818 -178.892 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 55.36 17.84 2.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.911 179.941 . . . . . . . . 3 3 . 1 . 088 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t0 56.24 -80.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.8 -179.962 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.4 t-80 -50.67 -61.46 2.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.848 0.356 . . . . 0.0 110.611 -179.922 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.1 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.463 179.944 . . . . . . . . 0 0 . 1 . 089 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 tptp . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.736 0.303 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 089 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.3 mt -123.08 -46.0 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.138 -179.272 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.683 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.8 mm -97.79 -99.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.034 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.57 -9.4 0.71 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 176.67 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.83 -48.23 5.01 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.441 -1.38 . . . . 0.0 110.065 177.953 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -86.63 25.76 1.2 Allowed 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.923 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 18' ' ' ASP . . . 78.21 48.6 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.864 -178.893 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.7 mt 62.6 1.86 0.84 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.268 -179.686 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 16' ' ' ALA . 27.9 t70 51.08 46.24 26.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.633 -179.938 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 11.1 t60 55.5 35.68 25.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.583 -179.976 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.067 -179.946 . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.6 tptt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.02 0.438 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.2 mt -142.79 -45.35 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.098 -179.947 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.678 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.9 mt -78.44 -90.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.923 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.73 -7.17 4.24 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 107.546 -2.222 . . . . 0.0 107.546 175.706 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.45 -47.13 6.54 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.859 -1.671 . . . . 0.0 110.229 178.443 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.07 28.2 0.83 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.75 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.25 40.36 0.25 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.641 -178.801 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.1 tp 58.54 36.75 25.38 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.218 -179.847 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 54.92 -83.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.703 -179.899 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 28.0 m80 -52.59 -63.7 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.717 -179.929 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.193 -179.874 . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt . . . . . 0 N--CA 1.461 0.1 0 CA-C-O 121.008 0.433 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.93 -41.7 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.22 -179.704 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.682 ' C ' ' H ' ' A' ' 14' ' ' GLY . 31.2 mt -75.63 -89.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.379 -179.794 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.21 -5.62 3.45 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 107.631 -2.188 . . . . 0.0 107.631 175.673 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.84 -45.87 6.54 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 113.03 -1.585 . . . . 0.0 110.097 178.342 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.79 28.63 1.3 Allowed 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.813 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 73.28 46.27 0.23 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.54 -178.668 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.8 mt 64.28 11.66 6.56 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.202 -179.494 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.1 t70 58.45 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 -179.823 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 33.6 t-80 -160.16 32.05 0.17 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.618 179.997 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 N--CA 1.468 0.445 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.264 179.806 . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.0 tttt . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 120.552 0.215 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.6 mt -116.68 -47.52 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.545 -179.085 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.665 ' C ' ' H ' ' A' ' 14' ' ' GLY . 70.4 mt -94.77 -98.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.728 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.3 -9.4 1.49 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 176.916 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.665 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.59 -48.65 5.48 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 113.105 -1.548 . . . . 0.0 109.857 177.859 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.93 29.88 0.61 Allowed 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.737 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.34 42.92 0.3 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.84 -178.85 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.5 tp 59.47 50.7 7.25 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.286 -179.809 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.7 t0 56.74 35.61 26.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.463 -179.874 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.2 m80 55.91 39.57 30.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.561 179.966 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.194 179.868 . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.9 mt -113.3 -48.92 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 120.759 0.314 . . . . 0.0 111.754 -179.094 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.659 ' C ' ' H ' ' A' ' 14' ' ' GLY . 59.8 mt -91.83 -99.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.473 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.82 -8.27 1.3 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 176.915 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.659 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.52 -47.91 5.81 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 113.113 -1.544 . . . . 0.0 109.617 177.931 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -82.55 30.03 0.43 Allowed 'General case' 0 C--N 1.343 0.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.479 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.55 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.54 36.68 0.6 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.673 -178.831 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.53 ' C ' ' H ' ' A' ' 19' ' ' HIS . 1.1 tt 54.44 38.49 29.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.972 -179.732 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.5 t70 59.19 1.19 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.09 179.933 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.53 ' H ' ' C ' ' A' ' 17' ' ' LEU . 47.5 t-80 -172.28 -72.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.879 0.371 . . . . 0.0 110.541 179.923 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.278 -179.913 . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 tptm . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 121.169 0.509 . . . . 0.0 109.789 . . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.3 mt -132.77 -39.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.501 -179.721 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.691 ' C ' ' H ' ' A' ' 14' ' ' GLY . 84.6 mt -75.49 -89.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.93 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.408 ' H ' ' HB ' ' A' ' 12' ' ' ILE . . . -60.23 -4.56 3.73 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 175.334 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.691 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.78 -45.38 6.79 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 113.128 -1.536 . . . . 0.0 109.855 178.16 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.44 29.46 1.28 Allowed 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.573 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 70.08 46.94 0.6 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.221 -178.422 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.5 mt 63.81 12.79 6.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.021 -179.219 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 t0 56.63 46.25 20.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.691 -179.94 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.8 m170 50.15 49.83 19.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.617 179.99 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.519 -179.922 . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.466 0.174 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.9 mt -122.73 -44.22 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 120.859 0.361 . . . . 0.0 111.205 -179.113 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.67 ' C ' ' H ' ' A' ' 14' ' ' GLY . 67.6 mt -97.79 -97.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 -178.655 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.69 -7.35 2.15 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 176.884 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.67 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.79 -47.12 5.46 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 113.317 -1.442 . . . . 0.0 109.593 177.915 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.93 30.55 0.44 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.556 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.541 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.1 38.43 0.56 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.935 -178.99 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 50.37 29.85 4.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.981 -179.833 . . . . . . . . 3 3 . 1 . 095 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.7 t70 55.1 -82.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.747 -179.903 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 19.4 t-80 -48.17 -66.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.696 -179.891 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.411 179.745 . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.869 0.366 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.4 mt -133.08 -50.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.167 -179.964 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.675 ' C ' ' H ' ' A' ' 14' ' ' GLY . 33.0 mm -76.62 -95.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.781 179.876 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.67 -9.53 1.21 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 176.313 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.77 -48.16 6.79 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 112.978 -1.611 . . . . 0.0 110.204 178.168 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -85.77 29.02 0.73 Allowed 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.753 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.77 38.73 0.25 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.882 -178.917 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 58.03 47.58 14.55 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.186 179.83 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.434 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 12.6 m-20 60.95 -76.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.74 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 17' ' ' LEU . 73.0 m80 -155.62 54.6 0.61 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.825 0.345 . . . . 0.0 110.465 -179.951 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 7.4 mp . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.221 179.973 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.1 tttp . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 . . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.4 mt -123.18 -45.66 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 120.802 0.334 . . . . 0.0 111.166 -179.189 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.69 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.8 mt -92.62 -97.19 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.101 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.17 -7.44 1.86 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 176.219 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.69 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.49 -47.46 5.68 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 113.225 -1.487 . . . . 0.0 109.942 177.993 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.69 28.94 0.46 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.51 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.567 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.78 38.54 0.46 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.41 -178.699 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.6 tp 57.02 47.79 16.87 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.173 -179.688 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.6 t70 52.22 29.72 6.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.464 -179.964 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 52.06 55.9 8.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.508 -179.986 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.359 -179.985 . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 tttm . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 120.478 0.18 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.9 mt -117.75 -47.71 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.761 0.315 . . . . 0.0 111.355 -179.098 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 14' ' ' GLY . 59.1 mt -95.48 -99.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.993 -178.547 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.88 -10.11 0.96 Allowed Glycine 0 C--N 1.345 1.034 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 177.128 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.79 -48.89 5.32 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 113.057 -1.571 . . . . 0.0 109.797 177.951 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -84.01 28.54 0.6 Allowed 'General case' 0 C--N 1.342 0.277 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.951 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.95 38.71 0.13 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.356 -179.343 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 51.82 31.25 7.97 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.174 179.77 . . . . . . . . 3 3 . 1 . 098 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.0 t0 56.64 -79.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.831 -179.954 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 17' ' ' LEU . 17.0 m-70 -49.34 -67.12 0.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.74 179.935 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.173 179.988 . . . . . . . . 0 0 . 1 . 099 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.3 mttm . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 120.956 0.408 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 099 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.7 mt -137.65 -40.4 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.19 -179.56 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.716 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.2 mt -76.06 -89.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.928 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.04 -4.87 3.77 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 175.529 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.716 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.13 -45.55 6.56 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 113.02 -1.59 . . . . 0.0 110.144 178.365 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -90.62 29.34 1.32 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.832 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.64 46.9 0.26 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.425 -178.56 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.3 mt 65.11 13.48 8.73 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.389 0.431 . . . . 0.0 110.121 -179.393 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 t70 57.28 -78.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.041 179.761 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 17' ' ' LEU . 97.2 m-70 -50.26 -57.44 7.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.773 -179.801 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.173 179.974 . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.1 tttp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.926 0.393 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.6 mt -139.44 -48.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.803 179.924 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.677 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.3 mm -77.58 -94.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.419 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.407 ' H ' ' HB ' ' A' ' 12' ' ' ILE . . . -54.93 -8.97 1.59 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 176.24 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.17 -48.02 6.68 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 112.992 -1.604 . . . . 0.0 110.181 178.164 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -85.28 28.66 0.71 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.737 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.11 38.04 0.25 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.905 -179.019 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.4 tt 54.86 46.49 24.36 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.842 179.892 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 54.1 -84.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -179.754 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -162.28 50.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.524 179.876 . . . . . . . . 3 3 . 1 . 100 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.489 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 7.5 mp . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.251 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 45.5 p90 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.732 0.301 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.66 -70.43 0.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.123 0.487 . . . . 0.0 110.395 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -149.18 -17.19 0.29 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.6 ttm-85 -166.94 12.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.323 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.8 mt 60.05 112.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.189 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.98 50.31 18.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.734 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -63.94 -80.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.762 0.315 . . . . 0.0 110.639 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.17 131.63 20.42 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.904 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.61 -92.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.539 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -173.21 -17.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.931 0.396 . . . . 0.0 110.136 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.6 mt -136.28 -43.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.659 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.706 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.2 mt -92.29 -94.69 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.95 -5.97 2.51 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 108.131 -1.987 . . . . 0.0 108.131 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.706 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.48 -48.26 5.09 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 113.099 -1.551 . . . . 0.0 109.708 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.44 25.91 1.15 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.12 48.01 0.1 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.681 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.3 mt 60.93 29.28 18.92 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.104 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 53.7 61.69 2.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.436 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 49.19 45.75 23.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.697 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 7.4 mp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.139 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.0 m0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.771 0.319 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 10.3 mp -52.8 -87.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.142 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -151.73 -14.93 0.19 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.428 ' H ' ' H ' ' A' ' 5' ' ' ILE . 42.3 ttt85 -165.08 2.02 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.247 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.428 ' H ' ' H ' ' A' ' 4' ' ' ARG . 12.6 mt 55.7 55.67 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.189 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.43 22.97 0.02 OUTLIER Glycine 0 C--N 1.331 0.293 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -52.96 -53.64 46.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.322 . . . . 0.0 110.439 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 49.41 -136.59 21.73 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.17 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.8 t -148.25 -56.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 110.345 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' ILE . 81.7 tttt -163.73 -76.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.532 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' ALA . 15.8 pt -71.4 7.2 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.504 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.708 ' C ' ' H ' ' A' ' 14' ' ' GLY . 45.3 mm -71.41 -88.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.41 -3.94 3.4 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 107.479 -2.248 . . . . 0.0 107.479 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.708 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.0 -39.08 8.18 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 113.702 -1.249 . . . . 0.0 110.124 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 11' ' ' ILE . . . -90.88 25.94 2.24 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.78 35.4 0.21 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.6 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 53.48 33.33 15.84 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.91 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.5 t0 56.54 -79.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' LEU . 46.5 m-70 -50.2 -63.68 1.04 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.657 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.069 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.455 ' CD1' ' N ' ' A' ' 1' ' ' TRP . 29.4 m95 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.791 0.329 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 38.4 mt -73.73 -78.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.676 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -144.0 -17.58 0.58 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -148.33 13.26 0.96 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.542 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 mt 61.51 66.11 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.356 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.28 93.32 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.109 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -57.67 -166.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.725 0.297 . . . . 0.0 110.322 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.09 -128.69 1.61 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.189 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.53 ' C ' ' H ' ' A' ' 11' ' ' ILE . 15.7 t -65.0 -10.77 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.5 0.191 . . . . 0.0 110.549 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.3 tttt 72.85 -18.82 0.34 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.936 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.53 ' H ' ' C ' ' A' ' 9' ' ' VAL . 13.1 mt -117.84 -45.57 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.398 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.666 ' C ' ' H ' ' A' ' 14' ' ' GLY . 68.2 mt -94.97 -97.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.13 -8.42 1.53 Allowed Glycine 0 C--N 1.344 1.01 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.666 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.2 -47.48 5.48 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 113.227 -1.486 . . . . 0.0 110.106 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.46 26.34 0.8 Allowed 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 80.3 39.84 0.08 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.105 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.4 tp 55.76 22.85 5.81 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.335 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 53.72 -85.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.707 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.9 m-70 -49.8 -39.47 38.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.554 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.192 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.436 ' O ' ' CD2' ' A' ' 1' ' ' TRP . 44.7 p-90 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.814 0.34 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.9 tp -61.92 -79.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.238 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -150.57 -17.45 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 6' ' ' GLY . 59.1 mtp85 -147.52 3.27 0.75 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.525 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.1 mt 61.78 -76.95 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.46 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -81.5 44.11 3.02 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -63.44 148.19 49.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 0.0 110.667 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.2 -166.39 39.66 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.213 -0.518 . . . . 0.0 111.916 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.5 t -141.68 -87.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -171.39 -26.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.77 0.319 . . . . 0.0 110.834 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.7 mt -137.07 -45.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.218 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.687 ' C ' ' H ' ' A' ' 14' ' ' GLY . 66.3 mt -82.83 -93.97 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.64 -8.27 2.69 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 107.882 -2.087 . . . . 0.0 107.882 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.687 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.52 -48.06 6.49 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 113.099 -1.551 . . . . 0.0 109.946 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.89 30.05 0.77 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 73.54 41.61 0.44 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.573 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.7 tt 66.39 53.57 0.98 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.82 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.9 t0 55.51 -81.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.909 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.644 ' H ' ' HD1' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -150.34 39.24 0.73 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.559 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.434 179.887 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.591 ' C ' ' H ' ' A' ' 3' ' ' ARG . 8.1 m95 . . . . . 0 C--O 1.231 0.085 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.442 ' O ' ' CB ' ' A' ' 3' ' ' ARG . 24.0 mt 62.33 -5.81 0.17 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.384 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.591 ' H ' ' C ' ' A' ' 1' ' ' TRP . 37.3 ttt180 84.37 -50.97 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.124 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -167.21 52.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.186 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mt 48.2 69.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.709 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.59 -55.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.076 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.9 tttt 54.62 75.79 0.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.808 0.337 . . . . 0.0 110.413 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.78 136.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.03 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.441 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 31.5 m -154.86 21.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.795 0.331 . . . . 0.0 110.226 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.421 ' N ' ' CD ' ' A' ' 10' ' ' LYS . 3.5 mptp? -79.61 -12.15 59.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.867 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.39 -36.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.125 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.681 ' C ' ' H ' ' A' ' 14' ' ' GLY . 87.1 mt -77.3 -87.76 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.41 -4.95 5.64 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 107.199 -2.36 . . . . 0.0 107.199 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.91 -45.84 6.53 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 113.102 -1.549 . . . . 0.0 110.092 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.78 30.54 0.82 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 71.78 42.73 0.61 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.484 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 61.28 53.52 3.49 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.31 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.28 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.671 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 1.1 t60 -159.43 52.86 0.37 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 0.0 110.355 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.2 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.109 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 34.7 p-90 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.82 0.343 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 7.9 mp -65.46 -78.53 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.134 0.493 . . . . 0.0 110.098 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -166.26 -20.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 7' ' ' LYS . 5.8 ptp180 -161.73 6.69 0.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.415 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.0 pt 34.41 35.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.733 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.93 46.32 67.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.146 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 4' ' ' ARG . 84.2 tttt -77.74 122.14 24.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 110.503 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.54 79.81 0.2 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.974 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.411 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 31.6 m -154.23 26.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.845 0.355 . . . . 0.0 110.381 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -78.57 -14.23 59.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.059 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.9 mt -140.32 -37.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.167 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.675 ' C ' ' H ' ' A' ' 14' ' ' GLY . 39.1 mm -75.57 -87.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.98 -5.24 5.31 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 107.217 -2.353 . . . . 0.0 107.217 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.51 -44.81 7.18 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 113.207 -1.496 . . . . 0.0 110.266 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.51 27.8 1.06 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.69 39.06 0.35 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.573 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 58.66 44.69 17.03 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.259 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 54.64 36.59 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.437 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 13.4 t-80 51.04 46.47 26.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.606 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.477 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 1' ' ' TRP . 6.0 m95 . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.714 0.292 . . . . 0.0 110.486 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 26.5 mt -66.41 -72.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.031 0.443 . . . . 0.0 110.4 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.46 ' H ' ' H ' ' A' ' 4' ' ' ARG . 32.4 ttp180 -157.81 -13.84 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.46 ' H ' ' H ' ' A' ' 3' ' ' ARG . 75.6 mtm180 -148.39 6.01 0.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.898 -1.047 . . . . 0.0 109.356 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 mt 59.75 53.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.414 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 42.71 48.15 6.03 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.495 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -77.38 119.45 21.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.581 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.4 143.84 37.73 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.889 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.426 ' CG2' ' H ' ' A' ' 10' ' ' LYS . 1.5 m -65.86 -103.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.426 ' H ' ' CG2' ' A' ' 9' ' ' VAL . 81.9 tttt -151.48 -22.06 0.2 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.703 0.287 . . . . 0.0 110.558 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.4 mt -119.77 -54.89 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.191 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.683 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.7 mt -77.67 -95.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.691 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.34 -8.19 1.61 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.32 -48.2 6.09 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 112.835 -1.682 . . . . 0.0 110.102 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.98 28.66 1.01 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 73.67 46.98 0.18 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.63 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.7 mt 62.91 41.54 8.5 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 53.07 31.16 10.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.297 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 51.38 62.84 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.479 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.394 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 13.7 m95 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.772 0.32 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.4 tt -164.16 -71.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.967 0.413 . . . . 0.0 110.338 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.415 ' H ' ' H ' ' A' ' 4' ' ' ARG . 39.2 ttt85 -173.41 -18.3 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 6' ' ' GLY . 59.1 mtt-85 -146.17 -5.3 0.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.218 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.424 ' H ' ' H ' ' A' ' 4' ' ' ARG . 15.3 mt 60.74 -76.84 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.84 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -54.86 -32.4 55.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.09 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.5 tttp 55.78 80.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.879 0.371 . . . . 0.0 110.55 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.95 -154.77 51.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.988 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.0 t -148.49 -81.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.618 0.247 . . . . 0.0 110.401 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.4 -18.22 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.028 0.442 . . . . 0.0 109.845 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -118.85 -52.58 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.664 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.695 ' C ' ' H ' ' A' ' 14' ' ' GLY . 42.3 mm -73.84 -98.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.205 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.38 -10.71 0.6 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.695 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.24 -47.65 7.37 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 113.243 -1.479 . . . . 0.0 110.126 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -87.2 27.2 1.08 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.02 39.64 0.16 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.751 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 64.89 17.43 11.03 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.826 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.5 t70 55.35 -82.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.683 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 1.4 t-80 -54.39 -69.78 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.48 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 N--CA 1.464 0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.453 179.881 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.409 ' C ' ' H ' ' A' ' 3' ' ' ARG . 28.7 m-90 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.8 0.333 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.4 mt -63.86 -6.56 6.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.193 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 1' ' ' TRP . 23.7 mtp180 69.2 -65.8 0.28 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.167 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.17 -9.91 59.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.778 0.323 . . . . 0.0 110.625 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.6 mt 57.78 55.58 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.592 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.34 -28.3 0.38 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.168 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt 58.11 101.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.747 0.308 . . . . 0.0 110.278 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -51.13 126.26 26.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.015 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' CG2' ' H ' ' A' ' 10' ' ' LYS . 1.3 m -72.77 -102.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' H ' ' CG2' ' A' ' 9' ' ' VAL . 49.5 tttm -155.7 -22.19 0.11 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.834 0.35 . . . . 0.0 110.513 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.5 mt -117.5 -52.15 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.675 ' C ' ' H ' ' A' ' 14' ' ' GLY . 34.9 mm -85.76 -99.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.04 -11.15 0.54 Allowed Glycine 0 C--N 1.348 1.201 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.89 -49.88 5.83 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 113.12 -1.54 . . . . 0.0 109.875 177.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -84.86 29.33 0.63 Allowed 'General case' 0 C--N 1.345 0.395 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.82 37.79 0.15 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.478 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 52.49 36.76 21.13 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.213 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 53.51 -84.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.83 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 51.9 m80 -45.61 -63.39 0.97 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.083 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.495 ' O ' ' N ' ' A' ' 3' ' ' ARG . 96.2 m95 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.827 0.346 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 3.4 mm? 50.38 -88.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.337 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 1' ' ' TRP . 12.0 tpp180 -171.14 -11.59 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.435 ' H ' ' H ' ' A' ' 5' ' ' ILE . 13.2 ptm180 -166.27 -5.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.14 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.435 ' H ' ' H ' ' A' ' 4' ' ' ARG . 12.8 mt -108.62 63.18 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.864 0.364 . . . . 0.0 110.444 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.83 2.98 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -163.85 -29.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.332 . . . . 0.0 110.397 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.02 56.26 3.94 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.506 ' C ' ' H ' ' A' ' 11' ' ' ILE . 21.3 t -65.54 -21.62 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.596 0.236 . . . . 0.0 110.596 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.4 tttm 72.53 -19.06 0.31 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.359 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.506 ' H ' ' C ' ' A' ' 9' ' ' VAL . 13.0 mt -113.81 -48.21 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.83 0.348 . . . . 0.0 111.481 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.639 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.4 mm -96.56 -101.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.046 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.11 -12.09 0.47 Allowed Glycine 0 C--N 1.345 1.077 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.639 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.19 -48.51 5.66 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 113.504 -1.348 . . . . 0.0 110.055 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -84.15 22.39 1.21 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.509 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 83.22 41.96 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.951 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.8 tp 61.71 6.45 1.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.252 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 16' ' ' ALA . 33.0 t70 53.16 38.11 26.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.61 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 29.4 m170 50.03 55.42 9.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.631 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.227 -179.924 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 43.6 p-90 . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.847 0.356 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.497 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 7.6 mp -72.53 -77.46 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.124 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -146.37 -13.31 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -158.4 7.27 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.915 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.2 mt 56.58 51.71 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 45.32 45.89 11.04 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.114 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt 53.99 91.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 0.0 110.344 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 10' ' ' LYS . . . -61.01 -142.65 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.264 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 14' ' ' GLY . 33.6 t 58.11 -79.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.611 0.243 . . . . 0.0 110.683 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 8' ' ' GLY . 31.6 ttmt -44.89 -18.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.208 0.528 . . . . 0.0 110.627 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' VAL . 11.9 mt -112.54 -44.85 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.74 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.69 ' C ' ' H ' ' A' ' 14' ' ' GLY . 82.6 mt -73.65 -91.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.154 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.64 -8.61 2.05 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 176.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.69 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.23 -46.14 7.14 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 113.219 -1.491 . . . . 0.0 110.213 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -85.47 31.0 0.59 Allowed 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 73.16 37.68 0.74 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.684 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.7 tt 57.23 50.19 12.12 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.726 -0.789 . . . . 0.0 109.684 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 55.17 -82.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.665 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.573 ' N ' ' HD1' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -163.62 51.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.502 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.578 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.837 0.351 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.6 mt -72.21 -8.39 54.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.151 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 73.45 -63.74 0.42 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.643 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.44 ' N ' ' CD ' ' A' ' 4' ' ' ARG . 11.6 mpt_? -54.58 -26.42 32.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.0 tt -53.97 -36.6 31.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.119 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -75.28 -21.79 77.18 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 6' ' ' GLY . 54.9 tttm 60.9 134.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.867 0.365 . . . . 0.0 110.631 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.04 92.8 0.28 Allowed Glycine 0 C--N 1.33 0.225 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.059 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.42 -92.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -172.49 -23.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.853 0.358 . . . . 0.0 110.453 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -127.98 -44.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.772 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.68 ' C ' ' H ' ' A' ' 14' ' ' GLY . 69.0 mt -89.94 -95.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.0 -7.6 2.52 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.68 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.87 -47.0 6.04 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 113.182 -1.509 . . . . 0.0 110.032 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.31 30.27 0.54 Allowed 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.24 37.79 0.44 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.805 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 52.83 46.79 26.05 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.899 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 49.74 47.58 22.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.704 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 50.2 44.54 26.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.588 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 8.4 mp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.089 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.574 ' C ' ' H ' ' A' ' 3' ' ' ARG . 7.6 m-90 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.672 0.272 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.446 ' O ' ' CB ' ' A' ' 3' ' ' ARG . 13.9 mt 63.31 -6.6 0.19 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.391 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 1' ' ' TRP . 38.0 ttm-85 85.89 -73.46 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.491 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -89.91 6.5 41.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.762 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.2 mt 55.55 68.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.546 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 166.74 -16.9 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.179 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -76.82 84.91 3.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.985 0.421 . . . . 0.0 110.526 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.64 -145.48 4.21 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.902 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.2 t -73.21 -86.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.616 0.246 . . . . 0.0 110.446 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -172.06 -22.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.78 0.324 . . . . 0.0 110.244 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -134.31 -51.2 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.292 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.679 ' C ' ' H ' ' A' ' 14' ' ' GLY . 73.6 mt -77.05 -94.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 12' ' ' ILE . . . -56.27 -8.38 2.47 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 176.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.95 -47.43 7.12 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 112.853 -1.673 . . . . 0.0 110.047 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -85.72 30.5 0.64 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.15 37.94 0.58 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.634 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 19' ' ' HIS . 1.1 tt 57.22 38.49 28.82 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.848 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.4 t70 60.5 0.48 0.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.081 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.526 ' H ' ' C ' ' A' ' 17' ' ' LEU . 19.4 t-160 -173.43 -72.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.267 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.42 -179.846 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 2.5 m0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.776 0.322 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.1 tp -57.44 -81.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 110.253 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.47 ' NH2' ' NH2' ' A' ' 4' ' ' ARG . 32.7 ttt-85 -164.01 -16.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.47 ' NH2' ' NH2' ' A' ' 3' ' ' ARG . 65.3 mtt85 -151.29 -4.79 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.122 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mt 50.74 36.82 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.372 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.01 34.01 0.02 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.027 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -58.79 127.37 31.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.797 0.332 . . . . 0.0 110.442 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.95 152.44 17.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.148 -0.548 . . . . 0.0 111.926 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.412 ' CG2' ' H ' ' A' ' 10' ' ' LYS . 1.6 m -64.71 -103.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.428 ' H ' ' H ' ' A' ' 11' ' ' ILE . 44.5 tptt -160.71 -17.4 0.05 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.868 0.366 . . . . 0.0 110.12 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.428 ' H ' ' H ' ' A' ' 10' ' ' LYS . 11.9 mt -118.64 -48.66 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.65 ' C ' ' H ' ' A' ' 14' ' ' GLY . 44.0 mm -91.86 -99.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.69 -10.67 0.7 Allowed Glycine 0 C--N 1.347 1.139 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 176.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.65 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.43 -49.03 5.66 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 113.223 -1.488 . . . . 0.0 109.886 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -83.79 27.4 0.64 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 79.68 38.2 0.11 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.229 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.99 31.39 10.92 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.094 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 49.76 53.82 12.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 52.32 57.88 5.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.646 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.225 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 121.058 0.456 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.54 ' C ' ' H ' ' A' ' 5' ' ' ILE . 32.9 mt -134.77 -3.42 2.58 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.074 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -44.54 -21.1 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.534 0.683 . . . . 0.0 109.197 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.491 ' N ' ' C ' ' A' ' 2' ' ' LEU . 28.5 mmt180 -121.08 -13.11 8.61 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.49 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.54 ' H ' ' C ' ' A' ' 2' ' ' LEU . 10.0 mt 60.15 56.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.206 0 CA-C-O 121.079 0.466 . . . . 0.0 110.477 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 55.31 6.3 0.93 Allowed Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.863 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 5' ' ' ILE . 10.9 ttmm -72.36 -26.72 62.02 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.281 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.9 152.77 5.83 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.256 -0.497 . . . . 0.0 111.975 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.61 -80.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.69 0.281 . . . . 0.0 110.604 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -170.79 -23.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.764 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.5 mt -134.07 -47.28 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.223 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.663 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.1 mt -79.22 -92.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.99 -8.89 2.5 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 176.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.663 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.28 -48.5 6.37 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 112.923 -1.638 . . . . 0.0 110.27 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.68 28.65 0.86 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.74 41.25 0.18 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.876 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.6 tp 61.19 26.43 16.31 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.299 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 t0 58.31 -77.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.949 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.582 ' N ' ' HD1' ' A' ' 19' ' ' HIS . 1.0 OUTLIER -48.58 -62.46 1.49 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.756 0.313 . . . . 0.0 110.824 -179.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.514 -180.0 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.1 m0 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.753 0.311 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 18.9 tp -53.52 -81.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.163 0.506 . . . . 0.0 110.243 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -151.5 -10.37 0.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -175.47 7.53 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.278 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.1 tt -56.09 -41.78 70.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.253 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.39 13.35 22.12 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -172.96 47.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.749 0.309 . . . . 0.0 110.621 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . -72.03 147.33 41.12 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.787 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.403 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 28.9 m -76.55 32.54 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.714 0.293 . . . . 0.0 110.852 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 8' ' ' GLY . 28.1 mmtm -83.39 -11.65 57.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.12 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -139.9 -40.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.432 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.698 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.2 mt -76.46 -88.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.08 -5.78 4.79 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 107.271 -2.332 . . . . 0.0 107.271 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.698 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.34 -45.76 6.82 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 113.106 -1.547 . . . . 0.0 110.198 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.64 27.72 0.94 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.91 37.8 0.27 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.802 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.3 tp 58.66 27.15 15.44 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 55.33 -82.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 56.7 t-80 -49.45 -60.72 2.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.739 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.137 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 60.6 m95 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.8 mt -72.38 -5.76 38.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.515 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 5' ' ' ILE . 21.0 mmm180 64.92 -76.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.693 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.2 mmm-85 -75.68 14.35 0.65 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.836 0.351 . . . . 0.0 110.549 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 3' ' ' ARG . 12.1 mt 51.59 74.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.165 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 82.16 78.79 1.0 Allowed Glycine 0 C--N 1.331 0.303 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 6' ' ' GLY . 24.5 mtmm -60.31 -138.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.718 0.294 . . . . 0.0 110.694 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.93 -168.79 54.34 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.895 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 t -77.26 -66.77 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.878 0.37 . . . . 0.0 110.552 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -170.94 -58.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.505 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 15' ' ' ALA . 16.2 pt -78.3 6.54 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.681 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.693 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.9 mm -70.66 -89.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.22 -4.17 3.39 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 107.488 -2.245 . . . . 0.0 107.488 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.693 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.01 -38.99 8.81 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' ILE . . . -93.91 27.5 2.74 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 75.54 38.52 0.38 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.552 -178.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.4 tt 66.14 44.27 2.65 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.731 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 59.8 t0 55.29 35.35 24.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.493 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.3 m80 52.57 57.61 6.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.532 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 tt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.1 p90 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.77 0.319 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 4' ' ' ARG . 12.2 mt -73.6 -7.92 53.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.44 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 74.73 -38.1 0.37 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.418 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.482 ' H ' ' C ' ' A' ' 2' ' ' LEU . 70.3 mtp180 -73.76 -38.46 64.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.01 0.433 . . . . 0.0 110.022 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.8 tt -76.58 -35.53 26.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.222 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.19 -24.87 69.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.191 -0.528 . . . . 0.0 111.908 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -52.41 -27.59 16.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.383 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.25 130.19 0.2 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.019 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.8 t -69.29 -84.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.672 0.272 . . . . 0.0 110.448 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -171.18 -23.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.623 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.3 mt -131.07 -46.99 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.366 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.694 ' C ' ' H ' ' A' ' 14' ' ' GLY . 28.3 mt -81.99 -94.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.12 -7.38 1.79 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.694 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.24 -48.16 5.8 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.013 -1.593 . . . . 0.0 110.133 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.69 29.94 1.1 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.26 48.09 0.13 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.785 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.4 mt 64.08 49.83 2.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.8 t0 59.63 -76.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.746 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -162.45 26.95 0.11 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.729 0.299 . . . . 0.0 110.482 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.08 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.75 0.31 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.8 mt -66.23 -7.3 17.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.17 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 25.2 ttt85 69.56 -70.05 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.763 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 -67.45 -12.58 60.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.378 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.8 pt 34.24 49.42 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.63 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 8' ' ' GLY . . . -160.39 -30.21 0.02 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.27 -0.491 . . . . 0.0 111.971 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -76.62 39.99 0.22 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.807 0.337 . . . . 0.0 110.641 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 6' ' ' GLY . . . -167.68 118.31 0.78 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.0 t -70.03 -93.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.486 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -171.72 -23.65 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -129.3 -44.43 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.095 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.691 ' C ' ' H ' ' A' ' 14' ' ' GLY . 73.7 mt -90.75 -94.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.22 -6.98 3.47 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.691 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.45 -47.57 5.65 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 113.062 -1.569 . . . . 0.0 110.121 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.87 27.21 0.77 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.22 40.4 0.13 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.863 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.5 tp 56.56 23.2 7.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.248 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 57.48 11.62 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.184 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -171.3 -44.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.764 0.316 . . . . 0.0 110.648 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.126 -179.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 38.1 p90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.682 0.277 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 18.7 mt -68.59 -73.66 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.456 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -144.45 -14.39 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -172.7 19.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.172 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mt 61.19 95.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.218 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.58 54.65 7.33 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.124 -0.56 . . . . 0.0 111.887 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -49.06 -23.02 1.03 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 110.557 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.34 -156.73 23.83 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.193 -0.527 . . . . 0.0 111.917 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.9 t -145.98 -85.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -171.43 -23.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.853 0.359 . . . . 0.0 110.588 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.4 mt -139.6 -42.9 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.356 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.685 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.7 mt -86.84 -91.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.33 -6.62 4.55 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.685 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.4 -47.63 5.97 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 112.909 -1.645 . . . . 0.0 109.892 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.84 25.88 0.89 Allowed 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.78 43.15 0.18 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.576 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 69.51 51.69 0.47 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.377 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.6 t70 60.61 -76.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.591 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' HD1' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -160.77 50.85 0.27 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 0.0 110.397 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.143 -179.932 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 1.1 m0 . . . . . 0 N--CA 1.46 0.064 0 CA-C-O 121.015 0.436 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.53 ' C ' ' H ' ' A' ' 5' ' ' ILE . 37.5 mt -134.97 -3.07 2.53 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.045 178.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.9 ttt-85 -46.53 -17.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.52 ' H ' ' C ' ' A' ' 2' ' ' LEU . 70.8 mtp85 -131.22 -4.66 3.86 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.77 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.53 ' H ' ' C ' ' A' ' 2' ' ' LEU . 14.2 mt 59.89 89.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.224 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.386 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 173.61 -37.35 0.13 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 6' ' ' GLY . 81.0 tttt 58.83 152.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 110.712 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 70.62 170.3 9.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.076 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 11' ' ' ILE . 2.2 t -74.82 10.32 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.867 0.365 . . . . 0.0 110.179 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 8' ' ' GLY . 43.9 mttp 66.07 -13.53 0.16 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.513 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.572 ' H ' ' C ' ' A' ' 9' ' ' VAL . 11.4 mt -129.29 -43.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.775 0.321 . . . . 0.0 110.88 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.666 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.3 mt -94.69 -94.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.09 -7.19 3.52 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 176.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.666 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.07 -47.44 5.53 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 113.131 -1.534 . . . . 0.0 109.86 178.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.92 27.67 0.64 Allowed 'General case' 0 C--N 1.341 0.23 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.541 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.75 39.59 0.17 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.004 -179.072 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.2 tt 52.19 39.33 26.66 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.96 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.3 t70 54.57 -83.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.591 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' LEU . 23.9 m80 -52.57 -65.83 0.49 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.632 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.207 -179.936 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 12.6 m-90 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.837 0.351 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.2 tp -168.63 -83.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.082 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -152.4 -26.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' ILE . 32.7 mmt180 -132.44 -0.48 3.6 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.282 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 4' ' ' ARG . 13.1 mt 60.73 124.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.413 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.72 31.5 60.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.973 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.1 mttt 54.9 175.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.0 110.531 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.16 110.11 0.23 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.935 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.5 t -78.97 -83.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.617 0.246 . . . . 0.0 110.732 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -170.42 -26.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.912 0.386 . . . . 0.0 110.591 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -133.57 -45.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.358 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.676 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.9 mt -77.26 -91.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.13 -7.53 3.87 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 175.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.676 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.2 -47.16 6.63 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 112.895 -1.653 . . . . 0.0 110.159 178.314 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.35 30.74 0.68 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 73.6 40.07 0.52 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.73 -178.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 58.94 51.9 6.9 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.143 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 65.72 -74.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.03 38.4 0.26 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.795 0.331 . . . . 0.0 110.521 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.412 -179.986 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.87 0.367 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 2.0 mm? -73.86 -90.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.996 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -135.46 -11.67 2.12 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.867 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -148.05 9.29 0.87 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.076 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.0 mt 60.16 103.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.452 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 53.54 43.22 67.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.105 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 6' ' ' GLY . 21.7 pttp 37.57 -160.78 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.599 0.238 . . . . 0.0 111.566 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.3 152.45 51.29 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.076 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.4 t -74.78 -87.25 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -171.03 -23.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.764 0.316 . . . . 0.0 110.784 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.7 mp -119.86 -48.18 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.665 ' C ' ' H ' ' A' ' 14' ' ' GLY . 42.4 mm -91.45 -98.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.66 -179.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.0 -11.95 0.65 Allowed Glycine 0 C--N 1.346 1.11 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 176.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.665 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.89 -50.41 5.57 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 113.309 -1.445 . . . . 0.0 109.997 177.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -85.02 27.94 0.74 Allowed 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.08 44.68 0.13 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.771 -178.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.1 tp 66.75 11.3 8.14 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.19 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.9 t70 58.71 -77.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.5 t60 -77.87 13.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.722 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 9.8 mp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.064 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.552 ' C ' ' H ' ' A' ' 3' ' ' ARG . 8.5 m-90 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.661 0.267 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.559 ' C ' ' H ' ' A' ' 4' ' ' ARG . 14.3 mt 64.4 -8.38 0.2 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.425 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.552 ' H ' ' C ' ' A' ' 1' ' ' TRP . 49.0 mtp180 63.52 -13.85 0.08 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 2' ' ' LEU . 47.8 ttm-85 -157.38 31.37 0.28 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.978 0.418 . . . . 0.0 110.343 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.2 mm 44.16 69.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.452 ' H ' ' CB ' ' A' ' 2' ' ' LEU . . . 60.74 77.59 0.18 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.911 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -51.27 141.3 15.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 110.57 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.56 169.91 35.73 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.254 -0.498 . . . . 0.0 111.868 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.62 -85.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.701 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -171.63 -25.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.784 0.326 . . . . 0.0 110.615 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mt -139.12 -44.24 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.12 -179.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.655 ' C ' ' H ' ' A' ' 14' ' ' GLY . 7.7 mm -86.13 -93.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.19 -7.05 3.5 Favored Glycine 0 C--N 1.342 0.908 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 176.027 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.655 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.89 -47.97 6.0 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 113.006 -1.597 . . . . 0.0 110.031 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.74 29.77 0.69 Allowed 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.77 40.75 0.36 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.86 -178.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 58.36 20.91 7.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.695 -179.801 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.2 t0 56.95 -78.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.948 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.553 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 1.5 m-70 -46.83 -59.52 3.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.989 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.198 -179.919 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.489 ' C ' ' H ' ' A' ' 3' ' ' ARG . 4.2 m-90 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.68 0.276 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.491 ' CD2' ' H ' ' A' ' 7' ' ' LYS . 5.4 tp -52.17 -12.35 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.283 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.489 ' H ' ' C ' ' A' ' 1' ' ' TRP . 21.4 ttm180 75.78 -42.98 0.47 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.68 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 2' ' ' LEU . 71.0 mtt85 -86.8 -3.56 59.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.81 0.338 . . . . 0.0 110.449 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mt 53.05 67.84 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.364 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.68 72.93 1.02 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.125 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' H ' ' CD2' ' A' ' 2' ' ' LEU . 51.1 tttm -51.72 -81.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.755 0.312 . . . . 0.0 110.531 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.04 146.7 40.11 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.983 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.12 -86.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.52 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -170.95 -24.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.86 0.362 . . . . 0.0 110.188 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.62 -46.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.19 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.651 ' C ' ' H ' ' A' ' 14' ' ' GLY . 30.9 mt -78.3 -92.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.92 -8.72 2.34 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 175.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.651 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.54 -48.24 6.39 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 113.001 -1.599 . . . . 0.0 110.283 178.196 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.74 27.78 1.1 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.51 43.83 0.13 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.82 -178.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 65.62 17.53 10.93 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.447 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 58.53 -77.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.929 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 10.7 m-70 -52.97 -65.08 0.62 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.837 0.351 . . . . 0.0 110.604 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.175 -179.964 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.836 0.35 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 4' ' ' ARG . 5.4 tp -72.07 -4.34 28.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.135 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 79.87 -15.65 0.74 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.326 -179.654 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 2' ' ' LEU . 29.7 ptt180 -157.32 29.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.553 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.3 tt -60.44 -34.47 58.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.314 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.56 15.64 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -64.0 89.36 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.32 . . . . 0.0 110.558 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.53 124.88 9.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.028 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.76 -85.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.639 0.257 . . . . 0.0 110.419 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -171.1 -24.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.575 -179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.5 mt -132.59 -50.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.325 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.685 ' C ' ' H ' ' A' ' 14' ' ' GLY . 33.5 mm -78.41 -94.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.413 ' H ' ' HB ' ' A' ' 12' ' ' ILE . . . -54.34 -9.33 1.48 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 176.204 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.685 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.09 -48.63 6.38 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 112.959 -1.62 . . . . 0.0 110.229 178.151 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.96 27.96 0.73 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.53 37.95 0.17 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.014 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.1 tp 57.18 11.64 1.11 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.246 179.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER 58.58 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.92 -179.986 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 17' ' ' LEU . 57.8 t-80 -50.62 -44.4 57.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.838 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.12 -179.858 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.577 ' C ' ' H ' ' A' ' 3' ' ' ARG . 94.1 m95 . . . . . 0 C--O 1.23 0.068 0 N-CA-C 110.583 -0.154 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 23.2 mt 62.29 -5.66 0.17 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.363 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.577 ' H ' ' C ' ' A' ' 1' ' ' TRP . 37.3 mtt85 65.42 -74.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.699 -179.713 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 6' ' ' GLY . 98.9 mtt180 -71.96 11.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.808 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.497 ' H ' ' C ' ' A' ' 3' ' ' ARG . 35.3 pt 35.24 28.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.89 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . 153.19 61.71 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -51.19 94.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.933 0.397 . . . . 0.0 110.366 -179.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.69 -162.33 33.16 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.083 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.3 t -76.68 -82.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.682 0.277 . . . . 0.0 110.68 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -170.92 -26.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.761 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.0 mt -124.04 -54.21 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.364 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.675 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.4 mm -75.06 -98.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.021 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.97 -11.63 0.59 Allowed Glycine 0 C--N 1.347 1.178 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 176.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -77.82 -48.92 7.45 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.048 -1.576 . . . . 0.0 109.966 178.049 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -86.34 28.34 0.85 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.704 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.66 39.35 0.24 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.813 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 62.41 25.37 15.13 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.78 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.3 t70 58.01 -78.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' LEU . 16.2 m80 -51.04 -65.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.606 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.233 179.988 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.77 0.319 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 27.6 mt -71.91 -6.0 38.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.324 179.696 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 64.35 -73.06 0.06 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.1 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 65.3 mtp180 -72.31 5.18 3.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.915 -179.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mt 45.64 77.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.749 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 166.4 -37.7 0.25 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.104 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -168.63 149.68 4.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.831 0.348 . . . . 0.0 110.653 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.93 172.01 41.94 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.915 179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.403 ' CG2' ' H ' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -147.34 -99.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.846 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.403 ' H ' ' CG2' ' A' ' 9' ' ' VAL . 49.9 tttp -167.7 -20.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.99 0.424 . . . . 0.0 110.482 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.1 mt -111.44 -48.46 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.524 -179.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.665 ' C ' ' H ' ' A' ' 14' ' ' GLY . 40.7 mm -96.16 -101.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.093 -178.62 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.95 -12.08 0.43 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 177.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.665 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.47 -48.59 5.54 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 113.507 -1.347 . . . . 0.0 110.082 177.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -83.08 23.37 0.86 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.002 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 83.94 39.41 0.03 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.196 -179.336 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.4 tp 54.91 18.04 2.05 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.268 179.757 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 52.67 20.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.119 -179.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 m170 57.83 64.12 1.62 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.503 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.336 -179.952 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.498 ' O ' ' CD1' ' A' ' 1' ' ' TRP . 32.1 p90 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.852 0.358 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.3 mt -79.28 -72.16 0.41 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.529 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.51 -22.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.735 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -130.31 -1.15 4.51 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.608 179.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.8 mt 60.14 93.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.389 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 59.84 67.7 2.03 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.988 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -66.83 173.92 3.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.627 0.251 . . . . 0.0 110.401 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -173.28 -144.42 4.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.22 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -61.89 -89.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.762 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -172.14 -25.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.716 0.293 . . . . 0.0 110.612 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 mt -112.42 -51.08 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.327 -179.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.678 ' C ' ' H ' ' A' ' 14' ' ' GLY . 38.8 mm -89.73 -100.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.177 -179.036 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.63 -11.59 0.52 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 176.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.13 -49.65 5.85 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 113.294 -1.453 . . . . 0.0 109.946 177.737 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -85.26 28.2 0.74 Allowed 'General case' 0 C--N 1.345 0.41 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.747 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.18 41.77 0.15 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.047 -179.1 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 19' ' ' HIS . 4.1 tp 62.3 10.41 3.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.446 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.489 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 33.0 t70 57.63 5.05 0.29 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 55.7 m80 -157.49 -13.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 109.836 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.8 tp . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.313 179.874 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 78.3 m95 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.817 0.341 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.4 mp -63.63 -9.32 13.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.187 -179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 71.7 -66.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.764 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.3 ttt85 -74.12 -8.62 56.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.891 0.377 . . . . 0.0 110.276 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt 59.16 61.38 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.382 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.43 -70.33 0.17 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.98 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.451 ' CB ' ' NZ ' ' A' ' 7' ' ' LYS . 6.1 ttpm? -92.28 122.09 34.41 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.764 0.316 . . . . 0.0 110.506 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.72 -63.84 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.888 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 29.0 m -154.48 24.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.807 0.337 . . . . 0.0 110.464 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -74.78 -21.17 59.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.094 179.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.7 mt -134.42 -35.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.375 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.675 ' C ' ' H ' ' A' ' 14' ' ' GLY . 82.0 mt -74.83 -88.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.07 -4.72 4.85 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 175.407 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.15 -43.62 7.44 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 113.28 -1.46 . . . . 0.0 110.14 178.483 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -88.36 27.86 1.18 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.884 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.26 37.9 0.34 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.614 -178.722 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 55.21 48.67 18.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.898 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 48.62 29.94 2.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.746 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.2 m80 53.18 59.43 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.583 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.069 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.752 0.311 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.563 ' C ' ' H ' ' A' ' 4' ' ' ARG . 12.7 mt -72.29 -9.75 58.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.576 -179.876 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 68.44 -28.8 0.16 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.607 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.563 ' H ' ' C ' ' A' ' 2' ' ' LEU . 77.1 mtm-85 -90.0 -14.06 34.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.719 0.295 . . . . 0.0 110.428 -179.974 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 1.6 mp 52.72 97.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.849 -179.941 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.24 23.79 73.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.215 -0.516 . . . . 0.0 112.062 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 tptp 60.5 152.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.688 0.28 . . . . 0.0 110.299 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -165.58 176.52 41.1 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.082 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.1 t -69.12 -80.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 121.101 -0.239 . . . . 0.0 110.479 179.975 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -172.52 -25.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.868 0.366 . . . . 0.0 110.504 179.832 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.409 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -135.93 -46.38 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.268 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.684 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.4 mt -76.48 -92.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.409 ' H ' ' HB ' ' A' ' 12' ' ' ILE . . . -57.69 -8.04 3.76 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.932 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.684 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.07 -46.67 7.51 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 112.907 -1.646 . . . . 0.0 110.224 178.324 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.68 29.43 0.79 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.526 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.98 41.22 0.51 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.222 -178.448 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 63.15 51.94 2.63 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.05 -179.688 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 t0 59.8 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.579 -179.867 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.532 ' N ' ' HD1' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -167.46 53.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.492 179.884 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.132 179.965 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.483 ' O ' ' N ' ' A' ' 3' ' ' ARG . 60.8 t-105 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.732 0.301 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.448 ' N ' ' CG ' ' A' ' 1' ' ' TRP . 7.9 mt 53.25 -89.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.099 0.476 . . . . 0.0 109.886 -179.516 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 1' ' ' TRP . 31.8 ttm180 -172.91 -23.17 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.078 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -148.45 -2.45 0.5 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.506 179.566 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.5 mt 55.53 74.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.511 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.59 46.59 83.73 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.232 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt 48.69 -94.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.865 0.364 . . . . 0.0 110.762 179.865 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.46 170.89 44.07 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -179.946 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.81 -86.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.532 -179.849 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -171.34 -29.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.428 -179.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.1 mt -135.47 -47.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.9 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 14' ' ' GLY . 47.5 mm -76.7 -94.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.471 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.3 -9.49 1.53 Allowed Glycine 0 C--N 1.346 1.118 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 176.127 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.02 -47.79 6.89 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 113.175 -1.513 . . . . 0.0 110.203 178.253 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -87.93 28.75 1.0 Allowed 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.819 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.25 42.03 0.19 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.827 -178.954 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.2 tp 63.67 30.16 14.87 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.337 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.0 t0 56.36 -80.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.742 -179.989 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 74.5 m80 -49.29 -65.75 0.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.982 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.888 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.512 ' C ' ' H ' ' A' ' 3' ' ' ARG . 1.2 p90 . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 121.043 0.449 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.2 tp 68.94 -6.03 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.523 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.512 ' H ' ' C ' ' A' ' 1' ' ' TRP . 23.7 ttm180 75.11 -61.54 0.48 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.791 179.916 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.9 mtp85 -72.84 0.72 10.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.675 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.5 mt 52.78 63.23 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.339 179.997 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 52.86 24.35 19.09 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.034 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.4 tttp 52.89 94.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.768 0.318 . . . . 0.0 110.516 179.932 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.29 -162.09 51.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.941 179.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.6 t -76.42 -83.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.623 0.249 . . . . 0.0 110.683 -179.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -171.81 -19.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.913 0.387 . . . . 0.0 110.346 -179.895 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 21.5 mt -138.41 -45.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.69 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.8 mt -77.93 -92.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.68 -5.92 3.14 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 107.819 -2.113 . . . . 0.0 107.819 175.718 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.69 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.65 -47.57 5.9 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 112.893 -1.654 . . . . 0.0 110.172 178.261 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -88.34 29.21 0.99 Allowed 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.683 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 73.21 47.62 0.19 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.382 -178.652 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.1 mt 64.19 39.86 7.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.082 -179.391 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.1 t70 51.72 42.1 29.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.658 179.918 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.0 m170 50.62 36.76 14.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.643 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.17 -179.985 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.82 0.343 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 4' ' ' ARG . 23.8 mt -74.13 -11.01 60.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.378 179.937 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 72.11 -41.89 0.52 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.806 0.691 . . . . 0.0 111.26 179.792 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.418 ' H ' ' C ' ' A' ' 2' ' ' LEU . 46.6 ttp180 -83.81 -9.59 58.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.893 0.377 . . . . 0.0 110.4 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.4 mt 59.29 64.43 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.297 179.911 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.25 -71.6 0.12 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.909 179.954 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -146.22 -144.86 0.16 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.971 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.97 -179.37 32.81 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.0 t -68.3 -100.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.352 -179.842 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -155.74 -33.59 0.09 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.768 0.318 . . . . 0.0 110.258 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.3 mt -129.95 -48.13 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.255 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.69 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.0 mt -76.25 -93.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.859 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.66 -8.79 2.15 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 176.286 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.69 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.22 -47.42 6.99 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 112.873 -1.663 . . . . 0.0 110.167 178.276 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.41 27.96 0.89 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.834 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.43 38.95 0.2 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.892 -178.893 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 57.29 45.38 20.35 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.854 179.92 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 50.46 31.51 5.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.73 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.5 t60 51.41 60.4 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.696 179.845 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.5 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.264 179.87 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 34.0 p90 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.748 0.308 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.5 mt -73.63 -72.62 0.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.576 -179.897 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.5 ttt85 -155.74 -10.18 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.841 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.417 ' H ' ' H ' ' A' ' 5' ' ' ILE . 45.0 ttt85 -158.91 -0.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.44 179.641 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.417 ' H ' ' H ' ' A' ' 4' ' ' ARG . 1.7 tp 36.73 94.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.596 0.712 . . . . 0.0 111.043 -179.923 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.33 -25.8 0.26 Allowed Glycine 0 C--N 1.33 0.23 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.615 -179.752 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -169.48 177.02 4.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.74 0.305 . . . . 0.0 110.394 179.981 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.86 -124.12 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.065 -179.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.5 t -71.75 -91.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.56 -179.829 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -172.15 -26.76 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.763 0.316 . . . . 0.0 110.694 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.4 mt -131.45 -46.91 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.386 -179.556 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.669 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.1 mm -87.12 -95.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.865 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.84 -8.84 1.51 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 176.218 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.669 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.61 -49.34 5.48 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 113.063 -1.569 . . . . 0.0 110.087 178.082 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.94 26.57 1.13 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.754 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.65 47.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.736 -178.946 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.6 mt 62.61 11.37 4.73 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.484 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.6 t0 55.87 53.83 8.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.48 -179.592 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 55.32 55.93 6.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.674 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.2 mp . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.343 179.916 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 2.6 m0 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.853 0.358 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.3 tt -66.1 -70.16 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.188 -179.877 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -173.26 -23.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.999 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -153.45 7.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.961 179.304 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm 60.24 110.87 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.482 -179.913 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.91 52.55 40.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.111 179.924 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -65.94 152.42 44.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.31 . . . . 0.0 110.359 179.91 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.81 -148.11 50.2 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.855 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.91 -87.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.514 179.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -171.51 -25.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.939 0.4 . . . . 0.0 110.428 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 7.1 mm -132.14 -46.27 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.018 -179.943 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.681 ' C ' ' H ' ' A' ' 14' ' ' GLY . 72.2 mt -77.16 -92.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.47 -7.63 3.13 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 176.04 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.02 -47.24 6.66 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 112.9 -1.65 . . . . 0.0 110.258 178.235 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.49 28.74 0.83 Allowed 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.663 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.68 40.4 0.3 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.691 -178.749 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 60.08 49.36 7.57 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.282 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 58.72 -77.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.843 -179.883 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' LEU . 13.0 t-80 -159.36 56.92 0.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.779 0.323 . . . . 0.0 110.39 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.495 179.951 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 51.0 m95 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.758 0.313 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.83 -70.75 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.102 0.477 . . . . 0.0 110.336 179.846 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -158.67 -22.34 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.579 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 6' ' ' GLY . 96.9 mtt180 -150.65 4.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.373 179.425 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 5.1 tt 41.25 19.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.212 -179.669 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 8' ' ' GLY . . . -73.54 -48.63 17.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.73 179.601 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.7 tptt 55.19 -81.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.61 0.243 . . . . 0.0 110.568 179.848 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . 60.27 -160.17 22.99 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.865 -179.925 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.6 t -76.12 -84.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.597 0.236 . . . . 0.0 110.581 -179.988 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -171.37 -24.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 110.465 -179.968 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.3 mt -132.92 -50.01 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.163 -179.832 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.685 ' C ' ' H ' ' A' ' 14' ' ' GLY . 60.9 mt -76.52 -95.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.827 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.69 -9.66 1.82 Allowed Glycine 0 C--N 1.346 1.1 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 176.419 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.685 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.81 -47.92 7.47 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 112.9 -1.65 . . . . 0.0 110.116 178.098 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.63 28.97 0.82 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.717 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.82 40.19 0.38 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.486 -178.661 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 63.93 49.77 2.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.757 -179.708 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.49 ' CG ' ' HD1' ' A' ' 19' ' ' HIS . 30.3 t0 59.23 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.74 -179.782 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 17' ' ' LEU . 13.9 p-80 -159.26 44.03 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.821 0.344 . . . . 0.0 110.362 179.922 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.509 -179.912 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.452 ' CE3' ' O ' ' A' ' 1' ' ' TRP . 69.1 p-90 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.856 0.36 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 9.7 mp -65.3 -84.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.206 0.527 . . . . 0.0 110.105 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.442 ' H ' ' H ' ' A' ' 4' ' ' ARG . 61.3 ttm-85 -168.67 -17.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.787 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.442 ' H ' ' H ' ' A' ' 3' ' ' ARG . 71.6 mtp180 -148.43 -1.74 0.53 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.33 179.446 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.7 mm 57.69 68.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.469 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.88 -4.19 0.06 OUTLIER Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.245 -0.503 . . . . 0.0 111.968 179.819 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm 50.78 72.12 0.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.815 0.34 . . . . 0.0 110.319 -179.877 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -50.08 113.77 2.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.15 -0.547 . . . . 0.0 112.044 -179.878 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.8 t -76.04 -83.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.59 0.234 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -170.88 -24.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.717 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 3.7 mp -120.85 -59.8 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.667 -179.816 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.676 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.0 mt -76.13 -98.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.265 -179.331 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.34 -11.44 0.71 Allowed Glycine 0 C--N 1.347 1.186 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 176.993 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.676 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.09 -48.73 7.41 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.875 -1.662 . . . . 0.0 110.003 178.006 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -86.55 29.9 0.75 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.604 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.85 39.82 0.4 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.728 -178.879 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.5 tt 63.64 47.86 3.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.783 -179.896 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 54.04 -84.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.657 -179.822 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' LEU . 15.1 t-160 -161.17 50.71 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.459 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.411 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 9.7 mp . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.154 -180.0 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.2 m0 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.899 0.38 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.1 mt -67.94 -6.01 19.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.168 179.617 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 76.88 -59.97 0.47 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.62 -179.906 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -85.09 -14.77 46.12 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.847 0.356 . . . . 0.0 110.412 179.972 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 mt 50.18 63.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.406 179.93 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.2 -12.18 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.174 -179.898 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -161.44 137.38 7.98 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.862 0.363 . . . . 0.0 110.877 -179.918 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.31 120.18 0.59 Allowed Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.896 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.612 ' CG1' ' H ' ' A' ' 10' ' ' LYS . 7.3 p -80.36 -67.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.952 -179.554 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.612 ' H ' ' CG1' ' A' ' 9' ' ' VAL . 56.3 tttm -178.14 -35.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.671 0.272 . . . . 0.0 110.404 179.93 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.7 mt -120.66 -52.43 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.221 -178.847 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.672 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.4 mm -74.32 -97.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.229 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.77 -10.49 0.69 Allowed Glycine 0 C--N 1.346 1.104 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 176.711 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.672 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.8 -47.84 7.52 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 113.218 -1.491 . . . . 0.0 110.02 178.183 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -88.55 31.54 0.83 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.716 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.71 41.93 0.52 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.69 -178.75 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.2 tp 65.12 53.61 1.33 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.103 -179.721 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.0 t0 62.73 -75.49 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.844 -179.821 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.421 ' N ' ' O ' ' A' ' 17' ' ' LEU . 2.7 t60 -152.74 42.13 0.61 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.794 0.33 . . . . 0.0 110.369 -179.892 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.9 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.496 179.954 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.456 ' O ' ' CD1' ' A' ' 1' ' ' TRP . 23.7 p90 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.761 0.315 . . . . 0.0 110.51 . . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.8 mt -74.08 -72.13 0.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.674 -179.932 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.565 ' HE ' HH12 ' A' ' 4' ' ' ARG . 39.7 ttp180 -154.31 -13.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 179.849 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.565 HH12 ' HE ' ' A' ' 3' ' ' ARG . 30.0 mtt85 -148.24 2.37 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.671 179.634 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 mt 57.27 50.21 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.369 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 47.3 31.15 6.23 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.583 179.807 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 4' ' ' ARG . 54.0 mmtt -81.99 43.56 0.79 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.656 0.265 . . . . 0.0 110.412 179.824 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.71 -158.99 21.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.408 179.937 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.4 m 35.6 49.73 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.829 0.347 . . . . 0.0 111.912 -179.933 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -92.61 -16.3 25.79 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.307 179.563 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -129.11 -46.04 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.647 -179.609 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.707 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.2 mt -74.89 -92.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.659 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.08 -6.69 3.11 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 176.029 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.707 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.65 -45.33 7.35 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 113.082 -1.559 . . . . 0.0 110.139 178.327 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.77 29.9 0.77 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.573 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.03 37.46 0.63 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.513 -178.578 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.4 tt 58.24 47.32 14.4 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.878 -179.933 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.486 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 71.0 m-20 54.03 -83.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 17' ' ' LEU . 96.3 m-70 -158.21 52.11 0.43 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.366 179.974 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.081 -179.924 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.742 0.306 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 2.5 mm? -73.94 -85.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.037 0.446 . . . . 0.0 109.831 179.849 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -157.56 -16.93 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.718 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -150.17 0.98 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.448 179.487 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.0 mt 53.19 71.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.409 179.983 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.11 -55.75 0.23 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 121.217 -0.516 . . . . 0.0 111.965 179.911 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -63.96 134.14 54.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.78 0.324 . . . . 0.0 110.531 -179.949 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.13 172.26 0.14 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.124 -0.56 . . . . 0.0 111.983 179.98 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' A' ' 11' ' ' ILE . 39.0 t -148.48 -21.74 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.95 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.7 tttm 72.11 -18.85 0.3 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.228 -179.985 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.524 ' H ' ' C ' ' A' ' 9' ' ' VAL . 11.7 mt -116.9 -46.59 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.789 0.328 . . . . 0.0 111.573 -179.119 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.668 ' C ' ' H ' ' A' ' 14' ' ' GLY . 63.1 mt -95.78 -97.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.069 -178.564 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.35 -8.29 1.66 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 176.854 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.9 -48.02 5.35 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 113.155 -1.522 . . . . 0.0 109.808 177.999 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.11 27.06 0.41 Allowed 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.604 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.576 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.17 36.45 0.23 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.758 -179.042 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 51.3 32.14 7.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.265 -179.824 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 51.15 10.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.134 179.837 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.498 ' H ' ' C ' ' A' ' 17' ' ' LEU . 20.9 t-160 -168.3 -41.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.611 179.929 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.8 pp . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.584 -179.97 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 96.7 m95 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.865 0.364 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 4' ' ' ARG . 12.9 mt -72.99 -13.0 61.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.43 -179.985 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 69.68 -30.36 0.19 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.313 -179.891 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.549 ' H ' ' C ' ' A' ' 2' ' ' LEU . 69.1 mtt85 -84.4 -25.53 29.0 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.837 0.351 . . . . 0.0 110.214 179.614 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mt 60.12 84.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.552 -179.994 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 50.64 46.55 47.06 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.227 179.881 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt 48.59 -129.64 1.86 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.545 0.212 . . . . 0.0 110.523 179.937 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 163.66 -158.02 30.38 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.905 179.915 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.557 ' CG2' ' H ' ' A' ' 12' ' ' ILE . 15.4 m -76.79 15.68 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.713 -179.914 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 8' ' ' GLY . 59.9 tttt 73.27 -20.84 0.27 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.101 179.035 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.471 ' H ' ' C ' ' A' ' 9' ' ' VAL . 10.6 mt -112.07 -46.16 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.277 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.696 ' C ' ' H ' ' A' ' 14' ' ' GLY . 60.5 mt -95.99 -98.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.135 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.95 -6.8 1.41 Allowed Glycine 0 C--N 1.341 0.854 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.393 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.696 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.92 -46.53 5.35 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 113.291 -1.455 . . . . 0.0 110.001 178.332 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.29 28.56 0.72 Allowed 'General case' 0 C--N 1.343 0.292 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.728 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.26 41.47 0.28 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.797 -178.927 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.2 OUTLIER 68.25 37.19 2.89 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.014 -0.675 . . . . 0.0 109.72 -179.762 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.495 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 33.6 t70 55.71 -82.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.716 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' LEU . 96.8 m-70 -158.5 57.61 0.45 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.475 179.98 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.476 -179.943 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.43 ' O ' ' N ' ' A' ' 3' ' ' ARG . 21.3 p90 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.758 0.313 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 10.2 mp 51.98 -91.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.135 -179.99 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 1' ' ' TRP . 30.8 ttm180 -163.93 -19.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.75 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.442 ' H ' ' H ' ' A' ' 5' ' ' ILE . 58.8 ttt180 -171.8 5.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.174 179.691 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.442 ' H ' ' H ' ' A' ' 4' ' ' ARG . 12.2 mt 58.02 84.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.171 -179.852 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.45 64.36 2.19 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -179.7 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -64.31 -40.47 95.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.636 0.255 . . . . 0.0 110.783 -179.663 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 46.5 68.21 1.16 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.103 -179.876 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.418 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 20.3 m -76.15 32.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.75 0.31 . . . . 0.0 110.782 -179.839 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 8' ' ' GLY . 53.4 mttm -82.73 -11.39 58.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.231 179.907 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.6 mt -138.95 -39.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.193 -179.567 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.672 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.5 mt -75.83 -89.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.56 -5.52 5.12 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 175.385 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.672 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.36 -45.16 7.09 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 113.105 -1.547 . . . . 0.0 110.161 178.345 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -87.94 29.86 0.89 Allowed 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.653 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.59 40.78 0.61 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.407 -178.502 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.3 tp 63.14 20.4 12.26 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.214 -179.736 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.8 t70 58.83 -77.5 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' LEU . 20.7 m80 -49.25 -61.02 2.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.304 . . . . 0.0 110.711 -179.938 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.029 179.966 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 37.6 p90 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.795 0.331 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.4 mt -72.33 -7.66 50.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.613 -179.97 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 76.48 -47.02 0.54 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.54 -179.82 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 6' ' ' GLY . 83.3 mtm180 -78.01 -10.17 59.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.56 179.828 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 7' ' ' LYS . 12.0 mt 61.74 -76.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.637 -179.877 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 8' ' ' GLY . . . -73.98 9.03 9.77 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.157 -0.544 . . . . 0.0 111.927 179.989 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 5' ' ' ILE . 52.5 tttm 59.38 -77.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.61 0.243 . . . . 0.0 110.756 -179.974 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . 176.25 165.9 32.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.073 179.97 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.22 -84.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.517 0.199 . . . . 0.0 110.659 -179.933 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -170.91 -26.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.814 0.34 . . . . 0.0 110.726 179.955 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.3 mt -133.9 -52.07 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 109.979 -179.936 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.662 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.1 mm -76.51 -96.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.695 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.9 -11.08 0.85 Allowed Glycine 0 C--N 1.347 1.16 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 176.448 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.662 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.56 -48.87 6.99 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 113.053 -1.573 . . . . 0.0 110.28 178.056 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -86.44 27.18 0.97 Allowed 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.877 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.5 40.07 0.13 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.916 -179.086 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.3 tt 62.18 42.69 9.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.828 179.955 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.6 t0 50.9 34.96 11.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.552 -179.858 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.8 t60 53.96 62.06 2.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.483 179.922 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.294 179.974 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 98.5 m95 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.804 0.335 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.572 ' C ' ' H ' ' A' ' 4' ' ' ARG . 21.2 mt -66.04 -9.4 30.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.442 179.918 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 69.39 -29.65 0.18 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.975 -179.378 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.572 ' H ' ' C ' ' A' ' 2' ' ' LEU . 61.1 ttp180 -78.81 -24.8 44.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.261 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.3 mt -145.81 66.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.136 179.742 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 8' ' ' GLY . . . 179.21 -32.28 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.071 179.937 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER 53.32 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.985 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . 61.13 62.26 6.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.113 179.843 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.566 ' C ' ' H ' ' A' ' 11' ' ' ILE . 2.8 t -70.58 -3.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.835 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.2 mttp 66.51 -19.14 0.11 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.819 179.931 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.566 ' H ' ' C ' ' A' ' 9' ' ' VAL . 40.9 mm -118.22 -43.36 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.89 0.376 . . . . 0.0 111.415 -179.146 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.692 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.1 mt -98.54 -98.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.873 -178.65 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.67 -8.3 1.26 Allowed Glycine 0 C--N 1.342 0.914 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 176.743 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.692 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.6 -48.2 4.82 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 113.231 -1.485 . . . . 0.0 109.845 177.995 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.23 26.59 1.02 Allowed 'General case' 0 C--N 1.342 0.239 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.865 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.97 48.65 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.754 -178.918 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.0 mt 61.14 14.52 5.55 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.462 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.2 t70 58.67 -77.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 -179.706 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 63.6 t60 -164.9 47.76 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.914 0.388 . . . . 0.0 110.485 179.903 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.116 180.0 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.715 0.293 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.512 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 2.4 mm? -70.91 -89.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.924 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -135.03 -21.74 1.63 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.607 179.66 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 6' ' ' GLY . 40.2 mtt-85 -146.91 12.33 1.1 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.055 179.783 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.5 ' C ' ' H ' ' A' ' 7' ' ' LYS . 13.0 mt 62.25 -76.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.41 -179.742 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -73.05 15.32 2.45 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.89 179.858 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 5' ' ' ILE . 76.9 mttt 54.83 -177.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.636 179.986 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.41 79.62 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.689 -0.565 . . . . 0.0 111.689 -179.998 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.01 -91.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.68 -179.792 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -171.52 -27.29 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.856 0.36 . . . . 0.0 110.419 -179.994 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.7 mt -136.8 -45.52 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.149 -179.91 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.681 ' C ' ' H ' ' A' ' 14' ' ' GLY . 78.7 mt -84.07 -93.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.958 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.81 -8.34 2.88 Favored Glycine 0 C--N 1.343 0.955 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 175.959 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.8 -48.25 6.27 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 112.945 -1.628 . . . . 0.0 110.117 178.153 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.02 27.53 0.89 Allowed 'General case' 0 C--N 1.343 0.311 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.77 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.57 41.59 0.19 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.627 -178.871 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.6 tt 63.38 48.89 3.37 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.771 -179.786 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.8 t0 50.91 28.97 4.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.404 -179.825 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.8 t60 55.91 68.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.476 -179.796 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.4 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.244 -179.846 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.824 0.345 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.2 tp -64.76 -78.57 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.199 0.523 . . . . 0.0 110.078 179.863 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.414 ' H ' ' H ' ' A' ' 4' ' ' ARG . 54.0 ttp180 -165.91 -16.59 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.637 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 6' ' ' GLY . 72.2 mtm180 -149.97 -0.12 0.45 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.177 179.475 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 mt 62.6 -75.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.495 -179.826 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -156.68 31.1 0.56 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 179.833 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 6' ' ' GLY . 83.6 tttt 58.99 118.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.85 0.357 . . . . 0.0 110.63 -179.95 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.74 -125.43 0.76 Allowed Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 -179.967 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.0 t -149.08 -88.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.916 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -171.23 -31.28 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.818 0.342 . . . . 0.0 110.606 179.846 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.8 mt -130.35 -49.23 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.124 -179.826 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.678 ' C ' ' H ' ' A' ' 14' ' ' GLY . 28.2 mt -75.98 -95.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.886 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.12 -9.73 1.53 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 176.294 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.27 -47.81 7.25 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 113.019 -1.59 . . . . 0.0 110.074 178.036 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.8 29.36 1.03 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.823 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.14 41.71 0.28 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.615 -178.83 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.1 tt 69.33 39.38 1.67 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.893 -179.864 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.9 t0 48.56 49.29 18.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.654 -179.943 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 53.21 60.86 3.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 -179.891 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 7.9 mp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.03 -179.882 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.75 0.31 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.586 ' C ' ' H ' ' A' ' 4' ' ' ARG . 17.3 mt -74.19 -7.68 53.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.192 179.759 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.5 mtm-85 66.97 -24.12 0.11 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.619 -179.936 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.586 ' H ' ' C ' ' A' ' 2' ' ' LEU . 38.9 ttp180 -88.49 -39.58 14.09 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.882 0.372 . . . . 0.0 110.418 179.937 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 tp -54.47 -36.26 34.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.098 -179.905 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.54 -61.08 3.74 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.026 179.9 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.9 tttp 48.27 82.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.77 0.319 . . . . 0.0 110.63 179.917 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . -172.67 -14.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.023 179.957 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 33.6 m -76.03 19.08 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 110.802 -179.958 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 8' ' ' GLY . 11.1 ttmm -73.01 -21.94 60.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.099 0.476 . . . . 0.0 110.117 179.904 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.3 mt -131.44 -35.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.514 -179.485 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.692 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.7 mt -75.82 -87.6 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.908 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.08 -4.99 5.13 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 175.2 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.692 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.06 -44.48 7.07 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 113.209 -1.496 . . . . 0.0 110.193 178.471 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -87.51 27.72 1.07 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.953 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.492 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.05 37.34 0.28 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.707 -178.881 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.2 tt 55.97 43.04 27.92 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.052 179.921 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.0 t0 50.94 39.95 24.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.656 -179.994 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 51.53 45.63 27.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.551 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.352 -179.987 . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.502 ' O ' ' N ' ' A' ' 3' ' ' ARG . 34.3 m95 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.748 0.308 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 2.2 mm? 53.16 -87.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.971 179.894 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 1' ' ' TRP . 71.7 ttt180 -174.63 -24.24 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.975 179.947 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -175.98 4.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.443 179.607 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.5 mt 50.66 76.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.479 179.932 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.04 13.4 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.199 -0.524 . . . . 0.0 111.952 179.946 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -66.27 -66.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.66 0.266 . . . . 0.0 110.521 179.999 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.33 147.03 48.44 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.814 -179.991 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.64 -84.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.606 -179.861 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -170.81 -24.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.968 179.962 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.3 mt -132.59 -49.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.86 0.362 . . . . 0.0 110.452 -179.754 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.674 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.1 mm -81.99 -96.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.92 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.43 -8.63 1.26 Allowed Glycine 0 C--N 1.344 0.987 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 176.393 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.674 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.8 -48.97 5.9 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.1 -1.55 . . . . 0.0 110.002 178.015 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.71 29.67 0.99 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.586 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.3 48.84 0.23 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.571 -178.671 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.0 mt 64.53 31.63 12.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.204 -179.493 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.7 t70 53.03 44.68 30.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.957 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 50.56 65.48 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.647 179.948 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.203 -179.859 . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 1' ' ' TRP . 24.7 p90 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.712 0.291 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.2 tp -70.2 -72.81 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.471 . . . . 0.0 110.494 -179.959 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.433 ' H ' ' H ' ' A' ' 4' ' ' ARG . 50.1 ttt85 -162.34 -15.37 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.869 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.433 ' H ' ' H ' ' A' ' 3' ' ' ARG . 28.1 ttp180 -167.9 -2.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.194 179.744 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.439 ' C ' ' H ' ' A' ' 7' ' ' LYS . 12.1 mt 60.39 130.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.748 179.748 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.92 -2.23 5.1 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.285 179.692 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.439 ' H ' ' C ' ' A' ' 5' ' ' ILE . 45.3 mttp 54.53 85.09 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.716 0.293 . . . . 0.0 110.608 -179.957 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.06 -144.53 34.97 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.011 179.872 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.2 t -77.76 -93.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 121.281 -0.168 . . . . 0.0 110.696 -179.865 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -171.41 -22.41 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.839 -179.84 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.0 mt -131.06 -44.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.868 0.366 . . . . 0.0 110.764 -179.351 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.655 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.0 mt -89.99 -94.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.575 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.77 -7.33 3.26 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 176.215 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.655 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.67 -47.55 5.9 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 113.011 -1.594 . . . . 0.0 109.984 178.154 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.11 29.32 0.57 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.661 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.17 38.33 0.33 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.867 -178.958 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.1 tt 51.73 38.38 22.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.069 -179.946 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.6 t0 52.43 -85.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 17' ' ' LEU . 73.7 m-70 -53.11 -65.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.67 -179.854 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.023 -179.915 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 91.2 m95 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.876 0.37 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 4' ' ' ARG . 19.1 mt -73.62 -5.71 42.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.919 179.465 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.506 ' C ' ' H ' ' A' ' 5' ' ' ILE . 76.9 mtm180 61.83 -76.52 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.788 -179.913 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.588 ' NE ' ' N ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -68.87 7.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.319 179.929 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.506 ' H ' ' C ' ' A' ' 3' ' ' ARG . 5.9 mt 48.93 43.91 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 121.016 0.436 . . . . 0.0 110.313 -179.902 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.41 69.29 1.34 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.024 -179.838 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -154.25 -102.12 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.691 0.282 . . . . 0.0 110.335 179.895 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.57 104.08 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.773 -179.851 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.61 -85.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.657 -179.808 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -171.71 -25.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.848 0.356 . . . . 0.0 110.43 179.916 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 18.5 mt -125.27 -55.37 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.172 -179.916 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.677 ' C ' ' H ' ' A' ' 14' ' ' GLY . 34.6 mm -75.46 -98.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.928 -179.911 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.49 -10.99 0.68 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 176.794 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.56 -48.5 7.25 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 113.013 -1.593 . . . . 0.0 110.074 178.046 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -85.85 27.71 0.85 Allowed 'General case' 0 C--N 1.344 0.363 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.652 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.22 39.32 0.2 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.741 -178.923 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tt 58.01 48.8 12.66 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.6 179.945 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 53.97 22.84 3.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.205 -179.593 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.6 t60 56.01 63.14 2.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.635 -179.925 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.184 179.906 . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.454 ' O ' ' CD1' ' A' ' 1' ' ' TRP . 29.8 p90 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.86 0.362 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.1 mt -76.97 -73.38 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.542 -179.98 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.59 ' HE ' ' HZ2' ' A' ' 7' ' ' LYS . 46.2 mtm105 -147.06 -10.35 0.44 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.851 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 6' ' ' GLY . 7.6 tpp85 -166.36 10.12 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.419 179.835 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 7' ' ' LYS . 15.4 mt 62.86 -76.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.409 -179.739 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -75.98 38.06 1.31 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.144 179.885 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.59 ' HZ2' ' HE ' ' A' ' 3' ' ' ARG . 83.9 tttt -57.57 -44.36 85.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.819 0.342 . . . . 0.0 110.456 179.889 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.66 128.19 1.71 Allowed Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 111.749 -0.541 . . . . 0.0 111.749 -179.937 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 11' ' ' ILE . 44.3 t -61.29 -18.17 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 121.034 -0.267 . . . . 0.0 110.648 -179.796 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? 66.09 -14.05 0.15 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.792 179.836 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.547 ' H ' ' C ' ' A' ' 9' ' ' VAL . 14.7 mt -122.84 -45.63 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.75 0.31 . . . . 0.0 111.129 -179.642 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 14' ' ' GLY . 71.2 mt -95.03 -97.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.069 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.27 -8.48 1.67 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 176.462 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.55 -48.0 5.45 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 113.318 -1.441 . . . . 0.0 109.953 177.997 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.55 28.62 0.74 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.816 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.509 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.5 41.79 0.19 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.931 -179.011 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.0 tp 62.31 30.01 17.41 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.574 -179.996 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t0 55.23 -82.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 179.73 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 17' ' ' LEU . 61.0 m80 -47.75 -64.68 0.72 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.853 -179.812 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.453 -179.991 . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 120.994 0.426 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 5' ' ' ILE . 54.9 mt -137.32 -3.26 1.95 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.084 178.602 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -45.62 -18.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.472 0.653 . . . . 0.0 109.443 178.997 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.516 ' H ' ' C ' ' A' ' 2' ' ' LEU . 66.0 mtp180 -130.46 -5.94 4.22 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.847 178.823 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.522 ' H ' ' C ' ' A' ' 2' ' ' LEU . 12.2 mt 58.31 61.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.258 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.229 -179.91 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 66.48 51.2 44.27 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -179.806 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 6' ' ' GLY . 51.1 mttp 57.45 158.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.367 . . . . 0.0 110.517 -179.722 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.05 129.11 1.46 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.915 -179.898 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.82 -87.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.968 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -171.93 -24.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.76 0.314 . . . . 0.0 110.477 -179.993 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.413 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 11.5 mt -124.97 -51.91 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.542 -179.647 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.668 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.5 mm -74.67 -97.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.898 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.03 -10.24 0.73 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 176.738 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.17 -48.08 7.12 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 113.095 -1.552 . . . . 0.0 110.029 178.061 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -86.2 28.48 0.82 Allowed 'General case' 0 C--N 1.343 0.325 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.67 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.99 38.18 0.25 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.964 -179.055 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.5 tt 55.52 46.39 23.11 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.888 179.801 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 55.69 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.731 -179.903 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.566 ' N ' ' HD1' ' A' ' 19' ' ' HIS . 1.5 p-80 -157.03 44.71 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.418 -179.972 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.155 -179.98 . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.43 ' CD1' ' N ' ' A' ' 1' ' ' TRP . 31.6 m95 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.75 0.31 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' A' ' 4' ' ' ARG . 20.8 mt -72.17 -6.8 45.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.289 179.872 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.469 HH22 HH22 ' A' ' 4' ' ' ARG . 27.1 mtm-85 69.77 -31.87 0.22 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.456 179.975 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.535 ' H ' ' C ' ' A' ' 2' ' ' LEU . 70.7 mtt85 -80.03 -30.13 39.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.891 0.376 . . . . 0.0 110.275 179.834 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.8 mt 51.27 60.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.434 179.791 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.74 -37.3 0.1 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.004 179.929 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -51.36 102.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.693 0.282 . . . . 0.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.01 -153.36 8.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.257 179.833 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.3 t -142.45 -85.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.879 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -170.19 -23.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.181 179.863 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.59 -47.73 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.789 0.328 . . . . 0.0 111.649 -178.946 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.667 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.9 mt -94.86 -98.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.008 -178.681 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.57 -10.96 1.06 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 176.669 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.667 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.88 -49.8 5.2 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 113.199 -1.501 . . . . 0.0 109.936 177.771 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -84.28 25.87 0.82 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.941 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.53 44.51 0.07 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.856 -178.991 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.4 tp 62.78 31.5 16.47 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.305 -179.968 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.4 t0 56.84 -79.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' LEU . 35.6 m80 -54.92 -62.38 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.542 179.994 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.728 179.581 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.883 0.373 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 055 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.628 ' C ' ' H ' ' A' ' 4' ' ' ARG . 16.8 mt -82.84 -5.73 59.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.587 179.928 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.421 ' CD ' ' N ' ' A' ' 3' ' ' ARG . 1.1 mpt_? 62.75 -18.06 0.05 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.594 -179.444 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.628 ' H ' ' C ' ' A' ' 2' ' ' LEU . 99.9 mtt180 -101.11 -10.52 20.38 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.909 0.385 . . . . 0.0 110.391 179.771 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.4 tt -51.47 -26.93 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -174.56 18.22 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.125 -179.946 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 6' ' ' GLY . 15.7 mtpp 56.63 114.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 110.791 179.883 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.77 109.12 0.38 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 179.943 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.76 -80.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.646 0.26 . . . . 0.0 110.526 -179.902 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -171.22 -28.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.542 -179.867 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.1 mt -131.51 -44.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.068 -179.849 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.683 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.1 mt -75.34 -91.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' H ' ' HB ' ' A' ' 12' ' ' ILE . . . -58.5 -6.66 3.54 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 107.579 -2.208 . . . . 0.0 107.579 176.016 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.46 -45.72 7.25 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 112.98 -1.61 . . . . 0.0 110.035 178.315 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.5 29.96 0.74 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.618 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.11 37.53 0.61 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.5 -178.645 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.6 tt 56.79 46.26 20.23 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.797 -179.884 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 47.56 44.75 17.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.1 m80 54.73 45.77 26.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.597 -179.883 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.339 -179.993 . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.823 0.345 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.9 mt -71.05 -69.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.107 0.48 . . . . 0.0 110.276 179.743 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.417 ' H ' ' H ' ' A' ' 4' ' ' ARG . 48.6 ttt-85 -167.47 -11.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.664 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.417 ' H ' ' H ' ' A' ' 3' ' ' ARG . 8.2 ptm180 -174.84 8.15 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.527 179.732 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.413 ' H ' ' H ' ' A' ' 4' ' ' ARG . 18.6 mt 59.16 61.43 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.126 -179.782 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.42 19.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -179.9 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -53.9 -64.28 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -179.899 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.39 156.02 27.63 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.912 -179.957 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.43 -83.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.663 0.268 . . . . 0.0 110.521 -179.911 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.415 ' H ' ' H ' ' A' ' 11' ' ' ILE . 18.3 tptm -171.25 -17.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.905 0.383 . . . . 0.0 110.402 -179.78 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.415 ' H ' ' H ' ' A' ' 10' ' ' LYS . 12.4 mt -124.43 -49.76 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.764 -179.819 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.663 ' C ' ' H ' ' A' ' 14' ' ' GLY . 25.9 mt -81.9 -95.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.945 -179.424 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.401 ' H ' ' HB ' ' A' ' 12' ' ' ILE . . . -53.89 -9.96 1.49 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 176.402 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.663 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.04 -49.38 6.01 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 112.994 -1.603 . . . . 0.0 110.247 177.985 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.78 28.24 0.91 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.799 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.69 43.93 0.12 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.841 -179.026 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 64.34 24.8 13.34 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.477 -179.997 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.3 t70 57.47 -78.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 50.0 m80 -49.79 -67.07 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.452 179.873 . . . . . . . . 0 0 . 1 . 057 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.579 ' C ' ' H ' ' A' ' 3' ' ' ARG . 30.7 m95 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.45 0.166 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 4' ' ' ARG . 19.8 mt 62.34 -5.45 0.18 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.191 -179.822 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.579 ' H ' ' C ' ' A' ' 1' ' ' TRP . 9.3 mpt_? 58.45 -76.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.684 -179.739 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 2' ' ' LEU . 78.3 mtp180 -72.37 15.63 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.92 -179.804 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.514 ' H ' ' C ' ' A' ' 3' ' ' ARG . 12.1 mt 46.84 61.57 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.724 0.297 . . . . 0.0 110.69 179.872 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.56 -60.0 0.01 OUTLIER Glycine 0 C--N 1.33 0.198 0 N-CA-C 111.95 -0.46 . . . . 0.0 111.95 -179.889 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -167.71 -37.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.706 0.289 . . . . 0.0 110.75 179.962 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.83 -155.45 26.75 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.047 179.904 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.5 t -77.99 -63.23 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.885 0.374 . . . . 0.0 110.327 179.93 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -169.74 -61.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.483 179.907 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' ALA . 16.6 pt -81.2 4.96 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.647 179.994 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.712 ' C ' ' H ' ' A' ' 14' ' ' GLY . 38.9 mm -70.83 -88.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.301 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.32 -3.76 3.16 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 175.402 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.712 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.08 -38.33 8.61 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 113.77 -1.215 . . . . 0.0 110.137 178.604 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 11' ' ' ILE . . . -94.17 26.03 3.49 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.873 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 79.07 37.29 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.653 -178.886 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 3.7 tp 61.94 11.35 4.13 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.41 179.719 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 60.05 -77.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.469 -179.579 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -55.07 -70.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 110.559 179.797 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.463 0.222 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.479 179.906 . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.773 0.32 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.0 mt -74.08 -15.45 61.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.558 -179.932 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 76.68 -50.94 0.58 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.59 -179.938 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -75.49 -6.03 48.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.505 179.934 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.7 mt 57.5 68.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.488 179.936 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 53.83 25.47 30.07 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.981 179.901 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt 57.21 108.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.797 0.332 . . . . 0.0 110.604 179.996 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 9' ' ' VAL . . . 173.63 123.85 0.75 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.115 179.967 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.413 ' CG2' ' H ' ' A' ' 10' ' ' LYS . 1.9 m -55.49 -105.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.833 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.413 ' H ' ' CG2' ' A' ' 9' ' ' VAL . 33.2 ttmt -158.52 -21.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.919 0.39 . . . . 0.0 110.425 179.997 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.81 -49.47 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.895 -179.05 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 14' ' ' GLY . 23.5 mt -95.54 -99.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.385 -178.24 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.27 -10.83 0.93 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 177.097 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.1 -49.24 5.38 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 113.155 -1.523 . . . . 0.0 109.756 177.877 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -84.48 29.52 0.59 Allowed 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.607 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.17 43.91 0.27 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.74 -178.898 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 61.17 34.47 18.88 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.953 -179.693 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 t70 57.89 -78.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.928 -179.799 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 86.8 m-70 -64.89 -64.29 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.705 -179.77 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.461 -179.786 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.582 ' C ' ' H ' ' A' ' 3' ' ' ARG . 4.7 m-90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.675 0.274 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.9 mt 63.49 -7.92 0.17 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.353 -179.921 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.582 ' H ' ' C ' ' A' ' 1' ' ' TRP . 1.7 tpt180 76.14 -56.44 0.58 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.786 179.79 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -69.87 -10.25 57.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.777 0.322 . . . . 0.0 110.692 -179.817 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 mm 58.12 65.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.432 179.962 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 50.08 52.71 25.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.86 -179.986 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 6' ' ' GLY . 34.3 tptt 60.86 136.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 110.623 -179.935 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.55 73.26 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.951 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.55 -84.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.64 0.257 . . . . 0.0 110.797 -179.624 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -171.39 -29.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.942 0.401 . . . . 0.0 110.26 -179.819 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -137.98 -43.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.776 -179.953 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.674 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.7 mt -77.37 -90.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.525 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.59 -7.27 4.18 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 175.772 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.674 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.26 -46.7 6.84 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 112.931 -1.635 . . . . 0.0 110.199 178.431 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.14 27.08 0.94 Allowed 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.797 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.61 39.05 0.19 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.683 -178.894 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 57.43 47.17 16.89 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.991 179.931 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 54.33 -83.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 179.966 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.7 t-80 -157.4 40.33 0.3 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.425 179.975 . . . . . . . . 0 0 . 1 . 060 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.57 ' C ' ' H ' ' A' ' 3' ' ' ARG . 70.8 m95 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.731 0.301 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.602 ' C ' ' H ' ' A' ' 4' ' ' ARG . 25.1 mt 63.48 -8.69 0.15 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.668 179.927 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.57 ' H ' ' C ' ' A' ' 1' ' ' TRP . 77.0 mtt180 62.76 -15.93 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.819 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.602 ' H ' ' C ' ' A' ' 2' ' ' LEU . 55.2 ttp180 -95.36 -43.11 8.17 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.853 0.358 . . . . 0.0 110.201 -179.958 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.6 mm -86.41 -33.24 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.443 -179.979 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.44 -68.3 1.7 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.853 179.87 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt 50.37 17.14 0.32 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.744 0.307 . . . . 0.0 110.757 179.822 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.51 111.56 0.3 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.963 -179.99 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.58 -88.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.393 -179.958 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -172.17 -25.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.705 0.288 . . . . 0.0 110.718 179.901 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.5 mt -130.7 -46.57 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.624 -179.474 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.693 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.9 mt -84.53 -94.33 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.835 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.57 -7.26 2.02 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 176.074 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.693 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.22 -48.63 5.6 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 112.915 -1.642 . . . . 0.0 109.955 178.031 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.25 29.16 0.98 Allowed 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.588 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.46 49.15 0.21 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.586 -178.572 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 11.1 mt 63.52 6.08 2.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.157 -179.293 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 16' ' ' ALA . 38.3 t70 58.22 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 -179.977 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -158.76 54.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.306 179.941 . . . . . . . . 3 3 . 1 . 060 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.201 -179.857 . . . . . . . . 0 0 . 1 . 061 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.575 ' C ' ' H ' ' A' ' 3' ' ' ARG . 75.9 m95 . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.558 0.218 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.8 mt 62.79 -6.52 0.16 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.394 179.948 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.575 ' H ' ' C ' ' A' ' 1' ' ' TRP . 40.7 ttp180 72.47 -70.0 0.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.593 179.99 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.73 -0.95 4.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.508 -179.928 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 3' ' ' ARG . 10.2 mm 56.02 68.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.605 179.885 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 52.8 34.83 45.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.093 179.894 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.6 tttt 53.51 79.54 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 0.0 110.532 179.919 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.31 144.65 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.938 -179.949 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.6 t -71.18 -88.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.481 -179.907 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -170.61 -24.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.716 0.293 . . . . 0.0 110.991 179.869 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.8 mt -133.13 -44.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.905 0.383 . . . . 0.0 110.701 -179.548 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.0 mt -90.35 -94.32 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.662 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.48 -8.58 2.75 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 176.306 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.79 -49.07 5.54 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 112.986 -1.607 . . . . 0.0 109.985 178.017 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.86 29.62 0.62 Allowed 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.728 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.95 40.97 0.25 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.113 -179.168 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.7 OUTLIER 56.53 13.9 1.5 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.69 -179.98 . . . . . . . . 3 3 . 1 . 061 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.9 t0 55.57 -82.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.792 -179.942 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 49.6 m80 -58.44 -20.18 42.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.57 -179.987 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 -179.908 . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 2.9 m0 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.852 0.358 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.6 -75.73 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.132 0.491 . . . . 0.0 109.941 179.754 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -153.3 -13.03 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.035 179.839 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.425 ' O ' ' N ' ' A' ' 6' ' ' GLY . 40.0 ttt-85 -161.39 6.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.447 179.754 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.0 mt 61.91 -77.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.689 -179.921 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -83.67 60.69 4.84 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 179.955 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -50.98 124.76 12.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.788 0.327 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.89 128.52 37.25 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.207 -0.52 . . . . 0.0 111.986 -179.928 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.14 -82.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.672 0.272 . . . . 0.0 110.52 -179.95 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -172.02 -19.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.85 0.357 . . . . 0.0 110.196 -179.848 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.5 mt -136.86 -46.25 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.934 0.397 . . . . 0.0 110.367 -179.735 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.692 ' C ' ' H ' ' A' ' 14' ' ' GLY . 71.4 mt -80.16 -93.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.945 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.12 -6.65 3.13 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 176.127 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.692 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.43 -46.54 6.85 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 112.963 -1.619 . . . . 0.0 109.886 178.219 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.43 30.29 0.63 Allowed 'General case' 0 C--N 1.345 0.396 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.506 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 73.46 38.0 0.67 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.441 -178.596 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.6 tt 54.36 52.27 12.79 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.771 -179.738 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER 56.1 -80.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.947 179.927 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -160.95 48.68 0.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.362 -179.939 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.038 -179.896 . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.572 ' C ' ' H ' ' A' ' 3' ' ' ARG . 67.5 m95 . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 120.606 0.241 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 4' ' ' ARG . 16.4 mt 63.15 -6.9 0.17 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.508 -179.879 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.572 ' H ' ' C ' ' A' ' 1' ' ' TRP . 68.4 mtm180 64.76 -72.31 0.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.917 -179.876 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' LEU . 30.7 ttm180 -59.33 -8.69 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.337 179.934 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.409 ' H ' ' C ' ' A' ' 3' ' ' ARG . 29.7 pt 34.84 43.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.493 -179.694 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' H ' ' H ' ' A' ' 7' ' ' LYS . . . -170.45 0.96 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.84 -179.999 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' H ' ' H ' ' A' ' 6' ' ' GLY . 31.1 ttmt -54.82 97.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 0.0 110.468 -179.961 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.66 -105.68 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.016 -0.612 . . . . 0.0 111.83 179.918 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.92 -81.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.616 0.246 . . . . 0.0 110.498 179.925 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -172.14 -25.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.862 0.363 . . . . 0.0 110.284 179.854 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.0 mt -135.72 -50.45 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.831 179.939 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.677 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.6 mm -76.53 -96.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.602 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.6 -10.37 0.93 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 176.387 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.05 -48.56 6.87 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 113.109 -1.545 . . . . 0.0 110.171 178.082 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -86.95 29.1 0.84 Allowed 'General case' 0 C--N 1.344 0.337 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.772 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.52 39.74 0.24 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.991 -178.993 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.2 tt 63.09 43.63 6.35 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.966 179.844 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.1 t0 49.0 32.29 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.559 -179.977 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 54.79 73.92 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.475 -179.865 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.0 tp . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.52 -179.979 . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 39.5 p90 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.759 0.314 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.5 mt -77.42 -72.58 0.35 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 -179.813 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.641 HH12 ' NE ' ' A' ' 4' ' ' ARG . 64.3 ttp85 -172.73 -14.88 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.968 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.641 ' NE ' HH12 ' A' ' 3' ' ' ARG . 11.3 ptp180 -172.79 4.93 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.489 179.612 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mm 53.18 58.2 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.242 -179.888 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.92 25.54 0.02 OUTLIER Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -179.915 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -52.26 -70.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.727 0.298 . . . . 0.0 110.209 -179.929 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . -168.25 48.55 0.23 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.798 179.986 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.445 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 30.4 m -76.72 21.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.783 0.325 . . . . 0.0 110.812 -179.838 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 8' ' ' GLY . 50.2 mtpt -78.7 -14.58 59.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.252 -179.997 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.3 mt -133.15 -38.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.148 -179.789 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.68 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.6 mt -75.58 -89.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.825 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.96 -5.66 4.49 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 107.332 -2.307 . . . . 0.0 107.332 175.385 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.68 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.29 -44.73 7.34 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 113.167 -1.516 . . . . 0.0 110.038 178.379 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.69 28.35 1.16 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.889 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.55 38.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.596 -178.766 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 3.2 tp 63.22 48.99 3.45 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 53.8 -84.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.754 179.822 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 58.4 m80 -150.36 57.17 0.94 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.353 179.993 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.514 -179.966 . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.492 ' O ' ' N ' ' A' ' 3' ' ' ARG . 10.1 t90 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.793 0.33 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.478 ' N ' ' CG ' ' A' ' 1' ' ' TRP . 32.4 tp 53.92 -86.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.292 179.967 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 1' ' ' TRP . 52.0 ttp180 -174.14 -23.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.931 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.401 ' H ' ' H ' ' A' ' 3' ' ' ARG . 54.8 ttt180 -161.55 6.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.093 179.743 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.2 pt 35.43 39.24 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.59 -179.951 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.38 -7.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.0 179.995 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -77.54 73.99 4.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.742 0.305 . . . . 0.0 110.531 -179.929 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.22 122.32 0.6 Allowed Glycine 0 C--N 1.33 0.243 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.973 179.929 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.5 -87.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.401 179.893 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -171.29 -23.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.911 179.891 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.7 mt -120.69 -47.41 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 120.793 0.33 . . . . 0.0 111.26 -179.163 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.69 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.3 mt -91.28 -97.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.128 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.21 -8.93 1.26 Allowed Glycine 0 C--N 1.343 0.933 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 176.524 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.69 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.53 -48.96 5.37 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 113.147 -1.526 . . . . 0.0 109.935 177.984 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.38 28.91 0.91 Allowed 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.723 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 18' ' ' ASP . . . 73.87 48.78 0.13 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.556 -178.724 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.9 mt 65.1 -1.55 0.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.351 -179.427 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 16' ' ' ALA . 26.3 t70 53.9 -83.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.765 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 2.4 t60 -46.98 -37.79 9.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.95 -179.882 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.068 179.973 . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.43 ' CD1' ' N ' ' A' ' 1' ' ' TRP . 24.1 m95 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.887 0.375 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 46.2 mt -76.19 -75.89 0.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.514 -179.916 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -143.42 -18.96 0.62 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.617 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.554 ' C ' ' H ' ' A' ' 6' ' ' GLY . 93.6 mtt180 -149.98 12.02 0.75 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.662 179.675 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mt 70.14 -30.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.96 -179.925 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.554 ' H ' ' C ' ' A' ' 4' ' ' ARG . . . -165.59 92.9 0.11 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.882 179.701 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -48.5 153.65 0.74 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.766 0.317 . . . . 0.0 110.683 179.916 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.56 -102.59 0.45 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.798 -179.961 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.5 t -147.27 -73.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.688 0.28 . . . . 0.0 110.29 179.799 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 12' ' ' ILE . 75.3 tttt -171.4 -59.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.368 -179.977 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 15' ' ' ALA . 19.4 pt -78.02 10.79 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.403 180.0 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.676 ' C ' ' H ' ' A' ' 14' ' ' GLY . 6.8 mm -74.52 -86.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.515 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.405 ' H ' ' HB ' ' A' ' 12' ' ' ILE . . . -62.49 -3.15 5.07 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 175.249 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.676 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.53 -40.77 7.15 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 113.663 -1.269 . . . . 0.0 110.314 178.637 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' ILE . . . -90.49 26.21 2.05 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.873 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 79.43 37.16 0.14 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.876 -178.945 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.1 tp 59.24 17.92 6.14 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.546 179.76 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 56.93 6.95 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.794 179.728 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.477 ' H ' ' C ' ' A' ' 17' ' ' LEU . 54.6 t-80 -170.34 -59.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.522 -179.961 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.204 -179.987 . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.776 0.322 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.478 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 7.8 mp -67.79 -85.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.918 179.922 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -134.11 -15.22 2.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.66 179.664 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 5' ' ' ILE . 20.9 ttm180 -169.94 13.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.578 179.811 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.402 ' O ' ' O ' ' A' ' 4' ' ' ARG . 2.6 tt 34.63 96.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.538 -179.944 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.21 -28.19 0.15 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.811 179.969 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -72.5 159.98 33.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.773 0.321 . . . . 0.0 110.53 179.959 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.05 152.58 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.907 -179.983 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.77 -84.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.474 -179.956 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -171.83 -25.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.816 0.341 . . . . 0.0 110.489 179.908 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.8 mt -139.68 -43.89 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.02 -179.855 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.685 ' C ' ' H ' ' A' ' 14' ' ' GLY . 23.7 mt -84.43 -93.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.771 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.89 -6.25 2.63 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 175.751 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.685 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.38 -47.36 5.75 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 113.066 -1.567 . . . . 0.0 110.158 178.265 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.32 29.03 1.14 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.726 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.63 47.82 0.12 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.721 -178.821 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.4 mt 63.71 17.81 10.7 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.247 0.342 . . . . 0.0 110.137 -179.596 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 59.56 -76.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.766 179.894 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.692 ' H ' ' HD1' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -154.68 52.56 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.82 0.343 . . . . 0.0 110.427 -179.991 . . . . . . . . 3 3 . 1 . 067 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.304 -179.967 . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 . . . . . 0 N--CA 1.46 0.063 0 CA-C-O 121.001 0.429 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 4' ' ' ARG . 5.8 tp -70.19 -4.41 21.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.013 179.757 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 6' ' ' GLY . 18.5 mmm180 64.03 -74.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.245 -179.63 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 2' ' ' LEU . 69.9 ttt180 -44.48 -25.08 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.025 179.892 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.6 tt -81.07 -37.48 15.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.776 0.322 . . . . 0.0 110.518 -179.982 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -68.84 -28.67 72.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.982 179.978 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 6' ' ' GLY . 17.5 mtpp 56.39 116.46 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.095 0.474 . . . . 0.0 111.05 179.871 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.0 119.74 0.9 Allowed Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 179.97 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.8 t -75.93 -94.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.673 -179.769 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -171.33 -23.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.927 0.394 . . . . 0.0 110.406 -179.874 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.11 -43.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.332 -179.861 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.681 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.5 mt -88.0 -93.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.94 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.47 -6.66 3.51 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 175.941 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.73 -47.48 5.9 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 113.046 -1.577 . . . . 0.0 109.939 178.152 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.88 29.73 0.61 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.708 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.47 38.68 0.38 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.773 -178.941 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 56.39 33.89 23.21 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.969 -179.973 . . . . . . . . 3 3 . 1 . 068 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.7 t0 58.02 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.781 -179.962 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.574 ' H ' ' HD1' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -155.3 62.24 0.63 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.268 179.875 . . . . . . . . 3 3 . 1 . 068 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.373 -179.771 . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.895 0.379 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 23.9 mt -69.6 -5.43 24.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.469 179.898 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 77.36 -47.33 0.5 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.592 -179.886 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -70.35 -46.17 64.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.39 . . . . 0.0 110.365 179.838 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mm -83.92 -19.09 9.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.466 179.973 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.24 -30.3 69.59 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.017 -179.97 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -164.22 -80.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.669 0.271 . . . . 0.0 110.386 -179.99 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 45.89 89.3 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.185 179.905 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' A' ' 11' ' ' ILE . 2.8 t -70.82 0.14 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.924 0.392 . . . . 0.0 110.036 179.881 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 8' ' ' GLY . 45.6 mttm 66.47 -13.47 0.17 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.575 179.794 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.543 ' H ' ' C ' ' A' ' 9' ' ' VAL . 17.8 mt -126.4 -45.2 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.832 0.348 . . . . 0.0 110.97 -179.357 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.677 ' C ' ' H ' ' A' ' 14' ' ' GLY . 66.1 mt -95.97 -96.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.248 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.38 -7.76 2.18 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 176.434 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.0 -48.75 5.04 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 113.053 -1.573 . . . . 0.0 109.557 177.922 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.2 29.15 0.67 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 177.526 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.06 48.03 0.28 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.451 -178.687 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.0 mt 62.54 22.52 13.34 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.366 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.9 t70 55.73 -82.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.625 -179.875 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 31.9 m-70 -53.66 -33.93 56.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.59 179.973 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.163 -179.985 . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.901 0.382 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 tp -63.77 -16.96 62.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.243 179.907 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.451 ' C ' ' H ' ' A' ' 5' ' ' ILE . 33.1 ttt85 73.93 -64.72 0.38 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.369 -179.764 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 6' ' ' GLY . 77.0 mtp180 -69.57 3.13 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.257 179.651 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.451 ' H ' ' C ' ' A' ' 3' ' ' ARG . 13.1 mm 60.94 -75.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.497 -179.897 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -143.73 56.13 0.56 Allowed Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.962 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.2 mttm 59.1 65.63 1.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.806 0.336 . . . . 0.0 110.528 -179.851 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -165.45 163.69 36.75 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.901 -0.48 . . . . 0.0 111.901 -179.999 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -71.89 -81.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.631 0.253 . . . . 0.0 110.567 -179.832 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -171.34 -28.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.249 179.916 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.0 mt -132.06 -48.63 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.343 -179.894 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.677 ' C ' ' H ' ' A' ' 14' ' ' GLY . 65.3 mt -78.24 -94.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -179.788 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.11 -8.24 2.25 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 176.241 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.44 -47.53 6.81 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 112.899 -1.651 . . . . 0.0 110.186 178.133 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.82 29.31 0.81 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.757 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.75 39.29 0.33 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.755 -178.928 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 12' ' ' ILE . 0.9 OUTLIER 62.14 27.97 16.83 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.881 179.971 . . . . . . . . 3 3 . 1 . 070 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 t70 50.05 -91.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 179.949 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' LEU . 71.9 m80 -50.19 -25.2 3.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.732 -179.761 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.222 179.994 . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.741 0.305 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' A' ' 4' ' ' ARG . 16.6 mt -72.82 -10.68 60.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.53 179.925 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 73.11 -35.98 0.34 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 -179.898 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.523 ' H ' ' C ' ' A' ' 2' ' ' LEU . 40.6 ttm180 -74.02 -38.94 63.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.275 179.744 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 mt -96.94 -41.97 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.371 179.808 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -52.88 -30.69 37.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.159 -0.543 . . . . 0.0 111.84 179.875 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -75.58 102.14 5.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.772 0.32 . . . . 0.0 110.468 179.996 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.16 126.43 16.5 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.923 -179.936 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.2 -89.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.524 -179.964 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -171.86 -27.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.95 179.824 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.7 mt -123.91 -51.21 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.847 0.356 . . . . 0.0 110.867 -179.563 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.678 ' C ' ' H ' ' A' ' 14' ' ' GLY . 44.3 mm -83.79 -98.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.7 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.68 -10.89 0.73 Allowed Glycine 0 C--N 1.346 1.121 0 N-CA-C 108.544 -1.823 . . . . 0.0 108.544 176.654 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.57 -49.83 5.97 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 113.136 -1.532 . . . . 0.0 110.058 177.919 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -86.09 28.42 0.82 Allowed 'General case' 0 C--N 1.345 0.398 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.833 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.43 42.19 0.13 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.084 -179.16 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 60.87 44.49 10.72 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.633 179.796 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.9 t70 53.58 47.56 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 179.915 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 51.1 53.86 12.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.701 179.818 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 7.6 mp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.261 179.952 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.572 ' C ' ' H ' ' A' ' 3' ' ' ARG . 92.7 m95 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.687 0.28 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 4' ' ' ARG . 17.3 mt 63.66 -8.33 0.16 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.411 -179.992 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.572 ' H ' ' C ' ' A' ' 1' ' ' TRP . 47.7 ttp180 66.28 -14.46 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.478 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.551 ' H ' ' C ' ' A' ' 2' ' ' LEU . 92.6 mtt180 -138.7 -3.79 1.64 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.591 0.234 . . . . 0.0 110.7 -179.68 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 mt 60.53 -77.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.539 179.975 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -78.14 53.65 3.83 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 179.782 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -53.34 -76.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.6 0.238 . . . . 0.0 110.542 -179.705 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.87 113.02 4.03 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 179.82 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.91 -95.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.589 -179.861 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -172.08 -23.56 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.775 0.321 . . . . 0.0 110.469 179.959 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.3 mt -135.41 -44.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.559 -179.486 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.656 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.1 mt -90.34 -95.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.748 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.44 -8.34 1.76 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 175.976 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.656 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.64 -49.15 5.26 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 113.142 -1.529 . . . . 0.0 109.992 177.978 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.94 28.08 0.94 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.808 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.19 48.07 0.1 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.742 -178.877 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.6 mt 64.31 33.97 11.02 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.325 0.391 . . . . 0.0 110.259 -179.773 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 t0 57.0 -78.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.954 179.785 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 17' ' ' LEU . 16.1 p-80 -145.63 51.74 1.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.328 -179.871 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.195 179.986 . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 86.1 m95 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.834 0.35 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.539 ' C ' ' H ' ' A' ' 4' ' ' ARG . 15.7 mt -75.95 -15.73 60.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.641 -179.98 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 74.25 -22.42 0.25 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.495 -179.471 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.539 ' H ' ' C ' ' A' ' 2' ' ' LEU . 13.3 mmt85 -93.51 -15.02 25.95 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.342 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 mt 52.97 54.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.948 -179.898 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 47.01 20.59 0.75 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.202 -179.912 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.47 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 1.3 tppp? -170.17 -138.02 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.463 179.966 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.47 ' H ' ' CG ' ' A' ' 7' ' ' LYS . . . 155.18 -173.38 33.44 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -179.951 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -79.63 29.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.817 0.341 . . . . 0.0 110.633 179.929 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 8' ' ' GLY . 19.3 tptm -77.97 -16.98 57.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.289 -179.997 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.409 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.3 mt -138.5 -36.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.539 -179.64 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.6 mt -75.03 -88.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.989 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.44 -4.73 5.44 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 175.173 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.07 -43.87 7.35 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 113.197 -1.502 . . . . 0.0 110.258 178.389 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -88.06 28.07 1.11 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.702 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.88 39.25 0.42 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.454 -178.626 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 19' ' ' HIS . 5.0 tp 60.19 41.26 17.07 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.333 -179.778 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.9 0.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.492 ' H ' ' C ' ' A' ' 17' ' ' LEU . 6.7 t60 -170.79 -65.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 110.65 179.946 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 16' ' ' ALA . 16.7 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.847 0.356 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 074 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.5 mt -66.95 -6.12 15.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.278 179.708 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 71.61 -68.5 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.882 179.928 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -48.48 -21.64 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.817 0.341 . . . . 0.0 110.414 -179.81 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.44 62.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.063 179.959 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.68 -42.43 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.849 -179.982 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -70.34 -60.75 2.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.368 . . . . 0.0 110.401 179.934 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.21 104.1 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.853 -179.98 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.5 t -72.65 -84.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.613 0.244 . . . . 0.0 110.509 -179.942 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -171.43 -29.64 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.538 179.95 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 6.8 mm -131.52 -51.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.863 -179.981 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.668 ' C ' ' H ' ' A' ' 14' ' ' GLY . 42.6 mm -76.0 -97.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.841 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.01 -11.05 0.88 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 176.766 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.34 -48.93 7.09 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 113.029 -1.585 . . . . 0.0 110.128 178.024 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -85.19 28.8 0.69 Allowed 'General case' 0 C--N 1.343 0.323 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.597 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.93 38.47 0.25 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.899 -179.019 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tt 55.63 45.64 24.34 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.671 179.924 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 54.55 33.19 18.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.379 -179.703 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.0 m80 58.59 45.88 15.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.547 -179.987 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.137 179.912 . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.792 0.33 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.528 ' C ' ' H ' ' A' ' 4' ' ' ARG . 17.8 mt -73.55 -6.99 50.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.679 179.934 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 73.33 -36.2 0.34 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.292 -179.54 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.528 ' H ' ' C ' ' A' ' 2' ' ' LEU . 72.9 mtm180 -71.32 -32.12 68.23 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.275 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.4 pt -76.52 -29.72 18.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.357 179.761 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.42 -30.08 60.94 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.293 -0.48 . . . . 0.0 111.996 -179.95 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt 52.07 176.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 110.55 179.963 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.41 137.97 41.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.006 -179.898 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.4 t -76.62 -87.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 -179.991 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -171.29 -25.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.416 179.755 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.2 mp -132.46 -48.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 121.058 0.456 . . . . 0.0 110.341 179.569 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.661 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.1 mt -83.67 -94.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.667 -179.66 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.03 -8.59 2.38 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 176.1 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.661 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.52 -48.74 6.13 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 113.004 -1.598 . . . . 0.0 109.863 178.025 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.69 30.55 0.72 Allowed 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.553 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.21 44.15 0.46 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.527 -178.702 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.7 tp 65.27 21.67 12.04 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.279 -179.711 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.8 t70 56.14 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.998 179.853 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' LEU . 12.5 t-80 -49.32 -29.87 6.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.885 -179.687 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 tt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.15 179.985 . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.572 ' C ' ' H ' ' A' ' 3' ' ' ARG . 49.3 m95 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.669 0.271 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.583 ' C ' ' H ' ' A' ' 4' ' ' ARG . 18.7 mt 63.31 -7.62 0.16 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.472 179.892 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.572 ' H ' ' C ' ' A' ' 1' ' ' TRP . 40.1 mtt-85 66.43 -22.4 0.1 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.855 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.583 ' H ' ' C ' ' A' ' 2' ' ' LEU . 96.9 mtt180 -91.01 -34.35 15.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.854 0.359 . . . . 0.0 110.644 -179.965 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.0 mt 59.27 94.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.654 179.744 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 8' ' ' GLY . . . 46.08 18.17 0.26 Allowed Glycine 0 C--N 1.33 0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.458 179.647 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? 52.95 10.04 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.703 0.287 . . . . 0.0 110.731 179.904 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 6' ' ' GLY . . . -73.87 105.21 1.76 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.119 -0.562 . . . . 0.0 111.892 179.895 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.36 -95.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.438 -179.801 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -172.64 -24.4 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.823 0.344 . . . . 0.0 110.468 179.831 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.2 mt -137.44 -44.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.416 -179.483 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.686 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.0 mt -87.67 -94.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.849 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.79 -6.23 2.51 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 175.992 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.686 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.1 -47.71 5.69 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 113.182 -1.509 . . . . 0.0 109.755 177.987 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.76 27.37 1.15 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.484 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.9 48.19 0.19 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.408 -178.607 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 19' ' ' HIS . 9.6 mt 61.95 35.88 15.98 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.176 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 55.77 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.716 -179.669 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 17' ' ' LEU . 3.8 p-80 -162.27 46.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.472 -179.995 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.323 179.974 . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.741 0.305 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.97 -9.65 58.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.179 179.845 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 76.51 -49.07 0.57 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.619 179.962 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.3 mtp85 -73.47 -8.1 54.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.861 0.362 . . . . 0.0 110.379 179.895 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.9 mt -142.08 64.77 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.092 179.863 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.17 -35.18 0.2 Allowed Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -179.894 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.3 mttm 55.56 54.08 8.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.754 0.312 . . . . 0.0 110.803 179.689 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.18 107.24 1.71 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.703 179.708 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.35 -87.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.721 -179.693 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -170.86 -27.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.908 0.385 . . . . 0.0 110.247 -179.92 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 14.9 mt -131.71 -50.47 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.898 179.912 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.658 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.1 mm -76.68 -96.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.705 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.39 -9.66 1.1 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 108.379 -1.889 . . . . 0.0 108.379 176.425 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.658 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.97 -47.87 6.86 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 113.005 -1.597 . . . . 0.0 110.252 178.249 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.27 27.92 0.88 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.865 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.43 38.6 0.16 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.988 -179.083 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 58.21 42.36 22.09 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.691 179.836 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 54.61 -83.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.576 -179.849 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -163.01 52.97 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.36 179.954 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.187 -179.999 . . . . . . . . 0 0 . 1 . 078 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.807 0.337 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 078 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 tp -76.44 -73.01 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.533 -179.869 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -155.16 -12.31 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.833 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -153.02 2.47 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.548 179.556 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.0 mt 56.11 91.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.625 179.968 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.22 -24.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.184 -0.531 . . . . 0.0 111.973 -179.998 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt 56.46 106.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.803 0.335 . . . . 0.0 110.51 179.963 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.12 -164.16 54.34 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.191 179.948 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.42 -99.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.882 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -164.23 -20.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 110.481 179.785 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.7 mm -110.03 -46.83 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.83 -178.959 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.644 ' C ' ' H ' ' A' ' 14' ' ' GLY . 47.2 mm -98.36 -101.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.139 -178.695 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.47 -11.45 0.47 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 177.252 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.644 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.37 -48.09 5.47 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 177.824 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -82.97 27.13 0.56 Allowed 'General case' 0 C--N 1.342 0.265 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.642 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.35 39.99 0.14 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.968 -179.12 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 55.17 22.26 4.52 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.078 -179.983 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 53.56 -86.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.454 -179.742 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -50.21 -37.21 34.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.542 179.94 . . . . . . . . 3 3 . 1 . 078 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.165 179.921 . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.421 ' O ' ' CG ' ' A' ' 1' ' ' TRP . 71.7 t-105 . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 121.074 0.464 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.5 tp -178.84 -58.8 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.379 179.901 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -170.73 -21.46 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.774 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -177.38 19.47 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.208 179.456 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.9 mt 61.36 130.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.664 179.962 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.13 -66.46 2.54 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.703 179.438 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -87.31 -178.36 6.17 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.908 0.385 . . . . 0.0 110.944 -179.448 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.43 67.83 0.97 Allowed Glycine 0 C--N 1.335 0.501 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.989 -179.941 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.3 m -156.62 23.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.834 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -75.83 -14.85 60.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.985 0.421 . . . . 0.0 110.337 179.854 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 14.1 mt -138.35 -37.9 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.034 -179.565 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.683 ' C ' ' H ' ' A' ' 14' ' ' GLY . 86.3 mt -73.96 -88.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.788 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.97 -5.19 5.23 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 175.585 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.02 -43.28 7.66 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 113.091 -1.555 . . . . 0.0 110.189 178.504 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -88.1 28.4 1.07 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.845 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.49 37.06 0.45 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.509 -178.639 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.4 tt 54.2 49.59 18.31 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.838 -179.934 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 49.87 23.8 1.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.609 -179.989 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 54.08 57.59 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.468 -179.912 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.4 tp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.13 -179.838 . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 33.2 p90 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.713 0.292 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.5 mt -72.59 -74.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.526 -179.994 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 30.7 mtm105 -148.11 -11.76 0.37 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.711 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 5' ' ' ILE . 36.8 ttp180 -166.15 7.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.475 179.864 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.403 ' H ' ' H ' ' A' ' 4' ' ' ARG . 6.7 mt 55.56 48.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.365 179.991 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.05 43.17 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.03 -179.873 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -75.33 -74.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.323 . . . . 0.0 110.597 179.993 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.35 156.42 22.16 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.858 -179.997 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.3 t -74.47 -84.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.64 0.257 . . . . 0.0 110.587 -179.926 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -167.51 -23.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.567 -179.887 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.3 mt -139.71 -46.99 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.039 179.937 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.672 ' C ' ' H ' ' A' ' 14' ' ' GLY . 37.5 mt -78.14 -92.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.789 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.01 -8.19 2.95 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 176.121 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.672 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.25 -47.67 6.83 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 112.93 -1.635 . . . . 0.0 110.13 178.131 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.96 28.68 0.78 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.642 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.51 39.45 0.35 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.715 -178.848 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.1 tt 60.25 39.14 19.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.945 179.979 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 38.5 t70 47.88 61.38 3.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.5 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 27.0 p80 41.16 51.28 3.41 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.261 -179.98 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 7.7 mp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.187 179.975 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.401 ' CD1' ' N ' ' A' ' 1' ' ' TRP . 40.2 m95 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.695 0.283 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 3.1 mm? -63.12 -88.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.917 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -140.3 -15.73 0.96 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 179.591 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 55.8 mtt85 -154.22 17.18 0.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.503 179.532 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 7' ' ' LYS . 6.7 mt 56.54 43.75 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.949 -179.647 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 41.38 25.47 0.16 Allowed Glycine 0 C--N 1.332 0.348 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.445 -179.89 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 5' ' ' ILE . 52.5 tttm -69.43 -36.53 76.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.644 -179.831 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.38 166.56 29.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.163 179.969 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.2 t -74.47 -83.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.615 0.245 . . . . 0.0 110.421 179.993 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -171.1 -27.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.506 179.963 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.9 mm -133.69 -47.39 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.988 -179.924 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.685 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.8 mt -80.0 -93.39 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.862 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.6 -7.62 3.29 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 176.171 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.685 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.64 -47.38 6.79 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 112.799 -1.7 . . . . 0.0 110.008 178.165 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.67 29.35 0.61 Allowed 'General case' 0 C--N 1.343 0.319 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.467 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.5 38.46 0.5 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.444 -178.734 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.6 tt 54.76 50.86 14.85 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.632 -179.746 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t0 55.43 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.695 -179.796 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' LEU . 8.7 t60 -164.39 44.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.524 179.873 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.123 -179.97 . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.423 ' O ' ' CD2' ' A' ' 1' ' ' TRP . 42.4 p-90 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.808 0.337 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 7.7 mp -65.71 -88.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.255 -179.96 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -146.44 -11.04 0.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.895 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 5' ' ' ILE . 42.7 ttt85 -163.72 5.0 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.449 179.683 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.403 ' H ' ' H ' ' A' ' 4' ' ' ARG . 17.5 mt 60.57 93.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.393 179.97 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.33 68.79 1.53 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.022 -179.892 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.56 -170.61 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 110.547 180.0 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.27 104.44 0.13 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.993 179.948 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.0 t -77.88 -82.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.656 0.265 . . . . 0.0 110.522 -179.982 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -170.95 -25.46 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.721 -179.858 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -125.96 -52.62 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.391 -179.672 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.697 ' C ' ' H ' ' A' ' 14' ' ' GLY . 39.8 mm -75.58 -97.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.921 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.23 -10.28 0.8 Allowed Glycine 0 C--N 1.346 1.133 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 176.648 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.697 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.28 -48.08 7.07 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.144 -1.528 . . . . 0.0 110.258 178.053 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -88.34 30.36 0.89 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.797 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.44 42.81 0.29 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.802 -178.852 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.6 tp 63.82 51.52 2.36 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.25 -179.827 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 t0 69.91 -70.55 0.14 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.591 -179.758 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -159.88 19.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.457 179.934 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.248 179.876 . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.466 ' O ' ' CD1' ' A' ' 1' ' ' TRP . 28.5 p90 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.908 0.385 . . . . 0.0 110.511 . . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 9.0 mp -78.06 -76.24 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.932 179.852 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -148.09 -22.72 0.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.744 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -147.79 8.39 0.87 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.36 179.303 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mt 60.53 94.5 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.264 -179.812 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.23 53.76 4.67 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.704 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -60.42 123.24 16.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 110.586 -179.78 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.56 138.14 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.081 179.732 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.412 ' CG2' ' H ' ' A' ' 10' ' ' LYS . 1.5 m -57.12 -103.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.84 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.412 ' H ' ' CG2' ' A' ' 9' ' ' VAL . 54.8 tttm -158.2 -22.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.714 0.292 . . . . 0.0 110.731 -179.758 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -114.4 -49.1 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.411 -179.207 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.662 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.6 mt -91.8 -99.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.687 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.58 -10.74 1.01 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 176.931 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.662 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.83 -49.14 5.81 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.126 -1.537 . . . . 0.0 109.764 177.881 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -85.73 29.49 0.7 Allowed 'General case' 0 C--N 1.344 0.342 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.597 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.16 43.48 0.29 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.647 -178.853 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.6 tp 65.7 -1.19 1.09 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.231 -179.725 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 16' ' ' ALA . 19.5 t70 51.35 -85.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.08 179.647 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 84.5 m-70 -49.02 -17.96 0.25 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.931 -179.708 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.341 -179.976 . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 61.6 m95 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.754 0.311 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 18.2 tp -59.52 -81.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.09 0.472 . . . . 0.0 110.059 179.932 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.422 ' H ' ' H ' ' A' ' 4' ' ' ARG . 52.0 ttt85 -173.64 -18.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.754 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.422 ' H ' ' H ' ' A' ' 3' ' ' ARG . 68.5 mtp180 -149.87 6.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.35 179.413 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 mt 61.82 76.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.438 -179.877 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 56.95 82.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.069 179.871 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -53.36 -31.47 44.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 110.24 179.803 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 49.67 99.99 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.208 179.839 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' CG2' ' H ' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -66.75 -101.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.739 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.408 ' H ' ' CG2' ' A' ' 9' ' ' VAL . 72.3 tttt -162.52 -17.65 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.885 0.374 . . . . 0.0 110.48 -179.924 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.0 mm -119.38 -43.73 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.569 -178.946 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 14' ' ' GLY . 58.4 mt -96.73 -97.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.645 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.18 -7.44 1.87 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 176.493 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.05 -46.77 5.51 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 113.306 -1.447 . . . . 0.0 109.845 178.124 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.93 29.06 0.47 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.62 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.548 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 75.91 38.38 0.35 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.779 -178.91 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.4 tp 53.2 41.31 32.14 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.234 -179.731 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 55.48 31.46 17.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.321 -179.76 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.3 m80 53.23 69.02 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.378 -179.877 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.18 -179.849 . . . . . . . . 0 0 . 1 . 085 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.772 0.32 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 085 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.474 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 7.7 mp -64.14 -88.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.072 179.957 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.404 ' H ' ' H ' ' A' ' 4' ' ' ARG . 63.8 ttt-85 -142.3 -15.52 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.776 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.404 ' H ' ' H ' ' A' ' 3' ' ' ARG . 11.9 tpt180 -171.31 11.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.312 179.687 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.2 mt 59.86 85.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.355 -179.904 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.01 73.85 0.8 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.002 179.933 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -70.92 -3.14 17.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.473 179.943 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.66 -126.64 0.87 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.011 179.986 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.525 ' C ' ' H ' ' A' ' 11' ' ' ILE . 51.2 t -64.51 -14.49 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.651 0.262 . . . . 0.0 110.433 179.959 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 tttm 72.08 -20.0 0.26 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.396 179.845 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.525 ' H ' ' C ' ' A' ' 9' ' ' VAL . 12.9 mt -122.39 -44.69 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.737 0.303 . . . . 0.0 111.301 -179.189 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.67 ' C ' ' H ' ' A' ' 14' ' ' GLY . 69.9 mt -95.0 -95.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.935 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.95 -7.72 2.57 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 176.367 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.67 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.11 -48.02 5.29 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 113.08 -1.56 . . . . 0.0 110.001 178.193 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.25 27.86 0.56 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.834 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.77 39.88 0.16 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.936 -179.005 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.2 tp 54.22 39.46 30.81 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.255 -179.939 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 57.14 -79.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.752 179.996 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' LEU . 38.6 t-80 -63.58 -60.94 2.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 0.0 110.583 -179.999 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.206 -179.969 . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.825 0.345 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.5 mt -70.56 -7.29 42.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.484 -179.958 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 76.06 -45.19 0.52 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -73.04 -35.67 66.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.363 . . . . 0.0 110.322 179.855 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.8 tp -70.18 -36.71 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.094 179.895 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.74 -33.78 88.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.079 -0.582 . . . . 0.0 111.825 179.943 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -167.03 139.95 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.78 0.324 . . . . 0.0 110.479 179.914 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . -178.04 -135.57 2.31 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.015 -179.985 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.444 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 35.6 m -77.32 26.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.728 0.299 . . . . 0.0 110.813 -179.905 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -80.47 -17.33 52.0 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.741 . . . . . . . . 3 3 . 1 . 086 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -131.57 -38.86 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.434 -179.542 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.691 ' C ' ' H ' ' A' ' 14' ' ' GLY . 86.5 mt -76.36 -88.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.8 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.25 -4.06 4.45 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 175.343 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.691 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.69 -45.35 6.45 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 113.092 -1.554 . . . . 0.0 110.0 178.357 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.22 27.94 1.32 Allowed 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.755 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.458 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 73.28 45.73 0.26 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.437 -178.582 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.8 mt 63.91 28.7 14.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.297 -179.42 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 48.97 27.31 1.61 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.629 -179.905 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.0 m80 53.57 48.46 21.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.332 -179.782 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.279 -179.924 . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.803 0.335 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 37.9 tp -62.29 -14.2 36.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.924 179.843 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 78.65 -50.69 0.46 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.29 179.877 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -78.38 -34.52 48.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.435 179.674 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.8 mt 48.9 51.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.537 179.972 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 166.14 -2.54 0.05 OUTLIER Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.028 -179.934 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt 54.53 176.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.732 0.301 . . . . 0.0 110.639 -179.982 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.07 151.11 11.24 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.235 -0.507 . . . . 0.0 111.835 -179.989 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.9 t -73.54 -83.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.677 -179.883 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -170.89 -20.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.765 -179.885 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -135.99 -47.89 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.8 0.333 . . . . 0.0 110.58 -179.731 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.661 ' C ' ' H ' ' A' ' 14' ' ' GLY . 25.2 mt -84.09 -94.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.986 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.21 -9.42 2.08 Favored Glycine 0 C--N 1.345 1.033 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 176.201 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.661 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.98 -49.41 6.02 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 112.922 -1.639 . . . . 0.0 110.0 177.956 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.51 29.17 0.79 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.679 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.48 44.01 0.24 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.652 -178.917 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.5 tp 65.58 22.35 11.74 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.286 -179.908 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.2 t0 55.77 25.24 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.286 -179.817 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 53.58 70.25 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.438 -179.8 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.366 -179.902 . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 91.4 m95 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.864 0.364 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.579 ' C ' ' H ' ' A' ' 4' ' ' ARG . 18.3 mt -78.53 -10.42 59.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.7 -179.905 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 64.73 -13.92 0.1 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.708 -179.897 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.579 ' H ' ' C ' ' A' ' 2' ' ' LEU . 54.6 mtt85 -109.77 -14.69 14.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.735 0.303 . . . . 0.0 110.534 -179.926 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.9 tt -51.12 -29.66 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.46 179.958 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' GLY . . . 171.04 13.01 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.185 -0.531 . . . . 0.0 111.791 179.954 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 58.63 -77.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.589 0.233 . . . . 0.0 110.796 179.928 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 67.93 68.41 1.66 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.763 -179.994 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 m -76.76 32.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 110.789 -179.747 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 8' ' ' GLY . 26.7 mmtp -82.78 -11.59 58.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 110.332 179.804 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.402 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.7 mt -139.92 -39.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.134 -179.532 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.689 ' C ' ' H ' ' A' ' 14' ' ' GLY . 70.0 mt -75.75 -88.83 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.948 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.44 -5.53 4.98 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 175.427 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.689 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.93 -44.65 7.04 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.147 -1.526 . . . . 0.0 110.342 178.498 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -87.37 27.04 1.13 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.849 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.05 37.77 0.2 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.818 -178.892 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 55.36 17.84 2.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.911 179.941 . . . . . . . . 3 3 . 1 . 088 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t0 56.24 -80.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.8 -179.962 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.4 t-80 -50.67 -61.46 2.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.848 0.356 . . . . 0.0 110.611 -179.922 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.1 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.463 179.944 . . . . . . . . 0 0 . 1 . 089 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 41.4 m95 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.794 0.33 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 089 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 4' ' ' ARG . 12.2 mt -73.43 -13.91 61.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.414 179.896 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 74.62 -38.83 0.4 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.634 -179.996 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.48 ' H ' ' C ' ' A' ' 2' ' ' LEU . 73.9 mtt-85 -76.54 -24.12 53.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.917 0.389 . . . . 0.0 110.435 179.881 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.8 tp -55.32 -39.12 50.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.033 179.895 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.28 -12.34 84.68 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 179.888 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -168.83 105.48 0.42 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.725 0.298 . . . . 0.0 110.481 -179.886 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.87 -89.54 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.139 179.974 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 11' ' ' ILE . 14.6 t -146.44 -15.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.808 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 tptp 70.63 -13.8 0.45 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.254 179.798 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.505 ' H ' ' C ' ' A' ' 9' ' ' VAL . 13.3 mt -123.08 -46.0 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.138 -179.272 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.683 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.8 mm -97.79 -99.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.034 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.57 -9.4 0.71 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 176.67 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.83 -48.23 5.01 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.441 -1.38 . . . . 0.0 110.065 177.953 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -86.63 25.76 1.2 Allowed 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.923 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 18' ' ' ASP . . . 78.21 48.6 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.864 -178.893 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.7 mt 62.6 1.86 0.84 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.268 -179.686 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 16' ' ' ALA . 27.9 t70 51.08 46.24 26.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.633 -179.938 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 11.1 t60 55.5 35.68 25.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.583 -179.976 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.067 -179.946 . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.799 0.333 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.9 mt -69.47 -68.8 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.222 0.534 . . . . 0.0 110.558 179.984 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -172.02 -16.51 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.988 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.429 ' H ' ' H ' ' A' ' 5' ' ' ILE . 3.0 ptp85 -178.63 10.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.215 179.652 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.429 ' H ' ' H ' ' A' ' 4' ' ' ARG . 10.6 mm 58.71 82.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.229 -179.76 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' H ' ' H ' ' A' ' 7' ' ' LYS . . . -163.68 -7.2 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 -179.915 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' H ' ' H ' ' A' ' 6' ' ' GLY . 15.7 mtpp 55.75 -154.17 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.672 0.273 . . . . 0.0 110.308 179.889 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -42.07 144.3 0.96 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.466 -179.751 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.8 t -71.67 -77.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.736 0.303 . . . . 0.0 110.534 -179.925 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -172.19 -18.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.02 0.438 . . . . 0.0 109.98 -179.908 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.2 mt -142.79 -45.35 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.098 -179.947 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.678 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.9 mt -78.44 -90.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.923 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.73 -7.17 4.24 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 107.546 -2.222 . . . . 0.0 107.546 175.706 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.678 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.45 -47.13 6.54 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.859 -1.671 . . . . 0.0 110.229 178.443 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -86.07 28.2 0.83 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.75 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.25 40.36 0.25 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.641 -178.801 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.1 tp 58.54 36.75 25.38 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.218 -179.847 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 54.92 -83.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.703 -179.899 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 28.0 m80 -52.59 -63.7 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.717 -179.929 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.193 -179.874 . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 74.1 m95 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.906 0.384 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.512 ' C ' ' H ' ' A' ' 4' ' ' ARG . 14.9 mt -72.79 -16.84 61.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.413 179.922 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 73.53 -35.87 0.33 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.827 179.946 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.512 ' H ' ' C ' ' A' ' 2' ' ' LEU . 72.2 mtt85 -78.78 -20.14 50.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.562 -179.979 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mt -146.22 68.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.251 179.978 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.04 -48.86 0.18 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.83 179.979 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 53.76 172.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.752 0.31 . . . . 0.0 110.637 179.941 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 170.58 154.13 9.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.272 -0.49 . . . . 0.0 111.932 179.929 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 14' ' ' GLY . 29.8 m -74.41 16.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.618 0.247 . . . . 0.0 110.728 -179.946 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.496 ' H ' ' C ' ' A' ' 8' ' ' GLY . 49.3 mtpt -77.76 -14.16 59.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.008 0.433 . . . . 0.0 110.026 179.69 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.93 -41.7 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.22 -179.704 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.682 ' C ' ' H ' ' A' ' 14' ' ' GLY . 31.2 mt -75.63 -89.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.379 -179.794 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.21 -5.62 3.45 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 107.631 -2.188 . . . . 0.0 107.631 175.673 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.84 -45.87 6.54 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 113.03 -1.585 . . . . 0.0 110.097 178.342 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.79 28.63 1.3 Allowed 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.813 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 73.28 46.27 0.23 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.54 -178.668 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.8 mt 64.28 11.66 6.56 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.202 -179.494 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.1 t70 58.45 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 -179.823 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 33.6 t-80 -160.16 32.05 0.17 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.618 179.997 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 N--CA 1.468 0.445 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.264 179.806 . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.562 ' C ' ' H ' ' A' ' 3' ' ' ARG . 89.8 m95 . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.759 0.314 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.583 ' C ' ' H ' ' A' ' 4' ' ' ARG . 23.2 mt 63.75 -8.84 0.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.62 179.979 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' A' ' 1' ' ' TRP . 65.7 mtt180 62.97 -13.65 0.07 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.6 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.583 ' H ' ' C ' ' A' ' 2' ' ' LEU . 74.9 mtp180 -135.37 -0.74 2.65 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.717 0.294 . . . . 0.0 110.527 -179.731 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.5 mt 51.47 79.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.227 -179.86 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.68 68.02 1.27 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 111.636 -0.585 . . . . 0.0 111.636 -179.57 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -49.98 -20.18 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.636 0.255 . . . . 0.0 110.936 -179.678 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.07 -108.03 0.26 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.351 179.963 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.503 ' C ' ' H ' ' A' ' 11' ' ' ILE . 30.2 t -140.3 -14.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.77 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.0 tttt 73.27 -18.99 0.34 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.211 179.849 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.503 ' H ' ' C ' ' A' ' 9' ' ' VAL . 11.6 mt -116.68 -47.52 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.545 -179.085 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.665 ' C ' ' H ' ' A' ' 14' ' ' GLY . 70.4 mt -94.77 -98.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.728 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.3 -9.4 1.49 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 176.916 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.665 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.59 -48.65 5.48 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 113.105 -1.548 . . . . 0.0 109.857 177.859 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.93 29.88 0.61 Allowed 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.737 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.34 42.92 0.3 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.84 -178.85 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.5 tp 59.47 50.7 7.25 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.286 -179.809 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.7 t0 56.74 35.61 26.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.463 -179.874 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.2 m80 55.91 39.57 30.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.561 179.966 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.194 179.868 . . . . . . . . 0 0 . 1 . 093 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.79 0.328 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 093 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.9 mt -69.2 -7.23 34.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.472 -179.947 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 7' ' ' LYS . 27.3 ttm180 73.21 -66.5 0.31 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.758 -179.928 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -57.79 -15.68 8.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.718 -179.845 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 tp -61.4 -30.92 49.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.121 179.964 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.32 -14.65 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 179.971 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 3' ' ' ARG . 68.5 tttt 63.31 -131.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.909 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.44 125.61 7.06 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.365 -0.445 . . . . 0.0 112.077 -179.798 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.531 ' C ' ' H ' ' A' ' 11' ' ' ILE . 25.9 t -60.21 -19.7 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.764 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm 70.96 -23.59 0.17 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.488 179.879 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.531 ' H ' ' C ' ' A' ' 9' ' ' VAL . 10.9 mt -113.3 -48.92 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 120.759 0.314 . . . . 0.0 111.754 -179.094 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.659 ' C ' ' H ' ' A' ' 14' ' ' GLY . 59.8 mt -91.83 -99.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.473 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.82 -8.27 1.3 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 176.915 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.659 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.52 -47.91 5.81 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 113.113 -1.544 . . . . 0.0 109.617 177.931 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -82.55 30.03 0.43 Allowed 'General case' 0 C--N 1.343 0.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.479 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.55 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.54 36.68 0.6 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.673 -178.831 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.53 ' C ' ' H ' ' A' ' 19' ' ' HIS . 1.1 tt 54.44 38.49 29.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.972 -179.732 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.5 t70 59.19 1.19 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.09 179.933 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.53 ' H ' ' C ' ' A' ' 17' ' ' LEU . 47.5 t-80 -172.28 -72.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.879 0.371 . . . . 0.0 110.541 179.923 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.278 -179.913 . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.791 0.329 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.57 ' C ' ' H ' ' A' ' 4' ' ' ARG . 14.7 mt -70.63 -6.68 38.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.248 179.799 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 66.58 -13.83 0.17 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.448 -179.941 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.57 ' H ' ' C ' ' A' ' 2' ' ' LEU . 59.1 mtt-85 -132.91 1.46 3.59 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.922 0.391 . . . . 0.0 110.068 179.79 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mt 50.19 53.6 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.627 179.759 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.89 -71.58 0.27 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.38 -0.438 . . . . 0.0 112.043 179.937 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -71.01 -158.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.657 0.265 . . . . 0.0 110.415 -179.73 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 83.46 -26.26 4.64 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 -179.967 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 16.7 m -78.04 28.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 110.611 179.962 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 8' ' ' GLY . 18.9 tptm -80.44 -16.25 54.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.169 0.509 . . . . 0.0 109.789 179.808 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.3 mt -132.77 -39.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.501 -179.721 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.691 ' C ' ' H ' ' A' ' 14' ' ' GLY . 84.6 mt -75.49 -89.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.93 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.408 ' H ' ' HB ' ' A' ' 12' ' ' ILE . . . -60.23 -4.56 3.73 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 175.334 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.691 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.78 -45.38 6.79 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 113.128 -1.536 . . . . 0.0 109.855 178.16 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.44 29.46 1.28 Allowed 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.573 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 70.08 46.94 0.6 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.221 -178.422 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.5 mt 63.81 12.79 6.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.021 -179.219 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 t0 56.63 46.25 20.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.691 -179.94 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.8 m170 50.15 49.83 19.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.617 179.99 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.519 -179.922 . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 31.5 p90 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.689 0.28 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.92 -71.56 0.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.129 0.49 . . . . 0.0 110.415 -179.995 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.448 ' H ' ' H ' ' A' ' 4' ' ' ARG . 70.4 ttt180 -163.15 -16.68 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.827 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 6' ' ' GLY . 57.0 ttt-85 -166.51 9.84 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.933 179.628 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.7 pt 37.32 25.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.498 -179.818 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -110.86 -67.29 0.55 Allowed Glycine 0 C--N 1.335 0.506 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 179.83 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -77.9 133.84 38.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.723 0.297 . . . . 0.0 110.372 179.906 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.46 135.24 2.58 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.082 -179.996 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 11' ' ' ILE . 21.8 t -74.2 -14.52 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 179.988 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? 68.49 -13.21 0.32 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.341 179.752 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.549 ' H ' ' C ' ' A' ' 9' ' ' VAL . 18.9 mt -122.73 -44.22 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 120.859 0.361 . . . . 0.0 111.205 -179.113 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.67 ' C ' ' H ' ' A' ' 14' ' ' GLY . 67.6 mt -97.79 -97.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 -178.655 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.69 -7.35 2.15 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 176.884 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.67 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.79 -47.12 5.46 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 113.317 -1.442 . . . . 0.0 109.593 177.915 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.93 30.55 0.44 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.556 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.541 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.1 38.43 0.56 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.935 -178.99 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 50.37 29.85 4.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.981 -179.833 . . . . . . . . 3 3 . 1 . 095 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.7 t70 55.1 -82.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.747 -179.903 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 19.4 t-80 -48.17 -66.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.696 -179.891 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.411 179.745 . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.799 0.333 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' A' ' 4' ' ' ARG . 6.5 mp -68.9 -11.03 60.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.035 -179.954 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 28.6 ttt85 75.4 -36.89 0.32 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.379 -179.685 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.539 ' HE ' ' N ' ' A' ' 4' ' ' ARG . 4.7 mmp_? -77.21 -19.65 56.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.3 179.648 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 6' ' ' GLY . 15.8 tt -60.89 -43.64 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.52 179.983 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 8' ' ' GLY . . . -168.38 2.2 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 -179.98 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 83.4 tttt 56.88 -80.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.519 0.2 . . . . 0.0 110.94 179.937 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . 54.77 93.4 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.87 -179.787 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.6 t -72.85 -88.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 121.134 -0.227 . . . . 0.0 110.709 -179.856 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -171.87 -26.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.869 0.366 . . . . 0.0 110.58 -179.879 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.4 mt -133.08 -50.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.167 -179.964 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.675 ' C ' ' H ' ' A' ' 14' ' ' GLY . 33.0 mm -76.62 -95.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.781 179.876 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.67 -9.53 1.21 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 176.313 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.77 -48.16 6.79 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 112.978 -1.611 . . . . 0.0 110.204 178.168 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -85.77 29.02 0.73 Allowed 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.753 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 76.77 38.73 0.25 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.882 -178.917 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 58.03 47.58 14.55 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.186 179.83 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.434 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 12.6 m-20 60.95 -76.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.74 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 17' ' ' LEU . 73.0 m80 -155.62 54.6 0.61 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.825 0.345 . . . . 0.0 110.465 -179.951 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 7.4 mp . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.221 179.973 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 85.0 m95 . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.769 0.318 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 40.7 tp -51.93 -17.54 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.951 179.802 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.467 ' C ' ' HE ' ' A' ' 4' ' ' ARG . 49.0 ttm-85 76.0 -44.13 0.49 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.603 179.903 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.616 ' HE ' ' N ' ' A' ' 4' ' ' ARG . 4.0 mmp_? -77.58 -19.15 56.1 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.273 179.652 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.3 pt 34.59 37.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.688 179.88 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.0 22.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.232 -0.509 . . . . 0.0 111.865 -179.977 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt 51.12 99.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.858 0.361 . . . . 0.0 110.374 -179.996 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.74 142.16 44.91 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.2 -179.792 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.521 ' C ' ' H ' ' A' ' 11' ' ' ILE . 41.2 t -74.87 -12.52 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.704 0.287 . . . . 0.0 110.265 179.918 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.1 tttp 71.38 -20.5 0.23 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.541 179.745 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.521 ' H ' ' C ' ' A' ' 9' ' ' VAL . 16.4 mt -123.18 -45.66 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 120.802 0.334 . . . . 0.0 111.166 -179.189 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.69 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.8 mt -92.62 -97.19 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.101 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.17 -7.44 1.86 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 176.219 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.69 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.49 -47.46 5.68 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 113.225 -1.487 . . . . 0.0 109.942 177.993 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.69 28.94 0.46 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.51 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.567 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.78 38.54 0.46 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.41 -178.699 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.6 tp 57.02 47.79 16.87 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.173 -179.688 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.6 t70 52.22 29.72 6.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.464 -179.964 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 52.06 55.9 8.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.508 -179.986 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.359 -179.985 . . . . . . . . 0 0 . 1 . 098 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.511 ' C ' ' H ' ' A' ' 3' ' ' ARG . 23.8 m-90 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.721 0.296 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 tp 67.66 -6.94 0.62 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.83 179.942 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.511 ' H ' ' C ' ' A' ' 1' ' ' TRP . 0.5 OUTLIER 72.94 -67.8 0.25 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.18 -179.865 . . . . . . . . 3 3 . 1 . 098 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -69.56 7.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.739 179.848 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.51 ' H ' ' C ' ' A' ' 3' ' ' ARG . 37.2 pt 36.06 46.66 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.733 179.852 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.34 66.83 1.57 Allowed Glycine 0 C--N 1.331 0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.063 179.849 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 53.2 -147.58 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.64 179.87 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.08 112.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.952 179.902 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.535 ' C ' ' H ' ' A' ' 11' ' ' ILE . 2.7 t -70.84 -1.41 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.857 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 tttm 71.73 -19.58 0.26 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.28 179.829 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.535 ' H ' ' C ' ' A' ' 9' ' ' VAL . 13.9 mt -117.75 -47.71 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.761 0.315 . . . . 0.0 111.355 -179.098 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 14' ' ' GLY . 59.1 mt -95.48 -99.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.993 -178.547 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.88 -10.11 0.96 Allowed Glycine 0 C--N 1.345 1.034 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 177.128 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.79 -48.89 5.32 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 113.057 -1.571 . . . . 0.0 109.797 177.951 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 12' ' ' ILE . . . -84.01 28.54 0.6 Allowed 'General case' 0 C--N 1.342 0.277 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.951 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 78.95 38.71 0.13 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.356 -179.343 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 51.82 31.25 7.97 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.174 179.77 . . . . . . . . 3 3 . 1 . 098 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.0 t0 56.64 -79.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.831 -179.954 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 17' ' ' LEU . 17.0 m-70 -49.34 -67.12 0.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.74 179.935 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.173 179.988 . . . . . . . . 0 0 . 1 . 099 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 78.4 m95 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.87 0.367 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 099 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 9.9 mp -64.44 -81.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.196 0.522 . . . . 0.0 110.037 179.799 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -169.27 -30.86 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.783 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -142.67 0.85 1.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.157 179.206 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.1 mt 59.28 83.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.283 -179.9 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.63 75.08 0.41 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.141 -0.552 . . . . 0.0 111.972 -179.967 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -73.19 175.23 6.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.651 -179.862 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 89.12 -0.67 81.98 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.185 179.922 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.425 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 30.2 m -76.35 31.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.625 0.25 . . . . 0.0 110.779 -179.975 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 8' ' ' GLY . 56.3 mttm -83.35 -12.19 56.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.956 0.408 . . . . 0.0 110.224 179.871 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.7 mt -137.65 -40.4 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.19 -179.56 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.716 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.2 mt -76.06 -89.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.928 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.04 -4.87 3.77 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 175.529 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.716 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.13 -45.55 6.56 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 113.02 -1.59 . . . . 0.0 110.144 178.365 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -90.62 29.34 1.32 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.832 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 72.64 46.9 0.26 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.425 -178.56 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.3 mt 65.11 13.48 8.73 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.389 0.431 . . . . 0.0 110.121 -179.393 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 t70 57.28 -78.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.041 179.761 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 17' ' ' LEU . 97.2 m-70 -50.26 -57.44 7.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.773 -179.801 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.173 179.974 . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 26.9 m95 . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.764 0.316 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 2.4 mm? -68.13 -85.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.063 0.459 . . . . 0.0 110.053 -179.886 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 4' ' ' ARG . 47.6 ttm-85 -157.82 -15.47 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.82 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.415 ' H ' ' H ' ' A' ' 5' ' ' ILE . 4.4 tpt180 -165.11 6.87 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.355 179.753 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 1.9 mp 53.91 93.54 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.166 179.939 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 44.84 43.1 8.11 Favored Glycine 0 CA--C 1.518 0.278 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.723 179.616 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.49 ' N ' ' CD ' ' A' ' 7' ' ' LYS . 3.1 mptp? 50.24 100.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.915 0.388 . . . . 0.0 110.621 179.557 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -49.96 142.21 13.53 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.764 179.736 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.6 -82.39 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 110.624 -179.919 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -171.34 -24.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.29 -179.958 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.6 mt -139.44 -48.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.803 179.924 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.677 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.3 mm -77.58 -94.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.419 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.407 ' H ' ' HB ' ' A' ' 12' ' ' ILE . . . -54.93 -8.97 1.59 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 176.24 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.677 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.17 -48.02 6.68 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 112.992 -1.604 . . . . 0.0 110.181 178.164 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 11' ' ' ILE . . . -85.28 28.66 0.71 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.737 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 77.11 38.04 0.25 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.905 -179.019 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.4 tt 54.86 46.49 24.36 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.842 179.892 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 54.1 -84.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -179.754 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -162.28 50.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.524 179.876 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.489 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 7.5 mp . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.251 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.4 tptp . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.931 0.396 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 14.6 mt -136.28 -43.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.659 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.2 mt -92.29 -94.69 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.95 -5.97 2.51 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 108.131 -1.987 . . . . 0.0 108.131 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.48 -48.26 5.09 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 113.099 -1.551 . . . . 0.0 109.708 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.44 25.91 1.15 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.12 48.01 0.1 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.681 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.3 mt 60.93 29.28 18.92 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.104 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 53.7 61.69 2.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.436 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 49.19 45.75 23.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.697 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.4 mp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.139 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 12' ' ' ILE . 81.7 tttt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.586 0.231 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' ALA . 15.8 pt -71.4 7.2 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.504 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.621 ' C ' ' H ' ' A' ' 14' ' ' GLY . 45.3 mm -71.41 -88.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.41 -3.94 3.4 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 107.479 -2.248 . . . . 0.0 107.479 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.0 -39.08 8.18 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 113.702 -1.249 . . . . 0.0 110.124 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -90.88 25.94 2.24 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.78 35.4 0.21 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.6 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 53.48 33.33 15.84 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.91 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.5 t0 56.54 -79.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' LEU . 46.5 m-70 -50.2 -63.68 1.04 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.657 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.069 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.3 tttt . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.773 0.32 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.1 mt -117.84 -45.57 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.398 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 14' ' ' GLY . 68.2 mt -94.97 -97.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.13 -8.42 1.53 Allowed Glycine 0 C--N 1.344 1.01 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.2 -47.48 5.48 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 113.227 -1.486 . . . . 0.0 110.106 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.46 26.34 0.8 Allowed 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 80.3 39.84 0.08 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.105 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.4 tp 55.76 22.85 5.81 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.335 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 53.72 -85.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.707 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' LEU . 20.2 m80 -49.8 -39.47 38.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.554 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.451 ' C ' HD23 ' A' ' 20' ' ' LEU . 2.0 tt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.192 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.7 tttt . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.77 0.319 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.7 mt -137.07 -45.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.218 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.596 ' C ' ' H ' ' A' ' 14' ' ' GLY . 66.3 mt -82.83 -93.97 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.64 -8.27 2.69 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 107.882 -2.087 . . . . 0.0 107.882 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.52 -48.06 6.49 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 113.099 -1.551 . . . . 0.0 109.946 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.89 30.05 0.77 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.54 41.61 0.44 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.573 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.7 tt 66.39 53.57 0.98 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.82 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.9 t0 55.51 -81.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.909 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.506 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -150.34 39.24 0.73 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.559 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.434 179.887 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.421 ' N ' ' CD ' ' A' ' 10' ' ' LYS . 3.5 mptp? . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 121.004 0.43 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.39 -36.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.125 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.607 ' C ' ' H ' ' A' ' 14' ' ' GLY . 87.1 mt -77.3 -87.76 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.41 -4.95 5.64 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 107.199 -2.36 . . . . 0.0 107.199 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.91 -45.84 6.53 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 113.102 -1.549 . . . . 0.0 110.092 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.78 30.54 0.82 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 71.78 42.73 0.61 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.484 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 61.28 53.52 3.49 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.31 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.28 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.671 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 1.1 t60 -159.43 52.86 0.37 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 0.0 110.355 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 20' ' ' LEU . 9.2 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.109 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.007 0.432 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.9 mt -140.32 -37.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.167 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.603 ' C ' ' H ' ' A' ' 14' ' ' GLY . 39.1 mm -75.57 -87.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.98 -5.24 5.31 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 107.217 -2.353 . . . . 0.0 107.217 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.51 -44.81 7.18 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 113.207 -1.496 . . . . 0.0 110.266 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.51 27.8 1.06 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.69 39.06 0.35 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.573 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 58.66 44.69 17.03 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.259 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 54.64 36.59 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.437 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 13.4 t-80 51.04 46.47 26.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.606 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.477 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.9 tttt . . . . . 0 N--CA 1.464 0.253 0 CA-C-O 120.703 0.287 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.4 mt -119.77 -54.89 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.191 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.7 mt -77.67 -95.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.691 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.34 -8.19 1.61 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.32 -48.2 6.09 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 112.835 -1.682 . . . . 0.0 110.102 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.98 28.66 1.01 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.67 46.98 0.18 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.63 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.7 mt 62.91 41.54 8.5 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 53.07 31.16 10.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.297 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 51.38 62.84 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.479 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.394 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 121.028 0.442 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -118.85 -52.58 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.664 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.613 ' C ' ' H ' ' A' ' 14' ' ' GLY . 42.3 mm -73.84 -98.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.205 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.38 -10.71 0.6 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.24 -47.65 7.37 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 113.243 -1.479 . . . . 0.0 110.126 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.2 27.2 1.08 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.02 39.64 0.16 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.751 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 64.89 17.43 11.03 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.826 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.5 t70 55.35 -82.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.683 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 1.4 t-80 -54.39 -69.78 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.48 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 N--CA 1.464 0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.453 179.881 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.5 tttm . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.834 0.35 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.5 mt -117.5 -52.15 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 34.9 mm -85.76 -99.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.04 -11.15 0.54 Allowed Glycine 0 C--N 1.348 1.201 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.89 -49.88 5.83 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 113.12 -1.54 . . . . 0.0 109.875 177.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.544 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.86 29.33 0.63 Allowed 'General case' 0 C--N 1.345 0.395 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.82 37.79 0.15 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.478 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 52.49 36.76 21.13 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.213 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 53.51 -84.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.83 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 51.9 m80 -45.61 -63.39 0.97 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.083 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.4 tttm . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 120.554 0.216 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.445 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.0 mt -113.81 -48.21 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.83 0.348 . . . . 0.0 111.481 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.563 ' C ' ' N ' ' A' ' 14' ' ' GLY . 41.4 mm -96.56 -101.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.046 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.425 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -50.11 -12.09 0.47 Allowed Glycine 0 C--N 1.345 1.077 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.563 ' N ' ' C ' ' A' ' 12' ' ' ILE . . . -82.19 -48.51 5.66 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 113.504 -1.348 . . . . 0.0 110.055 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.59 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.15 22.39 1.21 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 83.22 41.96 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.951 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.8 tp 61.71 6.45 1.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.252 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.0 t70 53.16 38.11 26.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.61 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 29.4 m170 50.03 55.42 9.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.631 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.227 -179.924 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 121.208 0.528 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 11.9 mt -112.54 -44.85 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.74 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.592 ' C ' ' H ' ' A' ' 14' ' ' GLY . 82.6 mt -73.65 -91.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.154 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.64 -8.61 2.05 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 176.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.23 -46.14 7.14 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 113.219 -1.491 . . . . 0.0 110.213 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.47 31.0 0.59 Allowed 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.16 37.68 0.74 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.684 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.7 tt 57.23 50.19 12.12 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.726 -0.789 . . . . 0.0 109.684 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 55.17 -82.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.665 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -163.62 51.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.502 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.578 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 82.5 tttt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.853 0.358 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -127.98 -44.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.772 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 69.0 mt -89.94 -95.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.0 -7.6 2.52 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.87 -47.0 6.04 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 113.182 -1.509 . . . . 0.0 110.032 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.31 30.27 0.54 Allowed 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.24 37.79 0.44 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.805 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 52.83 46.79 26.05 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.899 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 49.74 47.58 22.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.704 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 50.2 44.54 26.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.588 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 20' ' ' LEU . 8.4 mp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.089 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 tptp . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.78 0.324 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -134.31 -51.2 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.292 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 73.6 mt -77.05 -94.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.27 -8.38 2.47 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 176.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.95 -47.43 7.12 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 112.853 -1.673 . . . . 0.0 110.047 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.72 30.5 0.64 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.15 37.94 0.58 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.634 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 19' ' ' HIS . 1.1 tt 57.22 38.49 28.82 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.848 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.4 t70 60.5 0.48 0.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.081 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.466 ' H ' ' C ' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -173.43 -72.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.267 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.42 -179.846 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.5 tptt . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 120.868 0.366 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.9 mt -118.64 -48.66 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 14' ' ' GLY . 44.0 mm -91.86 -99.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.425 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.69 -10.67 0.7 Allowed Glycine 0 C--N 1.347 1.139 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 176.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.591 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.43 -49.03 5.66 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 113.223 -1.488 . . . . 0.0 109.886 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.555 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -83.79 27.4 0.64 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 79.68 38.2 0.11 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.229 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.99 31.39 10.92 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.094 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 49.76 53.82 12.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 52.32 57.88 5.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.646 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.225 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.771 0.319 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.5 mt -134.07 -47.28 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.223 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.1 mt -79.22 -92.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.99 -8.89 2.5 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 176.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.28 -48.5 6.37 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 112.923 -1.638 . . . . 0.0 110.27 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.68 28.65 0.86 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.74 41.25 0.18 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.876 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.6 tp 61.19 26.43 16.31 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.299 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 t0 58.31 -77.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.949 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.548 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER -48.58 -62.46 1.49 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.756 0.313 . . . . 0.0 110.824 -179.758 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.514 -180.0 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm . . . . . 0 N--CA 1.461 0.111 0 CA-C-O 120.985 0.421 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -139.9 -40.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.432 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.617 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.2 mt -76.46 -88.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.08 -5.78 4.79 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 107.271 -2.332 . . . . 0.0 107.271 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.617 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.34 -45.76 6.82 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 113.106 -1.547 . . . . 0.0 110.198 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.64 27.72 0.94 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.91 37.8 0.27 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.802 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.3 tp 58.66 27.15 15.44 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 55.33 -82.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 56.7 t-80 -49.45 -60.72 2.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.739 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.137 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.664 0.269 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 15' ' ' ALA . 16.2 pt -78.3 6.54 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.681 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.9 mm -70.66 -89.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.22 -4.17 3.39 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 107.488 -2.245 . . . . 0.0 107.488 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.01 -38.99 8.81 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -93.91 27.5 2.74 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.54 38.52 0.38 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.552 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.4 tt 66.14 44.27 2.65 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.731 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 59.8 t0 55.29 35.35 24.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.493 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.3 m80 52.57 57.61 6.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.532 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.471 ' C ' HD23 ' A' ' 20' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.6 tttp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.901 0.382 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 15.3 mt -131.07 -46.99 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.366 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.603 ' C ' ' H ' ' A' ' 14' ' ' GLY . 28.3 mt -81.99 -94.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.425 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -56.12 -7.38 1.79 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.24 -48.16 5.8 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.013 -1.593 . . . . 0.0 110.133 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -89.69 29.94 1.1 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.26 48.09 0.13 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.785 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.4 mt 64.08 49.83 2.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.8 t0 59.63 -76.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.746 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -162.45 26.95 0.11 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.729 0.299 . . . . 0.0 110.482 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.422 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.08 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.2 tttp . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.651 0.262 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -129.3 -44.43 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.095 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 73.7 mt -90.75 -94.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.22 -6.98 3.47 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.45 -47.57 5.65 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 113.062 -1.569 . . . . 0.0 110.121 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.87 27.21 0.77 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.22 40.4 0.13 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.863 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.5 tp 56.56 23.2 7.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.248 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 57.48 11.62 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.184 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -171.3 -44.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.764 0.316 . . . . 0.0 110.648 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.405 ' H ' ' HB3' ' A' ' 17' ' ' LEU . 1.2 tt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.126 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.1 tttt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.853 0.359 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.4 mt -139.6 -42.9 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.356 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.7 mt -86.84 -91.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.33 -6.62 4.55 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.4 -47.63 5.97 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 112.909 -1.645 . . . . 0.0 109.892 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.51 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.84 25.88 0.89 Allowed 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.78 43.15 0.18 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.576 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 69.51 51.69 0.47 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.377 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.6 t70 60.61 -76.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.591 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.478 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -160.77 50.85 0.27 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 0.0 110.397 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.41 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.143 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.9 mttp . . . . . 0 N--CA 1.467 0.375 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.4 mt -129.29 -43.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.775 0.321 . . . . 0.0 110.88 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.3 mt -94.69 -94.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.09 -7.19 3.52 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 176.304 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.07 -47.44 5.53 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 113.131 -1.534 . . . . 0.0 109.86 178.2 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -83.92 27.67 0.64 Allowed 'General case' 0 C--N 1.341 0.23 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.75 39.59 0.17 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.004 -179.072 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.2 tt 52.19 39.33 26.66 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.96 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.3 t70 54.57 -83.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.591 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' LEU . 23.9 m80 -52.57 -65.83 0.49 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.632 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.207 -179.936 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.912 0.386 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -133.57 -45.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.358 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.58 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.9 mt -77.26 -91.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.13 -7.53 3.87 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 175.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.58 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.2 -47.16 6.63 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 112.895 -1.653 . . . . 0.0 110.159 178.314 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.35 30.74 0.68 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.65 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.6 40.07 0.52 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.73 -178.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 58.94 51.9 6.9 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.143 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 65.72 -74.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.03 38.4 0.26 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.795 0.331 . . . . 0.0 110.521 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.412 -179.986 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.5 tttp . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.764 0.316 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.7 mp -119.86 -48.18 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.374 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.57 ' C ' ' N ' ' A' ' 14' ' ' GLY . 42.4 mm -91.45 -98.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.66 -179.464 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.0 -11.95 0.65 Allowed Glycine 0 C--N 1.346 1.11 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 176.485 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.57 ' N ' ' C ' ' A' ' 12' ' ' ILE . . . -79.89 -50.41 5.57 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 113.309 -1.445 . . . . 0.0 109.997 177.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.02 27.94 0.74 Allowed 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.794 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.08 44.68 0.13 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.771 -178.911 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.1 tp 66.75 11.3 8.14 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.19 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.9 t70 58.71 -77.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.5 t60 -77.87 13.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.722 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 20' ' ' LEU . 9.8 mp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.064 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.0 tttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.784 0.326 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mt -139.12 -44.24 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.12 -179.679 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 7.7 mm -86.13 -93.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.19 -7.05 3.5 Favored Glycine 0 C--N 1.342 0.908 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 176.027 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.89 -47.97 6.0 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 113.006 -1.597 . . . . 0.0 110.031 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.74 29.77 0.69 Allowed 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.693 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.77 40.75 0.36 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.86 -178.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 58.36 20.91 7.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.695 -179.801 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.2 t0 56.95 -78.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.948 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.553 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 1.5 m-70 -46.83 -59.52 3.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.989 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.198 -179.919 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.2 tptt . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.86 0.362 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.62 -46.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.19 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 14' ' ' GLY . 30.9 mt -78.3 -92.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.92 -8.72 2.34 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 175.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.54 -48.24 6.39 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 113.001 -1.599 . . . . 0.0 110.283 178.196 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.74 27.78 1.1 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.854 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.51 43.83 0.13 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.82 -178.812 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 65.62 17.53 10.93 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.447 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 58.53 -77.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.929 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 10.7 m-70 -52.97 -65.08 0.62 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.837 0.351 . . . . 0.0 110.604 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.175 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.8 tttp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.723 0.297 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.5 mt -132.59 -50.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.325 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 33.5 mm -78.41 -94.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.34 -9.33 1.48 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 176.204 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.09 -48.63 6.38 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 112.959 -1.62 . . . . 0.0 110.229 178.151 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.96 27.96 0.73 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.783 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.53 37.95 0.17 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.014 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.1 tp 57.18 11.64 1.11 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.246 179.738 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER 58.58 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.92 -179.986 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 17' ' ' LEU . 57.8 t-80 -50.62 -44.4 57.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.838 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.4 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.12 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.6 tttm . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.672 0.272 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.0 mt -124.04 -54.21 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.364 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.4 mm -75.06 -98.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.021 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.409 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -50.97 -11.63 0.59 Allowed Glycine 0 C--N 1.347 1.178 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 176.862 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.591 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -77.82 -48.92 7.45 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.048 -1.576 . . . . 0.0 109.966 178.049 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.34 28.34 0.85 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.704 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.66 39.35 0.24 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.813 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 62.41 25.37 15.13 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.78 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.3 t70 58.01 -78.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' LEU . 16.2 m80 -51.04 -65.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.606 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.233 179.988 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.9 tttp . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.99 0.424 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.1 mt -111.44 -48.46 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.524 -179.131 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 14' ' ' GLY . 40.7 mm -96.16 -101.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.093 -178.62 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.95 -12.08 0.43 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 177.04 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.47 -48.59 5.54 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 113.507 -1.347 . . . . 0.0 110.082 177.98 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -83.08 23.37 0.86 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.002 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 83.94 39.41 0.03 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.196 -179.336 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.4 tp 54.91 18.04 2.05 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.268 179.757 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 52.67 20.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.119 -179.602 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 m170 57.83 64.12 1.62 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.503 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.336 -179.952 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.716 0.293 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.3 mt -112.42 -51.08 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.327 -179.169 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 14' ' ' GLY . 38.8 mm -89.73 -100.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.177 -179.036 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.406 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -50.63 -11.59 0.52 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 176.949 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.13 -49.65 5.85 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 113.294 -1.453 . . . . 0.0 109.946 177.737 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.26 28.2 0.74 Allowed 'General case' 0 C--N 1.345 0.41 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.747 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.18 41.77 0.15 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.047 -179.1 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 19' ' ' HIS . 4.1 tp 62.3 10.41 3.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.446 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.489 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 33.0 t70 57.63 5.05 0.29 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 55.7 m80 -157.49 -13.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 109.836 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.43 ' H ' ' H ' ' A' ' 19' ' ' HIS . 18.8 tp . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.313 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 tttp . . . . . 0 C--O 1.232 0.137 0 CA-C-O 121.054 0.454 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.7 mt -134.42 -35.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.375 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.602 ' C ' ' H ' ' A' ' 14' ' ' GLY . 82.0 mt -74.83 -88.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.07 -4.72 4.85 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 175.407 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.15 -43.62 7.44 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 113.28 -1.46 . . . . 0.0 110.14 178.483 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.36 27.86 1.18 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.884 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.26 37.9 0.34 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.614 -178.722 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 55.21 48.67 18.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.898 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 48.62 29.94 2.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.746 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.2 m80 53.18 59.43 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.583 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.069 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.6 tttp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.868 0.366 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.409 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -135.93 -46.38 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.268 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.4 mt -76.48 -92.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.69 -8.04 3.76 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.932 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.07 -46.67 7.51 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 112.907 -1.646 . . . . 0.0 110.224 178.324 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.68 29.43 0.79 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.526 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.98 41.22 0.51 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.222 -178.448 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 63.15 51.94 2.63 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.05 -179.688 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 t0 59.8 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.579 -179.867 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -167.46 53.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.492 179.884 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.132 179.965 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 tttp . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.793 0.33 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.1 mt -135.47 -47.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.9 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 14' ' ' GLY . 47.5 mm -76.7 -94.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.471 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.408 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -54.3 -9.49 1.53 Allowed Glycine 0 C--N 1.346 1.118 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 176.127 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.02 -47.79 6.89 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 113.175 -1.513 . . . . 0.0 110.203 178.253 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.93 28.75 1.0 Allowed 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.819 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.25 42.03 0.19 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.827 -178.954 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.2 tp 63.67 30.16 14.87 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.337 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.0 t0 56.36 -80.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.742 -179.989 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 74.5 m80 -49.29 -65.75 0.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.982 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.888 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 tptp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.913 0.387 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 21.5 mt -138.41 -45.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.62 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.8 mt -77.93 -92.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.68 -5.92 3.14 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 107.819 -2.113 . . . . 0.0 107.819 175.718 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.62 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.65 -47.57 5.9 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 112.893 -1.654 . . . . 0.0 110.172 178.261 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.34 29.21 0.99 Allowed 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.683 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.21 47.62 0.19 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.382 -178.652 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.1 mt 64.19 39.86 7.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.082 -179.391 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.1 t70 51.72 42.1 29.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.658 179.918 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.0 m170 50.62 36.76 14.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.643 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.17 -179.985 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.9 mttt . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.768 0.318 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.3 mt -129.95 -48.13 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.255 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.61 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.0 mt -76.25 -93.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.859 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.66 -8.79 2.15 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 176.286 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.22 -47.42 6.99 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 112.873 -1.663 . . . . 0.0 110.167 178.276 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.41 27.96 0.89 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.834 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.43 38.95 0.2 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.892 -178.893 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 57.29 45.38 20.35 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.854 179.92 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 50.46 31.51 5.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.73 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.5 t60 51.41 60.4 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.696 179.845 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.5 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.264 179.87 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.6 tttm . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.763 0.316 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.4 mt -131.45 -46.91 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.386 -179.556 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.601 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.1 mm -87.12 -95.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.865 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.84 -8.84 1.51 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 176.218 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.61 -49.34 5.48 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 113.063 -1.569 . . . . 0.0 110.087 178.082 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.94 26.57 1.13 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.754 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.65 47.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.736 -178.946 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.6 mt 62.61 11.37 4.73 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.484 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.6 t0 55.87 53.83 8.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.48 -179.592 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 55.32 55.93 6.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.674 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 20' ' ' LEU . 9.2 mp . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.343 179.916 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.1 tttt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.939 0.4 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 7.1 mm -132.14 -46.27 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.018 -179.943 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 14' ' ' GLY . 72.2 mt -77.16 -92.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.47 -7.63 3.13 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 176.04 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.02 -47.24 6.66 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 112.9 -1.65 . . . . 0.0 110.258 178.235 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.49 28.74 0.83 Allowed 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.663 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.68 40.4 0.3 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.691 -178.749 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 60.08 49.36 7.57 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.282 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 58.72 -77.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.843 -179.883 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' LEU . 13.0 t-80 -159.36 56.92 0.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.779 0.323 . . . . 0.0 110.39 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.495 179.951 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.3 tttm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.817 0.341 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.3 mt -132.92 -50.01 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.163 -179.832 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 60.9 mt -76.52 -95.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.827 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.69 -9.66 1.82 Allowed Glycine 0 C--N 1.346 1.1 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 176.419 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.81 -47.92 7.47 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 112.9 -1.65 . . . . 0.0 110.116 178.098 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.63 28.97 0.82 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.717 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.82 40.19 0.38 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.486 -178.661 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 63.93 49.77 2.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.757 -179.708 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.3 t0 59.23 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.74 -179.782 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 17' ' ' LEU . 13.9 p-80 -159.26 44.03 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.821 0.344 . . . . 0.0 110.362 179.922 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.509 -179.912 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.665 0.269 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 3.7 mp -120.85 -59.8 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.667 -179.816 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.0 mt -76.13 -98.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.265 -179.331 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.34 -11.44 0.71 Allowed Glycine 0 C--N 1.347 1.186 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 176.993 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.09 -48.73 7.41 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.875 -1.662 . . . . 0.0 110.003 178.006 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.55 29.9 0.75 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.604 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.85 39.82 0.4 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.728 -178.879 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.5 tt 63.64 47.86 3.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.783 -179.896 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 54.04 -84.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.657 -179.822 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -161.17 50.71 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.459 179.954 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 20' ' ' LEU . 9.7 mp . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.154 -180.0 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.3 tttm . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.671 0.272 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.7 mt -120.66 -52.43 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.221 -178.847 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.4 mm -74.32 -97.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.229 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.77 -10.49 0.69 Allowed Glycine 0 C--N 1.346 1.104 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 176.711 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.8 -47.84 7.52 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 113.218 -1.491 . . . . 0.0 110.02 178.183 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.55 31.54 0.83 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.716 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.71 41.93 0.52 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.69 -178.75 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.2 tp 65.12 53.61 1.33 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.103 -179.721 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.0 t0 62.73 -75.49 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.844 -179.821 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.421 ' N ' ' O ' ' A' ' 17' ' ' LEU . 2.7 t60 -152.74 42.13 0.61 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.794 0.33 . . . . 0.0 110.369 -179.892 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.9 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.496 179.954 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 mttp . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.827 0.346 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -129.11 -46.04 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.647 -179.609 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.614 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.2 mt -74.89 -92.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.659 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.08 -6.69 3.11 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 176.029 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.65 -45.33 7.35 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 113.082 -1.559 . . . . 0.0 110.139 178.327 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.77 29.9 0.77 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.573 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.03 37.46 0.63 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.513 -178.578 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.4 tt 58.24 47.32 14.4 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.878 -179.933 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.486 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 71.0 m-20 54.03 -83.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 17' ' ' LEU . 96.3 m-70 -158.21 52.11 0.43 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.366 179.974 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.081 -179.924 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.7 tttm . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 120.649 0.261 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.7 mt -116.9 -46.59 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.789 0.328 . . . . 0.0 111.573 -179.119 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 63.1 mt -95.78 -97.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.069 -178.564 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.35 -8.29 1.66 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 176.854 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.9 -48.02 5.35 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 113.155 -1.522 . . . . 0.0 109.808 177.999 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -81.11 27.06 0.41 Allowed 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.604 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.17 36.45 0.23 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.758 -179.042 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 51.3 32.14 7.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.265 -179.824 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 51.15 10.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.134 179.837 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.443 ' H ' ' C ' ' A' ' 17' ' ' LEU . 20.9 t-160 -168.3 -41.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.611 179.929 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.8 pp . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.584 -179.97 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.9 tttt . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 10.6 mt -112.07 -46.16 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.277 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.6 ' C ' ' H ' ' A' ' 14' ' ' GLY . 60.5 mt -95.99 -98.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.135 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.95 -6.8 1.41 Allowed Glycine 0 C--N 1.341 0.854 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.393 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.6 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.92 -46.53 5.35 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 113.291 -1.455 . . . . 0.0 110.001 178.332 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.29 28.56 0.72 Allowed 'General case' 0 C--N 1.343 0.292 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.728 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.26 41.47 0.28 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.797 -178.927 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.2 OUTLIER 68.25 37.19 2.89 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.014 -0.675 . . . . 0.0 109.72 -179.762 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.495 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 33.6 t70 55.71 -82.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.716 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' LEU . 96.8 m-70 -158.5 57.61 0.45 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.475 179.98 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.476 -179.943 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.4 mttm . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.911 0.386 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.6 mt -138.95 -39.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.193 -179.567 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.5 mt -75.83 -89.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.56 -5.52 5.12 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 175.385 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.36 -45.16 7.09 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 113.105 -1.547 . . . . 0.0 110.161 178.345 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.94 29.86 0.89 Allowed 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.653 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.59 40.78 0.61 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.407 -178.502 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.3 tp 63.14 20.4 12.26 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.214 -179.736 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.8 t70 58.83 -77.5 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' LEU . 20.7 m80 -49.25 -61.02 2.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.304 . . . . 0.0 110.711 -179.938 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.029 179.966 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.814 0.34 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.3 mt -133.9 -52.07 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 109.979 -179.936 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.1 mm -76.51 -96.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.695 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.9 -11.08 0.85 Allowed Glycine 0 C--N 1.347 1.16 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 176.448 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.56 -48.87 6.99 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 113.053 -1.573 . . . . 0.0 110.28 178.056 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.552 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.44 27.18 0.97 Allowed 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.877 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.5 40.07 0.13 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.916 -179.086 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.3 tt 62.18 42.69 9.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.828 179.955 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.6 t0 50.9 34.96 11.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.552 -179.858 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.8 t60 53.96 62.06 2.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.483 179.922 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.294 179.974 . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.2 mttp . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 40.9 mm -118.22 -43.36 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.89 0.376 . . . . 0.0 111.415 -179.146 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.1 mt -98.54 -98.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.873 -178.65 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -54.67 -8.3 1.26 Allowed Glycine 0 C--N 1.342 0.914 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 176.743 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.6 -48.2 4.82 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 113.231 -1.485 . . . . 0.0 109.845 177.995 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.23 26.59 1.02 Allowed 'General case' 0 C--N 1.342 0.239 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.865 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.97 48.65 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.754 -178.918 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.0 mt 61.14 14.52 5.55 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.462 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.2 t70 58.67 -77.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 -179.706 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 63.6 t60 -164.9 47.76 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.914 0.388 . . . . 0.0 110.485 179.903 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.116 180.0 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.856 0.36 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.7 mt -136.8 -45.52 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.149 -179.91 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 14' ' ' GLY . 78.7 mt -84.07 -93.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.958 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.81 -8.34 2.88 Favored Glycine 0 C--N 1.343 0.955 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 175.959 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.591 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.8 -48.25 6.27 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 112.945 -1.628 . . . . 0.0 110.117 178.153 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.02 27.53 0.89 Allowed 'General case' 0 C--N 1.343 0.311 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.77 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.57 41.59 0.19 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.627 -178.871 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.6 tt 63.38 48.89 3.37 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.771 -179.786 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.8 t0 50.91 28.97 4.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.404 -179.825 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.8 t60 55.91 68.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.476 -179.796 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.4 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.244 -179.846 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.818 0.342 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.8 mt -130.35 -49.23 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.124 -179.826 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.602 ' C ' ' H ' ' A' ' 14' ' ' GLY . 28.2 mt -75.98 -95.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.886 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -54.12 -9.73 1.53 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 176.294 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.27 -47.81 7.25 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 113.019 -1.59 . . . . 0.0 110.074 178.036 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.8 29.36 1.03 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.823 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.14 41.71 0.28 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.615 -178.83 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.1 tt 69.33 39.38 1.67 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.893 -179.864 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.9 t0 48.56 49.29 18.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.654 -179.943 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 53.21 60.86 3.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 -179.891 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.9 mp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.03 -179.882 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.099 0.476 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.3 mt -131.44 -35.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.514 -179.485 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.601 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.7 mt -75.82 -87.6 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.908 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.08 -4.99 5.13 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 175.2 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.06 -44.48 7.07 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 113.209 -1.496 . . . . 0.0 110.193 178.471 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.51 27.72 1.07 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.953 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.05 37.34 0.28 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.707 -178.881 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.2 tt 55.97 43.04 27.92 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.052 179.921 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.0 t0 50.94 39.95 24.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.656 -179.994 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 51.53 45.63 27.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.551 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.352 -179.987 . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.9 tttm . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.669 0.271 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.3 mt -132.59 -49.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.86 0.362 . . . . 0.0 110.452 -179.754 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.607 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.1 mm -81.99 -96.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.92 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.43 -8.63 1.26 Allowed Glycine 0 C--N 1.344 0.987 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 176.393 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.8 -48.97 5.9 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.1 -1.55 . . . . 0.0 110.002 178.015 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.71 29.67 0.99 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.586 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.3 48.84 0.23 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.571 -178.671 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.0 mt 64.53 31.63 12.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.204 -179.493 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.7 t70 53.03 44.68 30.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.957 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 50.56 65.48 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.647 179.948 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.203 -179.859 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.9 tttp . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 120.714 0.292 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.0 mt -131.06 -44.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.868 0.366 . . . . 0.0 110.764 -179.351 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.0 mt -89.99 -94.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.575 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.77 -7.33 3.26 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 176.215 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.67 -47.55 5.9 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 113.011 -1.594 . . . . 0.0 109.984 178.154 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.11 29.32 0.57 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.661 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.17 38.33 0.33 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.867 -178.958 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.1 tt 51.73 38.38 22.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.069 -179.946 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.6 t0 52.43 -85.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 17' ' ' LEU . 73.7 m-70 -53.11 -65.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.67 -179.854 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.023 -179.915 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.4 tttm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.848 0.356 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 051 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 18.5 mt -125.27 -55.37 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.172 -179.916 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' GLY . 34.6 mm -75.46 -98.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.928 -179.911 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.49 -10.99 0.68 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 176.794 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.56 -48.5 7.25 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 113.013 -1.593 . . . . 0.0 110.074 178.046 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.544 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.85 27.71 0.85 Allowed 'General case' 0 C--N 1.344 0.363 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.652 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.22 39.32 0.2 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.741 -178.923 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tt 58.01 48.8 12.66 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.6 179.945 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 53.97 22.84 3.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.205 -179.593 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.6 t60 56.01 63.14 2.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.635 -179.925 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.184 179.906 . . . . . . . . 0 0 . 1 . 052 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 052 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 14.7 mt -122.84 -45.63 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.75 0.31 . . . . 0.0 111.129 -179.642 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 14' ' ' GLY . 71.2 mt -95.03 -97.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.069 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.27 -8.48 1.67 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 176.462 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.55 -48.0 5.45 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 113.318 -1.441 . . . . 0.0 109.953 177.997 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.55 28.62 0.74 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.816 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.5 41.79 0.19 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.931 -179.011 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.0 tp 62.31 30.01 17.41 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.574 -179.996 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t0 55.23 -82.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 179.73 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 17' ' ' LEU . 61.0 m80 -47.75 -64.68 0.72 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.853 -179.812 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.453 -179.991 . . . . . . . . 0 0 . 1 . 053 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.9 tttm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.76 0.314 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 053 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.413 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 11.5 mt -124.97 -51.91 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.542 -179.647 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.5 mm -74.67 -97.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.898 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.41 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.03 -10.24 0.73 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 176.738 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.17 -48.08 7.12 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 113.095 -1.552 . . . . 0.0 110.029 178.061 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.2 28.48 0.82 Allowed 'General case' 0 C--N 1.343 0.325 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.67 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.99 38.18 0.25 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.964 -179.055 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.5 tt 55.52 46.39 23.11 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.888 179.801 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 55.69 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.731 -179.903 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LEU . 1.5 p-80 -157.03 44.71 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.418 -179.972 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.43 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.155 -179.98 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.4 tttt . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.621 0.248 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 054 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.7 mp -115.59 -47.73 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.789 0.328 . . . . 0.0 111.649 -178.946 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.9 mt -94.86 -98.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.008 -178.681 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.453 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.57 -10.96 1.06 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 176.669 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.88 -49.8 5.2 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 113.199 -1.501 . . . . 0.0 109.936 177.771 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.28 25.87 0.82 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.941 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.53 44.51 0.07 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.856 -178.991 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.4 tp 62.78 31.5 16.47 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.305 -179.968 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.4 t0 56.84 -79.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' LEU . 35.6 m80 -54.92 -62.38 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.542 179.994 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.541 ' N ' HD23 ' A' ' 20' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.728 179.581 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 tttp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.822 0.344 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 055 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.1 mt -131.51 -44.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.068 -179.849 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.1 mt -75.34 -91.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.5 -6.66 3.54 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 107.579 -2.208 . . . . 0.0 107.579 176.016 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.46 -45.72 7.25 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 112.98 -1.61 . . . . 0.0 110.035 178.315 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.5 29.96 0.74 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.618 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.11 37.53 0.61 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.5 -178.645 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.6 tt 56.79 46.26 20.23 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.797 -179.884 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 47.56 44.75 17.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.1 m80 54.73 45.77 26.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.597 -179.883 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.339 -179.993 . . . . . . . . 0 0 . 1 . 056 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.3 tptm . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.905 0.383 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 056 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.4 mt -124.43 -49.76 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.764 -179.819 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 14' ' ' GLY . 25.9 mt -81.9 -95.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.945 -179.424 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -53.89 -9.96 1.49 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 176.402 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.04 -49.38 6.01 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 112.994 -1.603 . . . . 0.0 110.247 177.985 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.539 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.78 28.24 0.91 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.799 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.69 43.93 0.12 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.841 -179.026 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 64.34 24.8 13.34 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.477 -179.997 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.3 t70 57.47 -78.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 50.0 m80 -49.79 -67.07 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.452 179.873 . . . . . . . . 0 0 . 1 . 057 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttm . . . . . 0 CA--C 1.522 -0.101 0 CA-C-O 120.604 0.24 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 057 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' ALA . 16.6 pt -81.2 4.96 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.647 179.994 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.625 ' C ' ' H ' ' A' ' 14' ' ' GLY . 38.9 mm -70.83 -88.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.301 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.32 -3.76 3.16 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 175.402 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.625 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.08 -38.33 8.61 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 113.77 -1.215 . . . . 0.0 110.137 178.604 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -94.17 26.03 3.49 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.873 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 79.07 37.29 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.653 -178.886 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 3.7 tp 61.94 11.35 4.13 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.41 179.719 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 60.05 -77.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.469 -179.579 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -55.07 -70.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 110.559 179.797 . . . . . . . . 3 3 . 1 . 057 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.463 0.222 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.479 179.906 . . . . . . . . 0 0 . 1 . 058 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt . . . . . 0 CA--C 1.53 0.203 0 CA-C-O 120.919 0.39 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 058 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.7 mp -109.81 -49.47 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.895 -179.05 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' GLY . 23.5 mt -95.54 -99.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.385 -178.24 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.27 -10.83 0.93 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 177.097 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.578 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.1 -49.24 5.38 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 113.155 -1.523 . . . . 0.0 109.756 177.877 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.48 29.52 0.59 Allowed 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.607 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.17 43.91 0.27 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.74 -178.898 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 61.17 34.47 18.88 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.953 -179.693 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 t70 57.89 -78.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.928 -179.799 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 86.8 m-70 -64.89 -64.29 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.705 -179.77 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.461 -179.786 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.2 tttp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.942 0.401 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 059 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -137.98 -43.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.776 -179.953 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.585 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.7 mt -77.37 -90.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.525 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.59 -7.27 4.18 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 175.772 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.585 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.26 -46.7 6.84 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 112.931 -1.635 . . . . 0.0 110.199 178.431 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.535 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.14 27.08 0.94 Allowed 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.797 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.61 39.05 0.19 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.683 -178.894 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 57.43 47.17 16.89 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.991 179.931 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 54.33 -83.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 179.966 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.7 t-80 -157.4 40.33 0.3 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.425 179.975 . . . . . . . . 0 0 . 1 . 060 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.5 tttp . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.705 0.288 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 060 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.5 mt -130.7 -46.57 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.624 -179.474 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.623 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.9 mt -84.53 -94.33 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.835 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.424 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -56.57 -7.26 2.02 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 176.074 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.623 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.22 -48.63 5.6 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 112.915 -1.642 . . . . 0.0 109.955 178.031 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.25 29.16 0.98 Allowed 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.588 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.46 49.15 0.21 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.586 -178.572 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 11.1 mt 63.52 6.08 2.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.157 -179.293 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.3 t70 58.22 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 -179.977 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -158.76 54.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.306 179.941 . . . . . . . . 3 3 . 1 . 060 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.201 -179.857 . . . . . . . . 0 0 . 1 . 061 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.1 tttp . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.716 0.293 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 061 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.8 mt -133.13 -44.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.905 0.383 . . . . 0.0 110.701 -179.548 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.0 mt -90.35 -94.32 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.662 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.48 -8.58 2.75 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 176.306 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.79 -49.07 5.54 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 112.986 -1.607 . . . . 0.0 109.985 178.017 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.86 29.62 0.62 Allowed 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.728 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.95 40.97 0.25 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.113 -179.168 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.7 OUTLIER 56.53 13.9 1.5 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.69 -179.98 . . . . . . . . 3 3 . 1 . 061 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.9 t0 55.57 -82.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.792 -179.942 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 49.6 m80 -58.44 -20.18 42.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.57 -179.987 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 -179.908 . . . . . . . . 0 0 . 1 . 062 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.5 tptm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.85 0.357 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 062 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.5 mt -136.86 -46.25 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.934 0.397 . . . . 0.0 110.367 -179.735 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.62 ' C ' ' H ' ' A' ' 14' ' ' GLY . 71.4 mt -80.16 -93.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.945 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.12 -6.65 3.13 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 176.127 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.62 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.43 -46.54 6.85 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 112.963 -1.619 . . . . 0.0 109.886 178.219 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.43 30.29 0.63 Allowed 'General case' 0 C--N 1.345 0.396 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.506 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.46 38.0 0.67 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.441 -178.596 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.6 tt 54.36 52.27 12.79 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.771 -179.738 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER 56.1 -80.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.947 179.927 . . . . . . . . 3 3 . 1 . 062 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -160.95 48.68 0.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.362 -179.939 . . . . . . . . 3 3 . 1 . 062 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.421 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.038 -179.896 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.7 tttp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.862 0.363 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 063 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.0 mt -135.72 -50.45 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.831 179.939 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.6 mm -76.53 -96.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.602 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.6 -10.37 0.93 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 176.387 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.05 -48.56 6.87 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 113.109 -1.545 . . . . 0.0 110.171 178.082 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.95 29.1 0.84 Allowed 'General case' 0 C--N 1.344 0.337 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.772 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.52 39.74 0.24 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.991 -178.993 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.2 tt 63.09 43.63 6.35 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.966 179.844 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.1 t0 49.0 32.29 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.559 -179.977 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 54.79 73.92 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.475 -179.865 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.0 tp . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.52 -179.979 . . . . . . . . 0 0 . 1 . 064 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.955 0.407 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 064 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.3 mt -133.15 -38.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.148 -179.789 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.607 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.6 mt -75.58 -89.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.825 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.96 -5.66 4.49 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 107.332 -2.307 . . . . 0.0 107.332 175.385 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.29 -44.73 7.34 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 113.167 -1.516 . . . . 0.0 110.038 178.379 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.69 28.35 1.16 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.889 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.55 38.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.596 -178.766 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 3.2 tp 63.22 48.99 3.45 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 53.8 -84.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.754 179.822 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 58.4 m80 -150.36 57.17 0.94 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.353 179.993 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.514 -179.966 . . . . . . . . 0 0 . 1 . 065 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 tttm . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.6 0.238 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 065 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.447 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.7 mt -120.69 -47.41 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 120.793 0.33 . . . . 0.0 111.26 -179.163 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.3 mt -91.28 -97.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.128 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.448 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -54.21 -8.93 1.26 Allowed Glycine 0 C--N 1.343 0.933 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 176.524 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.53 -48.96 5.37 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 113.147 -1.526 . . . . 0.0 109.935 177.984 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.507 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.38 28.91 0.91 Allowed 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.723 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.87 48.78 0.13 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.556 -178.724 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.9 mt 65.1 -1.55 0.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.351 -179.427 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 16' ' ' ALA . 26.3 t70 53.9 -83.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.765 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 2.4 t60 -46.98 -37.79 9.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.95 -179.882 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.452 ' C ' HD23 ' A' ' 20' ' ' LEU . 2.0 tt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.068 179.973 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.3 tttt . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.735 0.302 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 066 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 19.4 pt -78.02 10.79 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.403 180.0 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 14' ' ' GLY . 6.8 mm -74.52 -86.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.515 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.49 -3.15 5.07 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 175.249 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.53 -40.77 7.15 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 113.663 -1.269 . . . . 0.0 110.314 178.637 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -90.49 26.21 2.05 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.873 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 79.43 37.16 0.14 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.876 -178.945 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.1 tp 59.24 17.92 6.14 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.546 179.76 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 56.93 6.95 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.794 179.728 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.409 ' H ' ' C ' ' A' ' 17' ' ' LEU . 54.6 t-80 -170.34 -59.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.522 -179.961 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.204 -179.987 . . . . . . . . 0 0 . 1 . 067 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.7 tttt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.816 0.341 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 067 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.8 mt -139.68 -43.89 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.02 -179.855 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.606 ' C ' ' H ' ' A' ' 14' ' ' GLY . 23.7 mt -84.43 -93.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.771 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.89 -6.25 2.63 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 175.751 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.38 -47.36 5.75 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 113.066 -1.567 . . . . 0.0 110.158 178.265 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -89.32 29.03 1.14 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.726 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.63 47.82 0.12 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.721 -178.821 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.4 mt 63.71 17.81 10.7 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.247 0.342 . . . . 0.0 110.137 -179.596 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 59.56 -76.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.766 179.894 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.513 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -154.68 52.56 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.82 0.343 . . . . 0.0 110.427 -179.991 . . . . . . . . 3 3 . 1 . 067 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.304 -179.967 . . . . . . . . 0 0 . 1 . 068 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.927 0.394 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 068 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.11 -43.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.332 -179.861 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.61 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.5 mt -88.0 -93.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.94 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.47 -6.66 3.51 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 175.941 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.73 -47.48 5.9 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 113.046 -1.577 . . . . 0.0 109.939 178.152 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.524 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.88 29.73 0.61 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.708 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.47 38.68 0.38 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.773 -178.941 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 56.39 33.89 23.21 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.969 -179.973 . . . . . . . . 3 3 . 1 . 068 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.7 t0 58.02 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.781 -179.962 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -155.3 62.24 0.63 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.268 179.875 . . . . . . . . 3 3 . 1 . 068 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.373 -179.771 . . . . . . . . 0 0 . 1 . 069 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.6 mttm . . . . . 0 N--CA 1.468 0.425 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 069 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 17.8 mt -126.4 -45.2 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.832 0.348 . . . . 0.0 110.97 -179.357 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' GLY . 66.1 mt -95.97 -96.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.248 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.38 -7.76 2.18 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 176.434 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.0 -48.75 5.04 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 113.053 -1.573 . . . . 0.0 109.557 177.922 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.2 29.15 0.67 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 177.526 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.06 48.03 0.28 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.451 -178.687 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.0 mt 62.54 22.52 13.34 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.366 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.9 t70 55.73 -82.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.625 -179.875 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 31.9 m-70 -53.66 -33.93 56.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.59 179.973 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.163 -179.985 . . . . . . . . 0 0 . 1 . 070 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.1 tptp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.773 0.321 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 070 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.0 mt -132.06 -48.63 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.343 -179.894 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 14' ' ' GLY . 65.3 mt -78.24 -94.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -179.788 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.11 -8.24 2.25 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 176.241 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.44 -47.53 6.81 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 112.899 -1.651 . . . . 0.0 110.186 178.133 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.525 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.82 29.31 0.81 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.757 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.75 39.29 0.33 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.755 -178.928 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 12' ' ' ILE . 0.9 OUTLIER 62.14 27.97 16.83 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.881 179.971 . . . . . . . . 3 3 . 1 . 070 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 t70 50.05 -91.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 179.949 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' LEU . 71.9 m80 -50.19 -25.2 3.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.732 -179.761 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.222 179.994 . . . . . . . . 0 0 . 1 . 071 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 tttp . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.592 0.234 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 071 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.7 mt -123.91 -51.21 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.847 0.356 . . . . 0.0 110.867 -179.563 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 44.3 mm -83.79 -98.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.7 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.68 -10.89 0.73 Allowed Glycine 0 C--N 1.346 1.121 0 N-CA-C 108.544 -1.823 . . . . 0.0 108.544 176.654 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.57 -49.83 5.97 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 113.136 -1.532 . . . . 0.0 110.058 177.919 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.09 28.42 0.82 Allowed 'General case' 0 C--N 1.345 0.398 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.833 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.43 42.19 0.13 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.084 -179.16 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 60.87 44.49 10.72 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.633 179.796 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.9 t70 53.58 47.56 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 179.915 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 51.1 53.86 12.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.701 179.818 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.6 mp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.261 179.952 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.9 tttp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.775 0.321 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 072 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.3 mt -135.41 -44.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.559 -179.486 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.1 mt -90.34 -95.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.748 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.433 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.44 -8.34 1.76 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 175.976 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.64 -49.15 5.26 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 113.142 -1.529 . . . . 0.0 109.992 177.978 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.94 28.08 0.94 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.808 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.19 48.07 0.1 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.742 -178.877 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.6 mt 64.31 33.97 11.02 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.325 0.391 . . . . 0.0 110.259 -179.773 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 t0 57.0 -78.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.954 179.785 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 17' ' ' LEU . 16.1 p-80 -145.63 51.74 1.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.328 -179.871 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.195 179.986 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.3 tptm . . . . . 0 CA--C 1.529 0.138 0 CA-C-O 120.959 0.409 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 073 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.409 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.3 mt -138.5 -36.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.539 -179.64 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.6 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.6 mt -75.03 -88.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.989 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.44 -4.73 5.44 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 175.173 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.6 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.07 -43.87 7.35 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 113.197 -1.502 . . . . 0.0 110.258 178.389 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.06 28.07 1.11 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.702 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.88 39.25 0.42 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.454 -178.626 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.0 tp 60.19 41.26 17.07 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.333 -179.778 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.9 0.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.428 ' H ' ' C ' ' A' ' 17' ' ' LEU . 6.7 t60 -170.79 -65.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 110.65 179.946 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 16' ' ' ALA . 16.7 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.759 0.314 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 074 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 6.8 mm -131.52 -51.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.863 -179.981 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' GLY . 42.6 mm -76.0 -97.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.841 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.01 -11.05 0.88 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 176.766 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.34 -48.93 7.09 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 113.029 -1.585 . . . . 0.0 110.128 178.024 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.19 28.8 0.69 Allowed 'General case' 0 C--N 1.343 0.323 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.597 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.93 38.47 0.25 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.899 -179.019 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tt 55.63 45.64 24.34 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.671 179.924 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 54.55 33.19 18.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.379 -179.703 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.0 m80 58.59 45.88 15.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.547 -179.987 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.405 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.137 179.912 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.2 tttt . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.586 0.231 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 075 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.2 mp -132.46 -48.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 121.058 0.456 . . . . 0.0 110.341 179.569 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.1 mt -83.67 -94.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.667 -179.66 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.03 -8.59 2.38 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 176.1 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.52 -48.74 6.13 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 113.004 -1.598 . . . . 0.0 109.863 178.025 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.69 30.55 0.72 Allowed 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.553 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.21 44.15 0.46 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.527 -178.702 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.7 tp 65.27 21.67 12.04 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.279 -179.711 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.8 t70 56.14 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.998 179.853 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' LEU . 12.5 t-80 -49.32 -29.87 6.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.885 -179.687 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.454 ' C ' HD23 ' A' ' 20' ' ' LEU . 2.8 tt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.15 179.985 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.823 0.344 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 076 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.2 mt -137.44 -44.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.416 -179.483 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.598 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.0 mt -87.67 -94.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.849 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.79 -6.23 2.51 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 175.992 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.1 -47.71 5.69 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 113.182 -1.509 . . . . 0.0 109.755 177.987 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.76 27.37 1.15 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.484 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.9 48.19 0.19 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.408 -178.607 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 19' ' ' HIS . 9.6 mt 61.95 35.88 15.98 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.176 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 55.77 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.716 -179.669 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 17' ' ' LEU . 3.8 p-80 -162.27 46.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.472 -179.995 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.323 179.974 . . . . . . . . 0 0 . 1 . 077 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.908 0.385 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 077 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 14.9 mt -131.71 -50.47 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.898 179.912 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.1 mm -76.68 -96.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.705 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.39 -9.66 1.1 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 108.379 -1.889 . . . . 0.0 108.379 176.425 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.97 -47.87 6.86 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 113.005 -1.597 . . . . 0.0 110.252 178.249 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.27 27.92 0.88 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.865 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.43 38.6 0.16 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.988 -179.083 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 58.21 42.36 22.09 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.691 179.836 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 54.61 -83.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.576 -179.849 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -163.01 52.97 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.36 179.954 . . . . . . . . 3 3 . 1 . 077 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.187 -179.999 . . . . . . . . 0 0 . 1 . 078 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.926 0.393 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 078 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 26.7 mm -110.03 -46.83 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.83 -178.959 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 14' ' ' GLY . 47.2 mm -98.36 -101.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.139 -178.695 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -50.47 -11.45 0.47 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 177.252 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.37 -48.09 5.47 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 177.824 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.97 27.13 0.56 Allowed 'General case' 0 C--N 1.342 0.265 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.642 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.35 39.99 0.14 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.968 -179.12 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 55.17 22.26 4.52 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.078 -179.983 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 53.56 -86.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.454 -179.742 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -50.21 -37.21 34.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.542 179.94 . . . . . . . . 3 3 . 1 . 078 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.43 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.165 179.921 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.985 0.421 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 079 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 14.1 mt -138.35 -37.9 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.034 -179.565 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.611 ' C ' ' H ' ' A' ' 14' ' ' GLY . 86.3 mt -73.96 -88.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.788 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.97 -5.19 5.23 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 175.585 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.02 -43.28 7.66 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 113.091 -1.555 . . . . 0.0 110.189 178.504 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.1 28.4 1.07 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.845 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.49 37.06 0.45 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.509 -178.639 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.4 tt 54.2 49.59 18.31 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.838 -179.934 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 49.87 23.8 1.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.609 -179.989 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 54.08 57.59 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.468 -179.912 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.4 tp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.13 -179.838 . . . . . . . . 0 0 . 1 . 080 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.6 tttp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.867 0.365 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 080 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.3 mt -139.71 -46.99 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.039 179.937 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' GLY . 37.5 mt -78.14 -92.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.789 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.01 -8.19 2.95 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 176.121 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.25 -47.67 6.83 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 112.93 -1.635 . . . . 0.0 110.13 178.131 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.96 28.68 0.78 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.642 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.51 39.45 0.35 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.715 -178.848 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.1 tt 60.25 39.14 19.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.945 179.979 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 38.5 t70 47.88 61.38 3.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.5 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 27.0 p80 41.16 51.28 3.41 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.261 -179.98 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.7 mp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.187 179.975 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.7 tttt . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.771 0.319 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 081 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.9 mm -133.69 -47.39 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.988 -179.924 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.8 mt -80.0 -93.39 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.862 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.6 -7.62 3.29 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 176.171 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.64 -47.38 6.79 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 112.799 -1.7 . . . . 0.0 110.008 178.165 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.67 29.35 0.61 Allowed 'General case' 0 C--N 1.343 0.319 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.467 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.5 38.46 0.5 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.444 -178.734 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.6 tt 54.76 50.86 14.85 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.632 -179.746 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t0 55.43 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.695 -179.796 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' LEU . 8.7 t60 -164.39 44.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.524 179.873 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.123 -179.97 . . . . . . . . 0 0 . 1 . 082 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.3 tttm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.715 0.293 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 082 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -125.96 -52.62 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.391 -179.672 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.614 ' C ' ' H ' ' A' ' 14' ' ' GLY . 39.8 mm -75.58 -97.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.921 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.23 -10.28 0.8 Allowed Glycine 0 C--N 1.346 1.133 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 176.648 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.28 -48.08 7.07 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.144 -1.528 . . . . 0.0 110.258 178.053 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.34 30.36 0.89 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.797 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.44 42.81 0.29 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.802 -178.852 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.6 tp 63.82 51.52 2.36 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.25 -179.827 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 t0 69.91 -70.55 0.14 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.591 -179.758 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -159.88 19.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.457 179.934 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.248 179.876 . . . . . . . . 0 0 . 1 . 083 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 tttm . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 120.714 0.292 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 083 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.0 mt -114.4 -49.1 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.411 -179.207 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.6 mt -91.8 -99.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.687 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.424 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.58 -10.74 1.01 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 176.931 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.83 -49.14 5.81 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.126 -1.537 . . . . 0.0 109.764 177.881 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.73 29.49 0.7 Allowed 'General case' 0 C--N 1.344 0.342 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.597 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.16 43.48 0.29 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.647 -178.853 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.6 tp 65.7 -1.19 1.09 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.231 -179.725 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 16' ' ' ALA . 19.5 t70 51.35 -85.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.08 179.647 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 84.5 m-70 -49.02 -17.96 0.25 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.931 -179.708 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.341 -179.976 . . . . . . . . 0 0 . 1 . 084 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 72.3 tttt . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.885 0.374 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 084 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.0 mm -119.38 -43.73 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.569 -178.946 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' GLY . 58.4 mt -96.73 -97.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.645 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.18 -7.44 1.87 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 176.493 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.05 -46.77 5.51 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 113.306 -1.447 . . . . 0.0 109.845 178.124 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.93 29.06 0.47 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.62 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.91 38.38 0.35 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.779 -178.91 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.4 tp 53.2 41.31 32.14 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.234 -179.731 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 55.48 31.46 17.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.321 -179.76 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.3 m80 53.23 69.02 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.378 -179.877 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.18 -179.849 . . . . . . . . 0 0 . 1 . 085 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 tttm . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.596 0.236 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 085 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -122.39 -44.69 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.737 0.303 . . . . 0.0 111.301 -179.189 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.579 ' C ' ' H ' ' A' ' 14' ' ' GLY . 69.9 mt -95.0 -95.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.935 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.95 -7.72 2.57 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 176.367 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.11 -48.02 5.29 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 113.08 -1.56 . . . . 0.0 110.001 178.193 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -83.25 27.86 0.56 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.834 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.77 39.88 0.16 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.936 -179.005 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.2 tp 54.22 39.46 30.81 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.255 -179.939 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 57.14 -79.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.752 179.996 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' LEU . 38.6 t-80 -63.58 -60.94 2.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 0.0 110.583 -179.999 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.206 -179.969 . . . . . . . . 0 0 . 1 . 086 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -131.57 -38.86 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.434 -179.542 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.609 ' C ' ' H ' ' A' ' 14' ' ' GLY . 86.5 mt -76.36 -88.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.8 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.25 -4.06 4.45 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 175.343 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.609 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.69 -45.35 6.45 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 113.092 -1.554 . . . . 0.0 110.0 178.357 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -89.22 27.94 1.32 Allowed 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.755 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.28 45.73 0.26 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.437 -178.582 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.8 mt 63.91 28.7 14.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.297 -179.42 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 48.97 27.31 1.61 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.629 -179.905 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.0 m80 53.57 48.46 21.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.332 -179.782 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.279 -179.924 . . . . . . . . 0 0 . 1 . 087 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 tptm . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.684 0.278 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 087 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -135.99 -47.89 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.8 0.333 . . . . 0.0 110.58 -179.731 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.592 ' C ' ' H ' ' A' ' 14' ' ' GLY . 25.2 mt -84.09 -94.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.986 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.417 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.21 -9.42 2.08 Favored Glycine 0 C--N 1.345 1.033 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 176.201 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.98 -49.41 6.02 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 112.922 -1.639 . . . . 0.0 110.0 177.956 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.51 29.17 0.79 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.679 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.48 44.01 0.24 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.652 -178.917 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.5 tp 65.58 22.35 11.74 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.286 -179.908 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.2 t0 55.77 25.24 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.286 -179.817 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 53.58 70.25 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.438 -179.8 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.366 -179.902 . . . . . . . . 0 0 . 1 . 088 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.967 0.413 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 088 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.402 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.7 mt -139.92 -39.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.134 -179.532 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.615 ' C ' ' H ' ' A' ' 14' ' ' GLY . 70.0 mt -75.75 -88.83 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.948 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.44 -5.53 4.98 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 175.427 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.615 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.93 -44.65 7.04 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.147 -1.526 . . . . 0.0 110.342 178.498 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.525 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.37 27.04 1.13 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.849 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.05 37.77 0.2 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.818 -178.892 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 55.36 17.84 2.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.911 179.941 . . . . . . . . 3 3 . 1 . 088 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t0 56.24 -80.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.8 -179.962 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.4 t-80 -50.67 -61.46 2.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.848 0.356 . . . . 0.0 110.611 -179.922 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.1 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.463 179.944 . . . . . . . . 0 0 . 1 . 089 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 tptp . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.736 0.303 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 089 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.475 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.3 mt -123.08 -46.0 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.138 -179.272 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.8 mm -97.79 -99.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.034 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.415 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.57 -9.4 0.71 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 176.67 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.83 -48.23 5.01 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.441 -1.38 . . . . 0.0 110.065 177.953 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.63 25.76 1.2 Allowed 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.923 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.21 48.6 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.864 -178.893 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.7 mt 62.6 1.86 0.84 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.268 -179.686 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 16' ' ' ALA . 27.9 t70 51.08 46.24 26.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.633 -179.938 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 11.1 t60 55.5 35.68 25.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.583 -179.976 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.067 -179.946 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.6 tptt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.02 0.438 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 090 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.2 mt -142.79 -45.35 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.098 -179.947 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.9 mt -78.44 -90.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.923 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.73 -7.17 4.24 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 107.546 -2.222 . . . . 0.0 107.546 175.706 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.45 -47.13 6.54 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.859 -1.671 . . . . 0.0 110.229 178.443 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.535 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.07 28.2 0.83 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.75 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.25 40.36 0.25 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.641 -178.801 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.1 tp 58.54 36.75 25.38 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.218 -179.847 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 54.92 -83.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.703 -179.899 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 28.0 m80 -52.59 -63.7 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.717 -179.929 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.41 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.193 -179.874 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt . . . . . 0 N--CA 1.461 0.1 0 CA-C-O 121.008 0.433 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 091 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.93 -41.7 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.22 -179.704 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.599 ' C ' ' H ' ' A' ' 14' ' ' GLY . 31.2 mt -75.63 -89.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.379 -179.794 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.21 -5.62 3.45 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 107.631 -2.188 . . . . 0.0 107.631 175.673 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.599 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.84 -45.87 6.54 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 113.03 -1.585 . . . . 0.0 110.097 178.342 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -89.79 28.63 1.3 Allowed 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.813 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.28 46.27 0.23 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.54 -178.668 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.8 mt 64.28 11.66 6.56 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.202 -179.494 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.1 t70 58.45 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 -179.823 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 33.6 t-80 -160.16 32.05 0.17 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.618 179.997 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 N--CA 1.468 0.445 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.264 179.806 . . . . . . . . 0 0 . 1 . 092 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.0 tttt . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 120.552 0.215 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 092 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.423 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.6 mt -116.68 -47.52 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.545 -179.085 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 14' ' ' GLY . 70.4 mt -94.77 -98.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.728 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.3 -9.4 1.49 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 176.916 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.584 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.59 -48.65 5.48 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 113.105 -1.548 . . . . 0.0 109.857 177.859 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.93 29.88 0.61 Allowed 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.737 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.34 42.92 0.3 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.84 -178.85 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.5 tp 59.47 50.7 7.25 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.286 -179.809 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.7 t0 56.74 35.61 26.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.463 -179.874 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.2 m80 55.91 39.57 30.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.561 179.966 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.194 179.868 . . . . . . . . 0 0 . 1 . 093 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 093 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.9 mt -113.3 -48.92 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 120.759 0.314 . . . . 0.0 111.754 -179.094 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.601 ' C ' ' H ' ' A' ' 14' ' ' GLY . 59.8 mt -91.83 -99.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.473 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.82 -8.27 1.3 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 176.915 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.52 -47.91 5.81 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 113.113 -1.544 . . . . 0.0 109.617 177.931 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.55 30.03 0.43 Allowed 'General case' 0 C--N 1.343 0.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.479 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.54 36.68 0.6 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.673 -178.831 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 19' ' ' HIS . 1.1 tt 54.44 38.49 29.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.972 -179.732 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.5 t70 59.19 1.19 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.09 179.933 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.476 ' H ' ' C ' ' A' ' 17' ' ' LEU . 47.5 t-80 -172.28 -72.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.879 0.371 . . . . 0.0 110.541 179.923 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.278 -179.913 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 tptm . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 121.169 0.509 . . . . 0.0 109.789 . . . . . . . . . 0 0 . 1 . 094 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.3 mt -132.77 -39.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.501 -179.721 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.61 ' C ' ' H ' ' A' ' 14' ' ' GLY . 84.6 mt -75.49 -89.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.93 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.23 -4.56 3.73 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 175.334 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.78 -45.38 6.79 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 113.128 -1.536 . . . . 0.0 109.855 178.16 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -90.44 29.46 1.28 Allowed 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.573 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 70.08 46.94 0.6 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.221 -178.422 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.5 mt 63.81 12.79 6.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.021 -179.219 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 t0 56.63 46.25 20.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.691 -179.94 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.8 m170 50.15 49.83 19.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.617 179.99 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.519 -179.922 . . . . . . . . 0 0 . 1 . 095 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.466 0.174 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 095 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.9 mt -122.73 -44.22 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 120.859 0.361 . . . . 0.0 111.205 -179.113 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.583 ' C ' ' H ' ' A' ' 14' ' ' GLY . 67.6 mt -97.79 -97.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 -178.655 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.69 -7.35 2.15 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 176.884 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.79 -47.12 5.46 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 113.317 -1.442 . . . . 0.0 109.593 177.915 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.93 30.55 0.44 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.556 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.1 38.43 0.56 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.935 -178.99 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 50.37 29.85 4.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.981 -179.833 . . . . . . . . 3 3 . 1 . 095 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.7 t70 55.1 -82.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.747 -179.903 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 19.4 t-80 -48.17 -66.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.696 -179.891 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.411 179.745 . . . . . . . . 0 0 . 1 . 096 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.869 0.366 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 096 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.4 mt -133.08 -50.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.167 -179.964 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.606 ' C ' ' H ' ' A' ' 14' ' ' GLY . 33.0 mm -76.62 -95.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.781 179.876 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.67 -9.53 1.21 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 176.313 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.77 -48.16 6.79 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 112.978 -1.611 . . . . 0.0 110.204 178.168 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.77 29.02 0.73 Allowed 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.753 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.77 38.73 0.25 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.882 -178.917 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 58.03 47.58 14.55 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.186 179.83 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.434 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 12.6 m-20 60.95 -76.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.74 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 17' ' ' LEU . 73.0 m80 -155.62 54.6 0.61 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.825 0.345 . . . . 0.0 110.465 -179.951 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.4 mp . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.221 179.973 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.1 tttp . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 . . . . . . . . . 0 0 . 1 . 097 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.4 mt -123.18 -45.66 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 120.802 0.334 . . . . 0.0 111.166 -179.189 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.8 mt -92.62 -97.19 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.101 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.17 -7.44 1.86 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 176.219 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.49 -47.46 5.68 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 113.225 -1.487 . . . . 0.0 109.942 177.993 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.69 28.94 0.46 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.51 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.78 38.54 0.46 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.41 -178.699 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.6 tp 57.02 47.79 16.87 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.173 -179.688 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.6 t70 52.22 29.72 6.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.464 -179.964 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 52.06 55.9 8.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.508 -179.986 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.359 -179.985 . . . . . . . . 0 0 . 1 . 098 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 tttm . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 120.478 0.18 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 098 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.9 mt -117.75 -47.71 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.761 0.315 . . . . 0.0 111.355 -179.098 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.579 ' C ' ' H ' ' A' ' 14' ' ' GLY . 59.1 mt -95.48 -99.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.993 -178.547 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.88 -10.11 0.96 Allowed Glycine 0 C--N 1.345 1.034 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 177.128 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.79 -48.89 5.32 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 113.057 -1.571 . . . . 0.0 109.797 177.951 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.01 28.54 0.6 Allowed 'General case' 0 C--N 1.342 0.277 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.951 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.95 38.71 0.13 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.356 -179.343 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 51.82 31.25 7.97 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.174 179.77 . . . . . . . . 3 3 . 1 . 098 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.0 t0 56.64 -79.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.831 -179.954 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 17' ' ' LEU . 17.0 m-70 -49.34 -67.12 0.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.74 179.935 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.173 179.988 . . . . . . . . 0 0 . 1 . 099 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.3 mttm . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 120.956 0.408 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 099 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.7 mt -137.65 -40.4 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.19 -179.56 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.634 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.2 mt -76.06 -89.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.928 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.04 -4.87 3.77 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 175.529 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.634 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.13 -45.55 6.56 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 113.02 -1.59 . . . . 0.0 110.144 178.365 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -90.62 29.34 1.32 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.832 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.64 46.9 0.26 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.425 -178.56 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.3 mt 65.11 13.48 8.73 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.389 0.431 . . . . 0.0 110.121 -179.393 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 t70 57.28 -78.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.041 179.761 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 17' ' ' LEU . 97.2 m-70 -50.26 -57.44 7.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.773 -179.801 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.173 179.974 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.1 tttp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.926 0.393 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 100 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.6 mt -139.44 -48.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.803 179.924 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.608 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.3 mm -77.58 -94.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.419 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.93 -8.97 1.59 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 176.24 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.608 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.17 -48.02 6.68 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 112.992 -1.604 . . . . 0.0 110.181 178.164 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.28 28.66 0.71 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.737 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.11 38.04 0.25 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.905 -179.019 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.4 tt 54.86 46.49 24.36 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.842 179.892 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 54.1 -84.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -179.754 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -162.28 50.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.524 179.876 . . . . . . . . 3 3 . 1 . 100 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.5 mp . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.251 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 45.5 p90 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.732 0.301 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.66 -70.43 0.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.123 0.487 . . . . 0.0 110.395 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -149.18 -17.19 0.29 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.6 ttm-85 -166.94 12.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.323 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.8 mt 60.05 112.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.189 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.98 50.31 18.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.734 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -63.94 -80.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.762 0.315 . . . . 0.0 110.639 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.17 131.63 20.42 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.904 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.61 -92.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.539 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -173.21 -17.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.931 0.396 . . . . 0.0 110.136 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 14.6 mt -136.28 -43.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.659 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.2 mt -92.29 -94.69 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.95 -5.97 2.51 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 108.131 -1.987 . . . . 0.0 108.131 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.48 -48.26 5.09 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 113.099 -1.551 . . . . 0.0 109.708 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.44 25.91 1.15 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.12 48.01 0.1 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.681 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.3 mt 60.93 29.28 18.92 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.104 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 53.7 61.69 2.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.436 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 49.19 45.75 23.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.697 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.4 mp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.139 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.0 m0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.771 0.319 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 2' ' ' LEU . 10.3 mp -52.8 -87.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.142 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -151.73 -14.93 0.19 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.3 ttt85 -165.08 2.02 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.247 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 mt 55.7 55.67 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.189 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.43 22.97 0.02 OUTLIER Glycine 0 C--N 1.331 0.293 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -52.96 -53.64 46.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.322 . . . . 0.0 110.439 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 49.41 -136.59 21.73 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.17 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.8 t -148.25 -56.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 110.345 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 12' ' ' ILE . 81.7 tttt -163.73 -76.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.532 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' ALA . 15.8 pt -71.4 7.2 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.504 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.621 ' C ' ' H ' ' A' ' 14' ' ' GLY . 45.3 mm -71.41 -88.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.41 -3.94 3.4 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 107.479 -2.248 . . . . 0.0 107.479 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.0 -39.08 8.18 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 113.702 -1.249 . . . . 0.0 110.124 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -90.88 25.94 2.24 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.78 35.4 0.21 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.6 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 53.48 33.33 15.84 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.91 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.5 t0 56.54 -79.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' LEU . 46.5 m-70 -50.2 -63.68 1.04 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.657 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.069 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.425 ' CZ3' HD11 ' A' ' 5' ' ' ILE . 29.4 m95 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.791 0.329 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 38.4 mt -73.73 -78.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.676 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -144.0 -17.58 0.58 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -148.33 13.26 0.96 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.542 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.425 HD11 ' CZ3' ' A' ' 1' ' ' TRP . 15.1 mt 61.51 66.11 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.356 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.28 93.32 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.109 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -57.67 -166.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.725 0.297 . . . . 0.0 110.322 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.09 -128.69 1.61 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.189 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.478 ' C ' ' H ' ' A' ' 11' ' ' ILE . 15.7 t -65.0 -10.77 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.5 0.191 . . . . 0.0 110.549 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.3 tttt 72.85 -18.82 0.34 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.936 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.478 ' H ' ' C ' ' A' ' 9' ' ' VAL . 13.1 mt -117.84 -45.57 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.398 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 14' ' ' GLY . 68.2 mt -94.97 -97.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.13 -8.42 1.53 Allowed Glycine 0 C--N 1.344 1.01 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.2 -47.48 5.48 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 113.227 -1.486 . . . . 0.0 110.106 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.46 26.34 0.8 Allowed 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 80.3 39.84 0.08 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.105 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.4 tp 55.76 22.85 5.81 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.335 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 53.72 -85.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.707 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' LEU . 20.2 m80 -49.8 -39.47 38.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.554 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.451 ' C ' HD23 ' A' ' 20' ' ' LEU . 2.0 tt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.192 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.436 ' O ' ' CD2' ' A' ' 1' ' ' TRP . 44.7 p-90 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.814 0.34 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.9 tp -61.92 -79.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.238 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.407 ' H ' ' H ' ' A' ' 4' ' ' ARG . 73.3 ttt180 -150.57 -17.45 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 6' ' ' GLY . 59.1 mtp85 -147.52 3.27 0.75 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.525 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.1 mt 61.78 -76.95 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.46 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -81.5 44.11 3.02 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -63.44 148.19 49.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 0.0 110.667 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.2 -166.39 39.66 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.213 -0.518 . . . . 0.0 111.916 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.5 t -141.68 -87.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -171.39 -26.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.77 0.319 . . . . 0.0 110.834 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.7 mt -137.07 -45.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.218 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.596 ' C ' ' H ' ' A' ' 14' ' ' GLY . 66.3 mt -82.83 -93.97 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.64 -8.27 2.69 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 107.882 -2.087 . . . . 0.0 107.882 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.52 -48.06 6.49 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 113.099 -1.551 . . . . 0.0 109.946 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.89 30.05 0.77 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.54 41.61 0.44 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.573 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.7 tt 66.39 53.57 0.98 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.82 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.9 t0 55.51 -81.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.909 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.506 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -150.34 39.24 0.73 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.559 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.434 179.887 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.537 ' C ' ' H ' ' A' ' 3' ' ' ARG . 8.1 m95 . . . . . 0 C--O 1.231 0.085 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.442 ' O ' ' CB ' ' A' ' 3' ' ' ARG . 24.0 mt 62.33 -5.81 0.17 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.384 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.537 ' H ' ' C ' ' A' ' 1' ' ' TRP . 37.3 ttt180 84.37 -50.97 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.124 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -167.21 52.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.186 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mt 48.2 69.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.709 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.59 -55.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.076 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.9 tttt 54.62 75.79 0.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.808 0.337 . . . . 0.0 110.413 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.78 136.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.03 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.441 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 31.5 m -154.86 21.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.795 0.331 . . . . 0.0 110.226 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.421 ' N ' ' CD ' ' A' ' 10' ' ' LYS . 3.5 mptp? -79.61 -12.15 59.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.867 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.39 -36.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.125 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.607 ' C ' ' H ' ' A' ' 14' ' ' GLY . 87.1 mt -77.3 -87.76 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.41 -4.95 5.64 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 107.199 -2.36 . . . . 0.0 107.199 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.91 -45.84 6.53 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 113.102 -1.549 . . . . 0.0 110.092 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.78 30.54 0.82 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 71.78 42.73 0.61 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.484 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 61.28 53.52 3.49 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.31 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.28 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.671 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 1.1 t60 -159.43 52.86 0.37 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 0.0 110.355 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 20' ' ' LEU . 9.2 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.109 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 34.7 p-90 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.82 0.343 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 2' ' ' LEU . 7.9 mp -65.46 -78.53 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.134 0.493 . . . . 0.0 110.098 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -166.26 -20.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 7' ' ' LYS . 5.8 ptp180 -161.73 6.69 0.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.415 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.0 pt 34.41 35.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.733 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.93 46.32 67.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.146 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 4' ' ' ARG . 84.2 tttt -77.74 122.14 24.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 110.503 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.54 79.81 0.2 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.974 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.411 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 31.6 m -154.23 26.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.845 0.355 . . . . 0.0 110.381 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -78.57 -14.23 59.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.059 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.9 mt -140.32 -37.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.167 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.603 ' C ' ' H ' ' A' ' 14' ' ' GLY . 39.1 mm -75.57 -87.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.98 -5.24 5.31 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 107.217 -2.353 . . . . 0.0 107.217 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.51 -44.81 7.18 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 113.207 -1.496 . . . . 0.0 110.266 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.51 27.8 1.06 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.69 39.06 0.35 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.573 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 58.66 44.69 17.03 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.259 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 54.64 36.59 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.437 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 13.4 t-80 51.04 46.47 26.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.606 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.477 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 1' ' ' TRP . 6.0 m95 . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.714 0.292 . . . . 0.0 110.486 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 26.5 mt -66.41 -72.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.031 0.443 . . . . 0.0 110.4 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.411 ' H ' ' H ' ' A' ' 4' ' ' ARG . 32.4 ttp180 -157.81 -13.84 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.411 ' H ' ' H ' ' A' ' 3' ' ' ARG . 75.6 mtm180 -148.39 6.01 0.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.898 -1.047 . . . . 0.0 109.356 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 mt 59.75 53.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.414 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 42.71 48.15 6.03 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.495 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -77.38 119.45 21.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.581 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.4 143.84 37.73 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.889 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.489 HG23 ' H ' ' A' ' 10' ' ' LYS . 1.5 m -65.86 -103.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.489 ' H ' HG23 ' A' ' 9' ' ' VAL . 81.9 tttt -151.48 -22.06 0.2 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.703 0.287 . . . . 0.0 110.558 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.4 mt -119.77 -54.89 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.191 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.7 mt -77.67 -95.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.691 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.34 -8.19 1.61 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.32 -48.2 6.09 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 112.835 -1.682 . . . . 0.0 110.102 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.98 28.66 1.01 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.67 46.98 0.18 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.63 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.7 mt 62.91 41.54 8.5 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 53.07 31.16 10.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.297 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 51.38 62.84 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.479 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.394 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 13.7 m95 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.772 0.32 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.42 ' C ' HD23 ' A' ' 2' ' ' LEU . 1.4 tt -164.16 -71.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.967 0.413 . . . . 0.0 110.338 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 39.2 ttt85 -173.41 -18.3 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 6' ' ' GLY . 59.1 mtt-85 -146.17 -5.3 0.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.218 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 mt 60.74 -76.84 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.84 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -54.86 -32.4 55.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.09 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.5 tttp 55.78 80.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.879 0.371 . . . . 0.0 110.55 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.95 -154.77 51.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.988 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.0 t -148.49 -81.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.618 0.247 . . . . 0.0 110.401 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.403 ' H ' ' H ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -169.4 -18.22 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.028 0.442 . . . . 0.0 109.845 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -118.85 -52.58 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.664 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.613 ' C ' ' H ' ' A' ' 14' ' ' GLY . 42.3 mm -73.84 -98.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.205 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.38 -10.71 0.6 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.24 -47.65 7.37 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 113.243 -1.479 . . . . 0.0 110.126 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.2 27.2 1.08 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.02 39.64 0.16 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.751 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 64.89 17.43 11.03 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.826 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.5 t70 55.35 -82.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.683 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 1.4 t-80 -54.39 -69.78 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.48 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 N--CA 1.464 0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.453 179.881 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.8 0.333 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.4 mt -63.86 -6.56 6.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.193 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 69.2 -65.8 0.28 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.167 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.17 -9.91 59.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.778 0.323 . . . . 0.0 110.625 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.6 mt 57.78 55.58 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.592 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.34 -28.3 0.38 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.168 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt 58.11 101.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.747 0.308 . . . . 0.0 110.278 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -51.13 126.26 26.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.015 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.487 HG23 ' H ' ' A' ' 10' ' ' LYS . 1.3 m -72.77 -102.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.487 ' H ' HG23 ' A' ' 9' ' ' VAL . 49.5 tttm -155.7 -22.19 0.11 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.834 0.35 . . . . 0.0 110.513 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.5 mt -117.5 -52.15 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 34.9 mm -85.76 -99.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.04 -11.15 0.54 Allowed Glycine 0 C--N 1.348 1.201 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.89 -49.88 5.83 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 113.12 -1.54 . . . . 0.0 109.875 177.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.544 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.86 29.33 0.63 Allowed 'General case' 0 C--N 1.345 0.395 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.82 37.79 0.15 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.478 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 52.49 36.76 21.13 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.213 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 53.51 -84.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.83 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 51.9 m80 -45.61 -63.39 0.97 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.083 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.495 ' O ' ' N ' ' A' ' 3' ' ' ARG . 96.2 m95 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.827 0.346 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 2' ' ' LEU . 3.4 mm? 50.38 -88.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.337 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 1' ' ' TRP . 12.0 tpp180 -171.14 -11.59 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.442 ' H ' ' H ' ' A' ' 5' ' ' ILE . 13.2 ptm180 -166.27 -5.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.14 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.442 ' H ' ' H ' ' A' ' 4' ' ' ARG . 12.8 mt -108.62 63.18 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.864 0.364 . . . . 0.0 110.444 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.83 2.98 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -163.85 -29.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.332 . . . . 0.0 110.397 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.02 56.26 3.94 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' C ' ' H ' ' A' ' 11' ' ' ILE . 21.3 t -65.54 -21.62 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.596 0.236 . . . . 0.0 110.596 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.4 tttm 72.53 -19.06 0.31 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.359 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.445 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.0 mt -113.81 -48.21 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.83 0.348 . . . . 0.0 111.481 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.563 ' C ' ' N ' ' A' ' 14' ' ' GLY . 41.4 mm -96.56 -101.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.046 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.425 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -50.11 -12.09 0.47 Allowed Glycine 0 C--N 1.345 1.077 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.563 ' N ' ' C ' ' A' ' 12' ' ' ILE . . . -82.19 -48.51 5.66 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 113.504 -1.348 . . . . 0.0 110.055 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.59 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.15 22.39 1.21 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 83.22 41.96 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.951 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.8 tp 61.71 6.45 1.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.252 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.0 t70 53.16 38.11 26.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.61 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 29.4 m170 50.03 55.42 9.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.631 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.227 -179.924 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 43.6 p-90 . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.847 0.356 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 2' ' ' LEU . 7.6 mp -72.53 -77.46 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.124 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.413 ' H ' ' H ' ' A' ' 4' ' ' ARG . 31.4 ttt-85 -146.37 -13.31 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.413 ' H ' ' H ' ' A' ' 3' ' ' ARG . 9.9 ptp180 -158.4 7.27 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.915 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.2 mt 56.58 51.71 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 45.32 45.89 11.04 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.114 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt 53.99 91.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 0.0 110.344 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 10' ' ' LYS . . . -61.01 -142.65 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.264 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 14' ' ' GLY . 33.6 t 58.11 -79.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.611 0.243 . . . . 0.0 110.683 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 8' ' ' GLY . 31.6 ttmt -44.89 -18.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.208 0.528 . . . . 0.0 110.627 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' VAL . 11.9 mt -112.54 -44.85 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.74 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.592 ' C ' ' H ' ' A' ' 14' ' ' GLY . 82.6 mt -73.65 -91.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.154 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.64 -8.61 2.05 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 176.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.23 -46.14 7.14 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 113.219 -1.491 . . . . 0.0 110.213 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.47 31.0 0.59 Allowed 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.16 37.68 0.74 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.684 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.7 tt 57.23 50.19 12.12 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.726 -0.789 . . . . 0.0 109.684 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 55.17 -82.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.665 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -163.62 51.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.502 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.578 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.837 0.351 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.6 mt -72.21 -8.39 54.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.151 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 73.45 -63.74 0.42 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.643 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.44 ' N ' ' CD ' ' A' ' 4' ' ' ARG . 11.6 mpt_? -54.58 -26.42 32.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.0 tt -53.97 -36.6 31.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.119 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -75.28 -21.79 77.18 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 6' ' ' GLY . 54.9 tttm 60.9 134.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.867 0.365 . . . . 0.0 110.631 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.04 92.8 0.28 Allowed Glycine 0 C--N 1.33 0.225 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.059 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.42 -92.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -172.49 -23.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.853 0.358 . . . . 0.0 110.453 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -127.98 -44.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.772 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 69.0 mt -89.94 -95.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.0 -7.6 2.52 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.87 -47.0 6.04 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 113.182 -1.509 . . . . 0.0 110.032 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.31 30.27 0.54 Allowed 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.24 37.79 0.44 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.805 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 52.83 46.79 26.05 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.899 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 49.74 47.58 22.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.704 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 50.2 44.54 26.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.588 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 20' ' ' LEU . 8.4 mp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.089 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.508 ' C ' ' H ' ' A' ' 3' ' ' ARG . 7.6 m-90 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.672 0.272 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.446 ' O ' ' CB ' ' A' ' 3' ' ' ARG . 13.9 mt 63.31 -6.6 0.19 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.391 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.508 ' H ' ' C ' ' A' ' 1' ' ' TRP . 38.0 ttm-85 85.89 -73.46 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.491 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -89.91 6.5 41.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.762 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.2 mt 55.55 68.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.546 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 166.74 -16.9 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.179 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -76.82 84.91 3.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.985 0.421 . . . . 0.0 110.526 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.64 -145.48 4.21 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.902 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.2 t -73.21 -86.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.616 0.246 . . . . 0.0 110.446 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -172.06 -22.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.78 0.324 . . . . 0.0 110.244 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -134.31 -51.2 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.292 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 73.6 mt -77.05 -94.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.27 -8.38 2.47 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 176.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.95 -47.43 7.12 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 112.853 -1.673 . . . . 0.0 110.047 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.72 30.5 0.64 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.15 37.94 0.58 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.634 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 19' ' ' HIS . 1.1 tt 57.22 38.49 28.82 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.848 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.4 t70 60.5 0.48 0.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.081 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.466 ' H ' ' C ' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -173.43 -72.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.267 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.42 -179.846 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 2.5 m0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.776 0.322 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.1 tp -57.44 -81.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 110.253 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.47 ' NH2' ' NH2' ' A' ' 4' ' ' ARG . 32.7 ttt-85 -164.01 -16.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.47 ' NH2' ' NH2' ' A' ' 3' ' ' ARG . 65.3 mtt85 -151.29 -4.79 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.122 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mt 50.74 36.82 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.372 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.01 34.01 0.02 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.027 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -58.79 127.37 31.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.797 0.332 . . . . 0.0 110.442 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.95 152.44 17.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.148 -0.548 . . . . 0.0 111.926 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.478 HG23 ' H ' ' A' ' 10' ' ' LYS . 1.6 m -64.71 -103.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.478 ' H ' HG23 ' A' ' 9' ' ' VAL . 44.5 tptt -160.71 -17.4 0.05 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.868 0.366 . . . . 0.0 110.12 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.9 mt -118.64 -48.66 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 14' ' ' GLY . 44.0 mm -91.86 -99.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.425 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.69 -10.67 0.7 Allowed Glycine 0 C--N 1.347 1.139 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 176.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.591 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.43 -49.03 5.66 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 113.223 -1.488 . . . . 0.0 109.886 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.555 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -83.79 27.4 0.64 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 79.68 38.2 0.11 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.229 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.99 31.39 10.92 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.094 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 49.76 53.82 12.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 52.32 57.88 5.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.646 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.225 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 121.058 0.456 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 5' ' ' ILE . 32.9 mt -134.77 -3.42 2.58 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.074 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -44.54 -21.1 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.534 0.683 . . . . 0.0 109.197 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.491 ' N ' ' C ' ' A' ' 2' ' ' LEU . 28.5 mmt180 -121.08 -13.11 8.61 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.49 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.532 ' H ' ' C ' ' A' ' 2' ' ' LEU . 10.0 mt 60.15 56.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.206 0 CA-C-O 121.079 0.466 . . . . 0.0 110.477 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 55.31 6.3 0.93 Allowed Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.863 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -72.36 -26.72 62.02 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.281 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.9 152.77 5.83 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.256 -0.497 . . . . 0.0 111.975 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.61 -80.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.69 0.281 . . . . 0.0 110.604 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -170.79 -23.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.764 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.5 mt -134.07 -47.28 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.223 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.1 mt -79.22 -92.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.99 -8.89 2.5 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 176.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.28 -48.5 6.37 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 112.923 -1.638 . . . . 0.0 110.27 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.68 28.65 0.86 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.74 41.25 0.18 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.876 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.6 tp 61.19 26.43 16.31 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.299 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 t0 58.31 -77.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.949 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.548 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER -48.58 -62.46 1.49 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.756 0.313 . . . . 0.0 110.824 -179.758 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.514 -180.0 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.1 m0 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.753 0.311 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 18.9 tp -53.52 -81.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.163 0.506 . . . . 0.0 110.243 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -151.5 -10.37 0.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -175.47 7.53 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.278 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 6' ' ' GLY . 16.1 tt -56.09 -41.78 70.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.253 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 5' ' ' ILE . . . -79.39 13.35 22.12 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -172.96 47.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.749 0.309 . . . . 0.0 110.621 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . -72.03 147.33 41.12 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.787 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.403 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 28.9 m -76.55 32.54 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.714 0.293 . . . . 0.0 110.852 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 8' ' ' GLY . 28.1 mmtm -83.39 -11.65 57.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.12 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -139.9 -40.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.432 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.617 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.2 mt -76.46 -88.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.08 -5.78 4.79 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 107.271 -2.332 . . . . 0.0 107.271 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.617 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.34 -45.76 6.82 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 113.106 -1.547 . . . . 0.0 110.198 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.64 27.72 0.94 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.91 37.8 0.27 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.802 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.3 tp 58.66 27.15 15.44 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 55.33 -82.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 56.7 t-80 -49.45 -60.72 2.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.739 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.137 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 60.6 m95 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.8 mt -72.38 -5.76 38.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.515 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.416 ' C ' ' H ' ' A' ' 5' ' ' ILE . 21.0 mmm180 64.92 -76.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.693 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.2 mmm-85 -75.68 14.35 0.65 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.836 0.351 . . . . 0.0 110.549 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.416 ' H ' ' C ' ' A' ' 3' ' ' ARG . 12.1 mt 51.59 74.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.165 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 82.16 78.79 1.0 Allowed Glycine 0 C--N 1.331 0.303 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 6' ' ' GLY . 24.5 mtmm -60.31 -138.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.718 0.294 . . . . 0.0 110.694 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.93 -168.79 54.34 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.895 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 t -77.26 -66.77 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.878 0.37 . . . . 0.0 110.552 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -170.94 -58.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.505 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 15' ' ' ALA . 16.2 pt -78.3 6.54 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.681 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.9 mm -70.66 -89.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.22 -4.17 3.39 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 107.488 -2.245 . . . . 0.0 107.488 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.01 -38.99 8.81 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -93.91 27.5 2.74 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.54 38.52 0.38 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.552 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.4 tt 66.14 44.27 2.65 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.731 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 59.8 t0 55.29 35.35 24.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.493 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.3 m80 52.57 57.61 6.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.532 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.471 ' C ' HD23 ' A' ' 20' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.1 p90 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.77 0.319 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.421 ' C ' ' H ' ' A' ' 4' ' ' ARG . 12.2 mt -73.6 -7.92 53.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.44 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 74.73 -38.1 0.37 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.418 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 2' ' ' LEU . 70.3 mtp180 -73.76 -38.46 64.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.01 0.433 . . . . 0.0 110.022 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 6' ' ' GLY . 16.8 tt -76.58 -35.53 26.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.222 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 5' ' ' ILE . . . -64.19 -24.87 69.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.191 -0.528 . . . . 0.0 111.908 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -52.41 -27.59 16.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.383 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.25 130.19 0.2 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.019 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.8 t -69.29 -84.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.672 0.272 . . . . 0.0 110.448 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -171.18 -23.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.623 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 15.3 mt -131.07 -46.99 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.366 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.603 ' C ' ' H ' ' A' ' 14' ' ' GLY . 28.3 mt -81.99 -94.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.425 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -56.12 -7.38 1.79 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.24 -48.16 5.8 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.013 -1.593 . . . . 0.0 110.133 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -89.69 29.94 1.1 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.26 48.09 0.13 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.785 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.4 mt 64.08 49.83 2.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.8 t0 59.63 -76.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.746 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -162.45 26.95 0.11 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.729 0.299 . . . . 0.0 110.482 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.422 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.08 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.75 0.31 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.8 mt -66.23 -7.3 17.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.17 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 25.2 ttt85 69.56 -70.05 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.763 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 -67.45 -12.58 60.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.378 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.8 pt 34.24 49.42 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.63 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 8' ' ' GLY . . . -160.39 -30.21 0.02 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.27 -0.491 . . . . 0.0 111.971 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -76.62 39.99 0.22 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.807 0.337 . . . . 0.0 110.641 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 6' ' ' GLY . . . -167.68 118.31 0.78 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.0 t -70.03 -93.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.486 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -171.72 -23.65 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -129.3 -44.43 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.095 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 73.7 mt -90.75 -94.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.22 -6.98 3.47 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.45 -47.57 5.65 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 113.062 -1.569 . . . . 0.0 110.121 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.87 27.21 0.77 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.22 40.4 0.13 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.863 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.5 tp 56.56 23.2 7.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.248 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 57.48 11.62 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.184 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -171.3 -44.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.764 0.316 . . . . 0.0 110.648 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.405 ' H ' ' HB3' ' A' ' 17' ' ' LEU . 1.2 tt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.126 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 38.1 p90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.682 0.277 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 18.7 mt -68.59 -73.66 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.456 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -144.45 -14.39 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -172.7 19.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.172 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mt 61.19 95.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.218 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.58 54.65 7.33 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.124 -0.56 . . . . 0.0 111.887 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -49.06 -23.02 1.03 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 110.557 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.34 -156.73 23.83 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.193 -0.527 . . . . 0.0 111.917 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.9 t -145.98 -85.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -171.43 -23.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.853 0.359 . . . . 0.0 110.588 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.4 mt -139.6 -42.9 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.356 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.7 mt -86.84 -91.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.33 -6.62 4.55 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.4 -47.63 5.97 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 112.909 -1.645 . . . . 0.0 109.892 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.51 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.84 25.88 0.89 Allowed 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.78 43.15 0.18 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.576 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 69.51 51.69 0.47 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.377 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.6 t70 60.61 -76.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.591 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.478 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -160.77 50.85 0.27 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 0.0 110.397 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.41 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.143 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 1.1 m0 . . . . . 0 N--CA 1.46 0.064 0 CA-C-O 121.015 0.436 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 5' ' ' ILE . 37.5 mt -134.97 -3.07 2.53 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.045 178.55 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.9 ttt-85 -46.53 -17.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.504 ' N ' ' C ' ' A' ' 2' ' ' LEU . 70.8 mtp85 -131.22 -4.66 3.86 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.77 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.517 ' H ' ' C ' ' A' ' 2' ' ' LEU . 14.2 mt 59.89 89.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.224 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.386 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 173.61 -37.35 0.13 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 6' ' ' GLY . 81.0 tttt 58.83 152.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 110.712 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 70.62 170.3 9.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.076 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 11' ' ' ILE . 2.2 t -74.82 10.32 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.867 0.365 . . . . 0.0 110.179 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 8' ' ' GLY . 43.9 mttp 66.07 -13.53 0.16 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.513 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.514 ' H ' ' C ' ' A' ' 9' ' ' VAL . 11.4 mt -129.29 -43.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.775 0.321 . . . . 0.0 110.88 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.3 mt -94.69 -94.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.09 -7.19 3.52 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 176.304 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.07 -47.44 5.53 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 113.131 -1.534 . . . . 0.0 109.86 178.2 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -83.92 27.67 0.64 Allowed 'General case' 0 C--N 1.341 0.23 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.75 39.59 0.17 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.004 -179.072 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.2 tt 52.19 39.33 26.66 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.96 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.3 t70 54.57 -83.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.591 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' LEU . 23.9 m80 -52.57 -65.83 0.49 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.632 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.207 -179.936 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 12.6 m-90 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.837 0.351 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.2 tp -168.63 -83.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.082 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -152.4 -26.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' ILE . 32.7 mmt180 -132.44 -0.48 3.6 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.282 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 4' ' ' ARG . 13.1 mt 60.73 124.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.413 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.72 31.5 60.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.973 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.1 mttt 54.9 175.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.0 110.531 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.16 110.11 0.23 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.935 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.5 t -78.97 -83.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.617 0.246 . . . . 0.0 110.732 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -170.42 -26.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.912 0.386 . . . . 0.0 110.591 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -133.57 -45.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.358 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.58 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.9 mt -77.26 -91.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.13 -7.53 3.87 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 175.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.58 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.2 -47.16 6.63 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 112.895 -1.653 . . . . 0.0 110.159 178.314 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.35 30.74 0.68 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.65 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.6 40.07 0.52 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.73 -178.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 58.94 51.9 6.9 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.143 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 65.72 -74.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.03 38.4 0.26 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.795 0.331 . . . . 0.0 110.521 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.412 -179.986 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.87 0.367 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 2.0 mm? -73.86 -90.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.996 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -135.46 -11.67 2.12 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.867 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -148.05 9.29 0.87 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.076 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.0 mt 60.16 103.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.452 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 53.54 43.22 67.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.105 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 6' ' ' GLY . 21.7 pttp 37.57 -160.78 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.599 0.238 . . . . 0.0 111.566 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.3 152.45 51.29 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.076 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.4 t -74.78 -87.25 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -171.03 -23.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.764 0.316 . . . . 0.0 110.784 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.7 mp -119.86 -48.18 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.374 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.57 ' C ' ' N ' ' A' ' 14' ' ' GLY . 42.4 mm -91.45 -98.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.66 -179.464 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.0 -11.95 0.65 Allowed Glycine 0 C--N 1.346 1.11 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 176.485 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.57 ' N ' ' C ' ' A' ' 12' ' ' ILE . . . -79.89 -50.41 5.57 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 113.309 -1.445 . . . . 0.0 109.997 177.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.02 27.94 0.74 Allowed 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.08 44.68 0.13 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.771 -178.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.1 tp 66.75 11.3 8.14 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.19 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.9 t70 58.71 -77.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.5 t60 -77.87 13.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.722 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 20' ' ' LEU . 9.8 mp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.064 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.512 ' C ' ' H ' ' A' ' 3' ' ' ARG . 8.5 m-90 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.661 0.267 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 4' ' ' ARG . 14.3 mt 64.4 -8.38 0.2 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.425 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.512 ' H ' ' C ' ' A' ' 1' ' ' TRP . 49.0 mtp180 63.52 -13.85 0.08 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.494 ' H ' ' C ' ' A' ' 2' ' ' LEU . 47.8 ttm-85 -157.38 31.37 0.28 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.978 0.418 . . . . 0.0 110.343 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.2 mm 44.16 69.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.449 ' H ' ' CB ' ' A' ' 2' ' ' LEU . . . 60.74 77.59 0.18 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.911 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -51.27 141.3 15.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 110.57 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.56 169.91 35.73 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.254 -0.498 . . . . 0.0 111.868 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.62 -85.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.701 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -171.63 -25.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.784 0.326 . . . . 0.0 110.615 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mt -139.12 -44.24 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.12 -179.679 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 7.7 mm -86.13 -93.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.19 -7.05 3.5 Favored Glycine 0 C--N 1.342 0.908 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 176.027 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.89 -47.97 6.0 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 113.006 -1.597 . . . . 0.0 110.031 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.74 29.77 0.69 Allowed 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.693 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.77 40.75 0.36 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.86 -178.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 58.36 20.91 7.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.695 -179.801 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.2 t0 56.95 -78.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.948 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.553 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 1.5 m-70 -46.83 -59.52 3.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.989 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.198 -179.919 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.433 ' C ' ' H ' ' A' ' 3' ' ' ARG . 4.2 m-90 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.68 0.276 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.49 ' CD2' ' H ' ' A' ' 7' ' ' LYS . 5.4 tp -52.17 -12.35 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.283 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 1' ' ' TRP . 21.4 ttm180 75.78 -42.98 0.47 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.68 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -86.8 -3.56 59.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.81 0.338 . . . . 0.0 110.449 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mt 53.05 67.84 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.364 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.68 72.93 1.02 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.125 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.49 ' H ' ' CD2' ' A' ' 2' ' ' LEU . 51.1 tttm -51.72 -81.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.755 0.312 . . . . 0.0 110.531 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.04 146.7 40.11 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.983 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.12 -86.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.52 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -170.95 -24.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.86 0.362 . . . . 0.0 110.188 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.62 -46.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.19 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 14' ' ' GLY . 30.9 mt -78.3 -92.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.92 -8.72 2.34 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 175.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.54 -48.24 6.39 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 113.001 -1.599 . . . . 0.0 110.283 178.196 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.74 27.78 1.1 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.854 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.51 43.83 0.13 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.82 -178.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 65.62 17.53 10.93 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.447 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 58.53 -77.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.929 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 10.7 m-70 -52.97 -65.08 0.62 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.837 0.351 . . . . 0.0 110.604 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.175 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.836 0.35 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 tp -72.07 -4.34 28.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.135 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 79.87 -15.65 0.74 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.326 -179.654 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -157.32 29.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.553 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.3 tt -60.44 -34.47 58.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.314 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.56 15.64 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -64.0 89.36 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.32 . . . . 0.0 110.558 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.53 124.88 9.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.028 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.76 -85.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.639 0.257 . . . . 0.0 110.419 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -171.1 -24.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.575 -179.924 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.5 mt -132.59 -50.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.325 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 33.5 mm -78.41 -94.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.34 -9.33 1.48 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 176.204 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.09 -48.63 6.38 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 112.959 -1.62 . . . . 0.0 110.229 178.151 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.96 27.96 0.73 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.783 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.53 37.95 0.17 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.014 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.1 tp 57.18 11.64 1.11 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.246 179.738 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER 58.58 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.92 -179.986 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 17' ' ' LEU . 57.8 t-80 -50.62 -44.4 57.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.838 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.4 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.12 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.522 ' C ' ' H ' ' A' ' 3' ' ' ARG . 94.1 m95 . . . . . 0 C--O 1.23 0.068 0 N-CA-C 110.583 -0.154 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 23.2 mt 62.29 -5.66 0.17 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.363 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 1' ' ' TRP . 37.3 mtt85 65.42 -74.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.699 -179.713 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 6' ' ' GLY . 98.9 mtt180 -71.96 11.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.808 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.447 ' H ' ' C ' ' A' ' 3' ' ' ARG . 35.3 pt 35.24 28.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.89 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . 153.19 61.71 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -51.19 94.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.933 0.397 . . . . 0.0 110.366 -179.848 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.69 -162.33 33.16 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.083 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.3 t -76.68 -82.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.682 0.277 . . . . 0.0 110.68 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -170.92 -26.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.761 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.0 mt -124.04 -54.21 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.364 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.4 mm -75.06 -98.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.021 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.409 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -50.97 -11.63 0.59 Allowed Glycine 0 C--N 1.347 1.178 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 176.862 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.591 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -77.82 -48.92 7.45 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.048 -1.576 . . . . 0.0 109.966 178.049 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.34 28.34 0.85 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.704 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.66 39.35 0.24 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.813 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 62.41 25.37 15.13 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.78 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.3 t70 58.01 -78.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' LEU . 16.2 m80 -51.04 -65.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.606 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.233 179.988 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.77 0.319 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 4' ' ' ARG . 27.6 mt -71.91 -6.0 38.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.324 179.696 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 64.35 -73.06 0.06 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.1 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 2' ' ' LEU . 65.3 mtp180 -72.31 5.18 3.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.915 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mt 45.64 77.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.749 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 166.4 -37.7 0.25 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.104 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -168.63 149.68 4.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.831 0.348 . . . . 0.0 110.653 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.93 172.01 41.94 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.915 179.936 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -147.34 -99.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.846 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' H ' HG23 ' A' ' 9' ' ' VAL . 49.9 tttp -167.7 -20.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.99 0.424 . . . . 0.0 110.482 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.1 mt -111.44 -48.46 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.524 -179.131 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 14' ' ' GLY . 40.7 mm -96.16 -101.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.093 -178.62 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.95 -12.08 0.43 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 177.04 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.47 -48.59 5.54 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 113.507 -1.347 . . . . 0.0 110.082 177.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -83.08 23.37 0.86 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.002 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 83.94 39.41 0.03 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.196 -179.336 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.4 tp 54.91 18.04 2.05 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.268 179.757 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 52.67 20.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.119 -179.602 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 m170 57.83 64.12 1.62 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.503 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.336 -179.952 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.498 ' O ' ' CD1' ' A' ' 1' ' ' TRP . 32.1 p90 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.852 0.358 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.3 mt -79.28 -72.16 0.41 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.529 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.51 -22.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.735 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -130.31 -1.15 4.51 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.608 179.403 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.8 mt 60.14 93.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.389 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 59.84 67.7 2.03 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.988 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -66.83 173.92 3.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.627 0.251 . . . . 0.0 110.401 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -173.28 -144.42 4.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.22 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -61.89 -89.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.762 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -172.14 -25.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.716 0.293 . . . . 0.0 110.612 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.3 mt -112.42 -51.08 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.327 -179.169 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 14' ' ' GLY . 38.8 mm -89.73 -100.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.177 -179.036 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.406 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -50.63 -11.59 0.52 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 176.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.13 -49.65 5.85 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 113.294 -1.453 . . . . 0.0 109.946 177.737 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.26 28.2 0.74 Allowed 'General case' 0 C--N 1.345 0.41 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.747 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.18 41.77 0.15 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.047 -179.1 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 19' ' ' HIS . 4.1 tp 62.3 10.41 3.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.446 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.489 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 33.0 t70 57.63 5.05 0.29 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 55.7 m80 -157.49 -13.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 109.836 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.43 ' H ' ' H ' ' A' ' 19' ' ' HIS . 18.8 tp . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.313 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 78.3 m95 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.817 0.341 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.609 HD12 ' H ' ' A' ' 2' ' ' LEU . 6.4 mp -63.63 -9.32 13.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.187 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 71.7 -66.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.764 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.3 ttt85 -74.12 -8.62 56.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.891 0.377 . . . . 0.0 110.276 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt 59.16 61.38 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.382 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.43 -70.33 0.17 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.98 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.451 ' CB ' ' NZ ' ' A' ' 7' ' ' LYS . 6.1 ttpm? -92.28 122.09 34.41 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.764 0.316 . . . . 0.0 110.506 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.72 -63.84 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.888 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 29.0 m -154.48 24.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.807 0.337 . . . . 0.0 110.464 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -74.78 -21.17 59.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.094 179.751 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.7 mt -134.42 -35.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.375 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.602 ' C ' ' H ' ' A' ' 14' ' ' GLY . 82.0 mt -74.83 -88.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.07 -4.72 4.85 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 175.407 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.15 -43.62 7.44 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 113.28 -1.46 . . . . 0.0 110.14 178.483 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.36 27.86 1.18 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.884 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.26 37.9 0.34 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.614 -178.722 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 55.21 48.67 18.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.898 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 48.62 29.94 2.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.746 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.2 m80 53.18 59.43 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.583 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.069 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.752 0.311 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 4' ' ' ARG . 12.7 mt -72.29 -9.75 58.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.576 -179.876 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 68.44 -28.8 0.16 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.607 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 2' ' ' LEU . 77.1 mtm-85 -90.0 -14.06 34.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.719 0.295 . . . . 0.0 110.428 -179.974 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.6 mp 52.72 97.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.849 -179.941 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.24 23.79 73.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.215 -0.516 . . . . 0.0 112.062 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 tptp 60.5 152.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.688 0.28 . . . . 0.0 110.299 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -165.58 176.52 41.1 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.082 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.1 t -69.12 -80.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 121.101 -0.239 . . . . 0.0 110.479 179.975 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -172.52 -25.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.868 0.366 . . . . 0.0 110.504 179.832 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.409 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -135.93 -46.38 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.268 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.4 mt -76.48 -92.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.69 -8.04 3.76 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.932 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.07 -46.67 7.51 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 112.907 -1.646 . . . . 0.0 110.224 178.324 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.68 29.43 0.79 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.526 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.98 41.22 0.51 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.222 -178.448 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 63.15 51.94 2.63 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.05 -179.688 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 t0 59.8 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.579 -179.867 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -167.46 53.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.492 179.884 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.132 179.965 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.483 ' O ' ' N ' ' A' ' 3' ' ' ARG . 60.8 t-105 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.732 0.301 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.448 ' N ' ' CG ' ' A' ' 1' ' ' TRP . 7.9 mt 53.25 -89.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.099 0.476 . . . . 0.0 109.886 -179.516 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 1' ' ' TRP . 31.8 ttm180 -172.91 -23.17 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.078 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -148.45 -2.45 0.5 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.506 179.566 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.5 mt 55.53 74.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.511 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.59 46.59 83.73 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.232 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt 48.69 -94.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.865 0.364 . . . . 0.0 110.762 179.865 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.46 170.89 44.07 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -179.946 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.81 -86.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.532 -179.849 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -171.34 -29.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.428 -179.95 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.1 mt -135.47 -47.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.9 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 14' ' ' GLY . 47.5 mm -76.7 -94.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.471 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.408 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -54.3 -9.49 1.53 Allowed Glycine 0 C--N 1.346 1.118 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 176.127 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.02 -47.79 6.89 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 113.175 -1.513 . . . . 0.0 110.203 178.253 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.93 28.75 1.0 Allowed 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.819 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.25 42.03 0.19 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.827 -178.954 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.2 tp 63.67 30.16 14.87 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.337 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.0 t0 56.36 -80.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.742 -179.989 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 74.5 m80 -49.29 -65.75 0.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.982 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.888 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.444 ' C ' ' H ' ' A' ' 3' ' ' ARG . 1.2 p90 . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 121.043 0.449 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.2 tp 68.94 -6.03 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.523 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 1' ' ' TRP . 23.7 ttm180 75.11 -61.54 0.48 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.791 179.916 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.9 mtp85 -72.84 0.72 10.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.675 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.5 mt 52.78 63.23 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.339 179.997 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 52.86 24.35 19.09 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.034 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.4 tttp 52.89 94.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.768 0.318 . . . . 0.0 110.516 179.932 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.29 -162.09 51.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.941 179.961 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.6 t -76.42 -83.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.623 0.249 . . . . 0.0 110.683 -179.927 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -171.81 -19.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.913 0.387 . . . . 0.0 110.346 -179.895 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 21.5 mt -138.41 -45.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.62 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.8 mt -77.93 -92.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.68 -5.92 3.14 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 107.819 -2.113 . . . . 0.0 107.819 175.718 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.62 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.65 -47.57 5.9 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 112.893 -1.654 . . . . 0.0 110.172 178.261 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.34 29.21 0.99 Allowed 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.683 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.21 47.62 0.19 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.382 -178.652 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.1 mt 64.19 39.86 7.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.082 -179.391 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.1 t70 51.72 42.1 29.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.658 179.918 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.0 m170 50.62 36.76 14.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.643 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.17 -179.985 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.82 0.343 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 23.8 mt -74.13 -11.01 60.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.378 179.937 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 72.11 -41.89 0.52 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.806 0.691 . . . . 0.0 111.26 179.792 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -83.81 -9.59 58.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.893 0.377 . . . . 0.0 110.4 -179.928 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.4 mt 59.29 64.43 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.297 179.911 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.25 -71.6 0.12 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.909 179.954 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -146.22 -144.86 0.16 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.971 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.97 -179.37 32.81 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.983 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.0 t -68.3 -100.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.352 -179.842 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -155.74 -33.59 0.09 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.768 0.318 . . . . 0.0 110.258 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.3 mt -129.95 -48.13 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.255 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.61 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.0 mt -76.25 -93.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.859 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.66 -8.79 2.15 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 176.286 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.22 -47.42 6.99 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 112.873 -1.663 . . . . 0.0 110.167 178.276 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.41 27.96 0.89 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.834 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.43 38.95 0.2 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.892 -178.893 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 57.29 45.38 20.35 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.854 179.92 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 50.46 31.51 5.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.73 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.5 t60 51.41 60.4 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.696 179.845 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.5 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.264 179.87 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 34.0 p90 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.748 0.308 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.5 mt -73.63 -72.62 0.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.576 -179.897 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.5 ttt85 -155.74 -10.18 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.841 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.0 ttt85 -158.91 -0.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.44 179.641 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 tp 36.73 94.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.596 0.712 . . . . 0.0 111.043 -179.923 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.33 -25.8 0.26 Allowed Glycine 0 C--N 1.33 0.23 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.615 -179.752 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -169.48 177.02 4.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.74 0.305 . . . . 0.0 110.394 179.981 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.86 -124.12 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.065 -179.93 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.5 t -71.75 -91.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.56 -179.829 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -172.15 -26.76 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.763 0.316 . . . . 0.0 110.694 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.4 mt -131.45 -46.91 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.386 -179.556 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.601 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.1 mm -87.12 -95.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.865 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.84 -8.84 1.51 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 176.218 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.61 -49.34 5.48 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 113.063 -1.569 . . . . 0.0 110.087 178.082 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.94 26.57 1.13 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.754 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.65 47.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.736 -178.946 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.6 mt 62.61 11.37 4.73 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.484 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.6 t0 55.87 53.83 8.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.48 -179.592 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 55.32 55.93 6.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.674 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 20' ' ' LEU . 9.2 mp . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.343 179.916 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 2.6 m0 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.853 0.358 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 2' ' ' LEU . 2.3 tt -66.1 -70.16 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.188 -179.877 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -173.26 -23.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.999 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -153.45 7.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.961 179.304 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm 60.24 110.87 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.482 -179.913 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.91 52.55 40.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.111 179.924 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -65.94 152.42 44.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.31 . . . . 0.0 110.359 179.91 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.81 -148.11 50.2 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.855 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.91 -87.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.514 179.907 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -171.51 -25.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.939 0.4 . . . . 0.0 110.428 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 7.1 mm -132.14 -46.27 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.018 -179.943 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 14' ' ' GLY . 72.2 mt -77.16 -92.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.47 -7.63 3.13 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 176.04 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.02 -47.24 6.66 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 112.9 -1.65 . . . . 0.0 110.258 178.235 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.49 28.74 0.83 Allowed 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.663 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.68 40.4 0.3 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.691 -178.749 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 60.08 49.36 7.57 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.282 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 58.72 -77.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.843 -179.883 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' LEU . 13.0 t-80 -159.36 56.92 0.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.779 0.323 . . . . 0.0 110.39 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.495 179.951 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 51.0 m95 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.758 0.313 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.83 -70.75 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.102 0.477 . . . . 0.0 110.336 179.846 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.441 ' H ' ' H ' ' A' ' 4' ' ' ARG . 35.7 ttm180 -158.67 -22.34 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.579 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 6' ' ' GLY . 96.9 mtt180 -150.65 4.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.373 179.425 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 5.1 tt 41.25 19.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.212 -179.669 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 8' ' ' GLY . . . -73.54 -48.63 17.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.73 179.601 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.7 tptt 55.19 -81.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.61 0.243 . . . . 0.0 110.568 179.848 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . 60.27 -160.17 22.99 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.865 -179.925 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.6 t -76.12 -84.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.597 0.236 . . . . 0.0 110.581 -179.988 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -171.37 -24.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 110.465 -179.968 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.3 mt -132.92 -50.01 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.163 -179.832 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 60.9 mt -76.52 -95.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.827 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.69 -9.66 1.82 Allowed Glycine 0 C--N 1.346 1.1 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 176.419 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.81 -47.92 7.47 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 112.9 -1.65 . . . . 0.0 110.116 178.098 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.63 28.97 0.82 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.717 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.82 40.19 0.38 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.486 -178.661 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 63.93 49.77 2.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.757 -179.708 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.3 t0 59.23 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.74 -179.782 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 17' ' ' LEU . 13.9 p-80 -159.26 44.03 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.821 0.344 . . . . 0.0 110.362 179.922 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.509 -179.912 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.452 ' CE3' ' O ' ' A' ' 1' ' ' TRP . 69.1 p-90 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.856 0.36 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 2' ' ' LEU . 9.7 mp -65.3 -84.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.206 0.527 . . . . 0.0 110.105 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -168.67 -17.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.787 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -148.43 -1.74 0.53 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.33 179.446 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.7 mm 57.69 68.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.469 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.88 -4.19 0.06 OUTLIER Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.245 -0.503 . . . . 0.0 111.968 179.819 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm 50.78 72.12 0.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.815 0.34 . . . . 0.0 110.319 -179.877 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -50.08 113.77 2.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.15 -0.547 . . . . 0.0 112.044 -179.878 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.8 t -76.04 -83.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.59 0.234 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -170.88 -24.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.717 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 3.7 mp -120.85 -59.8 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.667 -179.816 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.0 mt -76.13 -98.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.265 -179.331 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.34 -11.44 0.71 Allowed Glycine 0 C--N 1.347 1.186 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 176.993 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.09 -48.73 7.41 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.875 -1.662 . . . . 0.0 110.003 178.006 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.55 29.9 0.75 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.604 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.85 39.82 0.4 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.728 -178.879 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.5 tt 63.64 47.86 3.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.783 -179.896 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 54.04 -84.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.657 -179.822 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -161.17 50.71 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.459 179.954 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 20' ' ' LEU . 9.7 mp . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.154 -180.0 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.2 m0 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.899 0.38 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.1 mt -67.94 -6.01 19.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.168 179.617 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 76.88 -59.97 0.47 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.62 -179.906 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -85.09 -14.77 46.12 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.847 0.356 . . . . 0.0 110.412 179.972 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 mt 50.18 63.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.406 179.93 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.2 -12.18 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.174 -179.898 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -161.44 137.38 7.98 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.862 0.363 . . . . 0.0 110.877 -179.918 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.31 120.18 0.59 Allowed Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.896 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.841 HG13 ' H ' ' A' ' 10' ' ' LYS . 7.3 p -80.36 -67.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.952 -179.554 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.841 ' H ' HG13 ' A' ' 9' ' ' VAL . 56.3 tttm -178.14 -35.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.671 0.272 . . . . 0.0 110.404 179.93 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.423 ' H ' HG13 ' A' ' 9' ' ' VAL . 13.7 mt -120.66 -52.43 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.221 -178.847 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.4 mm -74.32 -97.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.229 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.77 -10.49 0.69 Allowed Glycine 0 C--N 1.346 1.104 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 176.711 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.8 -47.84 7.52 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 113.218 -1.491 . . . . 0.0 110.02 178.183 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.55 31.54 0.83 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.716 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.71 41.93 0.52 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.69 -178.75 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.2 tp 65.12 53.61 1.33 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.103 -179.721 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.0 t0 62.73 -75.49 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.844 -179.821 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.421 ' N ' ' O ' ' A' ' 17' ' ' LEU . 2.7 t60 -152.74 42.13 0.61 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.794 0.33 . . . . 0.0 110.369 -179.892 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.9 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.496 179.954 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.456 ' O ' ' CD1' ' A' ' 1' ' ' TRP . 23.7 p90 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.761 0.315 . . . . 0.0 110.51 . . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.8 mt -74.08 -72.13 0.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.674 -179.932 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.596 ' HE ' HH12 ' A' ' 4' ' ' ARG . 39.7 ttp180 -154.31 -13.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 179.849 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.596 HH12 ' HE ' ' A' ' 3' ' ' ARG . 30.0 mtt85 -148.24 2.37 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.671 179.634 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 mt 57.27 50.21 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.369 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 47.3 31.15 6.23 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.583 179.807 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 4' ' ' ARG . 54.0 mmtt -81.99 43.56 0.79 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.656 0.265 . . . . 0.0 110.412 179.824 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.405 ' N ' ' HZ2' ' A' ' 10' ' ' LYS . . . -176.71 -158.99 21.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.408 179.937 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.4 m 35.6 49.73 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.829 0.347 . . . . 0.0 111.912 -179.933 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HZ2' ' N ' ' A' ' 8' ' ' GLY . 57.0 mttp -92.61 -16.3 25.79 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.307 179.563 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -129.11 -46.04 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.647 -179.609 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.614 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.2 mt -74.89 -92.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.659 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.08 -6.69 3.11 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 176.029 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.65 -45.33 7.35 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 113.082 -1.559 . . . . 0.0 110.139 178.327 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.77 29.9 0.77 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.573 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.03 37.46 0.63 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.513 -178.578 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.4 tt 58.24 47.32 14.4 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.878 -179.933 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.486 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 71.0 m-20 54.03 -83.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 17' ' ' LEU . 96.3 m-70 -158.21 52.11 0.43 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.366 179.974 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.081 -179.924 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.742 0.306 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 2.5 mm? -73.94 -85.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.037 0.446 . . . . 0.0 109.831 179.849 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -157.56 -16.93 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.718 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -150.17 0.98 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.448 179.487 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.0 mt 53.19 71.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.409 179.983 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.11 -55.75 0.23 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 121.217 -0.516 . . . . 0.0 111.965 179.911 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -63.96 134.14 54.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.78 0.324 . . . . 0.0 110.531 -179.949 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.13 172.26 0.14 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.124 -0.56 . . . . 0.0 111.983 179.98 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 11' ' ' ILE . 39.0 t -148.48 -21.74 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.95 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.7 tttm 72.11 -18.85 0.3 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.228 -179.985 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.461 ' H ' ' C ' ' A' ' 9' ' ' VAL . 11.7 mt -116.9 -46.59 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.789 0.328 . . . . 0.0 111.573 -179.119 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 63.1 mt -95.78 -97.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.069 -178.564 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.35 -8.29 1.66 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 176.854 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.9 -48.02 5.35 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 113.155 -1.522 . . . . 0.0 109.808 177.999 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -81.11 27.06 0.41 Allowed 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.604 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.17 36.45 0.23 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.758 -179.042 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 51.3 32.14 7.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.265 -179.824 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 51.15 10.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.134 179.837 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.443 ' H ' ' C ' ' A' ' 17' ' ' LEU . 20.9 t-160 -168.3 -41.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.611 179.929 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.8 pp . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.584 -179.97 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 96.7 m95 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.865 0.364 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 4' ' ' ARG . 12.9 mt -72.99 -13.0 61.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.43 -179.985 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 69.68 -30.36 0.19 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.313 -179.891 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.49 ' H ' ' C ' ' A' ' 2' ' ' LEU . 69.1 mtt85 -84.4 -25.53 29.0 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.837 0.351 . . . . 0.0 110.214 179.614 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mt 60.12 84.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.552 -179.994 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 50.64 46.55 47.06 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.227 179.881 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt 48.59 -129.64 1.86 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.545 0.212 . . . . 0.0 110.523 179.937 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.66 -158.02 30.38 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.905 179.915 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.56 ' CG2' ' H ' ' A' ' 12' ' ' ILE . 15.4 m -76.79 15.68 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.713 -179.914 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.9 tttt 73.27 -20.84 0.27 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.101 179.035 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.514 ' H ' HG23 ' A' ' 9' ' ' VAL . 10.6 mt -112.07 -46.16 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.277 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.6 ' C ' ' H ' ' A' ' 14' ' ' GLY . 60.5 mt -95.99 -98.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.135 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.95 -6.8 1.41 Allowed Glycine 0 C--N 1.341 0.854 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.393 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.6 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.92 -46.53 5.35 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 113.291 -1.455 . . . . 0.0 110.001 178.332 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.29 28.56 0.72 Allowed 'General case' 0 C--N 1.343 0.292 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.728 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.26 41.47 0.28 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.797 -178.927 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.2 OUTLIER 68.25 37.19 2.89 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.014 -0.675 . . . . 0.0 109.72 -179.762 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.495 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 33.6 t70 55.71 -82.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.716 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' LEU . 96.8 m-70 -158.5 57.61 0.45 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.475 179.98 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.476 -179.943 . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.43 ' O ' ' N ' ' A' ' 3' ' ' ARG . 21.3 p90 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.758 0.313 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 2' ' ' LEU . 10.2 mp 51.98 -91.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.135 -179.99 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.433 ' H ' ' H ' ' A' ' 4' ' ' ARG . 30.8 ttm180 -163.93 -19.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.75 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.433 ' H ' ' H ' ' A' ' 3' ' ' ARG . 58.8 ttt180 -171.8 5.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.174 179.691 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt 58.02 84.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.171 -179.852 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.45 64.36 2.19 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -179.7 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -64.31 -40.47 95.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.636 0.255 . . . . 0.0 110.783 -179.663 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 46.5 68.21 1.16 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.103 -179.876 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.418 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 20.3 m -76.15 32.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.75 0.31 . . . . 0.0 110.782 -179.839 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.443 ' H ' ' C ' ' A' ' 8' ' ' GLY . 53.4 mttm -82.73 -11.39 58.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.231 179.907 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.6 mt -138.95 -39.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.193 -179.567 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.5 mt -75.83 -89.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.56 -5.52 5.12 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 175.385 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.36 -45.16 7.09 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 113.105 -1.547 . . . . 0.0 110.161 178.345 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.94 29.86 0.89 Allowed 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.653 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.59 40.78 0.61 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.407 -178.502 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.3 tp 63.14 20.4 12.26 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.214 -179.736 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.8 t70 58.83 -77.5 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' LEU . 20.7 m80 -49.25 -61.02 2.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.304 . . . . 0.0 110.711 -179.938 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.029 179.966 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 37.6 p90 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.795 0.331 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.4 mt -72.33 -7.66 50.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.613 -179.97 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 76.48 -47.02 0.54 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.54 -179.82 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 6' ' ' GLY . 83.3 mtm180 -78.01 -10.17 59.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.56 179.828 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mt 61.74 -76.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.637 -179.877 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 8' ' ' GLY . . . -73.98 9.03 9.77 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.157 -0.544 . . . . 0.0 111.927 179.989 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.5 tttm 59.38 -77.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.61 0.243 . . . . 0.0 110.756 -179.974 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . 176.25 165.9 32.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.073 179.97 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.22 -84.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.517 0.199 . . . . 0.0 110.659 -179.933 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -170.91 -26.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.814 0.34 . . . . 0.0 110.726 179.955 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.3 mt -133.9 -52.07 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 109.979 -179.936 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.1 mm -76.51 -96.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.695 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.9 -11.08 0.85 Allowed Glycine 0 C--N 1.347 1.16 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 176.448 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.56 -48.87 6.99 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 113.053 -1.573 . . . . 0.0 110.28 178.056 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.552 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.44 27.18 0.97 Allowed 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.877 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.5 40.07 0.13 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.916 -179.086 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.3 tt 62.18 42.69 9.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.828 179.955 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.6 t0 50.9 34.96 11.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.552 -179.858 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.8 t60 53.96 62.06 2.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.483 179.922 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.294 179.974 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 98.5 m95 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.804 0.335 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 4' ' ' ARG . 21.2 mt -66.04 -9.4 30.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.442 179.918 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 69.39 -29.65 0.18 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.975 -179.378 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' H ' ' C ' ' A' ' 2' ' ' LEU . 61.1 ttp180 -78.81 -24.8 44.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.261 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.3 mt -145.81 66.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.136 179.742 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 8' ' ' GLY . . . 179.21 -32.28 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.071 179.937 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER 53.32 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.985 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . 61.13 62.26 6.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.113 179.843 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 11' ' ' ILE . 2.8 t -70.58 -3.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.835 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.2 mttp 66.51 -19.14 0.11 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.819 179.931 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.511 ' H ' ' C ' ' A' ' 9' ' ' VAL . 40.9 mm -118.22 -43.36 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.89 0.376 . . . . 0.0 111.415 -179.146 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.1 mt -98.54 -98.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.873 -178.65 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -54.67 -8.3 1.26 Allowed Glycine 0 C--N 1.342 0.914 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 176.743 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.6 -48.2 4.82 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 113.231 -1.485 . . . . 0.0 109.845 177.995 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.23 26.59 1.02 Allowed 'General case' 0 C--N 1.342 0.239 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.865 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.97 48.65 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.754 -178.918 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.0 mt 61.14 14.52 5.55 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.462 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.2 t70 58.67 -77.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 -179.706 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 63.6 t60 -164.9 47.76 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.914 0.388 . . . . 0.0 110.485 179.903 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.116 180.0 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.715 0.293 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.521 HD22 ' N ' ' A' ' 2' ' ' LEU . 2.4 mm? -70.91 -89.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.924 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -135.03 -21.74 1.63 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.607 179.66 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 6' ' ' GLY . 40.2 mtt-85 -146.91 12.33 1.1 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.055 179.783 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.435 ' C ' ' H ' ' A' ' 7' ' ' LYS . 13.0 mt 62.25 -76.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.41 -179.742 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -73.05 15.32 2.45 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.89 179.858 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 5' ' ' ILE . 76.9 mttt 54.83 -177.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.636 179.986 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.41 79.62 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.689 -0.565 . . . . 0.0 111.689 -179.998 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.01 -91.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.68 -179.792 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -171.52 -27.29 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.856 0.36 . . . . 0.0 110.419 -179.994 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.7 mt -136.8 -45.52 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.149 -179.91 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 14' ' ' GLY . 78.7 mt -84.07 -93.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.958 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.81 -8.34 2.88 Favored Glycine 0 C--N 1.343 0.955 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 175.959 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.591 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.8 -48.25 6.27 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 112.945 -1.628 . . . . 0.0 110.117 178.153 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.02 27.53 0.89 Allowed 'General case' 0 C--N 1.343 0.311 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.77 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.57 41.59 0.19 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.627 -178.871 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.6 tt 63.38 48.89 3.37 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.771 -179.786 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.8 t0 50.91 28.97 4.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.404 -179.825 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.8 t60 55.91 68.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.476 -179.796 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.4 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.244 -179.846 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.824 0.345 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.2 tp -64.76 -78.57 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.199 0.523 . . . . 0.0 110.078 179.863 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -165.91 -16.59 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.637 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 6' ' ' GLY . 72.2 mtm180 -149.97 -0.12 0.45 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.177 179.475 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 mt 62.6 -75.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.495 -179.826 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -156.68 31.1 0.56 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 179.833 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 6' ' ' GLY . 83.6 tttt 58.99 118.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.85 0.357 . . . . 0.0 110.63 -179.95 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.74 -125.43 0.76 Allowed Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 -179.967 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.0 t -149.08 -88.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.916 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -171.23 -31.28 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.818 0.342 . . . . 0.0 110.606 179.846 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.8 mt -130.35 -49.23 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.124 -179.826 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.602 ' C ' ' H ' ' A' ' 14' ' ' GLY . 28.2 mt -75.98 -95.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.886 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -54.12 -9.73 1.53 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 176.294 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.27 -47.81 7.25 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 113.019 -1.59 . . . . 0.0 110.074 178.036 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.8 29.36 1.03 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.823 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.14 41.71 0.28 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.615 -178.83 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.1 tt 69.33 39.38 1.67 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.893 -179.864 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.9 t0 48.56 49.29 18.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.654 -179.943 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 53.21 60.86 3.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 -179.891 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.9 mp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.03 -179.882 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.75 0.31 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.534 ' C ' ' H ' ' A' ' 4' ' ' ARG . 17.3 mt -74.19 -7.68 53.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.192 179.759 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.5 mtm-85 66.97 -24.12 0.11 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.619 -179.936 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 2' ' ' LEU . 38.9 ttp180 -88.49 -39.58 14.09 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.882 0.372 . . . . 0.0 110.418 179.937 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 tp -54.47 -36.26 34.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.098 -179.905 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.54 -61.08 3.74 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.026 179.9 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.9 tttp 48.27 82.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.77 0.319 . . . . 0.0 110.63 179.917 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . -172.67 -14.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.023 179.957 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 33.6 m -76.03 19.08 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 110.802 -179.958 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 8' ' ' GLY . 11.1 ttmm -73.01 -21.94 60.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.099 0.476 . . . . 0.0 110.117 179.904 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.3 mt -131.44 -35.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.514 -179.485 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.601 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.7 mt -75.82 -87.6 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.908 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.08 -4.99 5.13 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 175.2 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.06 -44.48 7.07 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 113.209 -1.496 . . . . 0.0 110.193 178.471 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.51 27.72 1.07 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.953 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.05 37.34 0.28 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.707 -178.881 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.2 tt 55.97 43.04 27.92 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.052 179.921 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.0 t0 50.94 39.95 24.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.656 -179.994 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 51.53 45.63 27.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.551 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.352 -179.987 . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.502 ' O ' ' N ' ' A' ' 3' ' ' ARG . 34.3 m95 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.748 0.308 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 2.2 mm? 53.16 -87.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.971 179.894 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 1' ' ' TRP . 71.7 ttt180 -174.63 -24.24 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.975 179.947 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.419 ' H ' ' H ' ' A' ' 5' ' ' ILE . 14.7 ptm180 -175.98 4.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.443 179.607 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.419 ' H ' ' H ' ' A' ' 4' ' ' ARG . 13.5 mt 50.66 76.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.479 179.932 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.04 13.4 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.199 -0.524 . . . . 0.0 111.952 179.946 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -66.27 -66.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.66 0.266 . . . . 0.0 110.521 179.999 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.33 147.03 48.44 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.814 -179.991 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.64 -84.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.606 -179.861 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -170.81 -24.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.968 179.962 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.3 mt -132.59 -49.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.86 0.362 . . . . 0.0 110.452 -179.754 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.607 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.1 mm -81.99 -96.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.92 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.43 -8.63 1.26 Allowed Glycine 0 C--N 1.344 0.987 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 176.393 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.8 -48.97 5.9 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.1 -1.55 . . . . 0.0 110.002 178.015 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.71 29.67 0.99 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.586 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.3 48.84 0.23 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.571 -178.671 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.0 mt 64.53 31.63 12.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.204 -179.493 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.7 t70 53.03 44.68 30.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.957 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 50.56 65.48 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.647 179.948 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.203 -179.859 . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 1' ' ' TRP . 24.7 p90 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.712 0.291 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.2 tp -70.2 -72.81 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.471 . . . . 0.0 110.494 -179.959 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.406 ' H ' ' H ' ' A' ' 4' ' ' ARG . 50.1 ttt85 -162.34 -15.37 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.869 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.466 ' H ' ' H ' ' A' ' 5' ' ' ILE . 28.1 ttp180 -167.9 -2.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.194 179.744 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.466 ' H ' ' H ' ' A' ' 4' ' ' ARG . 12.1 mt 60.39 130.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.748 179.748 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.92 -2.23 5.1 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.285 179.692 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.3 mttp 54.53 85.09 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.716 0.293 . . . . 0.0 110.608 -179.957 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.06 -144.53 34.97 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.011 179.872 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.2 t -77.76 -93.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 121.281 -0.168 . . . . 0.0 110.696 -179.865 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -171.41 -22.41 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.839 -179.84 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.0 mt -131.06 -44.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.868 0.366 . . . . 0.0 110.764 -179.351 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.0 mt -89.99 -94.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.575 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.77 -7.33 3.26 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 176.215 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.67 -47.55 5.9 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 113.011 -1.594 . . . . 0.0 109.984 178.154 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.11 29.32 0.57 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.661 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.17 38.33 0.33 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.867 -178.958 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.1 tt 51.73 38.38 22.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.069 -179.946 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.6 t0 52.43 -85.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 17' ' ' LEU . 73.7 m-70 -53.11 -65.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.67 -179.854 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.023 -179.915 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 91.2 m95 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.876 0.37 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 051 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 4' ' ' ARG . 19.1 mt -73.62 -5.71 42.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.919 179.465 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.536 ' C ' ' HE ' ' A' ' 4' ' ' ARG . 76.9 mtm180 61.83 -76.52 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.788 -179.913 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.588 ' NE ' ' N ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -68.87 7.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.319 179.929 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.436 ' H ' ' C ' ' A' ' 3' ' ' ARG . 5.9 mt 48.93 43.91 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 121.016 0.436 . . . . 0.0 110.313 -179.902 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.41 69.29 1.34 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.024 -179.838 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -154.25 -102.12 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.691 0.282 . . . . 0.0 110.335 179.895 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.57 104.08 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.773 -179.851 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.61 -85.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.657 -179.808 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -171.71 -25.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.848 0.356 . . . . 0.0 110.43 179.916 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 18.5 mt -125.27 -55.37 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.172 -179.916 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' GLY . 34.6 mm -75.46 -98.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.928 -179.911 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.49 -10.99 0.68 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 176.794 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.56 -48.5 7.25 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 113.013 -1.593 . . . . 0.0 110.074 178.046 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.544 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.85 27.71 0.85 Allowed 'General case' 0 C--N 1.344 0.363 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.652 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.22 39.32 0.2 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.741 -178.923 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tt 58.01 48.8 12.66 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.6 179.945 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 53.97 22.84 3.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.205 -179.593 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.6 t60 56.01 63.14 2.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.635 -179.925 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.184 179.906 . . . . . . . . 0 0 . 1 . 052 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.454 ' O ' ' CD1' ' A' ' 1' ' ' TRP . 29.8 p90 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.86 0.362 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.1 mt -76.97 -73.38 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.542 -179.98 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.453 ' HE ' ' HZ2' ' A' ' 7' ' ' LYS . 46.2 mtm105 -147.06 -10.35 0.44 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.851 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 6' ' ' GLY . 7.6 tpp85 -166.36 10.12 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.419 179.835 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.4 mt 62.86 -76.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.409 -179.739 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -75.98 38.06 1.31 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.144 179.885 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' HZ2' ' HE ' ' A' ' 3' ' ' ARG . 83.9 tttt -57.57 -44.36 85.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.819 0.342 . . . . 0.0 110.456 179.889 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.66 128.19 1.71 Allowed Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 111.749 -0.541 . . . . 0.0 111.749 -179.937 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.499 ' C ' ' H ' ' A' ' 11' ' ' ILE . 44.3 t -61.29 -18.17 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 121.034 -0.267 . . . . 0.0 110.648 -179.796 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? 66.09 -14.05 0.15 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.792 179.836 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.499 ' H ' ' C ' ' A' ' 9' ' ' VAL . 14.7 mt -122.84 -45.63 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.75 0.31 . . . . 0.0 111.129 -179.642 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 14' ' ' GLY . 71.2 mt -95.03 -97.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.069 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.27 -8.48 1.67 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 176.462 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.55 -48.0 5.45 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 113.318 -1.441 . . . . 0.0 109.953 177.997 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.55 28.62 0.74 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.816 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.5 41.79 0.19 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.931 -179.011 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.0 tp 62.31 30.01 17.41 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.574 -179.996 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t0 55.23 -82.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 179.73 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 17' ' ' LEU . 61.0 m80 -47.75 -64.68 0.72 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.853 -179.812 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.453 -179.991 . . . . . . . . 0 0 . 1 . 053 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 120.994 0.426 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 053 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.514 ' C ' ' H ' ' A' ' 5' ' ' ILE . 54.9 mt -137.32 -3.26 1.95 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.084 178.602 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -45.62 -18.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.472 0.653 . . . . 0.0 109.443 178.997 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.499 ' N ' ' C ' ' A' ' 2' ' ' LEU . 66.0 mtp180 -130.46 -5.94 4.22 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.847 178.823 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.514 ' H ' ' C ' ' A' ' 2' ' ' LEU . 12.2 mt 58.31 61.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.258 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.229 -179.91 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 66.48 51.2 44.27 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -179.806 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 6' ' ' GLY . 51.1 mttp 57.45 158.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.367 . . . . 0.0 110.517 -179.722 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.05 129.11 1.46 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.915 -179.898 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.82 -87.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.968 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -171.93 -24.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.76 0.314 . . . . 0.0 110.477 -179.993 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.413 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 11.5 mt -124.97 -51.91 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.542 -179.647 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.5 mm -74.67 -97.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.898 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.41 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.03 -10.24 0.73 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 176.738 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.17 -48.08 7.12 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 113.095 -1.552 . . . . 0.0 110.029 178.061 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.2 28.48 0.82 Allowed 'General case' 0 C--N 1.343 0.325 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.67 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.99 38.18 0.25 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.964 -179.055 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.5 tt 55.52 46.39 23.11 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.888 179.801 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 55.69 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.731 -179.903 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LEU . 1.5 p-80 -157.03 44.71 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.418 -179.972 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.43 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.155 -179.98 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.43 ' CD1' ' N ' ' A' ' 1' ' ' TRP . 31.6 m95 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.75 0.31 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 4' ' ' ARG . 20.8 mt -72.17 -6.8 45.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.289 179.872 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.494 HH22 HH22 ' A' ' 4' ' ' ARG . 27.1 mtm-85 69.77 -31.87 0.22 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.456 179.975 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.494 HH22 HH22 ' A' ' 3' ' ' ARG . 70.7 mtt85 -80.03 -30.13 39.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.891 0.376 . . . . 0.0 110.275 179.834 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.8 mt 51.27 60.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.434 179.791 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.74 -37.3 0.1 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.004 179.929 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -51.36 102.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.693 0.282 . . . . 0.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.01 -153.36 8.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.257 179.833 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.3 t -142.45 -85.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.879 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -170.19 -23.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.181 179.863 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.7 mp -115.59 -47.73 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.789 0.328 . . . . 0.0 111.649 -178.946 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.9 mt -94.86 -98.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.008 -178.681 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.453 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.57 -10.96 1.06 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 176.669 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.88 -49.8 5.2 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 113.199 -1.501 . . . . 0.0 109.936 177.771 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.28 25.87 0.82 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.941 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.53 44.51 0.07 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.856 -178.991 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.4 tp 62.78 31.5 16.47 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.305 -179.968 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.4 t0 56.84 -79.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' LEU . 35.6 m80 -54.92 -62.38 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.542 179.994 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.541 ' N ' HD23 ' A' ' 20' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.728 179.581 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.883 0.373 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 055 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.574 ' C ' ' H ' ' A' ' 4' ' ' ARG . 16.8 mt -82.84 -5.73 59.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.587 179.928 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.421 ' CD ' ' N ' ' A' ' 3' ' ' ARG . 1.1 mpt_? 62.75 -18.06 0.05 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.594 -179.444 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 2' ' ' LEU . 99.9 mtt180 -101.11 -10.52 20.38 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.909 0.385 . . . . 0.0 110.391 179.771 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.4 tt -51.47 -26.93 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -174.56 18.22 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.125 -179.946 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 6' ' ' GLY . 15.7 mtpp 56.63 114.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 110.791 179.883 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.77 109.12 0.38 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 179.943 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.76 -80.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.646 0.26 . . . . 0.0 110.526 -179.902 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -171.22 -28.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.542 -179.867 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.1 mt -131.51 -44.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.068 -179.849 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.1 mt -75.34 -91.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.5 -6.66 3.54 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 107.579 -2.208 . . . . 0.0 107.579 176.016 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.46 -45.72 7.25 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 112.98 -1.61 . . . . 0.0 110.035 178.315 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.5 29.96 0.74 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.618 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.11 37.53 0.61 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.5 -178.645 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.6 tt 56.79 46.26 20.23 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.797 -179.884 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 47.56 44.75 17.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.1 m80 54.73 45.77 26.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.597 -179.883 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.339 -179.993 . . . . . . . . 0 0 . 1 . 056 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.823 0.345 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 056 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.9 mt -71.05 -69.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.107 0.48 . . . . 0.0 110.276 179.743 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.42 ' H ' ' H ' ' A' ' 4' ' ' ARG . 48.6 ttt-85 -167.47 -11.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.664 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.425 ' H ' ' H ' ' A' ' 5' ' ' ILE . 8.2 ptm180 -174.84 8.15 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.527 179.732 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.425 ' H ' ' H ' ' A' ' 4' ' ' ARG . 18.6 mt 59.16 61.43 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.126 -179.782 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.42 19.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -179.9 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -53.9 -64.28 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -179.899 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.39 156.02 27.63 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.912 -179.957 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.43 -83.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.663 0.268 . . . . 0.0 110.521 -179.911 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -171.25 -17.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.905 0.383 . . . . 0.0 110.402 -179.78 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.4 mt -124.43 -49.76 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.764 -179.819 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 14' ' ' GLY . 25.9 mt -81.9 -95.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.945 -179.424 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -53.89 -9.96 1.49 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 176.402 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.04 -49.38 6.01 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 112.994 -1.603 . . . . 0.0 110.247 177.985 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.539 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.78 28.24 0.91 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.799 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.69 43.93 0.12 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.841 -179.026 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 64.34 24.8 13.34 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.477 -179.997 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.3 t70 57.47 -78.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 50.0 m80 -49.79 -67.07 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.452 179.873 . . . . . . . . 0 0 . 1 . 057 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.516 ' C ' ' H ' ' A' ' 3' ' ' ARG . 30.7 m95 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.45 0.166 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 4' ' ' ARG . 19.8 mt 62.34 -5.45 0.18 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.191 -179.822 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.516 ' H ' ' C ' ' A' ' 1' ' ' TRP . 9.3 mpt_? 58.45 -76.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.684 -179.739 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 2' ' ' LEU . 78.3 mtp180 -72.37 15.63 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.92 -179.804 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.451 ' H ' ' C ' ' A' ' 3' ' ' ARG . 12.1 mt 46.84 61.57 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.724 0.297 . . . . 0.0 110.69 179.872 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.56 -60.0 0.01 OUTLIER Glycine 0 C--N 1.33 0.198 0 N-CA-C 111.95 -0.46 . . . . 0.0 111.95 -179.889 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -167.71 -37.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.706 0.289 . . . . 0.0 110.75 179.962 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.83 -155.45 26.75 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.047 179.904 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.5 t -77.99 -63.23 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.885 0.374 . . . . 0.0 110.327 179.93 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -169.74 -61.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.483 179.907 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' ALA . 16.6 pt -81.2 4.96 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.647 179.994 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.625 ' C ' ' H ' ' A' ' 14' ' ' GLY . 38.9 mm -70.83 -88.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.301 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.32 -3.76 3.16 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 175.402 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.625 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.08 -38.33 8.61 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 113.77 -1.215 . . . . 0.0 110.137 178.604 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -94.17 26.03 3.49 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.873 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 79.07 37.29 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.653 -178.886 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 3.7 tp 61.94 11.35 4.13 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.41 179.719 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 60.05 -77.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.469 -179.579 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -55.07 -70.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 110.559 179.797 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.463 0.222 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.479 179.906 . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.773 0.32 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.0 mt -74.08 -15.45 61.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.558 -179.932 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 76.68 -50.94 0.58 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.59 -179.938 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -75.49 -6.03 48.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.505 179.934 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.7 mt 57.5 68.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.488 179.936 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 53.83 25.47 30.07 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.981 179.901 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt 57.21 108.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.797 0.332 . . . . 0.0 110.604 179.996 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 9' ' ' VAL . . . 173.63 123.85 0.75 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.115 179.967 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.438 HG23 ' H ' ' A' ' 10' ' ' LYS . 1.9 m -55.49 -105.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.833 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.438 ' H ' HG23 ' A' ' 9' ' ' VAL . 33.2 ttmt -158.52 -21.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.919 0.39 . . . . 0.0 110.425 179.997 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.7 mp -109.81 -49.47 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.895 -179.05 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' GLY . 23.5 mt -95.54 -99.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.385 -178.24 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.27 -10.83 0.93 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 177.097 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.578 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.1 -49.24 5.38 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 113.155 -1.523 . . . . 0.0 109.756 177.877 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.48 29.52 0.59 Allowed 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.607 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.17 43.91 0.27 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.74 -178.898 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 61.17 34.47 18.88 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.953 -179.693 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 t70 57.89 -78.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.928 -179.799 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 86.8 m-70 -64.89 -64.29 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.705 -179.77 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.461 -179.786 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.531 ' C ' ' H ' ' A' ' 3' ' ' ARG . 4.7 m-90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.675 0.274 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.9 mt 63.49 -7.92 0.17 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.353 -179.921 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.531 ' H ' ' C ' ' A' ' 1' ' ' TRP . 1.7 tpt180 76.14 -56.44 0.58 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.786 179.79 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -69.87 -10.25 57.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.777 0.322 . . . . 0.0 110.692 -179.817 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 mm 58.12 65.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.432 179.962 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 50.08 52.71 25.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.86 -179.986 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 6' ' ' GLY . 34.3 tptt 60.86 136.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 110.623 -179.935 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.55 73.26 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.951 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.55 -84.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.64 0.257 . . . . 0.0 110.797 -179.624 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -171.39 -29.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.942 0.401 . . . . 0.0 110.26 -179.819 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -137.98 -43.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.776 -179.953 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.585 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.7 mt -77.37 -90.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.525 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.59 -7.27 4.18 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 175.772 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.585 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.26 -46.7 6.84 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 112.931 -1.635 . . . . 0.0 110.199 178.431 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.535 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.14 27.08 0.94 Allowed 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.797 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.61 39.05 0.19 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.683 -178.894 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 57.43 47.17 16.89 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.991 179.931 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 54.33 -83.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 179.966 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.7 t-80 -157.4 40.33 0.3 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.425 179.975 . . . . . . . . 0 0 . 1 . 060 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.51 ' C ' ' H ' ' A' ' 3' ' ' ARG . 70.8 m95 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.731 0.301 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.546 ' C ' ' H ' ' A' ' 4' ' ' ARG . 25.1 mt 63.48 -8.69 0.15 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.668 179.927 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.51 ' H ' ' C ' ' A' ' 1' ' ' TRP . 77.0 mtt180 62.76 -15.93 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.819 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.546 ' H ' ' C ' ' A' ' 2' ' ' LEU . 55.2 ttp180 -95.36 -43.11 8.17 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.853 0.358 . . . . 0.0 110.201 -179.958 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.6 mm -86.41 -33.24 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.443 -179.979 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.44 -68.3 1.7 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.853 179.87 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt 50.37 17.14 0.32 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.744 0.307 . . . . 0.0 110.757 179.822 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.51 111.56 0.3 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.963 -179.99 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.58 -88.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.393 -179.958 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -172.17 -25.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.705 0.288 . . . . 0.0 110.718 179.901 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.5 mt -130.7 -46.57 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.624 -179.474 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.623 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.9 mt -84.53 -94.33 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.835 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.424 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -56.57 -7.26 2.02 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 176.074 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.623 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.22 -48.63 5.6 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 112.915 -1.642 . . . . 0.0 109.955 178.031 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.25 29.16 0.98 Allowed 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.588 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.46 49.15 0.21 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.586 -178.572 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 11.1 mt 63.52 6.08 2.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.157 -179.293 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.3 t70 58.22 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 -179.977 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -158.76 54.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.306 179.941 . . . . . . . . 3 3 . 1 . 060 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.201 -179.857 . . . . . . . . 0 0 . 1 . 061 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.513 ' C ' ' H ' ' A' ' 3' ' ' ARG . 75.9 m95 . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.558 0.218 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.8 mt 62.79 -6.52 0.16 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.394 179.948 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.513 ' H ' ' C ' ' A' ' 1' ' ' TRP . 40.7 ttp180 72.47 -70.0 0.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.593 179.99 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.73 -0.95 4.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.508 -179.928 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 mm 56.02 68.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.605 179.885 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 52.8 34.83 45.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.093 179.894 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.6 tttt 53.51 79.54 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 0.0 110.532 179.919 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.31 144.65 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.938 -179.949 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.6 t -71.18 -88.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.481 -179.907 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -170.61 -24.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.716 0.293 . . . . 0.0 110.991 179.869 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.8 mt -133.13 -44.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.905 0.383 . . . . 0.0 110.701 -179.548 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.0 mt -90.35 -94.32 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.662 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.48 -8.58 2.75 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 176.306 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.79 -49.07 5.54 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 112.986 -1.607 . . . . 0.0 109.985 178.017 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.86 29.62 0.62 Allowed 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.728 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.95 40.97 0.25 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.113 -179.168 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.7 OUTLIER 56.53 13.9 1.5 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.69 -179.98 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.9 t0 55.57 -82.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.792 -179.942 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 49.6 m80 -58.44 -20.18 42.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.57 -179.987 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 -179.908 . . . . . . . . 0 0 . 1 . 062 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 2.9 m0 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.852 0.358 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 062 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.6 -75.73 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.132 0.491 . . . . 0.0 109.941 179.754 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -153.3 -13.03 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.035 179.839 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.425 ' O ' ' N ' ' A' ' 6' ' ' GLY . 40.0 ttt-85 -161.39 6.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.447 179.754 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.0 mt 61.91 -77.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.689 -179.921 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -83.67 60.69 4.84 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 179.955 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -50.98 124.76 12.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.788 0.327 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.89 128.52 37.25 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.207 -0.52 . . . . 0.0 111.986 -179.928 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.14 -82.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.672 0.272 . . . . 0.0 110.52 -179.95 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -172.02 -19.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.85 0.357 . . . . 0.0 110.196 -179.848 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.5 mt -136.86 -46.25 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.934 0.397 . . . . 0.0 110.367 -179.735 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.62 ' C ' ' H ' ' A' ' 14' ' ' GLY . 71.4 mt -80.16 -93.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.945 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.12 -6.65 3.13 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 176.127 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.62 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.43 -46.54 6.85 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 112.963 -1.619 . . . . 0.0 109.886 178.219 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.43 30.29 0.63 Allowed 'General case' 0 C--N 1.345 0.396 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.506 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.46 38.0 0.67 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.441 -178.596 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.6 tt 54.36 52.27 12.79 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.771 -179.738 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER 56.1 -80.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.947 179.927 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -160.95 48.68 0.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.362 -179.939 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.421 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.038 -179.896 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.52 ' C ' ' H ' ' A' ' 3' ' ' ARG . 67.5 m95 . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 120.606 0.241 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 4' ' ' ARG . 16.4 mt 63.15 -6.9 0.17 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.508 -179.879 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.52 ' H ' ' C ' ' A' ' 1' ' ' TRP . 68.4 mtm180 64.76 -72.31 0.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.917 -179.876 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' LEU . 30.7 ttm180 -59.33 -8.69 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.337 179.934 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.7 pt 34.84 43.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.493 -179.694 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.45 0.96 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.84 -179.999 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -54.82 97.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 0.0 110.468 -179.961 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.66 -105.68 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.016 -0.612 . . . . 0.0 111.83 179.918 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.92 -81.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.616 0.246 . . . . 0.0 110.498 179.925 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -172.14 -25.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.862 0.363 . . . . 0.0 110.284 179.854 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.0 mt -135.72 -50.45 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.831 179.939 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.6 mm -76.53 -96.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.602 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.6 -10.37 0.93 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 176.387 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.05 -48.56 6.87 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 113.109 -1.545 . . . . 0.0 110.171 178.082 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.95 29.1 0.84 Allowed 'General case' 0 C--N 1.344 0.337 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.772 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.52 39.74 0.24 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.991 -178.993 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.2 tt 63.09 43.63 6.35 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.966 179.844 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.1 t0 49.0 32.29 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.559 -179.977 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 54.79 73.92 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.475 -179.865 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.0 tp . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.52 -179.979 . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 39.5 p90 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.759 0.314 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.5 mt -77.42 -72.58 0.35 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 -179.813 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.652 HH12 ' NE ' ' A' ' 4' ' ' ARG . 64.3 ttp85 -172.73 -14.88 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.968 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.652 ' NE ' HH12 ' A' ' 3' ' ' ARG . 11.3 ptp180 -172.79 4.93 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.489 179.612 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mm 53.18 58.2 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.242 -179.888 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.92 25.54 0.02 OUTLIER Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -179.915 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -52.26 -70.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.727 0.298 . . . . 0.0 110.209 -179.929 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . -168.25 48.55 0.23 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.798 179.986 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.445 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 30.4 m -76.72 21.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.783 0.325 . . . . 0.0 110.812 -179.838 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 8' ' ' GLY . 50.2 mtpt -78.7 -14.58 59.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.252 -179.997 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.3 mt -133.15 -38.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.148 -179.789 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.607 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.6 mt -75.58 -89.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.825 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.96 -5.66 4.49 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 107.332 -2.307 . . . . 0.0 107.332 175.385 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.29 -44.73 7.34 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 113.167 -1.516 . . . . 0.0 110.038 178.379 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.69 28.35 1.16 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.889 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.55 38.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.596 -178.766 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 3.2 tp 63.22 48.99 3.45 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 53.8 -84.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.754 179.822 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 58.4 m80 -150.36 57.17 0.94 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.353 179.993 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.514 -179.966 . . . . . . . . 0 0 . 1 . 065 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.492 ' O ' ' N ' ' A' ' 3' ' ' ARG . 10.1 t90 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.793 0.33 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.478 ' N ' ' CG ' ' A' ' 1' ' ' TRP . 32.4 tp 53.92 -86.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.292 179.967 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 1' ' ' TRP . 52.0 ttp180 -174.14 -23.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.931 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.407 ' H ' ' H ' ' A' ' 5' ' ' ILE . 54.8 ttt180 -161.55 6.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.093 179.743 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' H ' ' H ' ' A' ' 4' ' ' ARG . 34.2 pt 35.43 39.24 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.59 -179.951 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.38 -7.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.0 179.995 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -77.54 73.99 4.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.742 0.305 . . . . 0.0 110.531 -179.929 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.22 122.32 0.6 Allowed Glycine 0 C--N 1.33 0.243 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.973 179.929 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.5 -87.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.401 179.893 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -171.29 -23.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.911 179.891 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.447 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.7 mt -120.69 -47.41 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 120.793 0.33 . . . . 0.0 111.26 -179.163 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.3 mt -91.28 -97.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.128 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.448 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -54.21 -8.93 1.26 Allowed Glycine 0 C--N 1.343 0.933 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 176.524 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.53 -48.96 5.37 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 113.147 -1.526 . . . . 0.0 109.935 177.984 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.507 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.38 28.91 0.91 Allowed 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.723 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.87 48.78 0.13 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.556 -178.724 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.9 mt 65.1 -1.55 0.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.351 -179.427 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 16' ' ' ALA . 26.3 t70 53.9 -83.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.765 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 2.4 t60 -46.98 -37.79 9.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.95 -179.882 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.452 ' C ' HD23 ' A' ' 20' ' ' LEU . 2.0 tt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.068 179.973 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 24.1 m95 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.887 0.375 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 066 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 46.2 mt -76.19 -75.89 0.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.514 -179.916 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.411 ' H ' ' H ' ' A' ' 4' ' ' ARG . 86.1 mtt180 -143.42 -18.96 0.62 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.617 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.493 ' C ' ' H ' ' A' ' 6' ' ' GLY . 93.6 mtt180 -149.98 12.02 0.75 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.662 179.675 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mt 70.14 -30.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.96 -179.925 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 4' ' ' ARG . . . -165.59 92.9 0.11 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.882 179.701 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -48.5 153.65 0.74 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.766 0.317 . . . . 0.0 110.683 179.916 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.56 -102.59 0.45 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.798 -179.961 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.5 t -147.27 -73.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.688 0.28 . . . . 0.0 110.29 179.799 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -171.4 -59.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.368 -179.977 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 19.4 pt -78.02 10.79 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.403 180.0 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 14' ' ' GLY . 6.8 mm -74.52 -86.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.515 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.49 -3.15 5.07 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 175.249 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.53 -40.77 7.15 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 113.663 -1.269 . . . . 0.0 110.314 178.637 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -90.49 26.21 2.05 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.873 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 79.43 37.16 0.14 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.876 -178.945 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.1 tp 59.24 17.92 6.14 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.546 179.76 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 56.93 6.95 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.794 179.728 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.409 ' H ' ' C ' ' A' ' 17' ' ' LEU . 54.6 t-80 -170.34 -59.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.522 -179.961 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.204 -179.987 . . . . . . . . 0 0 . 1 . 067 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.776 0.322 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 067 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 2' ' ' LEU . 7.8 mp -67.79 -85.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.918 179.922 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -134.11 -15.22 2.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.66 179.664 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 5' ' ' ILE . 20.9 ttm180 -169.94 13.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.578 179.811 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.402 ' O ' ' O ' ' A' ' 4' ' ' ARG . 2.6 tt 34.63 96.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.538 -179.944 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.21 -28.19 0.15 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.811 179.969 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -72.5 159.98 33.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.773 0.321 . . . . 0.0 110.53 179.959 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.05 152.58 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.907 -179.983 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.77 -84.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.474 -179.956 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -171.83 -25.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.816 0.341 . . . . 0.0 110.489 179.908 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.8 mt -139.68 -43.89 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.02 -179.855 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.606 ' C ' ' H ' ' A' ' 14' ' ' GLY . 23.7 mt -84.43 -93.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.771 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.89 -6.25 2.63 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 175.751 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.38 -47.36 5.75 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 113.066 -1.567 . . . . 0.0 110.158 178.265 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -89.32 29.03 1.14 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.726 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.63 47.82 0.12 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.721 -178.821 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.4 mt 63.71 17.81 10.7 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.247 0.342 . . . . 0.0 110.137 -179.596 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 59.56 -76.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.766 179.894 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.513 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -154.68 52.56 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.82 0.343 . . . . 0.0 110.427 -179.991 . . . . . . . . 3 3 . 1 . 067 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.304 -179.967 . . . . . . . . 0 0 . 1 . 068 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 . . . . . 0 N--CA 1.46 0.063 0 CA-C-O 121.001 0.429 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 068 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 4' ' ' ARG . 5.8 tp -70.19 -4.41 21.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.013 179.757 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 6' ' ' GLY . 18.5 mmm180 64.03 -74.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.245 -179.63 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 2' ' ' LEU . 69.9 ttt180 -44.48 -25.08 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.025 179.892 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 6' ' ' GLY . 17.6 tt -81.07 -37.48 15.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.776 0.322 . . . . 0.0 110.518 -179.982 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.424 ' N ' HG23 ' A' ' 5' ' ' ILE . . . -68.84 -28.67 72.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.982 179.978 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 6' ' ' GLY . 17.5 mtpp 56.39 116.46 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.095 0.474 . . . . 0.0 111.05 179.871 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.0 119.74 0.9 Allowed Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 179.97 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.8 t -75.93 -94.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.673 -179.769 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -171.33 -23.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.927 0.394 . . . . 0.0 110.406 -179.874 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.11 -43.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.332 -179.861 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.61 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.5 mt -88.0 -93.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.94 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.47 -6.66 3.51 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 175.941 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.73 -47.48 5.9 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 113.046 -1.577 . . . . 0.0 109.939 178.152 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.524 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.88 29.73 0.61 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.708 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.47 38.68 0.38 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.773 -178.941 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 56.39 33.89 23.21 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.969 -179.973 . . . . . . . . 3 3 . 1 . 068 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.7 t0 58.02 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.781 -179.962 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -155.3 62.24 0.63 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.268 179.875 . . . . . . . . 3 3 . 1 . 068 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.373 -179.771 . . . . . . . . 0 0 . 1 . 069 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.895 0.379 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 069 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 23.9 mt -69.6 -5.43 24.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.469 179.898 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 77.36 -47.33 0.5 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.592 -179.886 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -70.35 -46.17 64.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.39 . . . . 0.0 110.365 179.838 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mm -83.92 -19.09 9.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.466 179.973 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.24 -30.3 69.59 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.017 -179.97 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -164.22 -80.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.669 0.271 . . . . 0.0 110.386 -179.99 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.89 89.3 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.185 179.905 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' A' ' 11' ' ' ILE . 2.8 t -70.82 0.14 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.924 0.392 . . . . 0.0 110.036 179.881 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.6 mttm 66.47 -13.47 0.17 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.575 179.794 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.483 ' H ' ' C ' ' A' ' 9' ' ' VAL . 17.8 mt -126.4 -45.2 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.832 0.348 . . . . 0.0 110.97 -179.357 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' GLY . 66.1 mt -95.97 -96.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.248 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.38 -7.76 2.18 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 176.434 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.0 -48.75 5.04 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 113.053 -1.573 . . . . 0.0 109.557 177.922 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.2 29.15 0.67 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 177.526 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.06 48.03 0.28 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.451 -178.687 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.0 mt 62.54 22.52 13.34 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.366 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.9 t70 55.73 -82.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.625 -179.875 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 31.9 m-70 -53.66 -33.93 56.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.59 179.973 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.163 -179.985 . . . . . . . . 0 0 . 1 . 070 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.901 0.382 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 070 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 tp -63.77 -16.96 62.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.243 179.907 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 73.93 -64.72 0.38 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.369 -179.764 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 6' ' ' GLY . 77.0 mtp180 -69.57 3.13 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.257 179.651 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.1 mm 60.94 -75.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.497 -179.897 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -143.73 56.13 0.56 Allowed Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.962 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.2 mttm 59.1 65.63 1.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.806 0.336 . . . . 0.0 110.528 -179.851 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -165.45 163.69 36.75 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.901 -0.48 . . . . 0.0 111.901 -179.999 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -71.89 -81.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.631 0.253 . . . . 0.0 110.567 -179.832 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -171.34 -28.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.249 179.916 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.0 mt -132.06 -48.63 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.343 -179.894 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 14' ' ' GLY . 65.3 mt -78.24 -94.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -179.788 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.11 -8.24 2.25 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 176.241 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.44 -47.53 6.81 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 112.899 -1.651 . . . . 0.0 110.186 178.133 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.82 29.31 0.81 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.757 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.75 39.29 0.33 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.755 -178.928 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 12' ' ' ILE . 0.9 OUTLIER 62.14 27.97 16.83 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.881 179.971 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 t70 50.05 -91.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 179.949 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' LEU . 71.9 m80 -50.19 -25.2 3.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.732 -179.761 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.222 179.994 . . . . . . . . 0 0 . 1 . 071 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.741 0.305 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 071 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 4' ' ' ARG . 16.6 mt -72.82 -10.68 60.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.53 179.925 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 73.11 -35.98 0.34 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 -179.898 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.463 ' H ' ' C ' ' A' ' 2' ' ' LEU . 40.6 ttm180 -74.02 -38.94 63.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.275 179.744 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 mt -96.94 -41.97 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.371 179.808 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -52.88 -30.69 37.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.159 -0.543 . . . . 0.0 111.84 179.875 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -75.58 102.14 5.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.772 0.32 . . . . 0.0 110.468 179.996 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.16 126.43 16.5 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.923 -179.936 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.2 -89.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.524 -179.964 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -171.86 -27.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.95 179.824 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.7 mt -123.91 -51.21 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.847 0.356 . . . . 0.0 110.867 -179.563 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 44.3 mm -83.79 -98.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.7 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.68 -10.89 0.73 Allowed Glycine 0 C--N 1.346 1.121 0 N-CA-C 108.544 -1.823 . . . . 0.0 108.544 176.654 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.57 -49.83 5.97 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 113.136 -1.532 . . . . 0.0 110.058 177.919 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.09 28.42 0.82 Allowed 'General case' 0 C--N 1.345 0.398 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.833 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.43 42.19 0.13 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.084 -179.16 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 60.87 44.49 10.72 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.633 179.796 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.9 t70 53.58 47.56 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 179.915 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 51.1 53.86 12.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.701 179.818 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.6 mp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.261 179.952 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.511 ' C ' ' H ' ' A' ' 3' ' ' ARG . 92.7 m95 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.687 0.28 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 4' ' ' ARG . 17.3 mt 63.66 -8.33 0.16 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.411 -179.992 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.511 ' H ' ' C ' ' A' ' 1' ' ' TRP . 47.7 ttp180 66.28 -14.46 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.478 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.494 ' H ' ' C ' ' A' ' 2' ' ' LEU . 92.6 mtt180 -138.7 -3.79 1.64 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.591 0.234 . . . . 0.0 110.7 -179.68 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 mt 60.53 -77.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.539 179.975 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -78.14 53.65 3.83 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 179.782 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -53.34 -76.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.6 0.238 . . . . 0.0 110.542 -179.705 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.87 113.02 4.03 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 179.82 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.91 -95.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.589 -179.861 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -172.08 -23.56 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.775 0.321 . . . . 0.0 110.469 179.959 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.3 mt -135.41 -44.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.559 -179.486 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.1 mt -90.34 -95.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.748 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.433 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.44 -8.34 1.76 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 175.976 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.64 -49.15 5.26 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 113.142 -1.529 . . . . 0.0 109.992 177.978 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.94 28.08 0.94 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.808 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.19 48.07 0.1 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.742 -178.877 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.6 mt 64.31 33.97 11.02 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.325 0.391 . . . . 0.0 110.259 -179.773 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 t0 57.0 -78.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.954 179.785 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 17' ' ' LEU . 16.1 p-80 -145.63 51.74 1.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.328 -179.871 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.195 179.986 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 86.1 m95 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.834 0.35 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 073 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.477 ' C ' ' H ' ' A' ' 4' ' ' ARG . 15.7 mt -75.95 -15.73 60.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.641 -179.98 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 74.25 -22.42 0.25 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.495 -179.471 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' A' ' 2' ' ' LEU . 13.3 mmt85 -93.51 -15.02 25.95 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.342 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 mt 52.97 54.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.948 -179.898 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 47.01 20.59 0.75 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.202 -179.912 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 1.3 tppp? -170.17 -138.02 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.463 179.966 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.409 ' H ' ' CG ' ' A' ' 7' ' ' LYS . . . 155.18 -173.38 33.44 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -179.951 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -79.63 29.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.817 0.341 . . . . 0.0 110.633 179.929 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 8' ' ' GLY . 19.3 tptm -77.97 -16.98 57.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.289 -179.997 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.409 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.3 mt -138.5 -36.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.539 -179.64 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.6 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.6 mt -75.03 -88.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.989 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.44 -4.73 5.44 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 175.173 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.6 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.07 -43.87 7.35 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 113.197 -1.502 . . . . 0.0 110.258 178.389 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.06 28.07 1.11 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.702 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.88 39.25 0.42 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.454 -178.626 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.0 tp 60.19 41.26 17.07 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.333 -179.778 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.9 0.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.428 ' H ' ' C ' ' A' ' 17' ' ' LEU . 6.7 t60 -170.79 -65.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 110.65 179.946 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 16' ' ' ALA . 16.7 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.847 0.356 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 074 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.5 mt -66.95 -6.12 15.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.278 179.708 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 71.61 -68.5 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.882 179.928 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -48.48 -21.64 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.817 0.341 . . . . 0.0 110.414 -179.81 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.44 62.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.063 179.959 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.68 -42.43 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.849 -179.982 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -70.34 -60.75 2.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.368 . . . . 0.0 110.401 179.934 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.21 104.1 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.853 -179.98 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.5 t -72.65 -84.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.613 0.244 . . . . 0.0 110.509 -179.942 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -171.43 -29.64 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.538 179.95 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 6.8 mm -131.52 -51.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.863 -179.981 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' GLY . 42.6 mm -76.0 -97.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.841 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.01 -11.05 0.88 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 176.766 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.34 -48.93 7.09 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 113.029 -1.585 . . . . 0.0 110.128 178.024 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.19 28.8 0.69 Allowed 'General case' 0 C--N 1.343 0.323 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.597 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.93 38.47 0.25 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.899 -179.019 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tt 55.63 45.64 24.34 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.671 179.924 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 54.55 33.19 18.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.379 -179.703 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.0 m80 58.59 45.88 15.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.547 -179.987 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.405 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.137 179.912 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.792 0.33 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 075 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 4' ' ' ARG . 17.8 mt -73.55 -6.99 50.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.679 179.934 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 73.33 -36.2 0.34 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.292 -179.54 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.469 ' H ' ' C ' ' A' ' 2' ' ' LEU . 72.9 mtm180 -71.32 -32.12 68.23 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.275 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.4 pt -76.52 -29.72 18.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.357 179.761 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.42 -30.08 60.94 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.293 -0.48 . . . . 0.0 111.996 -179.95 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt 52.07 176.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 110.55 179.963 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.41 137.97 41.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.006 -179.898 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.4 t -76.62 -87.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 -179.991 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -171.29 -25.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.416 179.755 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.2 mp -132.46 -48.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 121.058 0.456 . . . . 0.0 110.341 179.569 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.1 mt -83.67 -94.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.667 -179.66 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.03 -8.59 2.38 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 176.1 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.52 -48.74 6.13 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 113.004 -1.598 . . . . 0.0 109.863 178.025 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.69 30.55 0.72 Allowed 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.553 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.21 44.15 0.46 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.527 -178.702 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.7 tp 65.27 21.67 12.04 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.279 -179.711 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.8 t70 56.14 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.998 179.853 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' LEU . 12.5 t-80 -49.32 -29.87 6.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.885 -179.687 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.454 ' C ' HD23 ' A' ' 20' ' ' LEU . 2.8 tt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.15 179.985 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.509 ' C ' ' H ' ' A' ' 3' ' ' ARG . 49.3 m95 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.669 0.271 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' A' ' 4' ' ' ARG . 18.7 mt 63.31 -7.62 0.16 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.472 179.892 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.509 ' H ' ' C ' ' A' ' 1' ' ' TRP . 40.1 mtt-85 66.43 -22.4 0.1 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.855 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.521 ' H ' ' C ' ' A' ' 2' ' ' LEU . 96.9 mtt180 -91.01 -34.35 15.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.854 0.359 . . . . 0.0 110.644 -179.965 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.0 mt 59.27 94.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.654 179.744 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' A' ' 8' ' ' GLY . . . 46.08 18.17 0.26 Allowed Glycine 0 C--N 1.33 0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.458 179.647 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? 52.95 10.04 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.703 0.287 . . . . 0.0 110.731 179.904 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 6' ' ' GLY . . . -73.87 105.21 1.76 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.119 -0.562 . . . . 0.0 111.892 179.895 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.36 -95.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.438 -179.801 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -172.64 -24.4 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.823 0.344 . . . . 0.0 110.468 179.831 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.2 mt -137.44 -44.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.416 -179.483 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.598 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.0 mt -87.67 -94.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.849 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.79 -6.23 2.51 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 175.992 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.1 -47.71 5.69 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 113.182 -1.509 . . . . 0.0 109.755 177.987 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.76 27.37 1.15 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.484 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.9 48.19 0.19 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.408 -178.607 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 19' ' ' HIS . 9.6 mt 61.95 35.88 15.98 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.176 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 55.77 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.716 -179.669 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 17' ' ' LEU . 3.8 p-80 -162.27 46.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.472 -179.995 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.323 179.974 . . . . . . . . 0 0 . 1 . 077 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.741 0.305 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 077 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.97 -9.65 58.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.179 179.845 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 76.51 -49.07 0.57 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.619 179.962 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.3 mtp85 -73.47 -8.1 54.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.861 0.362 . . . . 0.0 110.379 179.895 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.9 mt -142.08 64.77 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.092 179.863 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.17 -35.18 0.2 Allowed Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -179.894 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.3 mttm 55.56 54.08 8.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.754 0.312 . . . . 0.0 110.803 179.689 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.18 107.24 1.71 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.703 179.708 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.35 -87.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.721 -179.693 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -170.86 -27.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.908 0.385 . . . . 0.0 110.247 -179.92 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 14.9 mt -131.71 -50.47 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.898 179.912 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.1 mm -76.68 -96.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.705 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.39 -9.66 1.1 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 108.379 -1.889 . . . . 0.0 108.379 176.425 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.97 -47.87 6.86 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 113.005 -1.597 . . . . 0.0 110.252 178.249 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.27 27.92 0.88 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.865 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.43 38.6 0.16 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.988 -179.083 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 58.21 42.36 22.09 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.691 179.836 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 54.61 -83.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.576 -179.849 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -163.01 52.97 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.36 179.954 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.187 -179.999 . . . . . . . . 0 0 . 1 . 078 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.807 0.337 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 078 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 tp -76.44 -73.01 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.533 -179.869 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.454 ' H ' ' H ' ' A' ' 4' ' ' ARG . 37.4 ttm180 -155.16 -12.31 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.833 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.454 ' H ' ' H ' ' A' ' 3' ' ' ARG . 16.0 ptp180 -153.02 2.47 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.548 179.556 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.0 mt 56.11 91.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.625 179.968 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.22 -24.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.184 -0.531 . . . . 0.0 111.973 -179.998 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt 56.46 106.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.803 0.335 . . . . 0.0 110.51 179.963 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.12 -164.16 54.34 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.191 179.948 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.459 HG23 ' H ' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -145.42 -99.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.882 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.459 ' H ' HG23 ' A' ' 9' ' ' VAL . 32.2 ttmt -164.23 -20.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 110.481 179.785 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 26.7 mm -110.03 -46.83 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.83 -178.959 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 14' ' ' GLY . 47.2 mm -98.36 -101.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.139 -178.695 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -50.47 -11.45 0.47 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 177.252 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.37 -48.09 5.47 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 177.824 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.97 27.13 0.56 Allowed 'General case' 0 C--N 1.342 0.265 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.642 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.35 39.99 0.14 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.968 -179.12 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 55.17 22.26 4.52 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.078 -179.983 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 53.56 -86.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.454 -179.742 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -50.21 -37.21 34.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.542 179.94 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.43 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.165 179.921 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.421 ' O ' ' CG ' ' A' ' 1' ' ' TRP . 71.7 t-105 . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 121.074 0.464 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.5 tp -178.84 -58.8 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.379 179.901 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 4' ' ' ARG . 76.0 ttt180 -170.73 -21.46 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.774 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 3' ' ' ARG . 14.0 ptm180 -177.38 19.47 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.208 179.456 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.9 mt 61.36 130.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.664 179.962 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.13 -66.46 2.54 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.703 179.438 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -87.31 -178.36 6.17 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.908 0.385 . . . . 0.0 110.944 -179.448 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.43 67.83 0.97 Allowed Glycine 0 C--N 1.335 0.501 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.989 -179.941 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.3 m -156.62 23.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.834 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -75.83 -14.85 60.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.985 0.421 . . . . 0.0 110.337 179.854 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 14.1 mt -138.35 -37.9 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.034 -179.565 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.611 ' C ' ' H ' ' A' ' 14' ' ' GLY . 86.3 mt -73.96 -88.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.788 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.97 -5.19 5.23 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 175.585 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.02 -43.28 7.66 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 113.091 -1.555 . . . . 0.0 110.189 178.504 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.1 28.4 1.07 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.845 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.49 37.06 0.45 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.509 -178.639 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.4 tt 54.2 49.59 18.31 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.838 -179.934 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 49.87 23.8 1.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.609 -179.989 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 54.08 57.59 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.468 -179.912 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.4 tp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.13 -179.838 . . . . . . . . 0 0 . 1 . 080 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 33.2 p90 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.713 0.292 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 080 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.5 mt -72.59 -74.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.526 -179.994 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.411 ' H ' ' H ' ' A' ' 4' ' ' ARG . 30.7 mtm105 -148.11 -11.76 0.37 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.711 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.411 ' H ' ' H ' ' A' ' 3' ' ' ARG . 36.8 ttp180 -166.15 7.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.475 179.864 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.7 mt 55.56 48.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.365 179.991 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.05 43.17 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.03 -179.873 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -75.33 -74.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.323 . . . . 0.0 110.597 179.993 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.35 156.42 22.16 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.858 -179.997 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.3 t -74.47 -84.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.64 0.257 . . . . 0.0 110.587 -179.926 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -167.51 -23.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.567 -179.887 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.3 mt -139.71 -46.99 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.039 179.937 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' GLY . 37.5 mt -78.14 -92.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.789 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.01 -8.19 2.95 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 176.121 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.25 -47.67 6.83 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 112.93 -1.635 . . . . 0.0 110.13 178.131 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.96 28.68 0.78 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.642 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.51 39.45 0.35 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.715 -178.848 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.1 tt 60.25 39.14 19.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.945 179.979 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 38.5 t70 47.88 61.38 3.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.5 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 27.0 p80 41.16 51.28 3.41 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.261 -179.98 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.7 mp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.187 179.975 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 40.2 m95 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.695 0.283 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 081 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 2' ' ' LEU . 3.1 mm? -63.12 -88.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.917 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -140.3 -15.73 0.96 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 179.591 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 55.8 mtt85 -154.22 17.18 0.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.503 179.532 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 7' ' ' LYS . 6.7 mt 56.54 43.75 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.949 -179.647 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 41.38 25.47 0.16 Allowed Glycine 0 C--N 1.332 0.348 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.445 -179.89 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 5' ' ' ILE . 52.5 tttm -69.43 -36.53 76.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.644 -179.831 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.38 166.56 29.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.163 179.969 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.2 t -74.47 -83.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.615 0.245 . . . . 0.0 110.421 179.993 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -171.1 -27.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.506 179.963 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.9 mm -133.69 -47.39 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.988 -179.924 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.8 mt -80.0 -93.39 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.862 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.6 -7.62 3.29 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 176.171 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.64 -47.38 6.79 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 112.799 -1.7 . . . . 0.0 110.008 178.165 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.67 29.35 0.61 Allowed 'General case' 0 C--N 1.343 0.319 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.467 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.5 38.46 0.5 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.444 -178.734 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.6 tt 54.76 50.86 14.85 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.632 -179.746 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t0 55.43 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.695 -179.796 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' LEU . 8.7 t60 -164.39 44.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.524 179.873 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.123 -179.97 . . . . . . . . 0 0 . 1 . 082 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.423 ' O ' ' CD2' ' A' ' 1' ' ' TRP . 42.4 p-90 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.808 0.337 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.539 HD12 ' N ' ' A' ' 2' ' ' LEU . 7.7 mp -65.71 -88.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.255 -179.96 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 4' ' ' ARG . 54.3 ttt-85 -146.44 -11.04 0.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.895 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.413 ' H ' ' H ' ' A' ' 5' ' ' ILE . 42.7 ttt85 -163.72 5.0 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.449 179.683 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.413 ' H ' ' H ' ' A' ' 4' ' ' ARG . 17.5 mt 60.57 93.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.393 179.97 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.33 68.79 1.53 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.022 -179.892 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.56 -170.61 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 110.547 180.0 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.27 104.44 0.13 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.993 179.948 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.0 t -77.88 -82.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.656 0.265 . . . . 0.0 110.522 -179.982 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -170.95 -25.46 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.721 -179.858 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -125.96 -52.62 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.391 -179.672 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.614 ' C ' ' H ' ' A' ' 14' ' ' GLY . 39.8 mm -75.58 -97.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.921 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.23 -10.28 0.8 Allowed Glycine 0 C--N 1.346 1.133 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 176.648 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.28 -48.08 7.07 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.144 -1.528 . . . . 0.0 110.258 178.053 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.34 30.36 0.89 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.797 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.44 42.81 0.29 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.802 -178.852 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.6 tp 63.82 51.52 2.36 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.25 -179.827 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 t0 69.91 -70.55 0.14 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.591 -179.758 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -159.88 19.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.457 179.934 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.248 179.876 . . . . . . . . 0 0 . 1 . 083 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.466 ' O ' ' CD1' ' A' ' 1' ' ' TRP . 28.5 p90 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.908 0.385 . . . . 0.0 110.511 . . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 2' ' ' LEU . 9.0 mp -78.06 -76.24 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.932 179.852 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -148.09 -22.72 0.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.744 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -147.79 8.39 0.87 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.36 179.303 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mt 60.53 94.5 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.264 -179.812 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.23 53.76 4.67 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.704 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -60.42 123.24 16.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 110.586 -179.78 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.56 138.14 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.081 179.732 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.47 HG23 ' H ' ' A' ' 10' ' ' LYS . 1.5 m -57.12 -103.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.84 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.47 ' H ' HG23 ' A' ' 9' ' ' VAL . 54.8 tttm -158.2 -22.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.714 0.292 . . . . 0.0 110.731 -179.758 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.0 mt -114.4 -49.1 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.411 -179.207 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.6 mt -91.8 -99.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.687 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.424 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.58 -10.74 1.01 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 176.931 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.83 -49.14 5.81 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.126 -1.537 . . . . 0.0 109.764 177.881 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.73 29.49 0.7 Allowed 'General case' 0 C--N 1.344 0.342 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.597 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.16 43.48 0.29 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.647 -178.853 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.6 tp 65.7 -1.19 1.09 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.231 -179.725 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 16' ' ' ALA . 19.5 t70 51.35 -85.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.08 179.647 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 84.5 m-70 -49.02 -17.96 0.25 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.931 -179.708 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.341 -179.976 . . . . . . . . 0 0 . 1 . 084 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 61.6 m95 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.754 0.311 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 084 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 18.2 tp -59.52 -81.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.09 0.472 . . . . 0.0 110.059 179.932 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.42 ' H ' ' H ' ' A' ' 4' ' ' ARG . 52.0 ttt85 -173.64 -18.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.754 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.42 ' H ' ' H ' ' A' ' 3' ' ' ARG . 68.5 mtp180 -149.87 6.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.35 179.413 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 mt 61.82 76.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.438 -179.877 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 56.95 82.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.069 179.871 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -53.36 -31.47 44.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 110.24 179.803 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 49.67 99.99 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.208 179.839 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.463 HG23 ' H ' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -66.75 -101.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.739 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.463 ' H ' HG23 ' A' ' 9' ' ' VAL . 72.3 tttt -162.52 -17.65 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.885 0.374 . . . . 0.0 110.48 -179.924 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' H ' ' H ' ' A' ' 10' ' ' LYS . 7.0 mm -119.38 -43.73 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.569 -178.946 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' GLY . 58.4 mt -96.73 -97.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.645 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.18 -7.44 1.87 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 176.493 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.05 -46.77 5.51 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 113.306 -1.447 . . . . 0.0 109.845 178.124 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.93 29.06 0.47 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.62 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.91 38.38 0.35 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.779 -178.91 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.4 tp 53.2 41.31 32.14 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.234 -179.731 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 55.48 31.46 17.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.321 -179.76 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.3 m80 53.23 69.02 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.378 -179.877 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.18 -179.849 . . . . . . . . 0 0 . 1 . 085 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.772 0.32 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 085 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 2' ' ' LEU . 7.7 mp -64.14 -88.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.072 179.957 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -142.3 -15.52 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.776 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -171.31 11.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.312 179.687 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.2 mt 59.86 85.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.355 -179.904 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.01 73.85 0.8 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.002 179.933 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -70.92 -3.14 17.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.473 179.943 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.66 -126.64 0.87 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.011 179.986 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.463 ' C ' ' H ' ' A' ' 11' ' ' ILE . 51.2 t -64.51 -14.49 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.651 0.262 . . . . 0.0 110.433 179.959 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 tttm 72.08 -20.0 0.26 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.396 179.845 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.463 ' H ' ' C ' ' A' ' 9' ' ' VAL . 12.9 mt -122.39 -44.69 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.737 0.303 . . . . 0.0 111.301 -179.189 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.579 ' C ' ' H ' ' A' ' 14' ' ' GLY . 69.9 mt -95.0 -95.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.935 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.95 -7.72 2.57 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 176.367 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.11 -48.02 5.29 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 113.08 -1.56 . . . . 0.0 110.001 178.193 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -83.25 27.86 0.56 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.834 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.77 39.88 0.16 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.936 -179.005 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.2 tp 54.22 39.46 30.81 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.255 -179.939 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 57.14 -79.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.752 179.996 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' LEU . 38.6 t-80 -63.58 -60.94 2.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 0.0 110.583 -179.999 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.206 -179.969 . . . . . . . . 0 0 . 1 . 086 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.825 0.345 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 086 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.5 mt -70.56 -7.29 42.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.484 -179.958 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 76.06 -45.19 0.52 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -73.04 -35.67 66.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.363 . . . . 0.0 110.322 179.855 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 6' ' ' GLY . 8.8 tp -70.18 -36.71 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.094 179.895 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 5' ' ' ILE . . . -63.74 -33.78 88.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.079 -0.582 . . . . 0.0 111.825 179.943 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -167.03 139.95 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.78 0.324 . . . . 0.0 110.479 179.914 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . -178.04 -135.57 2.31 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.015 -179.985 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.444 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 35.6 m -77.32 26.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.728 0.299 . . . . 0.0 110.813 -179.905 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -80.47 -17.33 52.0 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.741 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -131.57 -38.86 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.434 -179.542 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.609 ' C ' ' H ' ' A' ' 14' ' ' GLY . 86.5 mt -76.36 -88.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.8 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.25 -4.06 4.45 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 175.343 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.609 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.69 -45.35 6.45 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 113.092 -1.554 . . . . 0.0 110.0 178.357 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -89.22 27.94 1.32 Allowed 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.755 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.28 45.73 0.26 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.437 -178.582 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.8 mt 63.91 28.7 14.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.297 -179.42 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 48.97 27.31 1.61 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.629 -179.905 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.0 m80 53.57 48.46 21.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.332 -179.782 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.279 -179.924 . . . . . . . . 0 0 . 1 . 087 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.803 0.335 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 087 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 37.9 tp -62.29 -14.2 36.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.924 179.843 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 78.65 -50.69 0.46 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.29 179.877 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -78.38 -34.52 48.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.435 179.674 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.8 mt 48.9 51.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.537 179.972 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 166.14 -2.54 0.05 OUTLIER Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.028 -179.934 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt 54.53 176.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.732 0.301 . . . . 0.0 110.639 -179.982 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.07 151.11 11.24 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.235 -0.507 . . . . 0.0 111.835 -179.989 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.9 t -73.54 -83.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.677 -179.883 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -170.89 -20.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.765 -179.885 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -135.99 -47.89 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.8 0.333 . . . . 0.0 110.58 -179.731 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.592 ' C ' ' H ' ' A' ' 14' ' ' GLY . 25.2 mt -84.09 -94.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.986 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.417 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.21 -9.42 2.08 Favored Glycine 0 C--N 1.345 1.033 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 176.201 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.98 -49.41 6.02 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 112.922 -1.639 . . . . 0.0 110.0 177.956 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.51 29.17 0.79 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.679 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.48 44.01 0.24 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.652 -178.917 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.5 tp 65.58 22.35 11.74 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.286 -179.908 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.2 t0 55.77 25.24 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.286 -179.817 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 53.58 70.25 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.438 -179.8 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.366 -179.902 . . . . . . . . 0 0 . 1 . 088 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 91.4 m95 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.864 0.364 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 088 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.529 ' C ' ' H ' ' A' ' 4' ' ' ARG . 18.3 mt -78.53 -10.42 59.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.7 -179.905 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 64.73 -13.92 0.1 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.708 -179.897 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.529 ' H ' ' C ' ' A' ' 2' ' ' LEU . 54.6 mtt85 -109.77 -14.69 14.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.735 0.303 . . . . 0.0 110.534 -179.926 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.9 tt -51.12 -29.66 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.46 179.958 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' GLY . . . 171.04 13.01 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.185 -0.531 . . . . 0.0 111.791 179.954 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' H ' ' H ' ' A' ' 6' ' ' GLY . 83.8 mttt 58.63 -77.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.589 0.233 . . . . 0.0 110.796 179.928 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . 67.93 68.41 1.66 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.763 -179.994 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 m -76.76 32.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 110.789 -179.747 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 8' ' ' GLY . 26.7 mmtp -82.78 -11.59 58.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 110.332 179.804 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.402 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.7 mt -139.92 -39.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.134 -179.532 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.615 ' C ' ' H ' ' A' ' 14' ' ' GLY . 70.0 mt -75.75 -88.83 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.948 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.44 -5.53 4.98 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 175.427 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.615 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.93 -44.65 7.04 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.147 -1.526 . . . . 0.0 110.342 178.498 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.37 27.04 1.13 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.849 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.05 37.77 0.2 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.818 -178.892 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 55.36 17.84 2.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.911 179.941 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t0 56.24 -80.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.8 -179.962 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.4 t-80 -50.67 -61.46 2.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.848 0.356 . . . . 0.0 110.611 -179.922 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.1 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.463 179.944 . . . . . . . . 0 0 . 1 . 089 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 41.4 m95 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.794 0.33 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 089 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 4' ' ' ARG . 12.2 mt -73.43 -13.91 61.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.414 179.896 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 74.62 -38.83 0.4 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.634 -179.996 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' A' ' 2' ' ' LEU . 73.9 mtt-85 -76.54 -24.12 53.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.917 0.389 . . . . 0.0 110.435 179.881 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 6' ' ' GLY . 7.8 tp -55.32 -39.12 50.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.033 179.895 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' N ' HG23 ' A' ' 5' ' ' ILE . . . -77.28 -12.34 84.68 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 179.888 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -168.83 105.48 0.42 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.725 0.298 . . . . 0.0 110.481 -179.886 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.87 -89.54 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.139 179.974 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 11' ' ' ILE . 14.6 t -146.44 -15.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.808 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 tptp 70.63 -13.8 0.45 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.254 179.798 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.475 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.3 mt -123.08 -46.0 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.138 -179.272 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.8 mm -97.79 -99.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.034 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.415 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.57 -9.4 0.71 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 176.67 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.83 -48.23 5.01 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.441 -1.38 . . . . 0.0 110.065 177.953 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.63 25.76 1.2 Allowed 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.923 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.21 48.6 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.864 -178.893 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.7 mt 62.6 1.86 0.84 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.268 -179.686 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 16' ' ' ALA . 27.9 t70 51.08 46.24 26.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.633 -179.938 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 11.1 t60 55.5 35.68 25.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.583 -179.976 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.067 -179.946 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.799 0.333 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 090 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.9 mt -69.47 -68.8 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.222 0.534 . . . . 0.0 110.558 179.984 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -172.02 -16.51 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.988 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -178.63 10.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.215 179.652 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.6 mm 58.71 82.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.229 -179.76 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.413 ' H ' ' H ' ' A' ' 7' ' ' LYS . . . -163.68 -7.2 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 -179.915 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.413 ' H ' ' H ' ' A' ' 6' ' ' GLY . 15.7 mtpp 55.75 -154.17 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.672 0.273 . . . . 0.0 110.308 179.889 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -42.07 144.3 0.96 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.466 -179.751 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.8 t -71.67 -77.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.736 0.303 . . . . 0.0 110.534 -179.925 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.409 ' H ' ' H ' ' A' ' 11' ' ' ILE . 46.6 tptt -172.19 -18.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.02 0.438 . . . . 0.0 109.98 -179.908 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.409 ' H ' ' H ' ' A' ' 10' ' ' LYS . 13.2 mt -142.79 -45.35 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.098 -179.947 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.9 mt -78.44 -90.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.923 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.73 -7.17 4.24 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 107.546 -2.222 . . . . 0.0 107.546 175.706 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.45 -47.13 6.54 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.859 -1.671 . . . . 0.0 110.229 178.443 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.535 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.07 28.2 0.83 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.75 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.25 40.36 0.25 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.641 -178.801 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.1 tp 58.54 36.75 25.38 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.218 -179.847 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 54.92 -83.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.703 -179.899 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 28.0 m80 -52.59 -63.7 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.717 -179.929 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.41 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.193 -179.874 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 74.1 m95 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.906 0.384 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 091 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 4' ' ' ARG . 14.9 mt -72.79 -16.84 61.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.413 179.922 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 73.53 -35.87 0.33 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.827 179.946 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.451 ' H ' ' C ' ' A' ' 2' ' ' LEU . 72.2 mtt85 -78.78 -20.14 50.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.562 -179.979 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mt -146.22 68.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.251 179.978 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.04 -48.86 0.18 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.83 179.979 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 53.76 172.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.752 0.31 . . . . 0.0 110.637 179.941 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 170.58 154.13 9.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.272 -0.49 . . . . 0.0 111.932 179.929 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 14' ' ' GLY . 29.8 m -74.41 16.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.618 0.247 . . . . 0.0 110.728 -179.946 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 8' ' ' GLY . 49.3 mtpt -77.76 -14.16 59.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.008 0.433 . . . . 0.0 110.026 179.69 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.93 -41.7 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.22 -179.704 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.599 ' C ' ' H ' ' A' ' 14' ' ' GLY . 31.2 mt -75.63 -89.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.379 -179.794 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.21 -5.62 3.45 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 107.631 -2.188 . . . . 0.0 107.631 175.673 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.599 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.84 -45.87 6.54 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 113.03 -1.585 . . . . 0.0 110.097 178.342 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -89.79 28.63 1.3 Allowed 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.813 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.28 46.27 0.23 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.54 -178.668 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.8 mt 64.28 11.66 6.56 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.202 -179.494 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.1 t70 58.45 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 -179.823 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 33.6 t-80 -160.16 32.05 0.17 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.618 179.997 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 N--CA 1.468 0.445 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.264 179.806 . . . . . . . . 0 0 . 1 . 092 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.506 ' C ' ' H ' ' A' ' 3' ' ' ARG . 89.8 m95 . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.759 0.314 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 4' ' ' ARG . 23.2 mt 63.75 -8.84 0.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.62 179.979 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.506 ' H ' ' C ' ' A' ' 1' ' ' TRP . 65.7 mtt180 62.97 -13.65 0.07 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.6 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 2' ' ' LEU . 74.9 mtp180 -135.37 -0.74 2.65 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.717 0.294 . . . . 0.0 110.527 -179.731 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.5 mt 51.47 79.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.227 -179.86 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.68 68.02 1.27 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 111.636 -0.585 . . . . 0.0 111.636 -179.57 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -49.98 -20.18 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.636 0.255 . . . . 0.0 110.936 -179.678 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.07 -108.03 0.26 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.351 179.963 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.44 ' C ' ' H ' ' A' ' 11' ' ' ILE . 30.2 t -140.3 -14.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.77 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.0 tttt 73.27 -18.99 0.34 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.211 179.849 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.44 ' H ' ' C ' ' A' ' 9' ' ' VAL . 11.6 mt -116.68 -47.52 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.545 -179.085 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 14' ' ' GLY . 70.4 mt -94.77 -98.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.728 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.3 -9.4 1.49 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 176.916 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.584 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.59 -48.65 5.48 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 113.105 -1.548 . . . . 0.0 109.857 177.859 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.93 29.88 0.61 Allowed 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.737 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.34 42.92 0.3 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.84 -178.85 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.5 tp 59.47 50.7 7.25 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.286 -179.809 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.7 t0 56.74 35.61 26.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.463 -179.874 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.2 m80 55.91 39.57 30.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.561 179.966 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.194 179.868 . . . . . . . . 0 0 . 1 . 093 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.79 0.328 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 093 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.9 mt -69.2 -7.23 34.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.472 -179.947 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 7' ' ' LYS . 27.3 ttm180 73.21 -66.5 0.31 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.758 -179.928 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -57.79 -15.68 8.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.718 -179.845 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 tp -61.4 -30.92 49.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.121 179.964 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.32 -14.65 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 179.971 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 3' ' ' ARG . 68.5 tttt 63.31 -131.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.909 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.44 125.61 7.06 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.365 -0.445 . . . . 0.0 112.077 -179.798 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.466 ' C ' ' H ' ' A' ' 11' ' ' ILE . 25.9 t -60.21 -19.7 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.764 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm 70.96 -23.59 0.17 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.488 179.879 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.466 ' H ' ' C ' ' A' ' 9' ' ' VAL . 10.9 mt -113.3 -48.92 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 120.759 0.314 . . . . 0.0 111.754 -179.094 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.601 ' C ' ' H ' ' A' ' 14' ' ' GLY . 59.8 mt -91.83 -99.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.473 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.82 -8.27 1.3 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 176.915 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.52 -47.91 5.81 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 113.113 -1.544 . . . . 0.0 109.617 177.931 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.55 30.03 0.43 Allowed 'General case' 0 C--N 1.343 0.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.479 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.54 36.68 0.6 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.673 -178.831 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 19' ' ' HIS . 1.1 tt 54.44 38.49 29.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.972 -179.732 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.5 t70 59.19 1.19 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.09 179.933 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.476 ' H ' ' C ' ' A' ' 17' ' ' LEU . 47.5 t-80 -172.28 -72.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.879 0.371 . . . . 0.0 110.541 179.923 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.278 -179.913 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.791 0.329 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 094 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 4' ' ' ARG . 14.7 mt -70.63 -6.68 38.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.248 179.799 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 66.58 -13.83 0.17 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.448 -179.941 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' H ' ' C ' ' A' ' 2' ' ' LEU . 59.1 mtt-85 -132.91 1.46 3.59 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.922 0.391 . . . . 0.0 110.068 179.79 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mt 50.19 53.6 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.627 179.759 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.89 -71.58 0.27 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.38 -0.438 . . . . 0.0 112.043 179.937 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -71.01 -158.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.657 0.265 . . . . 0.0 110.415 -179.73 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 83.46 -26.26 4.64 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 -179.967 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 16.7 m -78.04 28.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 110.611 179.962 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 8' ' ' GLY . 18.9 tptm -80.44 -16.25 54.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.169 0.509 . . . . 0.0 109.789 179.808 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.3 mt -132.77 -39.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.501 -179.721 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.61 ' C ' ' H ' ' A' ' 14' ' ' GLY . 84.6 mt -75.49 -89.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.93 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.23 -4.56 3.73 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 175.334 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.78 -45.38 6.79 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 113.128 -1.536 . . . . 0.0 109.855 178.16 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -90.44 29.46 1.28 Allowed 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.573 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 70.08 46.94 0.6 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.221 -178.422 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.5 mt 63.81 12.79 6.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.021 -179.219 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 t0 56.63 46.25 20.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.691 -179.94 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.8 m170 50.15 49.83 19.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.617 179.99 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.519 -179.922 . . . . . . . . 0 0 . 1 . 095 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 31.5 p90 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.689 0.28 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 095 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.92 -71.56 0.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.129 0.49 . . . . 0.0 110.415 -179.995 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -163.15 -16.68 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.827 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 6' ' ' GLY . 57.0 ttt-85 -166.51 9.84 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.933 179.628 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.7 pt 37.32 25.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.498 -179.818 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -110.86 -67.29 0.55 Allowed Glycine 0 C--N 1.335 0.506 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 179.83 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -77.9 133.84 38.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.723 0.297 . . . . 0.0 110.372 179.906 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.46 135.24 2.58 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.082 -179.996 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.481 ' C ' ' H ' ' A' ' 11' ' ' ILE . 21.8 t -74.2 -14.52 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 179.988 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? 68.49 -13.21 0.32 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.341 179.752 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.481 ' H ' ' C ' ' A' ' 9' ' ' VAL . 18.9 mt -122.73 -44.22 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 120.859 0.361 . . . . 0.0 111.205 -179.113 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.583 ' C ' ' H ' ' A' ' 14' ' ' GLY . 67.6 mt -97.79 -97.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 -178.655 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.69 -7.35 2.15 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 176.884 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.79 -47.12 5.46 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 113.317 -1.442 . . . . 0.0 109.593 177.915 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.93 30.55 0.44 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.556 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.1 38.43 0.56 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.935 -178.99 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 50.37 29.85 4.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.981 -179.833 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.7 t70 55.1 -82.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.747 -179.903 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 19.4 t-80 -48.17 -66.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.696 -179.891 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.411 179.745 . . . . . . . . 0 0 . 1 . 096 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.799 0.333 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 096 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 2' ' ' LEU . 6.5 mp -68.9 -11.03 60.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.035 -179.954 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.416 ' C ' ' HE ' ' A' ' 4' ' ' ARG . 28.6 ttt85 75.4 -36.89 0.32 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.379 -179.685 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.563 ' HE ' ' N ' ' A' ' 4' ' ' ARG . 4.7 mmp_? -77.21 -19.65 56.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.3 179.648 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 6' ' ' GLY . 15.8 tt -60.89 -43.64 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.52 179.983 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.53 ' N ' HG23 ' A' ' 5' ' ' ILE . . . -168.38 2.2 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 -179.98 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.42 ' H ' ' H ' ' A' ' 6' ' ' GLY . 83.4 tttt 56.88 -80.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.519 0.2 . . . . 0.0 110.94 179.937 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . 54.77 93.4 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.87 -179.787 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.6 t -72.85 -88.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 121.134 -0.227 . . . . 0.0 110.709 -179.856 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -171.87 -26.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.869 0.366 . . . . 0.0 110.58 -179.879 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.4 mt -133.08 -50.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.167 -179.964 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.606 ' C ' ' H ' ' A' ' 14' ' ' GLY . 33.0 mm -76.62 -95.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.781 179.876 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.67 -9.53 1.21 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 176.313 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.77 -48.16 6.79 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 112.978 -1.611 . . . . 0.0 110.204 178.168 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.77 29.02 0.73 Allowed 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.753 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.77 38.73 0.25 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.882 -178.917 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 58.03 47.58 14.55 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.186 179.83 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.434 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 12.6 m-20 60.95 -76.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.74 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 17' ' ' LEU . 73.0 m80 -155.62 54.6 0.61 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.825 0.345 . . . . 0.0 110.465 -179.951 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.4 mp . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.221 179.973 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 85.0 m95 . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.769 0.318 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 097 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 40.7 tp -51.93 -17.54 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.951 179.802 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.497 ' C ' ' HE ' ' A' ' 4' ' ' ARG . 49.0 ttm-85 76.0 -44.13 0.49 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.603 179.903 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.64 ' HE ' ' N ' ' A' ' 4' ' ' ARG . 4.0 mmp_? -77.58 -19.15 56.1 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.273 179.652 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.3 pt 34.59 37.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.688 179.88 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.0 22.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.232 -0.509 . . . . 0.0 111.865 -179.977 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt 51.12 99.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.858 0.361 . . . . 0.0 110.374 -179.996 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.74 142.16 44.91 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.2 -179.792 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.459 ' C ' ' H ' ' A' ' 11' ' ' ILE . 41.2 t -74.87 -12.52 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.704 0.287 . . . . 0.0 110.265 179.918 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.1 tttp 71.38 -20.5 0.23 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.541 179.745 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.459 ' H ' ' C ' ' A' ' 9' ' ' VAL . 16.4 mt -123.18 -45.66 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 120.802 0.334 . . . . 0.0 111.166 -179.189 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.8 mt -92.62 -97.19 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.101 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.17 -7.44 1.86 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 176.219 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.49 -47.46 5.68 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 113.225 -1.487 . . . . 0.0 109.942 177.993 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.69 28.94 0.46 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.51 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.78 38.54 0.46 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.41 -178.699 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.6 tp 57.02 47.79 16.87 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.173 -179.688 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.6 t70 52.22 29.72 6.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.464 -179.964 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 52.06 55.9 8.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.508 -179.986 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.359 -179.985 . . . . . . . . 0 0 . 1 . 098 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.454 ' C ' ' H ' ' A' ' 3' ' ' ARG . 23.8 m-90 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.721 0.296 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 tp 67.66 -6.94 0.62 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.83 179.942 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 1' ' ' TRP . 0.5 OUTLIER 72.94 -67.8 0.25 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.18 -179.865 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -69.56 7.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.739 179.848 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.452 ' H ' ' C ' ' A' ' 3' ' ' ARG . 37.2 pt 36.06 46.66 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.733 179.852 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.34 66.83 1.57 Allowed Glycine 0 C--N 1.331 0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.063 179.849 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 53.2 -147.58 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.64 179.87 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.08 112.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.952 179.902 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.472 ' C ' ' H ' ' A' ' 11' ' ' ILE . 2.7 t -70.84 -1.41 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.857 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 tttm 71.73 -19.58 0.26 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.28 179.829 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' A' ' 9' ' ' VAL . 13.9 mt -117.75 -47.71 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.761 0.315 . . . . 0.0 111.355 -179.098 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.579 ' C ' ' H ' ' A' ' 14' ' ' GLY . 59.1 mt -95.48 -99.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.993 -178.547 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.88 -10.11 0.96 Allowed Glycine 0 C--N 1.345 1.034 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 177.128 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.79 -48.89 5.32 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 113.057 -1.571 . . . . 0.0 109.797 177.951 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.01 28.54 0.6 Allowed 'General case' 0 C--N 1.342 0.277 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.951 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.95 38.71 0.13 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.356 -179.343 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 51.82 31.25 7.97 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.174 179.77 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.0 t0 56.64 -79.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.831 -179.954 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 17' ' ' LEU . 17.0 m-70 -49.34 -67.12 0.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.74 179.935 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.173 179.988 . . . . . . . . 0 0 . 1 . 099 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 78.4 m95 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.87 0.367 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 099 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 2' ' ' LEU . 9.9 mp -64.44 -81.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.196 0.522 . . . . 0.0 110.037 179.799 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -169.27 -30.86 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.783 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -142.67 0.85 1.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.157 179.206 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.1 mt 59.28 83.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.283 -179.9 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.63 75.08 0.41 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.141 -0.552 . . . . 0.0 111.972 -179.967 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -73.19 175.23 6.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.651 -179.862 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 89.12 -0.67 81.98 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.185 179.922 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.425 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 30.2 m -76.35 31.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.625 0.25 . . . . 0.0 110.779 -179.975 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 8' ' ' GLY . 56.3 mttm -83.35 -12.19 56.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.956 0.408 . . . . 0.0 110.224 179.871 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.7 mt -137.65 -40.4 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.19 -179.56 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.634 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.2 mt -76.06 -89.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.928 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.04 -4.87 3.77 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 175.529 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.634 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.13 -45.55 6.56 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 113.02 -1.59 . . . . 0.0 110.144 178.365 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -90.62 29.34 1.32 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.832 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.64 46.9 0.26 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.425 -178.56 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.3 mt 65.11 13.48 8.73 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.389 0.431 . . . . 0.0 110.121 -179.393 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 t70 57.28 -78.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.041 179.761 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 17' ' ' LEU . 97.2 m-70 -50.26 -57.44 7.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.773 -179.801 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.173 179.974 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 26.9 m95 . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.764 0.316 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 100 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 2.4 mm? -68.13 -85.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.063 0.459 . . . . 0.0 110.053 -179.886 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.4 ' H ' ' H ' ' A' ' 4' ' ' ARG . 47.6 ttm-85 -157.82 -15.47 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.82 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.4 ' H ' ' H ' ' A' ' 3' ' ' ARG . 4.4 tpt180 -165.11 6.87 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.355 179.753 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.704 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.9 mp 53.91 93.54 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.166 179.939 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 44.84 43.1 8.11 Favored Glycine 0 CA--C 1.518 0.278 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.723 179.616 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.49 ' N ' ' CD ' ' A' ' 7' ' ' LYS . 3.1 mptp? 50.24 100.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.915 0.388 . . . . 0.0 110.621 179.557 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -49.96 142.21 13.53 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.764 179.736 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.6 -82.39 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 110.624 -179.919 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -171.34 -24.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.29 -179.958 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.6 mt -139.44 -48.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.803 179.924 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.608 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.3 mm -77.58 -94.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.419 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.93 -8.97 1.59 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 176.24 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.608 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.17 -48.02 6.68 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 112.992 -1.604 . . . . 0.0 110.181 178.164 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.28 28.66 0.71 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.737 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.11 38.04 0.25 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.905 -179.019 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.4 tt 54.86 46.49 24.36 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.842 179.892 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 54.1 -84.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -179.754 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -162.28 50.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.524 179.876 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.5 mp . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.251 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.4 tptp . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.931 0.396 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 14.6 mt -136.28 -43.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.659 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.2 mt -92.29 -94.69 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.95 -5.97 2.51 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 108.131 -1.987 . . . . 0.0 108.131 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.48 -48.26 5.09 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 113.099 -1.551 . . . . 0.0 109.708 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.44 25.91 1.15 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.12 48.01 0.1 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.681 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.3 mt 60.93 29.28 18.92 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.104 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 53.7 61.69 2.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.436 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 49.19 45.75 23.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.697 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.569 HD12 ' N ' ' A' ' 20' ' ' LEU . 7.4 mp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.139 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 12' ' ' ILE . 81.7 tttt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.586 0.231 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' ALA . 15.8 pt -71.4 7.2 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.504 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.621 ' C ' ' H ' ' A' ' 14' ' ' GLY . 45.3 mm -71.41 -88.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.41 -3.94 3.4 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 107.479 -2.248 . . . . 0.0 107.479 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.0 -39.08 8.18 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 113.702 -1.249 . . . . 0.0 110.124 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -90.88 25.94 2.24 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.78 35.4 0.21 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.6 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 53.48 33.33 15.84 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.91 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.5 t0 56.54 -79.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' LEU . 46.5 m-70 -50.2 -63.68 1.04 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.657 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.069 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.3 tttt . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.773 0.32 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.1 mt -117.84 -45.57 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.398 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 14' ' ' GLY . 68.2 mt -94.97 -97.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.13 -8.42 1.53 Allowed Glycine 0 C--N 1.344 1.01 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.2 -47.48 5.48 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 113.227 -1.486 . . . . 0.0 110.106 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.46 26.34 0.8 Allowed 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 80.3 39.84 0.08 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.105 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.4 tp 55.76 22.85 5.81 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.335 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 53.72 -85.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.707 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.9 m-70 -49.8 -39.47 38.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.554 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.451 HD23 ' C ' ' A' ' 20' ' ' LEU . 2.0 tt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.192 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.7 tttt . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.77 0.319 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.7 mt -137.07 -45.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.218 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.596 ' C ' ' H ' ' A' ' 14' ' ' GLY . 66.3 mt -82.83 -93.97 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.64 -8.27 2.69 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 107.882 -2.087 . . . . 0.0 107.882 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.52 -48.06 6.49 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 113.099 -1.551 . . . . 0.0 109.946 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.89 30.05 0.77 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.54 41.61 0.44 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.573 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.7 tt 66.39 53.57 0.98 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.82 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.9 t0 55.51 -81.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.909 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.506 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -150.34 39.24 0.73 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.559 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.434 179.887 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.421 ' N ' ' CD ' ' A' ' 10' ' ' LYS . 3.5 mptp? . . . . . 0 N--CA 1.462 0.126 0 CA-C-O 121.004 0.43 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.39 -36.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.125 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.607 ' C ' ' H ' ' A' ' 14' ' ' GLY . 87.1 mt -77.3 -87.76 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.41 -4.95 5.64 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 107.199 -2.36 . . . . 0.0 107.199 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.91 -45.84 6.53 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 113.102 -1.549 . . . . 0.0 110.092 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.78 30.54 0.82 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 71.78 42.73 0.61 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.484 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 61.28 53.52 3.49 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.31 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.28 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.671 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 1.1 t60 -159.43 52.86 0.37 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 0.0 110.355 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.2 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.109 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.007 0.432 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.9 mt -140.32 -37.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.167 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.603 ' C ' ' H ' ' A' ' 14' ' ' GLY . 39.1 mm -75.57 -87.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.98 -5.24 5.31 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 107.217 -2.353 . . . . 0.0 107.217 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.51 -44.81 7.18 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 113.207 -1.496 . . . . 0.0 110.266 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.51 27.8 1.06 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.69 39.06 0.35 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.573 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 58.66 44.69 17.03 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.259 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 54.64 36.59 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.437 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.471 ' CG ' ' O ' ' A' ' 19' ' ' HIS . 13.4 t-80 51.04 46.47 26.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.606 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.477 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.9 tttt . . . . . 0 N--CA 1.464 0.253 0 CA-C-O 120.703 0.287 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.4 mt -119.77 -54.89 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.191 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.7 mt -77.67 -95.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.691 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.34 -8.19 1.61 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.32 -48.2 6.09 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 112.835 -1.682 . . . . 0.0 110.102 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.98 28.66 1.01 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.67 46.98 0.18 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.63 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.7 mt 62.91 41.54 8.5 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 53.07 31.16 10.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.297 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 51.38 62.84 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.479 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.394 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 121.028 0.442 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -118.85 -52.58 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.664 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.613 ' C ' ' H ' ' A' ' 14' ' ' GLY . 42.3 mm -73.84 -98.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.205 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.38 -10.71 0.6 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.24 -47.65 7.37 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 113.243 -1.479 . . . . 0.0 110.126 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.2 27.2 1.08 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.02 39.64 0.16 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.751 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 64.89 17.43 11.03 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.826 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.5 t70 55.35 -82.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.683 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 1.4 t-80 -54.39 -69.78 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.48 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 N--CA 1.464 0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.453 179.881 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.5 tttm . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.834 0.35 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.5 mt -117.5 -52.15 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 34.9 mm -85.76 -99.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.04 -11.15 0.54 Allowed Glycine 0 C--N 1.348 1.201 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.89 -49.88 5.83 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 113.12 -1.54 . . . . 0.0 109.875 177.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.544 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.86 29.33 0.63 Allowed 'General case' 0 C--N 1.345 0.395 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.82 37.79 0.15 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.478 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 52.49 36.76 21.13 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.213 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 53.51 -84.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.83 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 51.9 m80 -45.61 -63.39 0.97 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.083 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.4 tttm . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 120.554 0.216 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.445 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.0 mt -113.81 -48.21 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.83 0.348 . . . . 0.0 111.481 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.563 ' C ' ' N ' ' A' ' 14' ' ' GLY . 41.4 mm -96.56 -101.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.046 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.425 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -50.11 -12.09 0.47 Allowed Glycine 0 C--N 1.345 1.077 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.563 ' N ' ' C ' ' A' ' 12' ' ' ILE . . . -82.19 -48.51 5.66 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 113.504 -1.348 . . . . 0.0 110.055 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.59 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.15 22.39 1.21 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 83.22 41.96 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.951 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.8 tp 61.71 6.45 1.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.252 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.0 t70 53.16 38.11 26.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.61 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 29.4 m170 50.03 55.42 9.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.631 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.227 -179.924 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 121.208 0.528 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 11.9 mt -112.54 -44.85 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.74 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.592 ' C ' ' H ' ' A' ' 14' ' ' GLY . 82.6 mt -73.65 -91.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.154 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.64 -8.61 2.05 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 176.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.23 -46.14 7.14 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 113.219 -1.491 . . . . 0.0 110.213 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.47 31.0 0.59 Allowed 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.16 37.68 0.74 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.684 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.7 tt 57.23 50.19 12.12 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.726 -0.789 . . . . 0.0 109.684 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 55.17 -82.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.665 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -163.62 51.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.502 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.578 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 82.5 tttt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.853 0.358 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -127.98 -44.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.772 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 69.0 mt -89.94 -95.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.0 -7.6 2.52 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.87 -47.0 6.04 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 113.182 -1.509 . . . . 0.0 110.032 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.31 30.27 0.54 Allowed 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.24 37.79 0.44 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.805 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 52.83 46.79 26.05 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.899 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 49.74 47.58 22.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.704 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 50.2 44.54 26.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.588 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.4 mp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.089 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 tptp . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.78 0.324 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -134.31 -51.2 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.292 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 73.6 mt -77.05 -94.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.27 -8.38 2.47 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 176.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.95 -47.43 7.12 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 112.853 -1.673 . . . . 0.0 110.047 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.72 30.5 0.64 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.15 37.94 0.58 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.634 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 19' ' ' HIS . 1.1 tt 57.22 38.49 28.82 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.848 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.4 t70 60.5 0.48 0.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.081 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.466 ' H ' ' C ' ' A' ' 17' ' ' LEU . 19.4 t-160 -173.43 -72.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.267 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.42 -179.846 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.5 tptt . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 120.868 0.366 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.9 mt -118.64 -48.66 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 14' ' ' GLY . 44.0 mm -91.86 -99.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.425 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.69 -10.67 0.7 Allowed Glycine 0 C--N 1.347 1.139 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 176.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.591 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.43 -49.03 5.66 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 113.223 -1.488 . . . . 0.0 109.886 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.555 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -83.79 27.4 0.64 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 79.68 38.2 0.11 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.229 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.99 31.39 10.92 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.094 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 49.76 53.82 12.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 52.32 57.88 5.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.646 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.573 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.225 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.771 0.319 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.5 mt -134.07 -47.28 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.223 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.1 mt -79.22 -92.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.99 -8.89 2.5 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 176.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.28 -48.5 6.37 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 112.923 -1.638 . . . . 0.0 110.27 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.68 28.65 0.86 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.74 41.25 0.18 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.876 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.6 tp 61.19 26.43 16.31 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.299 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 t0 58.31 -77.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.949 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.548 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER -48.58 -62.46 1.49 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.756 0.313 . . . . 0.0 110.824 -179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.514 -180.0 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm . . . . . 0 N--CA 1.461 0.111 0 CA-C-O 120.985 0.421 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -139.9 -40.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.432 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.617 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.2 mt -76.46 -88.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.08 -5.78 4.79 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 107.271 -2.332 . . . . 0.0 107.271 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.617 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.34 -45.76 6.82 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 113.106 -1.547 . . . . 0.0 110.198 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.64 27.72 0.94 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.91 37.8 0.27 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.802 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.3 tp 58.66 27.15 15.44 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 55.33 -82.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 56.7 t-80 -49.45 -60.72 2.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.739 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.137 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.664 0.269 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 15' ' ' ALA . 16.2 pt -78.3 6.54 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.681 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.9 mm -70.66 -89.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.22 -4.17 3.39 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 107.488 -2.245 . . . . 0.0 107.488 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.01 -38.99 8.81 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -93.91 27.5 2.74 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.54 38.52 0.38 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.552 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.4 tt 66.14 44.27 2.65 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.731 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 59.8 t0 55.29 35.35 24.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.493 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.3 m80 52.57 57.61 6.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.532 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.471 HD23 ' C ' ' A' ' 20' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.6 tttp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.901 0.382 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 15.3 mt -131.07 -46.99 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.366 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.603 ' C ' ' H ' ' A' ' 14' ' ' GLY . 28.3 mt -81.99 -94.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.425 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -56.12 -7.38 1.79 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.24 -48.16 5.8 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.013 -1.593 . . . . 0.0 110.133 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -89.69 29.94 1.1 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.26 48.09 0.13 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.785 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.4 mt 64.08 49.83 2.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.8 t0 59.63 -76.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.746 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -162.45 26.95 0.11 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.729 0.299 . . . . 0.0 110.482 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.08 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.2 tttp . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.651 0.262 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -129.3 -44.43 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.095 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 73.7 mt -90.75 -94.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.22 -6.98 3.47 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.45 -47.57 5.65 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 113.062 -1.569 . . . . 0.0 110.121 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.87 27.21 0.77 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.22 40.4 0.13 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.863 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.5 tp 56.56 23.2 7.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.248 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 57.48 11.62 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.184 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -171.3 -44.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.764 0.316 . . . . 0.0 110.648 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.405 ' H ' ' HB3' ' A' ' 17' ' ' LEU . 1.2 tt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.126 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.1 tttt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.853 0.359 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.4 mt -139.6 -42.9 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.356 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.7 mt -86.84 -91.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.33 -6.62 4.55 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.4 -47.63 5.97 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 112.909 -1.645 . . . . 0.0 109.892 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.51 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.84 25.88 0.89 Allowed 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.78 43.15 0.18 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.576 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 69.51 51.69 0.47 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.377 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.6 t70 60.61 -76.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.591 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.478 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -160.77 50.85 0.27 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 0.0 110.397 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.143 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.9 mttp . . . . . 0 N--CA 1.467 0.375 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.4 mt -129.29 -43.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.775 0.321 . . . . 0.0 110.88 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.3 mt -94.69 -94.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.09 -7.19 3.52 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 176.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.07 -47.44 5.53 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 113.131 -1.534 . . . . 0.0 109.86 178.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -83.92 27.67 0.64 Allowed 'General case' 0 C--N 1.341 0.23 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.75 39.59 0.17 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.004 -179.072 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.2 tt 52.19 39.33 26.66 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.96 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.3 t70 54.57 -83.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.591 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' LEU . 23.9 m80 -52.57 -65.83 0.49 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.632 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.207 -179.936 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.912 0.386 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -133.57 -45.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.358 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.58 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.9 mt -77.26 -91.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.13 -7.53 3.87 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 175.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.58 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.2 -47.16 6.63 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 112.895 -1.653 . . . . 0.0 110.159 178.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.35 30.74 0.68 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.6 40.07 0.52 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.73 -178.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 58.94 51.9 6.9 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.143 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 65.72 -74.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.03 38.4 0.26 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.795 0.331 . . . . 0.0 110.521 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.412 -179.986 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.5 tttp . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.764 0.316 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.7 mp -119.86 -48.18 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.374 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.57 ' C ' ' N ' ' A' ' 14' ' ' GLY . 42.4 mm -91.45 -98.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.66 -179.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.0 -11.95 0.65 Allowed Glycine 0 C--N 1.346 1.11 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 176.485 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.57 ' N ' ' C ' ' A' ' 12' ' ' ILE . . . -79.89 -50.41 5.57 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 113.309 -1.445 . . . . 0.0 109.997 177.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.02 27.94 0.74 Allowed 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.08 44.68 0.13 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.771 -178.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.1 tp 66.75 11.3 8.14 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.19 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.9 t70 58.71 -77.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.5 t60 -77.87 13.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.722 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.8 mp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.064 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.0 tttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.784 0.326 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mt -139.12 -44.24 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.12 -179.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 7.7 mm -86.13 -93.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.19 -7.05 3.5 Favored Glycine 0 C--N 1.342 0.908 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 176.027 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.89 -47.97 6.0 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 113.006 -1.597 . . . . 0.0 110.031 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.74 29.77 0.69 Allowed 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.77 40.75 0.36 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.86 -178.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 58.36 20.91 7.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.695 -179.801 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.2 t0 56.95 -78.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.948 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.553 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 1.5 m-70 -46.83 -59.52 3.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.989 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.198 -179.919 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.2 tptt . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.86 0.362 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.62 -46.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.19 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 14' ' ' GLY . 30.9 mt -78.3 -92.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.92 -8.72 2.34 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 175.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.54 -48.24 6.39 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 113.001 -1.599 . . . . 0.0 110.283 178.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.74 27.78 1.1 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.51 43.83 0.13 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.82 -178.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 65.62 17.53 10.93 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.447 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 58.53 -77.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.929 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 10.7 m-70 -52.97 -65.08 0.62 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.837 0.351 . . . . 0.0 110.604 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.175 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.8 tttp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.723 0.297 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.5 mt -132.59 -50.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.325 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 33.5 mm -78.41 -94.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.34 -9.33 1.48 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 176.204 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.09 -48.63 6.38 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 112.959 -1.62 . . . . 0.0 110.229 178.151 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.96 27.96 0.73 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.783 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.53 37.95 0.17 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.014 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.1 tp 57.18 11.64 1.11 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.246 179.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER 58.58 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.92 -179.986 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 17' ' ' LEU . 57.8 t-80 -50.62 -44.4 57.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.838 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.4 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.12 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.6 tttm . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.672 0.272 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.0 mt -124.04 -54.21 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.364 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.4 mm -75.06 -98.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.021 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.409 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -50.97 -11.63 0.59 Allowed Glycine 0 C--N 1.347 1.178 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 176.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.591 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -77.82 -48.92 7.45 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.048 -1.576 . . . . 0.0 109.966 178.049 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.34 28.34 0.85 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.704 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.66 39.35 0.24 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.813 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 62.41 25.37 15.13 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.78 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.3 t70 58.01 -78.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' LEU . 16.2 m80 -51.04 -65.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.606 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.233 179.988 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.9 tttp . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.99 0.424 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.1 mt -111.44 -48.46 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.524 -179.131 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 14' ' ' GLY . 40.7 mm -96.16 -101.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.093 -178.62 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.95 -12.08 0.43 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 177.04 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.47 -48.59 5.54 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 113.507 -1.347 . . . . 0.0 110.082 177.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -83.08 23.37 0.86 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.002 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 83.94 39.41 0.03 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.196 -179.336 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.4 tp 54.91 18.04 2.05 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.268 179.757 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 52.67 20.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.119 -179.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 m170 57.83 64.12 1.62 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.503 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.336 -179.952 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.716 0.293 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.3 mt -112.42 -51.08 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.327 -179.169 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 14' ' ' GLY . 38.8 mm -89.73 -100.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.177 -179.036 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.406 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -50.63 -11.59 0.52 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 176.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.13 -49.65 5.85 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 113.294 -1.453 . . . . 0.0 109.946 177.737 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.26 28.2 0.74 Allowed 'General case' 0 C--N 1.345 0.41 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.747 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.18 41.77 0.15 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.047 -179.1 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 19' ' ' HIS . 4.1 tp 62.3 10.41 3.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.446 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.489 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 33.0 t70 57.63 5.05 0.29 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 55.7 m80 -157.49 -13.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 109.836 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.43 ' H ' ' H ' ' A' ' 19' ' ' HIS . 18.8 tp . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.313 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 tttp . . . . . 0 C--O 1.232 0.137 0 CA-C-O 121.054 0.454 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.7 mt -134.42 -35.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.375 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.602 ' C ' ' H ' ' A' ' 14' ' ' GLY . 82.0 mt -74.83 -88.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.07 -4.72 4.85 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 175.407 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.15 -43.62 7.44 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 113.28 -1.46 . . . . 0.0 110.14 178.483 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.36 27.86 1.18 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.884 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.26 37.9 0.34 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.614 -178.722 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 55.21 48.67 18.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.898 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 48.62 29.94 2.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.746 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.2 m80 53.18 59.43 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.583 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.069 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.6 tttp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.868 0.366 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.409 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -135.93 -46.38 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.268 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.4 mt -76.48 -92.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.69 -8.04 3.76 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.07 -46.67 7.51 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 112.907 -1.646 . . . . 0.0 110.224 178.324 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.68 29.43 0.79 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.526 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.98 41.22 0.51 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.222 -178.448 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 63.15 51.94 2.63 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.05 -179.688 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 t0 59.8 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.579 -179.867 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -167.46 53.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.492 179.884 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.132 179.965 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 tttp . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.793 0.33 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.1 mt -135.47 -47.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.9 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 14' ' ' GLY . 47.5 mm -76.7 -94.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.471 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.408 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -54.3 -9.49 1.53 Allowed Glycine 0 C--N 1.346 1.118 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 176.127 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.02 -47.79 6.89 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 113.175 -1.513 . . . . 0.0 110.203 178.253 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.93 28.75 1.0 Allowed 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.819 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.25 42.03 0.19 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.827 -178.954 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.2 tp 63.67 30.16 14.87 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.337 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.0 t0 56.36 -80.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.742 -179.989 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 74.5 m80 -49.29 -65.75 0.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.888 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 tptp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.913 0.387 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 21.5 mt -138.41 -45.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.62 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.8 mt -77.93 -92.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.68 -5.92 3.14 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 107.819 -2.113 . . . . 0.0 107.819 175.718 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.62 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.65 -47.57 5.9 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 112.893 -1.654 . . . . 0.0 110.172 178.261 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.34 29.21 0.99 Allowed 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.683 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.21 47.62 0.19 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.382 -178.652 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.1 mt 64.19 39.86 7.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.082 -179.391 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.1 t70 51.72 42.1 29.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.658 179.918 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.0 m170 50.62 36.76 14.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.643 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.17 -179.985 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.9 mttt . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.768 0.318 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.3 mt -129.95 -48.13 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.255 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.61 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.0 mt -76.25 -93.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.859 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.66 -8.79 2.15 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 176.286 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.22 -47.42 6.99 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 112.873 -1.663 . . . . 0.0 110.167 178.276 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.41 27.96 0.89 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.834 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.43 38.95 0.2 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.892 -178.893 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 57.29 45.38 20.35 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.854 179.92 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 50.46 31.51 5.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.73 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.5 t60 51.41 60.4 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.696 179.845 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.5 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.264 179.87 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.6 tttm . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.763 0.316 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.4 mt -131.45 -46.91 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.386 -179.556 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.601 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.1 mm -87.12 -95.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.865 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.84 -8.84 1.51 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 176.218 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.61 -49.34 5.48 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 113.063 -1.569 . . . . 0.0 110.087 178.082 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.94 26.57 1.13 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.754 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.65 47.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.736 -178.946 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.6 mt 62.61 11.37 4.73 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.484 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.6 t0 55.87 53.83 8.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.48 -179.592 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 55.32 55.93 6.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.674 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.2 mp . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.343 179.916 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.1 tttt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.939 0.4 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 7.1 mm -132.14 -46.27 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.018 -179.943 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 14' ' ' GLY . 72.2 mt -77.16 -92.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.47 -7.63 3.13 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 176.04 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.02 -47.24 6.66 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 112.9 -1.65 . . . . 0.0 110.258 178.235 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.49 28.74 0.83 Allowed 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.663 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.68 40.4 0.3 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.691 -178.749 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 60.08 49.36 7.57 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.282 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 58.72 -77.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.843 -179.883 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' LEU . 13.0 t-80 -159.36 56.92 0.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.779 0.323 . . . . 0.0 110.39 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.495 179.951 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.3 tttm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.817 0.341 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.3 mt -132.92 -50.01 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.163 -179.832 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 60.9 mt -76.52 -95.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.827 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.69 -9.66 1.82 Allowed Glycine 0 C--N 1.346 1.1 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 176.419 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.81 -47.92 7.47 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 112.9 -1.65 . . . . 0.0 110.116 178.098 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.63 28.97 0.82 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.717 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.82 40.19 0.38 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.486 -178.661 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 63.93 49.77 2.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.757 -179.708 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.3 t0 59.23 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.74 -179.782 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 17' ' ' LEU . 13.9 p-80 -159.26 44.03 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.821 0.344 . . . . 0.0 110.362 179.922 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.509 -179.912 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.665 0.269 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 3.7 mp -120.85 -59.8 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.667 -179.816 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.0 mt -76.13 -98.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.265 -179.331 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.34 -11.44 0.71 Allowed Glycine 0 C--N 1.347 1.186 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 176.993 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.09 -48.73 7.41 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.875 -1.662 . . . . 0.0 110.003 178.006 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.55 29.9 0.75 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.604 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.85 39.82 0.4 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.728 -178.879 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.5 tt 63.64 47.86 3.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.783 -179.896 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 54.04 -84.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.657 -179.822 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' LEU . 15.1 t-160 -161.17 50.71 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.459 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.7 mp . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.154 -180.0 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.3 tttm . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.671 0.272 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.7 mt -120.66 -52.43 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.221 -178.847 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.4 mm -74.32 -97.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.229 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.77 -10.49 0.69 Allowed Glycine 0 C--N 1.346 1.104 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 176.711 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.8 -47.84 7.52 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 113.218 -1.491 . . . . 0.0 110.02 178.183 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.55 31.54 0.83 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.716 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.71 41.93 0.52 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.69 -178.75 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.2 tp 65.12 53.61 1.33 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.103 -179.721 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.0 t0 62.73 -75.49 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.844 -179.821 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.421 ' N ' ' O ' ' A' ' 17' ' ' LEU . 2.7 t60 -152.74 42.13 0.61 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.794 0.33 . . . . 0.0 110.369 -179.892 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.9 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.496 179.954 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 mttp . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.827 0.346 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -129.11 -46.04 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.647 -179.609 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.614 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.2 mt -74.89 -92.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.659 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.08 -6.69 3.11 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 176.029 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.65 -45.33 7.35 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 113.082 -1.559 . . . . 0.0 110.139 178.327 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.77 29.9 0.77 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.573 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.03 37.46 0.63 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.513 -178.578 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.4 tt 58.24 47.32 14.4 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.878 -179.933 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.486 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 71.0 m-20 54.03 -83.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 17' ' ' LEU . 96.3 m-70 -158.21 52.11 0.43 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.366 179.974 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.081 -179.924 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.7 tttm . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 120.649 0.261 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.7 mt -116.9 -46.59 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.789 0.328 . . . . 0.0 111.573 -179.119 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 63.1 mt -95.78 -97.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.069 -178.564 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.35 -8.29 1.66 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 176.854 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.9 -48.02 5.35 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 113.155 -1.522 . . . . 0.0 109.808 177.999 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -81.11 27.06 0.41 Allowed 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.604 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.17 36.45 0.23 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.758 -179.042 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 51.3 32.14 7.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.265 -179.824 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 51.15 10.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.134 179.837 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.443 ' H ' ' C ' ' A' ' 17' ' ' LEU . 20.9 t-160 -168.3 -41.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.611 179.929 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.8 pp . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.584 -179.97 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.9 tttt . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 10.6 mt -112.07 -46.16 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.277 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.6 ' C ' ' H ' ' A' ' 14' ' ' GLY . 60.5 mt -95.99 -98.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.135 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.95 -6.8 1.41 Allowed Glycine 0 C--N 1.341 0.854 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.393 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.6 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.92 -46.53 5.35 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 113.291 -1.455 . . . . 0.0 110.001 178.332 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.29 28.56 0.72 Allowed 'General case' 0 C--N 1.343 0.292 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.728 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.26 41.47 0.28 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.797 -178.927 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.2 OUTLIER 68.25 37.19 2.89 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.014 -0.675 . . . . 0.0 109.72 -179.762 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.495 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 33.6 t70 55.71 -82.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.716 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' LEU . 96.8 m-70 -158.5 57.61 0.45 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.475 179.98 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.476 -179.943 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.4 mttm . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.911 0.386 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.6 mt -138.95 -39.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.193 -179.567 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.5 mt -75.83 -89.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.56 -5.52 5.12 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 175.385 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.36 -45.16 7.09 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 113.105 -1.547 . . . . 0.0 110.161 178.345 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.94 29.86 0.89 Allowed 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.653 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.59 40.78 0.61 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.407 -178.502 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.3 tp 63.14 20.4 12.26 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.214 -179.736 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.8 t70 58.83 -77.5 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' LEU . 20.7 m80 -49.25 -61.02 2.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.304 . . . . 0.0 110.711 -179.938 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.029 179.966 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.814 0.34 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.3 mt -133.9 -52.07 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 109.979 -179.936 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.1 mm -76.51 -96.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.695 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.9 -11.08 0.85 Allowed Glycine 0 C--N 1.347 1.16 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 176.448 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.56 -48.87 6.99 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 113.053 -1.573 . . . . 0.0 110.28 178.056 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.552 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.44 27.18 0.97 Allowed 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.877 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.5 40.07 0.13 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.916 -179.086 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.3 tt 62.18 42.69 9.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.828 179.955 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.6 t0 50.9 34.96 11.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.552 -179.858 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.8 t60 53.96 62.06 2.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.483 179.922 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.294 179.974 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.2 mttp . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 40.9 mm -118.22 -43.36 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.89 0.376 . . . . 0.0 111.415 -179.146 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.1 mt -98.54 -98.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.873 -178.65 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -54.67 -8.3 1.26 Allowed Glycine 0 C--N 1.342 0.914 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 176.743 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.6 -48.2 4.82 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 113.231 -1.485 . . . . 0.0 109.845 177.995 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.23 26.59 1.02 Allowed 'General case' 0 C--N 1.342 0.239 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.865 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.97 48.65 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.754 -178.918 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.0 mt 61.14 14.52 5.55 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.462 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.2 t70 58.67 -77.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 -179.706 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 63.6 t60 -164.9 47.76 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.914 0.388 . . . . 0.0 110.485 179.903 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.116 180.0 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.856 0.36 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.7 mt -136.8 -45.52 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.149 -179.91 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 14' ' ' GLY . 78.7 mt -84.07 -93.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.958 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.81 -8.34 2.88 Favored Glycine 0 C--N 1.343 0.955 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 175.959 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.591 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.8 -48.25 6.27 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 112.945 -1.628 . . . . 0.0 110.117 178.153 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.02 27.53 0.89 Allowed 'General case' 0 C--N 1.343 0.311 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.77 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.57 41.59 0.19 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.627 -178.871 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.6 tt 63.38 48.89 3.37 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.771 -179.786 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.8 t0 50.91 28.97 4.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.404 -179.825 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.8 t60 55.91 68.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.476 -179.796 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.4 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.244 -179.846 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.818 0.342 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.8 mt -130.35 -49.23 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.124 -179.826 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.602 ' C ' ' H ' ' A' ' 14' ' ' GLY . 28.2 mt -75.98 -95.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.886 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -54.12 -9.73 1.53 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 176.294 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.27 -47.81 7.25 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 113.019 -1.59 . . . . 0.0 110.074 178.036 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.8 29.36 1.03 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.823 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.14 41.71 0.28 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.615 -178.83 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.1 tt 69.33 39.38 1.67 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.893 -179.864 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.9 t0 48.56 49.29 18.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.654 -179.943 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 53.21 60.86 3.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 -179.891 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.569 HD12 ' N ' ' A' ' 20' ' ' LEU . 7.9 mp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.03 -179.882 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.099 0.476 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.3 mt -131.44 -35.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.514 -179.485 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.601 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.7 mt -75.82 -87.6 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.908 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.08 -4.99 5.13 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 175.2 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.06 -44.48 7.07 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 113.209 -1.496 . . . . 0.0 110.193 178.471 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.51 27.72 1.07 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.953 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.05 37.34 0.28 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.707 -178.881 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.2 tt 55.97 43.04 27.92 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.052 179.921 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.0 t0 50.94 39.95 24.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.656 -179.994 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 51.53 45.63 27.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.551 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.352 -179.987 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.9 tttm . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.669 0.271 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.3 mt -132.59 -49.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.86 0.362 . . . . 0.0 110.452 -179.754 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.607 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.1 mm -81.99 -96.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.92 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.43 -8.63 1.26 Allowed Glycine 0 C--N 1.344 0.987 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 176.393 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.8 -48.97 5.9 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.1 -1.55 . . . . 0.0 110.002 178.015 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.71 29.67 0.99 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.586 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.3 48.84 0.23 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.571 -178.671 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.0 mt 64.53 31.63 12.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.204 -179.493 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.7 t70 53.03 44.68 30.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.957 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 50.56 65.48 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.647 179.948 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.203 -179.859 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.9 tttp . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 120.714 0.292 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.0 mt -131.06 -44.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.868 0.366 . . . . 0.0 110.764 -179.351 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.0 mt -89.99 -94.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.575 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.77 -7.33 3.26 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 176.215 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.67 -47.55 5.9 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 113.011 -1.594 . . . . 0.0 109.984 178.154 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.11 29.32 0.57 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.661 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.17 38.33 0.33 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.867 -178.958 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.1 tt 51.73 38.38 22.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.069 -179.946 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.6 t0 52.43 -85.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 17' ' ' LEU . 73.7 m-70 -53.11 -65.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.67 -179.854 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.023 -179.915 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.4 tttm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.848 0.356 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 18.5 mt -125.27 -55.37 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.172 -179.916 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' GLY . 34.6 mm -75.46 -98.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.928 -179.911 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.49 -10.99 0.68 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 176.794 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.56 -48.5 7.25 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 113.013 -1.593 . . . . 0.0 110.074 178.046 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.544 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.85 27.71 0.85 Allowed 'General case' 0 C--N 1.344 0.363 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.652 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.22 39.32 0.2 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.741 -178.923 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tt 58.01 48.8 12.66 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.6 179.945 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 53.97 22.84 3.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.205 -179.593 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.6 t60 56.01 63.14 2.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.635 -179.925 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.184 179.906 . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 14.7 mt -122.84 -45.63 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.75 0.31 . . . . 0.0 111.129 -179.642 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 14' ' ' GLY . 71.2 mt -95.03 -97.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.069 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.27 -8.48 1.67 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 176.462 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.55 -48.0 5.45 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 113.318 -1.441 . . . . 0.0 109.953 177.997 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.55 28.62 0.74 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.816 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.5 41.79 0.19 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.931 -179.011 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.0 tp 62.31 30.01 17.41 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.574 -179.996 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t0 55.23 -82.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 179.73 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 17' ' ' LEU . 61.0 m80 -47.75 -64.68 0.72 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.853 -179.812 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.453 -179.991 . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.9 tttm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.76 0.314 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.413 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 11.5 mt -124.97 -51.91 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.542 -179.647 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.5 mm -74.67 -97.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.898 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.41 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.03 -10.24 0.73 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 176.738 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.17 -48.08 7.12 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 113.095 -1.552 . . . . 0.0 110.029 178.061 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.2 28.48 0.82 Allowed 'General case' 0 C--N 1.343 0.325 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.67 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.99 38.18 0.25 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.964 -179.055 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.5 tt 55.52 46.39 23.11 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.888 179.801 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 55.69 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.731 -179.903 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LEU . 1.5 p-80 -157.03 44.71 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.418 -179.972 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.155 -179.98 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.4 tttt . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.621 0.248 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.7 mp -115.59 -47.73 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.789 0.328 . . . . 0.0 111.649 -178.946 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.9 mt -94.86 -98.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.008 -178.681 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.453 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.57 -10.96 1.06 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 176.669 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.88 -49.8 5.2 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 113.199 -1.501 . . . . 0.0 109.936 177.771 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.28 25.87 0.82 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.941 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.53 44.51 0.07 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.856 -178.991 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.4 tp 62.78 31.5 16.47 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.305 -179.968 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.4 t0 56.84 -79.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' LEU . 35.6 m80 -54.92 -62.38 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.542 179.994 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.541 ' N ' HD23 ' A' ' 20' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.728 179.581 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 tttp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.822 0.344 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.1 mt -131.51 -44.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.068 -179.849 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.1 mt -75.34 -91.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.5 -6.66 3.54 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 107.579 -2.208 . . . . 0.0 107.579 176.016 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.46 -45.72 7.25 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 112.98 -1.61 . . . . 0.0 110.035 178.315 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.5 29.96 0.74 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.618 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.11 37.53 0.61 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.5 -178.645 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.6 tt 56.79 46.26 20.23 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.797 -179.884 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 47.56 44.75 17.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.1 m80 54.73 45.77 26.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.597 -179.883 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.339 -179.993 . . . . . . . . 0 0 . 1 . 056 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.3 tptm . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.905 0.383 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 056 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.4 mt -124.43 -49.76 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.764 -179.819 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 14' ' ' GLY . 25.9 mt -81.9 -95.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.945 -179.424 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -53.89 -9.96 1.49 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 176.402 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.04 -49.38 6.01 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 112.994 -1.603 . . . . 0.0 110.247 177.985 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.539 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.78 28.24 0.91 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.799 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.69 43.93 0.12 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.841 -179.026 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 64.34 24.8 13.34 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.477 -179.997 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.3 t70 57.47 -78.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 50.0 m80 -49.79 -67.07 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.452 179.873 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttm . . . . . 0 CA--C 1.522 -0.101 0 CA-C-O 120.604 0.24 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' ALA . 16.6 pt -81.2 4.96 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.647 179.994 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.625 ' C ' ' H ' ' A' ' 14' ' ' GLY . 38.9 mm -70.83 -88.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.301 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.32 -3.76 3.16 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 175.402 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.625 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.08 -38.33 8.61 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 113.77 -1.215 . . . . 0.0 110.137 178.604 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -94.17 26.03 3.49 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.873 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 79.07 37.29 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.653 -178.886 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 3.7 tp 61.94 11.35 4.13 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.41 179.719 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 60.05 -77.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.469 -179.579 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -55.07 -70.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 110.559 179.797 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.463 0.222 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.479 179.906 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt . . . . . 0 CA--C 1.53 0.203 0 CA-C-O 120.919 0.39 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.7 mp -109.81 -49.47 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.895 -179.05 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' GLY . 23.5 mt -95.54 -99.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.385 -178.24 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.27 -10.83 0.93 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 177.097 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.578 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.1 -49.24 5.38 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 113.155 -1.523 . . . . 0.0 109.756 177.877 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.48 29.52 0.59 Allowed 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.607 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.17 43.91 0.27 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.74 -178.898 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 61.17 34.47 18.88 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.953 -179.693 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 t70 57.89 -78.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.928 -179.799 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 86.8 m-70 -64.89 -64.29 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.705 -179.77 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.461 -179.786 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.2 tttp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.942 0.401 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -137.98 -43.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.776 -179.953 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.585 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.7 mt -77.37 -90.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.525 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.59 -7.27 4.18 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 175.772 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.585 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.26 -46.7 6.84 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 112.931 -1.635 . . . . 0.0 110.199 178.431 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.535 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.14 27.08 0.94 Allowed 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.797 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.61 39.05 0.19 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.683 -178.894 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 57.43 47.17 16.89 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.991 179.931 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 54.33 -83.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 179.966 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.7 t-80 -157.4 40.33 0.3 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.425 179.975 . . . . . . . . 0 0 . 1 . 060 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.5 tttp . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.705 0.288 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 060 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.5 mt -130.7 -46.57 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.624 -179.474 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.623 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.9 mt -84.53 -94.33 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.835 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.424 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -56.57 -7.26 2.02 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 176.074 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.623 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.22 -48.63 5.6 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 112.915 -1.642 . . . . 0.0 109.955 178.031 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.25 29.16 0.98 Allowed 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.588 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.46 49.15 0.21 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.586 -178.572 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 11.1 mt 63.52 6.08 2.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.157 -179.293 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.3 t70 58.22 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 -179.977 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -158.76 54.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.306 179.941 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.201 -179.857 . . . . . . . . 0 0 . 1 . 061 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.1 tttp . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.716 0.293 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 061 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.8 mt -133.13 -44.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.905 0.383 . . . . 0.0 110.701 -179.548 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.0 mt -90.35 -94.32 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.662 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.48 -8.58 2.75 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 176.306 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.79 -49.07 5.54 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 112.986 -1.607 . . . . 0.0 109.985 178.017 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.86 29.62 0.62 Allowed 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.728 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.95 40.97 0.25 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.113 -179.168 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.7 OUTLIER 56.53 13.9 1.5 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.69 -179.98 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.9 t0 55.57 -82.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.792 -179.942 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 49.6 m80 -58.44 -20.18 42.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.57 -179.987 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 -179.908 . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.5 tptm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.85 0.357 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.5 mt -136.86 -46.25 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.934 0.397 . . . . 0.0 110.367 -179.735 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.62 ' C ' ' H ' ' A' ' 14' ' ' GLY . 71.4 mt -80.16 -93.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.945 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.12 -6.65 3.13 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 176.127 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.62 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.43 -46.54 6.85 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 112.963 -1.619 . . . . 0.0 109.886 178.219 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.43 30.29 0.63 Allowed 'General case' 0 C--N 1.345 0.396 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.506 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.46 38.0 0.67 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.441 -178.596 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.6 tt 54.36 52.27 12.79 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.771 -179.738 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.433 ' N ' ' OD2' ' A' ' 18' ' ' ASP . 1.0 OUTLIER 56.1 -80.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.947 179.927 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -160.95 48.68 0.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.362 -179.939 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.038 -179.896 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.7 tttp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.862 0.363 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.0 mt -135.72 -50.45 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.831 179.939 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.6 mm -76.53 -96.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.602 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.6 -10.37 0.93 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 176.387 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.05 -48.56 6.87 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 113.109 -1.545 . . . . 0.0 110.171 178.082 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.95 29.1 0.84 Allowed 'General case' 0 C--N 1.344 0.337 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.772 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.52 39.74 0.24 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.991 -178.993 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.2 tt 63.09 43.63 6.35 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.966 179.844 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.1 t0 49.0 32.29 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.559 -179.977 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 54.79 73.92 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.475 -179.865 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.0 tp . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.52 -179.979 . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.955 0.407 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.3 mt -133.15 -38.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.148 -179.789 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.607 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.6 mt -75.58 -89.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.825 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.96 -5.66 4.49 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 107.332 -2.307 . . . . 0.0 107.332 175.385 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.29 -44.73 7.34 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 113.167 -1.516 . . . . 0.0 110.038 178.379 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.69 28.35 1.16 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.889 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.55 38.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.596 -178.766 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 3.2 tp 63.22 48.99 3.45 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 53.8 -84.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.754 179.822 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 58.4 m80 -150.36 57.17 0.94 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.353 179.993 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.514 -179.966 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 tttm . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.6 0.238 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 065 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.447 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.7 mt -120.69 -47.41 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 120.793 0.33 . . . . 0.0 111.26 -179.163 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.3 mt -91.28 -97.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.128 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.448 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -54.21 -8.93 1.26 Allowed Glycine 0 C--N 1.343 0.933 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 176.524 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.53 -48.96 5.37 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 113.147 -1.526 . . . . 0.0 109.935 177.984 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.507 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.38 28.91 0.91 Allowed 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.723 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.87 48.78 0.13 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.556 -178.724 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.9 mt 65.1 -1.55 0.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.351 -179.427 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 16' ' ' ALA . 26.3 t70 53.9 -83.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.765 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 2.4 t60 -46.98 -37.79 9.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.95 -179.882 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 20' ' ' LEU . 2.0 tt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.068 179.973 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.3 tttt . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.735 0.302 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 19.4 pt -78.02 10.79 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.403 180.0 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 14' ' ' GLY . 6.8 mm -74.52 -86.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.515 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.49 -3.15 5.07 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 175.249 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.53 -40.77 7.15 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 113.663 -1.269 . . . . 0.0 110.314 178.637 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -90.49 26.21 2.05 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.873 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 79.43 37.16 0.14 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.876 -178.945 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.1 tp 59.24 17.92 6.14 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.546 179.76 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 56.93 6.95 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.794 179.728 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.409 ' H ' ' C ' ' A' ' 17' ' ' LEU . 54.6 t-80 -170.34 -59.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.522 -179.961 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.204 -179.987 . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.7 tttt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.816 0.341 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.8 mt -139.68 -43.89 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.02 -179.855 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.606 ' C ' ' H ' ' A' ' 14' ' ' GLY . 23.7 mt -84.43 -93.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.771 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.89 -6.25 2.63 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 175.751 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.38 -47.36 5.75 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 113.066 -1.567 . . . . 0.0 110.158 178.265 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -89.32 29.03 1.14 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.726 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.63 47.82 0.12 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.721 -178.821 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.4 mt 63.71 17.81 10.7 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.247 0.342 . . . . 0.0 110.137 -179.596 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 59.56 -76.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.766 179.894 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.513 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -154.68 52.56 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.82 0.343 . . . . 0.0 110.427 -179.991 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.304 -179.967 . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.927 0.394 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.11 -43.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.332 -179.861 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.61 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.5 mt -88.0 -93.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.94 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.47 -6.66 3.51 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 175.941 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.73 -47.48 5.9 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 113.046 -1.577 . . . . 0.0 109.939 178.152 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.524 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.88 29.73 0.61 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.708 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.47 38.68 0.38 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.773 -178.941 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 56.39 33.89 23.21 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.969 -179.973 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.7 t0 58.02 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.781 -179.962 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -155.3 62.24 0.63 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.268 179.875 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.373 -179.771 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.6 mttm . . . . . 0 N--CA 1.468 0.425 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 17.8 mt -126.4 -45.2 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.832 0.348 . . . . 0.0 110.97 -179.357 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' GLY . 66.1 mt -95.97 -96.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.248 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.38 -7.76 2.18 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 176.434 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.0 -48.75 5.04 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 113.053 -1.573 . . . . 0.0 109.557 177.922 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.2 29.15 0.67 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 177.526 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.06 48.03 0.28 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.451 -178.687 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.0 mt 62.54 22.52 13.34 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.366 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.9 t70 55.73 -82.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.625 -179.875 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 31.9 m-70 -53.66 -33.93 56.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.59 179.973 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.163 -179.985 . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.1 tptp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.773 0.321 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.0 mt -132.06 -48.63 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.343 -179.894 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 14' ' ' GLY . 65.3 mt -78.24 -94.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -179.788 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.11 -8.24 2.25 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 176.241 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.44 -47.53 6.81 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 112.899 -1.651 . . . . 0.0 110.186 178.133 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.525 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.82 29.31 0.81 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.757 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.75 39.29 0.33 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.755 -178.928 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 12' ' ' ILE . 0.9 OUTLIER 62.14 27.97 16.83 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.881 179.971 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 t70 50.05 -91.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 179.949 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' LEU . 71.9 m80 -50.19 -25.2 3.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.732 -179.761 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.222 179.994 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 tttp . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.592 0.234 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.7 mt -123.91 -51.21 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.847 0.356 . . . . 0.0 110.867 -179.563 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 44.3 mm -83.79 -98.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.7 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.68 -10.89 0.73 Allowed Glycine 0 C--N 1.346 1.121 0 N-CA-C 108.544 -1.823 . . . . 0.0 108.544 176.654 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.57 -49.83 5.97 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 113.136 -1.532 . . . . 0.0 110.058 177.919 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.09 28.42 0.82 Allowed 'General case' 0 C--N 1.345 0.398 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.833 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.43 42.19 0.13 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.084 -179.16 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 60.87 44.49 10.72 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.633 179.796 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.9 t70 53.58 47.56 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 179.915 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 51.1 53.86 12.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.701 179.818 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 20' ' ' LEU . 7.6 mp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.261 179.952 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.9 tttp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.775 0.321 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.3 mt -135.41 -44.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.559 -179.486 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.1 mt -90.34 -95.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.748 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.433 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.44 -8.34 1.76 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 175.976 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.64 -49.15 5.26 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 113.142 -1.529 . . . . 0.0 109.992 177.978 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.94 28.08 0.94 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.808 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.19 48.07 0.1 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.742 -178.877 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.6 mt 64.31 33.97 11.02 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.325 0.391 . . . . 0.0 110.259 -179.773 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 t0 57.0 -78.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.954 179.785 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 17' ' ' LEU . 16.1 p-80 -145.63 51.74 1.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.328 -179.871 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.195 179.986 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.3 tptm . . . . . 0 CA--C 1.529 0.138 0 CA-C-O 120.959 0.409 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.409 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.3 mt -138.5 -36.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.539 -179.64 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.6 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.6 mt -75.03 -88.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.989 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.44 -4.73 5.44 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 175.173 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.6 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.07 -43.87 7.35 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 113.197 -1.502 . . . . 0.0 110.258 178.389 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.06 28.07 1.11 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.702 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.88 39.25 0.42 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.454 -178.626 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.0 tp 60.19 41.26 17.07 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.333 -179.778 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.9 0.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.428 ' H ' ' C ' ' A' ' 17' ' ' LEU . 6.7 t60 -170.79 -65.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 110.65 179.946 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 16' ' ' ALA . 16.7 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.759 0.314 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 6.8 mm -131.52 -51.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.863 -179.981 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' GLY . 42.6 mm -76.0 -97.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.841 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.01 -11.05 0.88 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 176.766 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.34 -48.93 7.09 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 113.029 -1.585 . . . . 0.0 110.128 178.024 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.19 28.8 0.69 Allowed 'General case' 0 C--N 1.343 0.323 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.597 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.93 38.47 0.25 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.899 -179.019 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tt 55.63 45.64 24.34 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.671 179.924 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 54.55 33.19 18.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.379 -179.703 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.0 m80 58.59 45.88 15.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.547 -179.987 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.405 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.137 179.912 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.2 tttt . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.586 0.231 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.2 mp -132.46 -48.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 121.058 0.456 . . . . 0.0 110.341 179.569 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.1 mt -83.67 -94.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.667 -179.66 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.03 -8.59 2.38 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 176.1 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.52 -48.74 6.13 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 113.004 -1.598 . . . . 0.0 109.863 178.025 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.69 30.55 0.72 Allowed 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.553 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.21 44.15 0.46 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.527 -178.702 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.7 tp 65.27 21.67 12.04 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.279 -179.711 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.8 t70 56.14 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.998 179.853 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' LEU . 12.5 t-80 -49.32 -29.87 6.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.885 -179.687 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.454 HD23 ' C ' ' A' ' 20' ' ' LEU . 2.8 tt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.15 179.985 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.823 0.344 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.2 mt -137.44 -44.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.416 -179.483 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.598 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.0 mt -87.67 -94.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.849 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.79 -6.23 2.51 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 175.992 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.1 -47.71 5.69 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 113.182 -1.509 . . . . 0.0 109.755 177.987 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.76 27.37 1.15 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.484 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.9 48.19 0.19 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.408 -178.607 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 19' ' ' HIS . 9.6 mt 61.95 35.88 15.98 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.176 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 55.77 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.716 -179.669 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 17' ' ' LEU . 3.8 p-80 -162.27 46.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.472 -179.995 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.323 179.974 . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.908 0.385 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 14.9 mt -131.71 -50.47 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.898 179.912 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.1 mm -76.68 -96.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.705 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.39 -9.66 1.1 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 108.379 -1.889 . . . . 0.0 108.379 176.425 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.97 -47.87 6.86 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 113.005 -1.597 . . . . 0.0 110.252 178.249 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.27 27.92 0.88 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.865 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.43 38.6 0.16 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.988 -179.083 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 58.21 42.36 22.09 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.691 179.836 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 54.61 -83.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.576 -179.849 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -163.01 52.97 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.36 179.954 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.187 -179.999 . . . . . . . . 0 0 . 1 . 078 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 120.926 0.393 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 078 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 26.7 mm -110.03 -46.83 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.83 -178.959 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 14' ' ' GLY . 47.2 mm -98.36 -101.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.139 -178.695 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -50.47 -11.45 0.47 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 177.252 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.37 -48.09 5.47 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 177.824 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.97 27.13 0.56 Allowed 'General case' 0 C--N 1.342 0.265 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.642 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.35 39.99 0.14 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.968 -179.12 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 55.17 22.26 4.52 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.078 -179.983 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 53.56 -86.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.454 -179.742 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -50.21 -37.21 34.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.542 179.94 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.165 179.921 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.985 0.421 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 14.1 mt -138.35 -37.9 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.034 -179.565 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.611 ' C ' ' H ' ' A' ' 14' ' ' GLY . 86.3 mt -73.96 -88.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.788 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.97 -5.19 5.23 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 175.585 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.02 -43.28 7.66 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 113.091 -1.555 . . . . 0.0 110.189 178.504 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.1 28.4 1.07 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.845 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.49 37.06 0.45 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.509 -178.639 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.4 tt 54.2 49.59 18.31 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.838 -179.934 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 49.87 23.8 1.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.609 -179.989 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 54.08 57.59 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.468 -179.912 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.4 tp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.13 -179.838 . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.6 tttp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.867 0.365 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.3 mt -139.71 -46.99 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.039 179.937 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' GLY . 37.5 mt -78.14 -92.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.789 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.01 -8.19 2.95 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 176.121 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.25 -47.67 6.83 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 112.93 -1.635 . . . . 0.0 110.13 178.131 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.96 28.68 0.78 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.642 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.51 39.45 0.35 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.715 -178.848 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.1 tt 60.25 39.14 19.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.945 179.979 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 38.5 t70 47.88 61.38 3.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.5 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 27.0 p80 41.16 51.28 3.41 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.261 -179.98 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 20' ' ' LEU . 7.7 mp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.187 179.975 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.7 tttt . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.771 0.319 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.9 mm -133.69 -47.39 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.988 -179.924 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.8 mt -80.0 -93.39 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.862 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.6 -7.62 3.29 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 176.171 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.64 -47.38 6.79 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 112.799 -1.7 . . . . 0.0 110.008 178.165 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.67 29.35 0.61 Allowed 'General case' 0 C--N 1.343 0.319 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.467 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.5 38.46 0.5 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.444 -178.734 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.6 tt 54.76 50.86 14.85 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.632 -179.746 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t0 55.43 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.695 -179.796 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' LEU . 8.7 t60 -164.39 44.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.524 179.873 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.123 -179.97 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.3 tttm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.715 0.293 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -125.96 -52.62 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.391 -179.672 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.614 ' C ' ' H ' ' A' ' 14' ' ' GLY . 39.8 mm -75.58 -97.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.921 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.23 -10.28 0.8 Allowed Glycine 0 C--N 1.346 1.133 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 176.648 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.28 -48.08 7.07 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.144 -1.528 . . . . 0.0 110.258 178.053 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.34 30.36 0.89 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.797 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.44 42.81 0.29 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.802 -178.852 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.6 tp 63.82 51.52 2.36 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.25 -179.827 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 t0 69.91 -70.55 0.14 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.591 -179.758 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -159.88 19.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.457 179.934 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.248 179.876 . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 tttm . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 120.714 0.292 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.0 mt -114.4 -49.1 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.411 -179.207 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.6 mt -91.8 -99.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.687 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.424 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.58 -10.74 1.01 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 176.931 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.83 -49.14 5.81 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.126 -1.537 . . . . 0.0 109.764 177.881 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.73 29.49 0.7 Allowed 'General case' 0 C--N 1.344 0.342 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.597 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.16 43.48 0.29 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.647 -178.853 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.6 tp 65.7 -1.19 1.09 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.231 -179.725 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 16' ' ' ALA . 19.5 t70 51.35 -85.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.08 179.647 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 84.5 m-70 -49.02 -17.96 0.25 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.931 -179.708 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.341 -179.976 . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 72.3 tttt . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.885 0.374 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.0 mm -119.38 -43.73 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.569 -178.946 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' GLY . 58.4 mt -96.73 -97.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.645 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.18 -7.44 1.87 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 176.493 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.05 -46.77 5.51 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 113.306 -1.447 . . . . 0.0 109.845 178.124 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.93 29.06 0.47 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.62 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.91 38.38 0.35 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.779 -178.91 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.4 tp 53.2 41.31 32.14 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.234 -179.731 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 55.48 31.46 17.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.321 -179.76 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.3 m80 53.23 69.02 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.378 -179.877 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.18 -179.849 . . . . . . . . 0 0 . 1 . 085 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 tttm . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.596 0.236 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -122.39 -44.69 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.737 0.303 . . . . 0.0 111.301 -179.189 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.579 ' C ' ' H ' ' A' ' 14' ' ' GLY . 69.9 mt -95.0 -95.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.935 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.95 -7.72 2.57 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 176.367 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.11 -48.02 5.29 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 113.08 -1.56 . . . . 0.0 110.001 178.193 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -83.25 27.86 0.56 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.834 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.77 39.88 0.16 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.936 -179.005 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.2 tp 54.22 39.46 30.81 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.255 -179.939 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 57.14 -79.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.752 179.996 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' LEU . 38.6 t-80 -63.58 -60.94 2.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 0.0 110.583 -179.999 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.206 -179.969 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -131.57 -38.86 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.434 -179.542 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.609 ' C ' ' H ' ' A' ' 14' ' ' GLY . 86.5 mt -76.36 -88.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.8 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.25 -4.06 4.45 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 175.343 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.609 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.69 -45.35 6.45 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 113.092 -1.554 . . . . 0.0 110.0 178.357 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -89.22 27.94 1.32 Allowed 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.755 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.28 45.73 0.26 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.437 -178.582 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.8 mt 63.91 28.7 14.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.297 -179.42 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 48.97 27.31 1.61 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.629 -179.905 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.0 m80 53.57 48.46 21.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.332 -179.782 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.279 -179.924 . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 tptm . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.684 0.278 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -135.99 -47.89 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.8 0.333 . . . . 0.0 110.58 -179.731 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.592 ' C ' ' H ' ' A' ' 14' ' ' GLY . 25.2 mt -84.09 -94.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.986 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.417 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.21 -9.42 2.08 Favored Glycine 0 C--N 1.345 1.033 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 176.201 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.98 -49.41 6.02 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 112.922 -1.639 . . . . 0.0 110.0 177.956 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.51 29.17 0.79 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.679 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.48 44.01 0.24 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.652 -178.917 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.5 tp 65.58 22.35 11.74 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.286 -179.908 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.2 t0 55.77 25.24 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.286 -179.817 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 53.58 70.25 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.438 -179.8 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.366 -179.902 . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.967 0.413 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.402 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.7 mt -139.92 -39.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.134 -179.532 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.615 ' C ' ' H ' ' A' ' 14' ' ' GLY . 70.0 mt -75.75 -88.83 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.948 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.44 -5.53 4.98 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 175.427 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.615 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.93 -44.65 7.04 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.147 -1.526 . . . . 0.0 110.342 178.498 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.525 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.37 27.04 1.13 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.849 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.05 37.77 0.2 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.818 -178.892 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 55.36 17.84 2.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.911 179.941 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t0 56.24 -80.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.8 -179.962 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.4 t-80 -50.67 -61.46 2.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.848 0.356 . . . . 0.0 110.611 -179.922 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.1 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.463 179.944 . . . . . . . . 0 0 . 1 . 089 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 tptp . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.736 0.303 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 089 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.475 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.3 mt -123.08 -46.0 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.138 -179.272 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.8 mm -97.79 -99.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.034 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.415 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.57 -9.4 0.71 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 176.67 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.83 -48.23 5.01 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.441 -1.38 . . . . 0.0 110.065 177.953 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.63 25.76 1.2 Allowed 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.923 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.21 48.6 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.864 -178.893 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.7 mt 62.6 1.86 0.84 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.268 -179.686 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 16' ' ' ALA . 27.9 t70 51.08 46.24 26.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.633 -179.938 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.443 ' CG ' ' O ' ' A' ' 19' ' ' HIS . 11.1 t60 55.5 35.68 25.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.583 -179.976 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.067 -179.946 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.6 tptt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.02 0.438 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.2 mt -142.79 -45.35 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.098 -179.947 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.9 mt -78.44 -90.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.923 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.73 -7.17 4.24 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 107.546 -2.222 . . . . 0.0 107.546 175.706 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.45 -47.13 6.54 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.859 -1.671 . . . . 0.0 110.229 178.443 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.535 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.07 28.2 0.83 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.75 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.25 40.36 0.25 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.641 -178.801 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.1 tp 58.54 36.75 25.38 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.218 -179.847 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 54.92 -83.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.703 -179.899 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 28.0 m80 -52.59 -63.7 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.717 -179.929 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.41 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.193 -179.874 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt . . . . . 0 N--CA 1.461 0.1 0 CA-C-O 121.008 0.433 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.93 -41.7 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.22 -179.704 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.599 ' C ' ' H ' ' A' ' 14' ' ' GLY . 31.2 mt -75.63 -89.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.379 -179.794 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.21 -5.62 3.45 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 107.631 -2.188 . . . . 0.0 107.631 175.673 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.599 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.84 -45.87 6.54 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 113.03 -1.585 . . . . 0.0 110.097 178.342 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -89.79 28.63 1.3 Allowed 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.813 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.28 46.27 0.23 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.54 -178.668 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.8 mt 64.28 11.66 6.56 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.202 -179.494 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.1 t70 58.45 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 -179.823 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 33.6 t-80 -160.16 32.05 0.17 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.618 179.997 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 N--CA 1.468 0.445 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.264 179.806 . . . . . . . . 0 0 . 1 . 092 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.0 tttt . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 120.552 0.215 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.423 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.6 mt -116.68 -47.52 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.545 -179.085 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 14' ' ' GLY . 70.4 mt -94.77 -98.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.728 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.3 -9.4 1.49 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 176.916 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.584 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.59 -48.65 5.48 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 113.105 -1.548 . . . . 0.0 109.857 177.859 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.93 29.88 0.61 Allowed 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.737 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.34 42.92 0.3 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.84 -178.85 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.5 tp 59.47 50.7 7.25 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.286 -179.809 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.7 t0 56.74 35.61 26.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.463 -179.874 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.2 m80 55.91 39.57 30.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.561 179.966 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.194 179.868 . . . . . . . . 0 0 . 1 . 093 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.9 mt -113.3 -48.92 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 120.759 0.314 . . . . 0.0 111.754 -179.094 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.601 ' C ' ' H ' ' A' ' 14' ' ' GLY . 59.8 mt -91.83 -99.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.473 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.82 -8.27 1.3 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 176.915 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.52 -47.91 5.81 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 113.113 -1.544 . . . . 0.0 109.617 177.931 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.55 30.03 0.43 Allowed 'General case' 0 C--N 1.343 0.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.479 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.54 36.68 0.6 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.673 -178.831 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 19' ' ' HIS . 1.1 tt 54.44 38.49 29.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.972 -179.732 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.5 t70 59.19 1.19 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.09 179.933 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.476 ' H ' ' C ' ' A' ' 17' ' ' LEU . 47.5 t-80 -172.28 -72.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.879 0.371 . . . . 0.0 110.541 179.923 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.278 -179.913 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 tptm . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 121.169 0.509 . . . . 0.0 109.789 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.3 mt -132.77 -39.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.501 -179.721 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.61 ' C ' ' H ' ' A' ' 14' ' ' GLY . 84.6 mt -75.49 -89.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.93 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.23 -4.56 3.73 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 175.334 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.78 -45.38 6.79 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 113.128 -1.536 . . . . 0.0 109.855 178.16 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -90.44 29.46 1.28 Allowed 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.573 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 70.08 46.94 0.6 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.221 -178.422 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.5 mt 63.81 12.79 6.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.021 -179.219 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 t0 56.63 46.25 20.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.691 -179.94 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.8 m170 50.15 49.83 19.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.617 179.99 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.519 -179.922 . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.466 0.174 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.9 mt -122.73 -44.22 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 120.859 0.361 . . . . 0.0 111.205 -179.113 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.583 ' C ' ' H ' ' A' ' 14' ' ' GLY . 67.6 mt -97.79 -97.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 -178.655 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.69 -7.35 2.15 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 176.884 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.79 -47.12 5.46 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 113.317 -1.442 . . . . 0.0 109.593 177.915 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.93 30.55 0.44 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.556 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.1 38.43 0.56 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.935 -178.99 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 50.37 29.85 4.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.981 -179.833 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.7 t70 55.1 -82.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.747 -179.903 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 19.4 t-80 -48.17 -66.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.696 -179.891 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.411 179.745 . . . . . . . . 0 0 . 1 . 096 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.869 0.366 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.4 mt -133.08 -50.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.167 -179.964 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.606 ' C ' ' H ' ' A' ' 14' ' ' GLY . 33.0 mm -76.62 -95.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.781 179.876 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.67 -9.53 1.21 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 176.313 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.77 -48.16 6.79 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 112.978 -1.611 . . . . 0.0 110.204 178.168 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.77 29.02 0.73 Allowed 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.753 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.77 38.73 0.25 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.882 -178.917 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 58.03 47.58 14.55 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.186 179.83 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.434 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 12.6 m-20 60.95 -76.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.74 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 17' ' ' LEU . 73.0 m80 -155.62 54.6 0.61 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.825 0.345 . . . . 0.0 110.465 -179.951 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 20' ' ' LEU . 7.4 mp . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.221 179.973 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.1 tttp . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.4 mt -123.18 -45.66 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 120.802 0.334 . . . . 0.0 111.166 -179.189 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.8 mt -92.62 -97.19 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.101 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.17 -7.44 1.86 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 176.219 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.49 -47.46 5.68 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 113.225 -1.487 . . . . 0.0 109.942 177.993 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.69 28.94 0.46 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.51 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.78 38.54 0.46 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.41 -178.699 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.6 tp 57.02 47.79 16.87 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.173 -179.688 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.6 t70 52.22 29.72 6.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.464 -179.964 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 52.06 55.9 8.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.508 -179.986 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.359 -179.985 . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 tttm . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 120.478 0.18 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.9 mt -117.75 -47.71 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.761 0.315 . . . . 0.0 111.355 -179.098 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.579 ' C ' ' H ' ' A' ' 14' ' ' GLY . 59.1 mt -95.48 -99.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.993 -178.547 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.88 -10.11 0.96 Allowed Glycine 0 C--N 1.345 1.034 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 177.128 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.79 -48.89 5.32 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 113.057 -1.571 . . . . 0.0 109.797 177.951 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.01 28.54 0.6 Allowed 'General case' 0 C--N 1.342 0.277 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.951 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.95 38.71 0.13 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.356 -179.343 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 51.82 31.25 7.97 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.174 179.77 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.0 t0 56.64 -79.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.831 -179.954 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 17' ' ' LEU . 17.0 m-70 -49.34 -67.12 0.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.74 179.935 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.173 179.988 . . . . . . . . 0 0 . 1 . 099 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.3 mttm . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 120.956 0.408 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.7 mt -137.65 -40.4 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.19 -179.56 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.634 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.2 mt -76.06 -89.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.928 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.04 -4.87 3.77 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 175.529 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.634 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.13 -45.55 6.56 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 113.02 -1.59 . . . . 0.0 110.144 178.365 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -90.62 29.34 1.32 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.832 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.64 46.9 0.26 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.425 -178.56 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.3 mt 65.11 13.48 8.73 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.389 0.431 . . . . 0.0 110.121 -179.393 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 t70 57.28 -78.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.041 179.761 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 17' ' ' LEU . 97.2 m-70 -50.26 -57.44 7.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.773 -179.801 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.173 179.974 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.1 tttp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.926 0.393 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.6 mt -139.44 -48.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.803 179.924 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.608 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.3 mm -77.58 -94.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.419 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.93 -8.97 1.59 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 176.24 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.608 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.17 -48.02 6.68 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 112.992 -1.604 . . . . 0.0 110.181 178.164 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.28 28.66 0.71 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.737 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.11 38.04 0.25 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.905 -179.019 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.4 tt 54.86 46.49 24.36 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.842 179.892 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 54.1 -84.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -179.754 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -162.28 50.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.524 179.876 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 20' ' ' LEU . 7.5 mp . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.251 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 45.5 p90 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.732 0.301 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.66 -70.43 0.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.123 0.487 . . . . 0.0 110.395 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -149.18 -17.19 0.29 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.6 ttm-85 -166.94 12.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.323 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.8 mt 60.05 112.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.189 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.98 50.31 18.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.734 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -63.94 -80.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.762 0.315 . . . . 0.0 110.639 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.17 131.63 20.42 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.904 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.61 -92.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.539 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -173.21 -17.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.931 0.396 . . . . 0.0 110.136 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 14.6 mt -136.28 -43.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.659 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.2 mt -92.29 -94.69 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.95 -5.97 2.51 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 108.131 -1.987 . . . . 0.0 108.131 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.48 -48.26 5.09 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 113.099 -1.551 . . . . 0.0 109.708 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.44 25.91 1.15 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.12 48.01 0.1 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.681 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.3 mt 60.93 29.28 18.92 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.104 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 53.7 61.69 2.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.436 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 49.19 45.75 23.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.697 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.569 HD12 ' N ' ' A' ' 20' ' ' LEU . 7.4 mp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.139 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.0 m0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.771 0.319 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 2' ' ' LEU . 10.3 mp -52.8 -87.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.142 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -151.73 -14.93 0.19 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.3 ttt85 -165.08 2.02 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.247 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 mt 55.7 55.67 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.189 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.43 22.97 0.02 OUTLIER Glycine 0 C--N 1.331 0.293 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -52.96 -53.64 46.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.322 . . . . 0.0 110.439 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 49.41 -136.59 21.73 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.17 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.8 t -148.25 -56.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 110.345 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 12' ' ' ILE . 81.7 tttt -163.73 -76.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.532 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' ALA . 15.8 pt -71.4 7.2 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.504 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.621 ' C ' ' H ' ' A' ' 14' ' ' GLY . 45.3 mm -71.41 -88.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.41 -3.94 3.4 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 107.479 -2.248 . . . . 0.0 107.479 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.0 -39.08 8.18 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 113.702 -1.249 . . . . 0.0 110.124 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -90.88 25.94 2.24 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.78 35.4 0.21 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.6 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 53.48 33.33 15.84 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.91 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.5 t0 56.54 -79.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' LEU . 46.5 m-70 -50.2 -63.68 1.04 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.657 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.069 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.425 ' CZ3' HD11 ' A' ' 5' ' ' ILE . 29.4 m95 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.791 0.329 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 38.4 mt -73.73 -78.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.676 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -144.0 -17.58 0.58 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -148.33 13.26 0.96 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.542 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.425 HD11 ' CZ3' ' A' ' 1' ' ' TRP . 15.1 mt 61.51 66.11 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.356 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.28 93.32 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.109 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -57.67 -166.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.725 0.297 . . . . 0.0 110.322 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.09 -128.69 1.61 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.189 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.478 ' C ' ' H ' ' A' ' 11' ' ' ILE . 15.7 t -65.0 -10.77 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.5 0.191 . . . . 0.0 110.549 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.3 tttt 72.85 -18.82 0.34 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.936 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.478 ' H ' ' C ' ' A' ' 9' ' ' VAL . 13.1 mt -117.84 -45.57 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.398 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 14' ' ' GLY . 68.2 mt -94.97 -97.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.13 -8.42 1.53 Allowed Glycine 0 C--N 1.344 1.01 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.2 -47.48 5.48 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 113.227 -1.486 . . . . 0.0 110.106 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.46 26.34 0.8 Allowed 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 80.3 39.84 0.08 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.105 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.4 tp 55.76 22.85 5.81 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.335 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 53.72 -85.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.707 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.9 m-70 -49.8 -39.47 38.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.554 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.451 HD23 ' C ' ' A' ' 20' ' ' LEU . 2.0 tt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.192 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.436 ' CD2' ' O ' ' A' ' 1' ' ' TRP . 44.7 p-90 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.814 0.34 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.9 tp -61.92 -79.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.238 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.407 ' H ' ' H ' ' A' ' 4' ' ' ARG . 73.3 ttt180 -150.57 -17.45 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 6' ' ' GLY . 59.1 mtp85 -147.52 3.27 0.75 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.525 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.1 mt 61.78 -76.95 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.46 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -81.5 44.11 3.02 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -63.44 148.19 49.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 0.0 110.667 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.2 -166.39 39.66 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.213 -0.518 . . . . 0.0 111.916 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.5 t -141.68 -87.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -171.39 -26.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.77 0.319 . . . . 0.0 110.834 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.7 mt -137.07 -45.86 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.218 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.596 ' C ' ' H ' ' A' ' 14' ' ' GLY . 66.3 mt -82.83 -93.97 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.64 -8.27 2.69 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 107.882 -2.087 . . . . 0.0 107.882 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.52 -48.06 6.49 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 113.099 -1.551 . . . . 0.0 109.946 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.89 30.05 0.77 Allowed 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.54 41.61 0.44 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.573 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.7 tt 66.39 53.57 0.98 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.82 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.9 t0 55.51 -81.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.909 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.506 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -150.34 39.24 0.73 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.559 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.434 179.887 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.537 ' C ' ' H ' ' A' ' 3' ' ' ARG . 8.1 m95 . . . . . 0 C--O 1.231 0.085 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.442 ' O ' ' CB ' ' A' ' 3' ' ' ARG . 24.0 mt 62.33 -5.81 0.17 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.384 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.537 ' H ' ' C ' ' A' ' 1' ' ' TRP . 37.3 ttt180 84.37 -50.97 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.124 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -167.21 52.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.186 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mt 48.2 69.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.709 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.59 -55.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.076 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.9 tttt 54.62 75.79 0.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.808 0.337 . . . . 0.0 110.413 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.78 136.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.03 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.441 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 31.5 m -154.86 21.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.795 0.331 . . . . 0.0 110.226 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.421 ' N ' ' CD ' ' A' ' 10' ' ' LYS . 3.5 mptp? -79.61 -12.15 59.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.867 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.39 -36.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.125 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.607 ' C ' ' H ' ' A' ' 14' ' ' GLY . 87.1 mt -77.3 -87.76 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.41 -4.95 5.64 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 107.199 -2.36 . . . . 0.0 107.199 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.91 -45.84 6.53 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 113.102 -1.549 . . . . 0.0 110.092 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.78 30.54 0.82 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 71.78 42.73 0.61 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.484 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 61.28 53.52 3.49 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.31 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.28 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.671 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 1.1 t60 -159.43 52.86 0.37 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 0.0 110.355 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.2 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.109 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 34.7 p-90 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.82 0.343 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 2' ' ' LEU . 7.9 mp -65.46 -78.53 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.134 0.493 . . . . 0.0 110.098 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -166.26 -20.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 7' ' ' LYS . 5.8 ptp180 -161.73 6.69 0.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.415 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.0 pt 34.41 35.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.733 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.93 46.32 67.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.146 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 4' ' ' ARG . 84.2 tttt -77.74 122.14 24.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 110.503 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.54 79.81 0.2 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.974 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.411 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 31.6 m -154.23 26.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.845 0.355 . . . . 0.0 110.381 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -78.57 -14.23 59.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.059 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.9 mt -140.32 -37.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.167 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.603 ' C ' ' H ' ' A' ' 14' ' ' GLY . 39.1 mm -75.57 -87.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.98 -5.24 5.31 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 107.217 -2.353 . . . . 0.0 107.217 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.51 -44.81 7.18 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 113.207 -1.496 . . . . 0.0 110.266 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.51 27.8 1.06 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.69 39.06 0.35 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.573 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 58.66 44.69 17.03 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.259 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 54.64 36.59 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.437 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.471 ' CG ' ' O ' ' A' ' 19' ' ' HIS . 13.4 t-80 51.04 46.47 26.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.606 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.477 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 1' ' ' TRP . 6.0 m95 . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.714 0.292 . . . . 0.0 110.486 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 26.5 mt -66.41 -72.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.031 0.443 . . . . 0.0 110.4 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.411 ' H ' ' H ' ' A' ' 4' ' ' ARG . 32.4 ttp180 -157.81 -13.84 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.411 ' H ' ' H ' ' A' ' 3' ' ' ARG . 75.6 mtm180 -148.39 6.01 0.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.898 -1.047 . . . . 0.0 109.356 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 mt 59.75 53.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.414 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 42.71 48.15 6.03 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.495 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -77.38 119.45 21.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.581 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.4 143.84 37.73 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.889 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.489 HG23 ' H ' ' A' ' 10' ' ' LYS . 1.5 m -65.86 -103.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.489 ' H ' HG23 ' A' ' 9' ' ' VAL . 81.9 tttt -151.48 -22.06 0.2 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.703 0.287 . . . . 0.0 110.558 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.4 mt -119.77 -54.89 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.191 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.7 mt -77.67 -95.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.691 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.34 -8.19 1.61 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.32 -48.2 6.09 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 112.835 -1.682 . . . . 0.0 110.102 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.98 28.66 1.01 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.67 46.98 0.18 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.63 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.7 mt 62.91 41.54 8.5 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 53.07 31.16 10.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.297 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 51.38 62.84 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.479 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.394 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 13.7 m95 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.772 0.32 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.42 ' C ' HD23 ' A' ' 2' ' ' LEU . 1.4 tt -164.16 -71.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.967 0.413 . . . . 0.0 110.338 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 39.2 ttt85 -173.41 -18.3 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 6' ' ' GLY . 59.1 mtt-85 -146.17 -5.3 0.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.218 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 mt 60.74 -76.84 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.84 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -54.86 -32.4 55.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.09 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.5 tttp 55.78 80.2 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.879 0.371 . . . . 0.0 110.55 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.95 -154.77 51.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.117 -0.563 . . . . 0.0 111.988 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.0 t -148.49 -81.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.618 0.247 . . . . 0.0 110.401 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.403 ' H ' ' H ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -169.4 -18.22 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.028 0.442 . . . . 0.0 109.845 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -118.85 -52.58 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.664 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.613 ' C ' ' H ' ' A' ' 14' ' ' GLY . 42.3 mm -73.84 -98.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.205 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.38 -10.71 0.6 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.24 -47.65 7.37 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 113.243 -1.479 . . . . 0.0 110.126 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.2 27.2 1.08 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.02 39.64 0.16 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.751 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 64.89 17.43 11.03 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.826 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.5 t70 55.35 -82.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.683 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 1.4 t-80 -54.39 -69.78 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.48 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 N--CA 1.464 0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.453 179.881 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.8 0.333 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.4 mt -63.86 -6.56 6.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.193 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 69.2 -65.8 0.28 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.167 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.17 -9.91 59.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.778 0.323 . . . . 0.0 110.625 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.6 mt 57.78 55.58 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.592 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.34 -28.3 0.38 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.168 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt 58.11 101.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.747 0.308 . . . . 0.0 110.278 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -51.13 126.26 26.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.015 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.487 HG23 ' H ' ' A' ' 10' ' ' LYS . 1.3 m -72.77 -102.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.487 ' H ' HG23 ' A' ' 9' ' ' VAL . 49.5 tttm -155.7 -22.19 0.11 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.834 0.35 . . . . 0.0 110.513 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.5 mt -117.5 -52.15 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 34.9 mm -85.76 -99.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.04 -11.15 0.54 Allowed Glycine 0 C--N 1.348 1.201 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.89 -49.88 5.83 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 113.12 -1.54 . . . . 0.0 109.875 177.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.544 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.86 29.33 0.63 Allowed 'General case' 0 C--N 1.345 0.395 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.82 37.79 0.15 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.478 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 52.49 36.76 21.13 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.213 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 53.51 -84.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.83 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 51.9 m80 -45.61 -63.39 0.97 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.083 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.495 ' O ' ' N ' ' A' ' 3' ' ' ARG . 96.2 m95 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.827 0.346 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 2' ' ' LEU . 3.4 mm? 50.38 -88.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.337 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 1' ' ' TRP . 12.0 tpp180 -171.14 -11.59 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.442 ' H ' ' H ' ' A' ' 5' ' ' ILE . 13.2 ptm180 -166.27 -5.15 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.14 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.442 ' H ' ' H ' ' A' ' 4' ' ' ARG . 12.8 mt -108.62 63.18 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.864 0.364 . . . . 0.0 110.444 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.83 2.98 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.5 pttm -163.85 -29.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.332 . . . . 0.0 110.397 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.02 56.26 3.94 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' C ' ' H ' ' A' ' 11' ' ' ILE . 21.3 t -65.54 -21.62 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.596 0.236 . . . . 0.0 110.596 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.4 tttm 72.53 -19.06 0.31 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.359 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.445 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.0 mt -113.81 -48.21 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.83 0.348 . . . . 0.0 111.481 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.563 ' C ' ' N ' ' A' ' 14' ' ' GLY . 41.4 mm -96.56 -101.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.046 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.425 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -50.11 -12.09 0.47 Allowed Glycine 0 C--N 1.345 1.077 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.563 ' N ' ' C ' ' A' ' 12' ' ' ILE . . . -82.19 -48.51 5.66 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 113.504 -1.348 . . . . 0.0 110.055 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.59 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.15 22.39 1.21 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 83.22 41.96 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.951 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.8 tp 61.71 6.45 1.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.252 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.0 t70 53.16 38.11 26.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.61 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 29.4 m170 50.03 55.42 9.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.631 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.227 -179.924 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 43.6 p-90 . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.847 0.356 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.594 ' N ' HD12 ' A' ' 2' ' ' LEU . 7.6 mp -72.53 -77.46 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.124 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.413 ' H ' ' H ' ' A' ' 4' ' ' ARG . 31.4 ttt-85 -146.37 -13.31 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.413 ' H ' ' H ' ' A' ' 3' ' ' ARG . 9.9 ptp180 -158.4 7.27 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.915 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.2 mt 56.58 51.71 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.332 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 45.32 45.89 11.04 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.114 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt 53.99 91.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 0.0 110.344 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 10' ' ' LYS . . . -61.01 -142.65 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.264 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 14' ' ' GLY . 33.6 t 58.11 -79.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.611 0.243 . . . . 0.0 110.683 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 8' ' ' GLY . 31.6 ttmt -44.89 -18.84 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.208 0.528 . . . . 0.0 110.627 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' VAL . 11.9 mt -112.54 -44.85 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.74 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.592 ' C ' ' H ' ' A' ' 14' ' ' GLY . 82.6 mt -73.65 -91.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.154 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.64 -8.61 2.05 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 176.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.23 -46.14 7.14 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 113.219 -1.491 . . . . 0.0 110.213 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.47 31.0 0.59 Allowed 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.16 37.68 0.74 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.684 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.7 tt 57.23 50.19 12.12 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 119.726 -0.789 . . . . 0.0 109.684 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 55.17 -82.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.665 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -163.62 51.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.502 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.578 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.837 0.351 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.6 mt -72.21 -8.39 54.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.151 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 73.45 -63.74 0.42 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.643 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.44 ' N ' ' CD ' ' A' ' 4' ' ' ARG . 11.6 mpt_? -54.58 -26.42 32.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.0 tt -53.97 -36.6 31.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.119 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -75.28 -21.79 77.18 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 6' ' ' GLY . 54.9 tttm 60.9 134.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.867 0.365 . . . . 0.0 110.631 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.04 92.8 0.28 Allowed Glycine 0 C--N 1.33 0.225 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.059 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.42 -92.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.412 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -172.49 -23.02 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.853 0.358 . . . . 0.0 110.453 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -127.98 -44.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.772 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 69.0 mt -89.94 -95.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.0 -7.6 2.52 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.87 -47.0 6.04 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 113.182 -1.509 . . . . 0.0 110.032 178.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.31 30.27 0.54 Allowed 'General case' 0 C--N 1.343 0.304 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.24 37.79 0.44 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.805 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 52.83 46.79 26.05 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.899 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 49.74 47.58 22.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.704 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 50.2 44.54 26.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.588 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 20' ' ' LEU . 8.4 mp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.089 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.508 ' C ' ' H ' ' A' ' 3' ' ' ARG . 7.6 m-90 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.672 0.272 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.446 ' O ' ' CB ' ' A' ' 3' ' ' ARG . 13.9 mt 63.31 -6.6 0.19 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.391 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.508 ' H ' ' C ' ' A' ' 1' ' ' TRP . 38.0 ttm-85 85.89 -73.46 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.491 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -89.91 6.5 41.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.762 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.2 mt 55.55 68.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.546 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 166.74 -16.9 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.179 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -76.82 84.91 3.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.985 0.421 . . . . 0.0 110.526 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.64 -145.48 4.21 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.902 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.2 t -73.21 -86.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.616 0.246 . . . . 0.0 110.446 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -172.06 -22.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.78 0.324 . . . . 0.0 110.244 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -134.31 -51.2 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.292 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 73.6 mt -77.05 -94.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.27 -8.38 2.47 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 176.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.95 -47.43 7.12 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 112.853 -1.673 . . . . 0.0 110.047 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.72 30.5 0.64 Allowed 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.15 37.94 0.58 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.634 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 19' ' ' HIS . 1.1 tt 57.22 38.49 28.82 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.848 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.4 t70 60.5 0.48 0.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.081 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.466 ' H ' ' C ' ' A' ' 17' ' ' LEU . 19.4 t-160 -173.43 -72.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.267 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.42 -179.846 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 2.5 m0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.776 0.322 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.1 tp -57.44 -81.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 110.253 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.47 ' NH2' ' NH2' ' A' ' 4' ' ' ARG . 32.7 ttt-85 -164.01 -16.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.47 ' NH2' ' NH2' ' A' ' 3' ' ' ARG . 65.3 mtt85 -151.29 -4.79 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.122 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mt 50.74 36.82 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.372 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.01 34.01 0.02 OUTLIER Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.027 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -58.79 127.37 31.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.797 0.332 . . . . 0.0 110.442 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -171.95 152.44 17.31 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.148 -0.548 . . . . 0.0 111.926 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.478 HG23 ' H ' ' A' ' 10' ' ' LYS . 1.6 m -64.71 -103.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.478 ' H ' HG23 ' A' ' 9' ' ' VAL . 44.5 tptt -160.71 -17.4 0.05 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.868 0.366 . . . . 0.0 110.12 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.9 mt -118.64 -48.66 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 14' ' ' GLY . 44.0 mm -91.86 -99.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.425 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.69 -10.67 0.7 Allowed Glycine 0 C--N 1.347 1.139 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 176.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.591 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.43 -49.03 5.66 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 113.223 -1.488 . . . . 0.0 109.886 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.555 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -83.79 27.4 0.64 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 79.68 38.2 0.11 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.229 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.99 31.39 10.92 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.094 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 49.76 53.82 12.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 52.32 57.88 5.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.646 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.573 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.5 mp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.225 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 121.058 0.456 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 5' ' ' ILE . 32.9 mt -134.77 -3.42 2.58 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.074 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -44.54 -21.1 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.534 0.683 . . . . 0.0 109.197 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.491 ' N ' ' C ' ' A' ' 2' ' ' LEU . 28.5 mmt180 -121.08 -13.11 8.61 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.49 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.532 ' H ' ' C ' ' A' ' 2' ' ' LEU . 10.0 mt 60.15 56.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.206 0 CA-C-O 121.079 0.466 . . . . 0.0 110.477 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 55.31 6.3 0.93 Allowed Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.863 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -72.36 -26.72 62.02 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.281 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.9 152.77 5.83 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.256 -0.497 . . . . 0.0 111.975 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.61 -80.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.69 0.281 . . . . 0.0 110.604 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -170.79 -23.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.764 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.5 mt -134.07 -47.28 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.223 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.1 mt -79.22 -92.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.99 -8.89 2.5 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 176.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.28 -48.5 6.37 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 112.923 -1.638 . . . . 0.0 110.27 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.68 28.65 0.86 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.74 41.25 0.18 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.876 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.6 tp 61.19 26.43 16.31 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.299 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 t0 58.31 -77.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.949 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.548 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER -48.58 -62.46 1.49 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.756 0.313 . . . . 0.0 110.824 -179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.514 -180.0 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.1 m0 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.753 0.311 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 18.9 tp -53.52 -81.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.163 0.506 . . . . 0.0 110.243 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -151.5 -10.37 0.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -175.47 7.53 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.278 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 6' ' ' GLY . 16.1 tt -56.09 -41.78 70.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.253 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.474 ' N ' HG23 ' A' ' 5' ' ' ILE . . . -79.39 13.35 22.12 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -172.96 47.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.749 0.309 . . . . 0.0 110.621 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . -72.03 147.33 41.12 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.787 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.403 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 28.9 m -76.55 32.54 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.714 0.293 . . . . 0.0 110.852 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 8' ' ' GLY . 28.1 mmtm -83.39 -11.65 57.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.12 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -139.9 -40.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.432 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.617 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.2 mt -76.46 -88.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.08 -5.78 4.79 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 107.271 -2.332 . . . . 0.0 107.271 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.617 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.34 -45.76 6.82 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 113.106 -1.547 . . . . 0.0 110.198 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.64 27.72 0.94 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.91 37.8 0.27 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.802 -178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.3 tp 58.66 27.15 15.44 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.402 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 55.33 -82.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 56.7 t-80 -49.45 -60.72 2.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.739 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.137 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 60.6 m95 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.8 mt -72.38 -5.76 38.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.515 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.416 ' C ' ' H ' ' A' ' 5' ' ' ILE . 21.0 mmm180 64.92 -76.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.693 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.2 mmm-85 -75.68 14.35 0.65 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.836 0.351 . . . . 0.0 110.549 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.416 ' H ' ' C ' ' A' ' 3' ' ' ARG . 12.1 mt 51.59 74.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.165 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 82.16 78.79 1.0 Allowed Glycine 0 C--N 1.331 0.303 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 6' ' ' GLY . 24.5 mtmm -60.31 -138.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.718 0.294 . . . . 0.0 110.694 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.93 -168.79 54.34 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.895 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 t -77.26 -66.77 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.878 0.37 . . . . 0.0 110.552 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -170.94 -58.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.505 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 15' ' ' ALA . 16.2 pt -78.3 6.54 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.681 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.9 mm -70.66 -89.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.22 -4.17 3.39 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 107.488 -2.245 . . . . 0.0 107.488 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.01 -38.99 8.81 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -93.91 27.5 2.74 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.54 38.52 0.38 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.552 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.4 tt 66.14 44.27 2.65 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.731 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 59.8 t0 55.29 35.35 24.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.493 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.3 m80 52.57 57.61 6.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.532 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.471 HD23 ' C ' ' A' ' 20' ' ' LEU . 2.4 tt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.1 p90 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.77 0.319 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.421 ' C ' ' H ' ' A' ' 4' ' ' ARG . 12.2 mt -73.6 -7.92 53.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.44 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 74.73 -38.1 0.37 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.418 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 2' ' ' LEU . 70.3 mtp180 -73.76 -38.46 64.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.01 0.433 . . . . 0.0 110.022 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 6' ' ' GLY . 16.8 tt -76.58 -35.53 26.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.222 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 5' ' ' ILE . . . -64.19 -24.87 69.23 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.191 -0.528 . . . . 0.0 111.908 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -52.41 -27.59 16.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.383 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.25 130.19 0.2 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.019 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.8 t -69.29 -84.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.672 0.272 . . . . 0.0 110.448 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -171.18 -23.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.623 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 15.3 mt -131.07 -46.99 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.366 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.603 ' C ' ' H ' ' A' ' 14' ' ' GLY . 28.3 mt -81.99 -94.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.425 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -56.12 -7.38 1.79 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.24 -48.16 5.8 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.013 -1.593 . . . . 0.0 110.133 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -89.69 29.94 1.1 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.26 48.09 0.13 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.785 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.4 mt 64.08 49.83 2.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.14 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.8 t0 59.63 -76.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.746 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -162.45 26.95 0.11 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.729 0.299 . . . . 0.0 110.482 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.08 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.75 0.31 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.8 mt -66.23 -7.3 17.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.17 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 25.2 ttt85 69.56 -70.05 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.763 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 -67.45 -12.58 60.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.378 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.8 pt 34.24 49.42 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.63 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 8' ' ' GLY . . . -160.39 -30.21 0.02 OUTLIER Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.27 -0.491 . . . . 0.0 111.971 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -76.62 39.99 0.22 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.807 0.337 . . . . 0.0 110.641 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 6' ' ' GLY . . . -167.68 118.31 0.78 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.0 t -70.03 -93.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.486 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -171.72 -23.65 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -129.3 -44.43 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.095 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 73.7 mt -90.75 -94.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.22 -6.98 3.47 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.45 -47.57 5.65 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 113.062 -1.569 . . . . 0.0 110.121 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.87 27.21 0.77 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.22 40.4 0.13 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.863 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.5 tp 56.56 23.2 7.37 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.248 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 57.48 11.62 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.184 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -171.3 -44.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.764 0.316 . . . . 0.0 110.648 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.405 ' H ' ' HB3' ' A' ' 17' ' ' LEU . 1.2 tt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.126 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 38.1 p90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.682 0.277 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 18.7 mt -68.59 -73.66 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.456 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -144.45 -14.39 0.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -172.7 19.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.172 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mt 61.19 95.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.218 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.58 54.65 7.33 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.124 -0.56 . . . . 0.0 111.887 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -49.06 -23.02 1.03 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 110.557 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.34 -156.73 23.83 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.193 -0.527 . . . . 0.0 111.917 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.9 t -145.98 -85.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -171.43 -23.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.853 0.359 . . . . 0.0 110.588 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.4 mt -139.6 -42.9 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.356 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.7 mt -86.84 -91.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.33 -6.62 4.55 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.4 -47.63 5.97 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 112.909 -1.645 . . . . 0.0 109.892 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.51 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.84 25.88 0.89 Allowed 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.78 43.15 0.18 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.576 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 69.51 51.69 0.47 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.377 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.6 t70 60.61 -76.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.591 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.478 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -160.77 50.85 0.27 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 0.0 110.397 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.143 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 1.1 m0 . . . . . 0 N--CA 1.46 0.064 0 CA-C-O 121.015 0.436 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 5' ' ' ILE . 37.5 mt -134.97 -3.07 2.53 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.045 178.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.9 ttt-85 -46.53 -17.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.504 ' N ' ' C ' ' A' ' 2' ' ' LEU . 70.8 mtp85 -131.22 -4.66 3.86 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.77 178.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.517 ' H ' ' C ' ' A' ' 2' ' ' LEU . 14.2 mt 59.89 89.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.224 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.386 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 173.61 -37.35 0.13 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 6' ' ' GLY . 81.0 tttt 58.83 152.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 110.712 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 70.62 170.3 9.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.076 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 11' ' ' ILE . 2.2 t -74.82 10.32 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.867 0.365 . . . . 0.0 110.179 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 8' ' ' GLY . 43.9 mttp 66.07 -13.53 0.16 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.513 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.514 ' H ' ' C ' ' A' ' 9' ' ' VAL . 11.4 mt -129.29 -43.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.775 0.321 . . . . 0.0 110.88 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.3 mt -94.69 -94.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.09 -7.19 3.52 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 176.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.07 -47.44 5.53 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 113.131 -1.534 . . . . 0.0 109.86 178.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -83.92 27.67 0.64 Allowed 'General case' 0 C--N 1.341 0.23 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.75 39.59 0.17 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.004 -179.072 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.2 tt 52.19 39.33 26.66 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.96 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.3 t70 54.57 -83.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.591 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' LEU . 23.9 m80 -52.57 -65.83 0.49 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.632 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.207 -179.936 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 12.6 m-90 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.837 0.351 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.2 tp -168.63 -83.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.082 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -152.4 -26.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' ILE . 32.7 mmt180 -132.44 -0.48 3.6 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.282 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 4' ' ' ARG . 13.1 mt 60.73 124.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.413 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.72 31.5 60.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.973 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.1 mttt 54.9 175.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.0 110.531 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.16 110.11 0.23 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.935 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.5 t -78.97 -83.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.617 0.246 . . . . 0.0 110.732 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -170.42 -26.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.912 0.386 . . . . 0.0 110.591 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -133.57 -45.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.358 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.58 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.9 mt -77.26 -91.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.13 -7.53 3.87 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 175.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.58 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.2 -47.16 6.63 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 112.895 -1.653 . . . . 0.0 110.159 178.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.35 30.74 0.68 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.6 40.07 0.52 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.73 -178.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 58.94 51.9 6.9 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.143 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 65.72 -74.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.862 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -158.03 38.4 0.26 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.795 0.331 . . . . 0.0 110.521 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.412 -179.986 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.87 0.367 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 2.0 mm? -73.86 -90.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.996 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -135.46 -11.67 2.12 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.867 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -148.05 9.29 0.87 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.076 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.0 mt 60.16 103.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.452 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 53.54 43.22 67.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.105 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 6' ' ' GLY . 21.7 pttp 37.57 -160.78 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.599 0.238 . . . . 0.0 111.566 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.3 152.45 51.29 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.076 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.4 t -74.78 -87.25 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -171.03 -23.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.764 0.316 . . . . 0.0 110.784 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.7 mp -119.86 -48.18 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.374 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.57 ' C ' ' N ' ' A' ' 14' ' ' GLY . 42.4 mm -91.45 -98.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.66 -179.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.0 -11.95 0.65 Allowed Glycine 0 C--N 1.346 1.11 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 176.485 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.57 ' N ' ' C ' ' A' ' 12' ' ' ILE . . . -79.89 -50.41 5.57 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 113.309 -1.445 . . . . 0.0 109.997 177.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.02 27.94 0.74 Allowed 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.08 44.68 0.13 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.771 -178.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.1 tp 66.75 11.3 8.14 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.19 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.9 t70 58.71 -77.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.5 t60 -77.87 13.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.722 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.8 mp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.064 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.512 ' C ' ' H ' ' A' ' 3' ' ' ARG . 8.5 m-90 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.661 0.267 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 4' ' ' ARG . 14.3 mt 64.4 -8.38 0.2 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.425 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.512 ' H ' ' C ' ' A' ' 1' ' ' TRP . 49.0 mtp180 63.52 -13.85 0.08 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.494 ' H ' ' C ' ' A' ' 2' ' ' LEU . 47.8 ttm-85 -157.38 31.37 0.28 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.978 0.418 . . . . 0.0 110.343 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.2 mm 44.16 69.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.449 ' H ' ' CB ' ' A' ' 2' ' ' LEU . . . 60.74 77.59 0.18 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.911 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -51.27 141.3 15.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 110.57 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.56 169.91 35.73 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.254 -0.498 . . . . 0.0 111.868 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.62 -85.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.701 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -171.63 -25.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.784 0.326 . . . . 0.0 110.615 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 mt -139.12 -44.24 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.12 -179.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 7.7 mm -86.13 -93.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.19 -7.05 3.5 Favored Glycine 0 C--N 1.342 0.908 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 176.027 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.89 -47.97 6.0 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 113.006 -1.597 . . . . 0.0 110.031 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.74 29.77 0.69 Allowed 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.77 40.75 0.36 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.86 -178.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 58.36 20.91 7.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.695 -179.801 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.2 t0 56.95 -78.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.948 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.553 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 1.5 m-70 -46.83 -59.52 3.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.989 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.198 -179.919 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.433 ' C ' ' H ' ' A' ' 3' ' ' ARG . 4.2 m-90 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.68 0.276 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.49 ' CD2' ' H ' ' A' ' 7' ' ' LYS . 5.4 tp -52.17 -12.35 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.283 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 1' ' ' TRP . 21.4 ttm180 75.78 -42.98 0.47 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.68 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -86.8 -3.56 59.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.81 0.338 . . . . 0.0 110.449 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mt 53.05 67.84 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.364 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.68 72.93 1.02 Allowed Glycine 0 C--N 1.331 0.255 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.125 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.49 ' H ' ' CD2' ' A' ' 2' ' ' LEU . 51.1 tttm -51.72 -81.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.755 0.312 . . . . 0.0 110.531 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.04 146.7 40.11 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.983 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.12 -86.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.52 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -170.95 -24.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.86 0.362 . . . . 0.0 110.188 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.62 -46.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.19 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 14' ' ' GLY . 30.9 mt -78.3 -92.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.92 -8.72 2.34 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 175.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.54 -48.24 6.39 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 113.001 -1.599 . . . . 0.0 110.283 178.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.74 27.78 1.1 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.51 43.83 0.13 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.82 -178.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 65.62 17.53 10.93 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.447 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 58.53 -77.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.929 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 10.7 m-70 -52.97 -65.08 0.62 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.837 0.351 . . . . 0.0 110.604 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.175 -179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.836 0.35 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 tp -72.07 -4.34 28.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.135 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 79.87 -15.65 0.74 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.326 -179.654 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -157.32 29.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.553 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.3 tt -60.44 -34.47 58.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.314 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.56 15.64 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -64.0 89.36 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.32 . . . . 0.0 110.558 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.53 124.88 9.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.028 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.76 -85.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.639 0.257 . . . . 0.0 110.419 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -171.1 -24.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.575 -179.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.5 mt -132.59 -50.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.325 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 33.5 mm -78.41 -94.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.34 -9.33 1.48 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 176.204 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.09 -48.63 6.38 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 112.959 -1.62 . . . . 0.0 110.229 178.151 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.96 27.96 0.73 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.783 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.53 37.95 0.17 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.014 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.1 tp 57.18 11.64 1.11 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.246 179.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER 58.58 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.92 -179.986 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 17' ' ' LEU . 57.8 t-80 -50.62 -44.4 57.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.838 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.4 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.12 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.522 ' C ' ' H ' ' A' ' 3' ' ' ARG . 94.1 m95 . . . . . 0 C--O 1.23 0.068 0 N-CA-C 110.583 -0.154 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 23.2 mt 62.29 -5.66 0.17 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.363 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 1' ' ' TRP . 37.3 mtt85 65.42 -74.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.699 -179.713 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 6' ' ' GLY . 98.9 mtt180 -71.96 11.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.808 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.447 ' H ' ' C ' ' A' ' 3' ' ' ARG . 35.3 pt 35.24 28.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.89 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . 153.19 61.71 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -51.19 94.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.933 0.397 . . . . 0.0 110.366 -179.848 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.69 -162.33 33.16 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.083 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.3 t -76.68 -82.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.682 0.277 . . . . 0.0 110.68 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -170.92 -26.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.761 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.0 mt -124.04 -54.21 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.364 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.4 mm -75.06 -98.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.021 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.409 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -50.97 -11.63 0.59 Allowed Glycine 0 C--N 1.347 1.178 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 176.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.591 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -77.82 -48.92 7.45 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 113.048 -1.576 . . . . 0.0 109.966 178.049 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.34 28.34 0.85 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.704 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.66 39.35 0.24 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.813 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 62.41 25.37 15.13 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.78 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.3 t70 58.01 -78.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' LEU . 16.2 m80 -51.04 -65.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.606 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.233 179.988 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.77 0.319 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 4' ' ' ARG . 27.6 mt -71.91 -6.0 38.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.324 179.696 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 64.35 -73.06 0.06 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.1 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 2' ' ' LEU . 65.3 mtp180 -72.31 5.18 3.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.915 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mt 45.64 77.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.749 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 166.4 -37.7 0.25 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.104 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -168.63 149.68 4.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.831 0.348 . . . . 0.0 110.653 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.93 172.01 41.94 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.915 179.936 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -147.34 -99.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.846 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' H ' HG23 ' A' ' 9' ' ' VAL . 49.9 tttp -167.7 -20.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.99 0.424 . . . . 0.0 110.482 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.1 mt -111.44 -48.46 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.524 -179.131 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 14' ' ' GLY . 40.7 mm -96.16 -101.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.093 -178.62 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.95 -12.08 0.43 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 177.04 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.47 -48.59 5.54 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 113.507 -1.347 . . . . 0.0 110.082 177.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -83.08 23.37 0.86 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.002 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 83.94 39.41 0.03 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.196 -179.336 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.4 tp 54.91 18.04 2.05 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.268 179.757 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 52.67 20.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.119 -179.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.7 m170 57.83 64.12 1.62 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.503 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.336 -179.952 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 1' ' ' TRP . 32.1 p90 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.852 0.358 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.3 mt -79.28 -72.16 0.41 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.529 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.51 -22.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.735 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -130.31 -1.15 4.51 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.608 179.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.8 mt 60.14 93.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.389 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 59.84 67.7 2.03 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.988 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -66.83 173.92 3.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.627 0.251 . . . . 0.0 110.401 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -173.28 -144.42 4.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.22 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -61.89 -89.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.762 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -172.14 -25.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.716 0.293 . . . . 0.0 110.612 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.3 mt -112.42 -51.08 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.327 -179.169 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 14' ' ' GLY . 38.8 mm -89.73 -100.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.177 -179.036 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.406 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -50.63 -11.59 0.52 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 176.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.13 -49.65 5.85 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 113.294 -1.453 . . . . 0.0 109.946 177.737 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.26 28.2 0.74 Allowed 'General case' 0 C--N 1.345 0.41 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.747 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.18 41.77 0.15 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.047 -179.1 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 19' ' ' HIS . 4.1 tp 62.3 10.41 3.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.446 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.489 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 33.0 t70 57.63 5.05 0.29 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 55.7 m80 -157.49 -13.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 109.836 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.43 ' H ' ' H ' ' A' ' 19' ' ' HIS . 18.8 tp . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.313 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 78.3 m95 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.817 0.341 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.609 HD12 ' H ' ' A' ' 2' ' ' LEU . 6.4 mp -63.63 -9.32 13.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.187 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 71.7 -66.31 0.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.764 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.3 ttt85 -74.12 -8.62 56.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.891 0.377 . . . . 0.0 110.276 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt 59.16 61.38 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.382 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.43 -70.33 0.17 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.98 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.451 ' NZ ' ' CB ' ' A' ' 7' ' ' LYS . 6.1 ttpm? -92.28 122.09 34.41 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.764 0.316 . . . . 0.0 110.506 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.72 -63.84 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.888 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 29.0 m -154.48 24.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.807 0.337 . . . . 0.0 110.464 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -74.78 -21.17 59.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.094 179.751 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.7 mt -134.42 -35.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.375 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.602 ' C ' ' H ' ' A' ' 14' ' ' GLY . 82.0 mt -74.83 -88.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.07 -4.72 4.85 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 107.171 -2.372 . . . . 0.0 107.171 175.407 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.15 -43.62 7.44 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 113.28 -1.46 . . . . 0.0 110.14 178.483 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.36 27.86 1.18 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.884 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.26 37.9 0.34 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.614 -178.722 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 55.21 48.67 18.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.898 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 48.62 29.94 2.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.746 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.2 m80 53.18 59.43 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.583 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.069 179.901 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.752 0.311 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 4' ' ' ARG . 12.7 mt -72.29 -9.75 58.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.576 -179.876 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 68.44 -28.8 0.16 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.607 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 2' ' ' LEU . 77.1 mtm-85 -90.0 -14.06 34.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.719 0.295 . . . . 0.0 110.428 -179.974 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.6 mp 52.72 97.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.849 -179.941 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.24 23.79 73.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.215 -0.516 . . . . 0.0 112.062 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 tptp 60.5 152.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.688 0.28 . . . . 0.0 110.299 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -165.58 176.52 41.1 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.082 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.1 t -69.12 -80.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 121.101 -0.239 . . . . 0.0 110.479 179.975 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -172.52 -25.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.868 0.366 . . . . 0.0 110.504 179.832 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.409 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -135.93 -46.38 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.268 -179.783 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.4 mt -76.48 -92.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.69 -8.04 3.76 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 175.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.07 -46.67 7.51 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 112.907 -1.646 . . . . 0.0 110.224 178.324 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.68 29.43 0.79 Allowed 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.526 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.98 41.22 0.51 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.222 -178.448 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 63.15 51.94 2.63 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.05 -179.688 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 t0 59.8 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.579 -179.867 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -167.46 53.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.492 179.884 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.132 179.965 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.483 ' O ' ' N ' ' A' ' 3' ' ' ARG . 60.8 t-105 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.732 0.301 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.448 ' N ' ' CG ' ' A' ' 1' ' ' TRP . 7.9 mt 53.25 -89.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.099 0.476 . . . . 0.0 109.886 -179.516 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 1' ' ' TRP . 31.8 ttm180 -172.91 -23.17 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.078 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -148.45 -2.45 0.5 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.506 179.566 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.5 mt 55.53 74.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.511 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.59 46.59 83.73 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.232 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt 48.69 -94.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.865 0.364 . . . . 0.0 110.762 179.865 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.46 170.89 44.07 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -179.946 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.81 -86.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.532 -179.849 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -171.34 -29.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.428 -179.95 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.1 mt -135.47 -47.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.9 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 14' ' ' GLY . 47.5 mm -76.7 -94.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.471 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.408 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -54.3 -9.49 1.53 Allowed Glycine 0 C--N 1.346 1.118 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 176.127 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.02 -47.79 6.89 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 113.175 -1.513 . . . . 0.0 110.203 178.253 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.93 28.75 1.0 Allowed 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.819 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.25 42.03 0.19 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.827 -178.954 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.2 tp 63.67 30.16 14.87 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.337 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.0 t0 56.36 -80.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.742 -179.989 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 74.5 m80 -49.29 -65.75 0.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.888 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.444 ' C ' ' H ' ' A' ' 3' ' ' ARG . 1.2 p90 . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 121.043 0.449 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.2 tp 68.94 -6.03 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.523 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 1' ' ' TRP . 23.7 ttm180 75.11 -61.54 0.48 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.791 179.916 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.9 mtp85 -72.84 0.72 10.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.675 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.5 mt 52.78 63.23 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.339 179.997 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 52.86 24.35 19.09 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.034 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.4 tttp 52.89 94.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.768 0.318 . . . . 0.0 110.516 179.932 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.29 -162.09 51.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.941 179.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.6 t -76.42 -83.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.623 0.249 . . . . 0.0 110.683 -179.927 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -171.81 -19.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.913 0.387 . . . . 0.0 110.346 -179.895 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 21.5 mt -138.41 -45.5 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.62 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.8 mt -77.93 -92.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.68 -5.92 3.14 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 107.819 -2.113 . . . . 0.0 107.819 175.718 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.62 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.65 -47.57 5.9 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 112.893 -1.654 . . . . 0.0 110.172 178.261 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.34 29.21 0.99 Allowed 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.683 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.21 47.62 0.19 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.382 -178.652 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.1 mt 64.19 39.86 7.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.082 -179.391 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.1 t70 51.72 42.1 29.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.658 179.918 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.0 m170 50.62 36.76 14.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.643 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.6 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.17 -179.985 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.82 0.343 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 23.8 mt -74.13 -11.01 60.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.378 179.937 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 72.11 -41.89 0.52 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.806 0.691 . . . . 0.0 111.26 179.792 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -83.81 -9.59 58.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.893 0.377 . . . . 0.0 110.4 -179.928 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.4 mt 59.29 64.43 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.297 179.911 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.25 -71.6 0.12 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.909 179.954 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -146.22 -144.86 0.16 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.971 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.97 -179.37 32.81 Favored Glycine 0 C--N 1.332 0.332 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.983 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.0 t -68.3 -100.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.352 -179.842 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -155.74 -33.59 0.09 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.768 0.318 . . . . 0.0 110.258 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.3 mt -129.95 -48.13 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.255 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.61 ' C ' ' H ' ' A' ' 14' ' ' GLY . 22.0 mt -76.25 -93.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.859 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.66 -8.79 2.15 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 176.286 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.22 -47.42 6.99 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 112.873 -1.663 . . . . 0.0 110.167 178.276 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.41 27.96 0.89 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.834 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.43 38.95 0.2 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.892 -178.893 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.5 tt 57.29 45.38 20.35 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.854 179.92 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 50.46 31.51 5.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.73 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.5 t60 51.41 60.4 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.696 179.845 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.5 tp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.264 179.87 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 34.0 p90 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.748 0.308 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.5 mt -73.63 -72.62 0.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.576 -179.897 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.5 ttt85 -155.74 -10.18 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.841 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.0 ttt85 -158.91 -0.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.44 179.641 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.7 tp 36.73 94.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.596 0.712 . . . . 0.0 111.043 -179.923 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.33 -25.8 0.26 Allowed Glycine 0 C--N 1.33 0.23 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.615 -179.752 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -169.48 177.02 4.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.74 0.305 . . . . 0.0 110.394 179.981 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.86 -124.12 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.065 -179.93 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.5 t -71.75 -91.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.56 -179.829 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -172.15 -26.76 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.763 0.316 . . . . 0.0 110.694 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.4 mt -131.45 -46.91 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.386 -179.556 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.601 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.1 mm -87.12 -95.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.865 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.84 -8.84 1.51 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 176.218 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.61 -49.34 5.48 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 113.063 -1.569 . . . . 0.0 110.087 178.082 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.94 26.57 1.13 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.754 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.65 47.84 0.07 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.736 -178.946 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.6 mt 62.61 11.37 4.73 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.484 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.6 t0 55.87 53.83 8.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.48 -179.592 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 55.32 55.93 6.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.674 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.2 mp . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.343 179.916 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 2.6 m0 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.853 0.358 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.46 HD23 ' C ' ' A' ' 2' ' ' LEU . 2.3 tt -66.1 -70.16 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.188 -179.877 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -173.26 -23.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.999 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -153.45 7.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.961 179.304 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm 60.24 110.87 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.482 -179.913 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.91 52.55 40.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.111 179.924 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -65.94 152.42 44.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.31 . . . . 0.0 110.359 179.91 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.81 -148.11 50.2 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.855 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.91 -87.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.514 179.907 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -171.51 -25.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.939 0.4 . . . . 0.0 110.428 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 7.1 mm -132.14 -46.27 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.018 -179.943 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 14' ' ' GLY . 72.2 mt -77.16 -92.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.47 -7.63 3.13 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 176.04 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.02 -47.24 6.66 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 112.9 -1.65 . . . . 0.0 110.258 178.235 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.49 28.74 0.83 Allowed 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.663 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.68 40.4 0.3 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.691 -178.749 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 60.08 49.36 7.57 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.282 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 58.72 -77.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.843 -179.883 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' LEU . 13.0 t-80 -159.36 56.92 0.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.779 0.323 . . . . 0.0 110.39 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.495 179.951 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 51.0 m95 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.758 0.313 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.83 -70.75 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.102 0.477 . . . . 0.0 110.336 179.846 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.441 ' H ' ' H ' ' A' ' 4' ' ' ARG . 35.7 ttm180 -158.67 -22.34 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.579 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 6' ' ' GLY . 96.9 mtt180 -150.65 4.92 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.373 179.425 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.415 ' O ' ' CG1' ' A' ' 5' ' ' ILE . 5.1 tt 41.25 19.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.212 -179.669 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 8' ' ' GLY . . . -73.54 -48.63 17.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.094 -0.574 . . . . 0.0 111.73 179.601 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.7 tptt 55.19 -81.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.61 0.243 . . . . 0.0 110.568 179.848 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . 60.27 -160.17 22.99 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.865 -179.925 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.6 t -76.12 -84.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.597 0.236 . . . . 0.0 110.581 -179.988 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -171.37 -24.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.341 . . . . 0.0 110.465 -179.968 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.3 mt -132.92 -50.01 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.163 -179.832 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 60.9 mt -76.52 -95.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.827 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.69 -9.66 1.82 Allowed Glycine 0 C--N 1.346 1.1 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 176.419 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.81 -47.92 7.47 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 112.9 -1.65 . . . . 0.0 110.116 178.098 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.63 28.97 0.82 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.717 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.82 40.19 0.38 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.486 -178.661 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 63.93 49.77 2.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.757 -179.708 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.3 t0 59.23 -77.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.74 -179.782 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 17' ' ' LEU . 13.9 p-80 -159.26 44.03 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.821 0.344 . . . . 0.0 110.362 179.922 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.509 -179.912 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.452 ' O ' ' CE3' ' A' ' 1' ' ' TRP . 69.1 p-90 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.856 0.36 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 2' ' ' LEU . 9.7 mp -65.3 -84.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.206 0.527 . . . . 0.0 110.105 179.902 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -168.67 -17.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.787 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -148.43 -1.74 0.53 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.33 179.446 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.7 mm 57.69 68.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.469 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.88 -4.19 0.06 OUTLIER Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.245 -0.503 . . . . 0.0 111.968 179.819 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm 50.78 72.12 0.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.815 0.34 . . . . 0.0 110.319 -179.877 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -50.08 113.77 2.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.15 -0.547 . . . . 0.0 112.044 -179.878 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.8 t -76.04 -83.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.59 0.234 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -170.88 -24.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.717 -179.996 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 3.7 mp -120.85 -59.8 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.667 -179.816 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.0 mt -76.13 -98.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.265 -179.331 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.34 -11.44 0.71 Allowed Glycine 0 C--N 1.347 1.186 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 176.993 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.09 -48.73 7.41 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.875 -1.662 . . . . 0.0 110.003 178.006 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.55 29.9 0.75 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.604 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.85 39.82 0.4 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.728 -178.879 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.5 tt 63.64 47.86 3.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.783 -179.896 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 54.04 -84.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.657 -179.822 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' LEU . 15.1 t-160 -161.17 50.71 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.459 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 20' ' ' LEU . 9.7 mp . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.154 -180.0 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 5.2 m0 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.899 0.38 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.1 mt -67.94 -6.01 19.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.168 179.617 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 76.88 -59.97 0.47 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.62 -179.906 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -85.09 -14.77 46.12 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.847 0.356 . . . . 0.0 110.412 179.972 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 mt 50.18 63.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.406 179.93 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.2 -12.18 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.174 -179.898 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -161.44 137.38 7.98 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.862 0.363 . . . . 0.0 110.877 -179.918 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.31 120.18 0.59 Allowed Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.896 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.841 HG13 ' H ' ' A' ' 10' ' ' LYS . 7.3 p -80.36 -67.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.952 -179.554 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.841 ' H ' HG13 ' A' ' 9' ' ' VAL . 56.3 tttm -178.14 -35.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.671 0.272 . . . . 0.0 110.404 179.93 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.423 ' H ' HG13 ' A' ' 9' ' ' VAL . 13.7 mt -120.66 -52.43 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.221 -178.847 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.4 mm -74.32 -97.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.229 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.77 -10.49 0.69 Allowed Glycine 0 C--N 1.346 1.104 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 176.711 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.8 -47.84 7.52 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 113.218 -1.491 . . . . 0.0 110.02 178.183 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.55 31.54 0.83 Allowed 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.716 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.71 41.93 0.52 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.69 -178.75 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.2 tp 65.12 53.61 1.33 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.103 -179.721 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.0 t0 62.73 -75.49 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.844 -179.821 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.421 ' N ' ' O ' ' A' ' 17' ' ' LEU . 2.7 t60 -152.74 42.13 0.61 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.794 0.33 . . . . 0.0 110.369 -179.892 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.9 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.496 179.954 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.456 ' CD1' ' O ' ' A' ' 1' ' ' TRP . 23.7 p90 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.761 0.315 . . . . 0.0 110.51 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.8 mt -74.08 -72.13 0.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.674 -179.932 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.596 ' HE ' HH12 ' A' ' 4' ' ' ARG . 39.7 ttp180 -154.31 -13.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 179.849 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.596 HH12 ' HE ' ' A' ' 3' ' ' ARG . 30.0 mtt85 -148.24 2.37 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.671 179.634 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 mt 57.27 50.21 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.369 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 47.3 31.15 6.23 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.583 179.807 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 4' ' ' ARG . 54.0 mmtt -81.99 43.56 0.79 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.656 0.265 . . . . 0.0 110.412 179.824 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.405 ' N ' ' HZ2' ' A' ' 10' ' ' LYS . . . -176.71 -158.99 21.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.408 179.937 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.4 m 35.6 49.73 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.829 0.347 . . . . 0.0 111.912 -179.933 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HZ2' ' N ' ' A' ' 8' ' ' GLY . 57.0 mttp -92.61 -16.3 25.79 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.307 179.563 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.8 mt -129.11 -46.04 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.647 -179.609 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.614 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.2 mt -74.89 -92.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.659 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.08 -6.69 3.11 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 176.029 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.65 -45.33 7.35 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 113.082 -1.559 . . . . 0.0 110.139 178.327 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.77 29.9 0.77 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.573 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.03 37.46 0.63 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.513 -178.578 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.4 tt 58.24 47.32 14.4 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.878 -179.933 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.486 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 71.0 m-20 54.03 -83.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -179.991 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 17' ' ' LEU . 96.3 m-70 -158.21 52.11 0.43 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.366 179.974 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 2.3 mm? . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.081 -179.924 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.742 0.306 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 2.5 mm? -73.94 -85.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.037 0.446 . . . . 0.0 109.831 179.849 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -157.56 -16.93 0.08 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.718 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -150.17 0.98 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.448 179.487 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.0 mt 53.19 71.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.409 179.983 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.11 -55.75 0.23 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 121.217 -0.516 . . . . 0.0 111.965 179.911 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -63.96 134.14 54.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.78 0.324 . . . . 0.0 110.531 -179.949 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.13 172.26 0.14 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.124 -0.56 . . . . 0.0 111.983 179.98 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 11' ' ' ILE . 39.0 t -148.48 -21.74 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.95 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.7 tttm 72.11 -18.85 0.3 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.228 -179.985 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.461 ' H ' ' C ' ' A' ' 9' ' ' VAL . 11.7 mt -116.9 -46.59 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.789 0.328 . . . . 0.0 111.573 -179.119 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 63.1 mt -95.78 -97.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.069 -178.564 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.35 -8.29 1.66 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 176.854 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.9 -48.02 5.35 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 113.155 -1.522 . . . . 0.0 109.808 177.999 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -81.11 27.06 0.41 Allowed 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.604 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.17 36.45 0.23 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.758 -179.042 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 51.3 32.14 7.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.265 -179.824 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 51.15 10.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.134 179.837 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.443 ' H ' ' C ' ' A' ' 17' ' ' LEU . 20.9 t-160 -168.3 -41.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.611 179.929 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 16' ' ' ALA . 2.8 pp . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.584 -179.97 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 96.7 m95 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.865 0.364 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 4' ' ' ARG . 12.9 mt -72.99 -13.0 61.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.43 -179.985 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 69.68 -30.36 0.19 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.313 -179.891 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.49 ' H ' ' C ' ' A' ' 2' ' ' LEU . 69.1 mtt85 -84.4 -25.53 29.0 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.837 0.351 . . . . 0.0 110.214 179.614 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mt 60.12 84.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.552 -179.994 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 50.64 46.55 47.06 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.227 179.881 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt 48.59 -129.64 1.86 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.545 0.212 . . . . 0.0 110.523 179.937 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.66 -158.02 30.38 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.905 179.915 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.56 ' CG2' ' H ' ' A' ' 12' ' ' ILE . 15.4 m -76.79 15.68 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.713 -179.914 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.9 tttt 73.27 -20.84 0.27 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.101 179.035 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.514 ' H ' HG23 ' A' ' 9' ' ' VAL . 10.6 mt -112.07 -46.16 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.277 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.6 ' C ' ' H ' ' A' ' 14' ' ' GLY . 60.5 mt -95.99 -98.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.135 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.95 -6.8 1.41 Allowed Glycine 0 C--N 1.341 0.854 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.393 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.6 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.92 -46.53 5.35 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 113.291 -1.455 . . . . 0.0 110.001 178.332 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.29 28.56 0.72 Allowed 'General case' 0 C--N 1.343 0.292 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.728 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.26 41.47 0.28 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.797 -178.927 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.2 OUTLIER 68.25 37.19 2.89 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.014 -0.675 . . . . 0.0 109.72 -179.762 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.495 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 33.6 t70 55.71 -82.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.716 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' LEU . 96.8 m-70 -158.5 57.61 0.45 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.475 179.98 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.476 -179.943 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.43 ' O ' ' N ' ' A' ' 3' ' ' ARG . 21.3 p90 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.758 0.313 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 2' ' ' LEU . 10.2 mp 51.98 -91.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.135 -179.99 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.433 ' H ' ' H ' ' A' ' 4' ' ' ARG . 30.8 ttm180 -163.93 -19.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.75 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.433 ' H ' ' H ' ' A' ' 3' ' ' ARG . 58.8 ttt180 -171.8 5.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.174 179.691 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt 58.02 84.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.171 -179.852 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.45 64.36 2.19 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -179.7 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -64.31 -40.47 95.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.636 0.255 . . . . 0.0 110.783 -179.663 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 46.5 68.21 1.16 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.103 -179.876 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.418 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 20.3 m -76.15 32.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.75 0.31 . . . . 0.0 110.782 -179.839 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.443 ' H ' ' C ' ' A' ' 8' ' ' GLY . 53.4 mttm -82.73 -11.39 58.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.231 179.907 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.6 mt -138.95 -39.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.193 -179.567 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.5 mt -75.83 -89.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.56 -5.52 5.12 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 175.385 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.36 -45.16 7.09 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 113.105 -1.547 . . . . 0.0 110.161 178.345 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.94 29.86 0.89 Allowed 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.653 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.59 40.78 0.61 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.407 -178.502 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.3 tp 63.14 20.4 12.26 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.214 -179.736 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.8 t70 58.83 -77.5 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' LEU . 20.7 m80 -49.25 -61.02 2.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.304 . . . . 0.0 110.711 -179.938 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.029 179.966 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 37.6 p90 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.795 0.331 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.4 mt -72.33 -7.66 50.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.613 -179.97 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 76.48 -47.02 0.54 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.54 -179.82 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 6' ' ' GLY . 83.3 mtm180 -78.01 -10.17 59.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.56 179.828 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mt 61.74 -76.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.637 -179.877 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 8' ' ' GLY . . . -73.98 9.03 9.77 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.157 -0.544 . . . . 0.0 111.927 179.989 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.5 tttm 59.38 -77.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.61 0.243 . . . . 0.0 110.756 -179.974 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . 176.25 165.9 32.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.073 179.97 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.22 -84.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.517 0.199 . . . . 0.0 110.659 -179.933 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -170.91 -26.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.814 0.34 . . . . 0.0 110.726 179.955 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.3 mt -133.9 -52.07 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 109.979 -179.936 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.1 mm -76.51 -96.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.695 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.9 -11.08 0.85 Allowed Glycine 0 C--N 1.347 1.16 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 176.448 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.56 -48.87 6.99 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 113.053 -1.573 . . . . 0.0 110.28 178.056 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.552 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.44 27.18 0.97 Allowed 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.877 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.5 40.07 0.13 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.916 -179.086 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.3 tt 62.18 42.69 9.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.828 179.955 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.6 t0 50.9 34.96 11.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.552 -179.858 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.8 t60 53.96 62.06 2.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.483 179.922 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.294 179.974 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 98.5 m95 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.804 0.335 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 4' ' ' ARG . 21.2 mt -66.04 -9.4 30.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.442 179.918 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 69.39 -29.65 0.18 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.975 -179.378 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' H ' ' C ' ' A' ' 2' ' ' LEU . 61.1 ttp180 -78.81 -24.8 44.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.261 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.3 mt -145.81 66.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.136 179.742 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 8' ' ' GLY . . . 179.21 -32.28 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.071 179.937 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER 53.32 -91.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.985 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . 61.13 62.26 6.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.113 179.843 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 11' ' ' ILE . 2.8 t -70.58 -3.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.835 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.2 mttp 66.51 -19.14 0.11 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.819 179.931 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.511 ' H ' ' C ' ' A' ' 9' ' ' VAL . 40.9 mm -118.22 -43.36 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.89 0.376 . . . . 0.0 111.415 -179.146 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.1 mt -98.54 -98.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.873 -178.65 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -54.67 -8.3 1.26 Allowed Glycine 0 C--N 1.342 0.914 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 176.743 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.6 -48.2 4.82 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 113.231 -1.485 . . . . 0.0 109.845 177.995 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.23 26.59 1.02 Allowed 'General case' 0 C--N 1.342 0.239 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.865 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.97 48.65 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.754 -178.918 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.0 mt 61.14 14.52 5.55 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.462 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.2 t70 58.67 -77.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.537 -179.706 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 63.6 t60 -164.9 47.76 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.914 0.388 . . . . 0.0 110.485 179.903 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.116 180.0 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.715 0.293 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.521 HD22 ' N ' ' A' ' 2' ' ' LEU . 2.4 mm? -70.91 -89.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.924 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -135.03 -21.74 1.63 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.607 179.66 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 6' ' ' GLY . 40.2 mtt-85 -146.91 12.33 1.1 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.055 179.783 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.435 ' C ' ' H ' ' A' ' 7' ' ' LYS . 13.0 mt 62.25 -76.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.41 -179.742 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -73.05 15.32 2.45 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.89 179.858 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 5' ' ' ILE . 76.9 mttt 54.83 -177.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.636 179.986 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.41 79.62 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 111.689 -0.565 . . . . 0.0 111.689 -179.998 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.3 t -61.01 -91.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.68 -179.792 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -171.52 -27.29 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.856 0.36 . . . . 0.0 110.419 -179.994 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.7 mt -136.8 -45.52 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.149 -179.91 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 14' ' ' GLY . 78.7 mt -84.07 -93.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.958 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.81 -8.34 2.88 Favored Glycine 0 C--N 1.343 0.955 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 175.959 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.591 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.8 -48.25 6.27 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 112.945 -1.628 . . . . 0.0 110.117 178.153 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.02 27.53 0.89 Allowed 'General case' 0 C--N 1.343 0.311 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.77 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.57 41.59 0.19 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.627 -178.871 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.6 tt 63.38 48.89 3.37 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.771 -179.786 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.8 t0 50.91 28.97 4.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.404 -179.825 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.8 t60 55.91 68.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.476 -179.796 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.4 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.244 -179.846 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.824 0.345 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.2 tp -64.76 -78.57 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.199 0.523 . . . . 0.0 110.078 179.863 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -165.91 -16.59 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.637 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 6' ' ' GLY . 72.2 mtm180 -149.97 -0.12 0.45 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.177 179.475 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 mt 62.6 -75.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.495 -179.826 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -156.68 31.1 0.56 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 179.833 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 6' ' ' GLY . 83.6 tttt 58.99 118.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.85 0.357 . . . . 0.0 110.63 -179.95 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.74 -125.43 0.76 Allowed Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 -179.967 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.0 t -149.08 -88.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.916 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -171.23 -31.28 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.818 0.342 . . . . 0.0 110.606 179.846 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.8 mt -130.35 -49.23 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.124 -179.826 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.602 ' C ' ' H ' ' A' ' 14' ' ' GLY . 28.2 mt -75.98 -95.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.886 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -54.12 -9.73 1.53 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 176.294 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.27 -47.81 7.25 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 113.019 -1.59 . . . . 0.0 110.074 178.036 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.8 29.36 1.03 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.823 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.14 41.71 0.28 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.615 -178.83 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.1 tt 69.33 39.38 1.67 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.453 -0.499 . . . . 0.0 109.893 -179.864 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.9 t0 48.56 49.29 18.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.654 -179.943 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 53.21 60.86 3.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 -179.891 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.569 HD12 ' N ' ' A' ' 20' ' ' LEU . 7.9 mp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.03 -179.882 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.75 0.31 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.534 ' C ' ' H ' ' A' ' 4' ' ' ARG . 17.3 mt -74.19 -7.68 53.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.192 179.759 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.5 mtm-85 66.97 -24.12 0.11 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.619 -179.936 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 2' ' ' LEU . 38.9 ttp180 -88.49 -39.58 14.09 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.882 0.372 . . . . 0.0 110.418 179.937 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 tp -54.47 -36.26 34.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.098 -179.905 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.54 -61.08 3.74 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.026 179.9 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 59.9 tttp 48.27 82.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.77 0.319 . . . . 0.0 110.63 179.917 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . -172.67 -14.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.023 179.957 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 33.6 m -76.03 19.08 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 110.802 -179.958 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 8' ' ' GLY . 11.1 ttmm -73.01 -21.94 60.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.099 0.476 . . . . 0.0 110.117 179.904 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.3 mt -131.44 -35.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.514 -179.485 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.601 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.7 mt -75.82 -87.6 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.908 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.08 -4.99 5.13 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 175.2 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.06 -44.48 7.07 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 113.209 -1.496 . . . . 0.0 110.193 178.471 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.51 27.72 1.07 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.953 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.05 37.34 0.28 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.707 -178.881 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.2 tt 55.97 43.04 27.92 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.052 179.921 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.0 t0 50.94 39.95 24.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.656 -179.994 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 51.53 45.63 27.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.551 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.352 -179.987 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.502 ' O ' ' N ' ' A' ' 3' ' ' ARG . 34.3 m95 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.748 0.308 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 2.2 mm? 53.16 -87.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.971 179.894 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 1' ' ' TRP . 71.7 ttt180 -174.63 -24.24 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.975 179.947 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.419 ' H ' ' H ' ' A' ' 5' ' ' ILE . 14.7 ptm180 -175.98 4.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.443 179.607 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.419 ' H ' ' H ' ' A' ' 4' ' ' ARG . 13.5 mt 50.66 76.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.479 179.932 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.04 13.4 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.199 -0.524 . . . . 0.0 111.952 179.946 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -66.27 -66.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.66 0.266 . . . . 0.0 110.521 179.999 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.33 147.03 48.44 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.091 -0.576 . . . . 0.0 111.814 -179.991 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.64 -84.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.606 -179.861 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -170.81 -24.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.968 179.962 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.3 mt -132.59 -49.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.86 0.362 . . . . 0.0 110.452 -179.754 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.607 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.1 mm -81.99 -96.36 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.92 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.43 -8.63 1.26 Allowed Glycine 0 C--N 1.344 0.987 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 176.393 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.8 -48.97 5.9 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.1 -1.55 . . . . 0.0 110.002 178.015 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.71 29.67 0.99 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.586 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.3 48.84 0.23 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.571 -178.671 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 12' ' ' ILE . 10.0 mt 64.53 31.63 12.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.204 -179.493 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.7 t70 53.03 44.68 30.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.957 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 50.56 65.48 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.647 179.948 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.203 -179.859 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.42 ' CD1' ' O ' ' A' ' 1' ' ' TRP . 24.7 p90 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.712 0.291 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.2 tp -70.2 -72.81 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.471 . . . . 0.0 110.494 -179.959 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.406 ' H ' ' H ' ' A' ' 4' ' ' ARG . 50.1 ttt85 -162.34 -15.37 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.869 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.466 ' H ' ' H ' ' A' ' 5' ' ' ILE . 28.1 ttp180 -167.9 -2.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.194 179.744 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.466 ' H ' ' H ' ' A' ' 4' ' ' ARG . 12.1 mt 60.39 130.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.748 179.748 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.92 -2.23 5.1 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.285 179.692 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.3 mttp 54.53 85.09 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.716 0.293 . . . . 0.0 110.608 -179.957 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.06 -144.53 34.97 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.011 179.872 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.2 t -77.76 -93.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 121.281 -0.168 . . . . 0.0 110.696 -179.865 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -171.41 -22.41 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.839 -179.84 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.0 mt -131.06 -44.55 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.868 0.366 . . . . 0.0 110.764 -179.351 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.0 mt -89.99 -94.41 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.575 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.77 -7.33 3.26 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 176.215 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.67 -47.55 5.9 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 113.011 -1.594 . . . . 0.0 109.984 178.154 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.11 29.32 0.57 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.661 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.17 38.33 0.33 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.867 -178.958 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.1 tt 51.73 38.38 22.79 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.069 -179.946 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.6 t0 52.43 -85.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.709 -179.945 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 17' ' ' LEU . 73.7 m-70 -53.11 -65.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.67 -179.854 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.023 -179.915 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 91.2 m95 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.876 0.37 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 4' ' ' ARG . 19.1 mt -73.62 -5.71 42.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.919 179.465 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.536 ' C ' ' HE ' ' A' ' 4' ' ' ARG . 76.9 mtm180 61.83 -76.52 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.788 -179.913 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.588 ' N ' ' NE ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -68.87 7.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.319 179.929 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.436 ' H ' ' C ' ' A' ' 3' ' ' ARG . 5.9 mt 48.93 43.91 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 121.016 0.436 . . . . 0.0 110.313 -179.902 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.41 69.29 1.34 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.024 -179.838 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -154.25 -102.12 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.691 0.282 . . . . 0.0 110.335 179.895 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.57 104.08 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.773 -179.851 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.61 -85.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.657 -179.808 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -171.71 -25.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.848 0.356 . . . . 0.0 110.43 179.916 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 18.5 mt -125.27 -55.37 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.172 -179.916 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' GLY . 34.6 mm -75.46 -98.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.928 -179.911 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.49 -10.99 0.68 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 176.794 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.56 -48.5 7.25 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 113.013 -1.593 . . . . 0.0 110.074 178.046 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.544 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.85 27.71 0.85 Allowed 'General case' 0 C--N 1.344 0.363 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.652 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.22 39.32 0.2 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.741 -178.923 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tt 58.01 48.8 12.66 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.6 179.945 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 53.97 22.84 3.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.205 -179.593 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.6 t60 56.01 63.14 2.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.635 -179.925 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.184 179.906 . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.454 ' CD1' ' O ' ' A' ' 1' ' ' TRP . 29.8 p90 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.86 0.362 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.1 mt -76.97 -73.38 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.542 -179.98 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.453 ' HE ' ' HZ2' ' A' ' 7' ' ' LYS . 46.2 mtm105 -147.06 -10.35 0.44 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.851 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 6' ' ' GLY . 7.6 tpp85 -166.36 10.12 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.419 179.835 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.4 mt 62.86 -76.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.409 -179.739 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -75.98 38.06 1.31 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.144 179.885 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' HZ2' ' HE ' ' A' ' 3' ' ' ARG . 83.9 tttt -57.57 -44.36 85.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.819 0.342 . . . . 0.0 110.456 179.889 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.66 128.19 1.71 Allowed Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 111.749 -0.541 . . . . 0.0 111.749 -179.937 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.499 ' C ' ' H ' ' A' ' 11' ' ' ILE . 44.3 t -61.29 -18.17 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 121.034 -0.267 . . . . 0.0 110.648 -179.796 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? 66.09 -14.05 0.15 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.792 179.836 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.499 ' H ' ' C ' ' A' ' 9' ' ' VAL . 14.7 mt -122.84 -45.63 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.75 0.31 . . . . 0.0 111.129 -179.642 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 14' ' ' GLY . 71.2 mt -95.03 -97.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.069 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.27 -8.48 1.67 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 176.462 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.55 -48.0 5.45 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 113.318 -1.441 . . . . 0.0 109.953 177.997 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.55 28.62 0.74 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.816 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.5 41.79 0.19 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.931 -179.011 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.0 tp 62.31 30.01 17.41 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.574 -179.996 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t0 55.23 -82.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 179.73 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 17' ' ' LEU . 61.0 m80 -47.75 -64.68 0.72 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.853 -179.812 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.453 -179.991 . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 120.994 0.426 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.514 ' C ' ' H ' ' A' ' 5' ' ' ILE . 54.9 mt -137.32 -3.26 1.95 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.084 178.602 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -45.62 -18.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.472 0.653 . . . . 0.0 109.443 178.997 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.499 ' N ' ' C ' ' A' ' 2' ' ' LEU . 66.0 mtp180 -130.46 -5.94 4.22 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.847 178.823 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.514 ' H ' ' C ' ' A' ' 2' ' ' LEU . 12.2 mt 58.31 61.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.258 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.229 -179.91 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 66.48 51.2 44.27 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 -179.806 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 6' ' ' GLY . 51.1 mttp 57.45 158.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.367 . . . . 0.0 110.517 -179.722 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.05 129.11 1.46 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.915 -179.898 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.82 -87.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.968 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -171.93 -24.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.76 0.314 . . . . 0.0 110.477 -179.993 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.413 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 11.5 mt -124.97 -51.91 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.542 -179.647 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.5 mm -74.67 -97.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.898 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.41 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.03 -10.24 0.73 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 176.738 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.17 -48.08 7.12 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 113.095 -1.552 . . . . 0.0 110.029 178.061 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.2 28.48 0.82 Allowed 'General case' 0 C--N 1.343 0.325 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.67 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.99 38.18 0.25 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.964 -179.055 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.5 tt 55.52 46.39 23.11 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.888 179.801 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 55.69 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.731 -179.903 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LEU . 1.5 p-80 -157.03 44.71 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.418 -179.972 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.155 -179.98 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.43 ' CD1' ' N ' ' A' ' 1' ' ' TRP . 31.6 m95 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.75 0.31 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 4' ' ' ARG . 20.8 mt -72.17 -6.8 45.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.289 179.872 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.494 HH22 HH22 ' A' ' 4' ' ' ARG . 27.1 mtm-85 69.77 -31.87 0.22 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.456 179.975 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.494 HH22 HH22 ' A' ' 3' ' ' ARG . 70.7 mtt85 -80.03 -30.13 39.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.891 0.376 . . . . 0.0 110.275 179.834 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.8 mt 51.27 60.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.434 179.791 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.74 -37.3 0.1 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.004 179.929 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -51.36 102.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.693 0.282 . . . . 0.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.01 -153.36 8.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.257 179.833 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.3 t -142.45 -85.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.879 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -170.19 -23.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.181 179.863 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.7 mp -115.59 -47.73 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.789 0.328 . . . . 0.0 111.649 -178.946 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 14' ' ' GLY . 24.9 mt -94.86 -98.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.008 -178.681 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.453 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.57 -10.96 1.06 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 176.669 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.57 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.88 -49.8 5.2 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 113.199 -1.501 . . . . 0.0 109.936 177.771 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.28 25.87 0.82 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.941 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.53 44.51 0.07 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.856 -178.991 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.4 tp 62.78 31.5 16.47 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.305 -179.968 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.4 t0 56.84 -79.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' LEU . 35.6 m80 -54.92 -62.38 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.542 179.994 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.541 ' N ' HD23 ' A' ' 20' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.728 179.581 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.883 0.373 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.574 ' C ' ' H ' ' A' ' 4' ' ' ARG . 16.8 mt -82.84 -5.73 59.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.587 179.928 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.421 ' CD ' ' N ' ' A' ' 3' ' ' ARG . 1.1 mpt_? 62.75 -18.06 0.05 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.594 -179.444 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 2' ' ' LEU . 99.9 mtt180 -101.11 -10.52 20.38 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.909 0.385 . . . . 0.0 110.391 179.771 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.4 tt -51.47 -26.93 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -174.56 18.22 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.125 -179.946 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 6' ' ' GLY . 15.7 mtpp 56.63 114.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 110.791 179.883 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.77 109.12 0.38 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 179.943 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.76 -80.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.646 0.26 . . . . 0.0 110.526 -179.902 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -171.22 -28.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.542 -179.867 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.1 mt -131.51 -44.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.068 -179.849 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 14' ' ' GLY . 79.1 mt -75.34 -91.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.5 -6.66 3.54 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 107.579 -2.208 . . . . 0.0 107.579 176.016 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.46 -45.72 7.25 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 112.98 -1.61 . . . . 0.0 110.035 178.315 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.5 29.96 0.74 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.618 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.11 37.53 0.61 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.5 -178.645 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.6 tt 56.79 46.26 20.23 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.797 -179.884 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 47.56 44.75 17.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.1 m80 54.73 45.77 26.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.597 -179.883 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.339 -179.993 . . . . . . . . 0 0 . 1 . 056 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.823 0.345 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 056 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.9 mt -71.05 -69.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.107 0.48 . . . . 0.0 110.276 179.743 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.42 ' H ' ' H ' ' A' ' 4' ' ' ARG . 48.6 ttt-85 -167.47 -11.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.664 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.425 ' H ' ' H ' ' A' ' 5' ' ' ILE . 8.2 ptm180 -174.84 8.15 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.527 179.732 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.425 ' H ' ' H ' ' A' ' 4' ' ' ARG . 18.6 mt 59.16 61.43 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.126 -179.782 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.42 19.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -179.9 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -53.9 -64.28 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -179.899 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.39 156.02 27.63 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.912 -179.957 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.43 -83.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.663 0.268 . . . . 0.0 110.521 -179.911 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -171.25 -17.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.905 0.383 . . . . 0.0 110.402 -179.78 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.4 mt -124.43 -49.76 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.764 -179.819 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 14' ' ' GLY . 25.9 mt -81.9 -95.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.945 -179.424 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -53.89 -9.96 1.49 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 176.402 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.04 -49.38 6.01 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 112.994 -1.603 . . . . 0.0 110.247 177.985 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.539 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.78 28.24 0.91 Allowed 'General case' 0 C--N 1.344 0.356 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.799 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.69 43.93 0.12 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.841 -179.026 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 64.34 24.8 13.34 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.477 -179.997 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.3 t70 57.47 -78.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' LEU . 50.0 m80 -49.79 -67.07 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.658 -179.918 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.452 179.873 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.516 ' C ' ' H ' ' A' ' 3' ' ' ARG . 30.7 m95 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.45 0.166 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 4' ' ' ARG . 19.8 mt 62.34 -5.45 0.18 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.191 -179.822 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.516 ' H ' ' C ' ' A' ' 1' ' ' TRP . 9.3 mpt_? 58.45 -76.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.684 -179.739 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 2' ' ' LEU . 78.3 mtp180 -72.37 15.63 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.92 -179.804 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.451 ' H ' ' C ' ' A' ' 3' ' ' ARG . 12.1 mt 46.84 61.57 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.724 0.297 . . . . 0.0 110.69 179.872 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.56 -60.0 0.01 OUTLIER Glycine 0 C--N 1.33 0.198 0 N-CA-C 111.95 -0.46 . . . . 0.0 111.95 -179.889 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -167.71 -37.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.706 0.289 . . . . 0.0 110.75 179.962 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.83 -155.45 26.75 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.047 179.904 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.5 t -77.99 -63.23 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.885 0.374 . . . . 0.0 110.327 179.93 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -169.74 -61.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.483 179.907 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' ALA . 16.6 pt -81.2 4.96 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.647 179.994 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.625 ' C ' ' H ' ' A' ' 14' ' ' GLY . 38.9 mm -70.83 -88.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.301 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.32 -3.76 3.16 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 175.402 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.625 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.08 -38.33 8.61 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 113.77 -1.215 . . . . 0.0 110.137 178.604 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -94.17 26.03 3.49 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.873 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 79.07 37.29 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.653 -178.886 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 3.7 tp 61.94 11.35 4.13 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.41 179.719 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.5 t70 60.05 -77.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.469 -179.579 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -55.07 -70.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.761 0.315 . . . . 0.0 110.559 179.797 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.463 0.222 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.479 179.906 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.773 0.32 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.0 mt -74.08 -15.45 61.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.558 -179.932 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 76.68 -50.94 0.58 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.59 -179.938 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -75.49 -6.03 48.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.505 179.934 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.7 mt 57.5 68.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.488 179.936 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 53.83 25.47 30.07 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.981 179.901 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt 57.21 108.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.797 0.332 . . . . 0.0 110.604 179.996 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 9' ' ' VAL . . . 173.63 123.85 0.75 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.115 179.967 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.438 HG23 ' H ' ' A' ' 10' ' ' LYS . 1.9 m -55.49 -105.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.833 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.438 ' H ' HG23 ' A' ' 9' ' ' VAL . 33.2 ttmt -158.52 -21.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.919 0.39 . . . . 0.0 110.425 179.997 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.7 mp -109.81 -49.47 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.895 -179.05 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' GLY . 23.5 mt -95.54 -99.79 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.385 -178.24 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.27 -10.83 0.93 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 177.097 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.578 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.1 -49.24 5.38 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 113.155 -1.523 . . . . 0.0 109.756 177.877 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.48 29.52 0.59 Allowed 'General case' 0 C--N 1.342 0.276 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.607 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.17 43.91 0.27 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.74 -178.898 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 61.17 34.47 18.88 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.953 -179.693 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 t70 57.89 -78.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.928 -179.799 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 86.8 m-70 -64.89 -64.29 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.705 -179.77 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.461 -179.786 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.531 ' C ' ' H ' ' A' ' 3' ' ' ARG . 4.7 m-90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.675 0.274 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.9 mt 63.49 -7.92 0.17 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.353 -179.921 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.531 ' H ' ' C ' ' A' ' 1' ' ' TRP . 1.7 tpt180 76.14 -56.44 0.58 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.786 179.79 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -69.87 -10.25 57.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.777 0.322 . . . . 0.0 110.692 -179.817 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 mm 58.12 65.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.432 179.962 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . 50.08 52.71 25.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.86 -179.986 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 6' ' ' GLY . 34.3 tptt 60.86 136.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 110.623 -179.935 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.55 73.26 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.951 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.55 -84.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.64 0.257 . . . . 0.0 110.797 -179.624 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -171.39 -29.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.942 0.401 . . . . 0.0 110.26 -179.819 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 mt -137.98 -43.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.776 -179.953 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.585 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.7 mt -77.37 -90.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.525 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.59 -7.27 4.18 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 107.576 -2.21 . . . . 0.0 107.576 175.772 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.585 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.26 -46.7 6.84 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 112.931 -1.635 . . . . 0.0 110.199 178.431 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.535 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.14 27.08 0.94 Allowed 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.797 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.61 39.05 0.19 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.683 -178.894 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 57.43 47.17 16.89 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.991 179.931 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 54.33 -83.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 179.966 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.7 t-80 -157.4 40.33 0.3 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.425 179.975 . . . . . . . . 0 0 . 1 . 060 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.51 ' C ' ' H ' ' A' ' 3' ' ' ARG . 70.8 m95 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.731 0.301 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.546 ' C ' ' H ' ' A' ' 4' ' ' ARG . 25.1 mt 63.48 -8.69 0.15 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.668 179.927 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.51 ' H ' ' C ' ' A' ' 1' ' ' TRP . 77.0 mtt180 62.76 -15.93 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.819 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.546 ' H ' ' C ' ' A' ' 2' ' ' LEU . 55.2 ttp180 -95.36 -43.11 8.17 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.853 0.358 . . . . 0.0 110.201 -179.958 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.6 mm -86.41 -33.24 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.443 -179.979 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.44 -68.3 1.7 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.853 179.87 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt 50.37 17.14 0.32 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.744 0.307 . . . . 0.0 110.757 179.822 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.51 111.56 0.3 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.963 -179.99 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.58 -88.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.393 -179.958 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -172.17 -25.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.705 0.288 . . . . 0.0 110.718 179.901 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 12.5 mt -130.7 -46.57 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.624 -179.474 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.623 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.9 mt -84.53 -94.33 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.835 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.424 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -56.57 -7.26 2.02 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 176.074 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.623 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.22 -48.63 5.6 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 112.915 -1.642 . . . . 0.0 109.955 178.031 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.25 29.16 0.98 Allowed 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.588 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.46 49.15 0.21 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.586 -178.572 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 11.1 mt 63.52 6.08 2.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.157 -179.293 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.3 t70 58.22 -77.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 -179.977 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -158.76 54.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.306 179.941 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.201 -179.857 . . . . . . . . 0 0 . 1 . 061 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.513 ' C ' ' H ' ' A' ' 3' ' ' ARG . 75.9 m95 . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.558 0.218 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.8 mt 62.79 -6.52 0.16 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.394 179.948 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.513 ' H ' ' C ' ' A' ' 1' ' ' TRP . 40.7 ttp180 72.47 -70.0 0.17 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.593 179.99 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.73 -0.95 4.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.508 -179.928 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.2 mm 56.02 68.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.605 179.885 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 52.8 34.83 45.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.093 179.894 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.6 tttt 53.51 79.54 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 0.0 110.532 179.919 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.31 144.65 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.938 -179.949 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.6 t -71.18 -88.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.481 -179.907 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -170.61 -24.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.716 0.293 . . . . 0.0 110.991 179.869 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.8 mt -133.13 -44.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.905 0.383 . . . . 0.0 110.701 -179.548 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.0 mt -90.35 -94.32 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.662 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.48 -8.58 2.75 Favored Glycine 0 C--N 1.343 0.959 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 176.306 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.79 -49.07 5.54 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 112.986 -1.607 . . . . 0.0 109.985 178.017 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.86 29.62 0.62 Allowed 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.728 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.95 40.97 0.25 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.113 -179.168 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.7 OUTLIER 56.53 13.9 1.5 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.69 -179.98 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.9 t0 55.57 -82.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.792 -179.942 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 49.6 m80 -58.44 -20.18 42.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.57 -179.987 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.288 -179.908 . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 2.9 m0 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.852 0.358 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.6 -75.73 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.132 0.491 . . . . 0.0 109.941 179.754 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -153.3 -13.03 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.035 179.839 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.425 ' O ' ' N ' ' A' ' 6' ' ' GLY . 40.0 ttt-85 -161.39 6.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.447 179.754 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.0 mt 61.91 -77.73 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.689 -179.921 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -83.67 60.69 4.84 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 179.955 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -50.98 124.76 12.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.788 0.327 . . . . 0.0 110.634 -179.857 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.89 128.52 37.25 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.207 -0.52 . . . . 0.0 111.986 -179.928 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.14 -82.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.672 0.272 . . . . 0.0 110.52 -179.95 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -172.02 -19.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.85 0.357 . . . . 0.0 110.196 -179.848 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.5 mt -136.86 -46.25 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 120.934 0.397 . . . . 0.0 110.367 -179.735 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.62 ' C ' ' H ' ' A' ' 14' ' ' GLY . 71.4 mt -80.16 -93.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.945 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.12 -6.65 3.13 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 176.127 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.62 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.43 -46.54 6.85 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 112.963 -1.619 . . . . 0.0 109.886 178.219 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.43 30.29 0.63 Allowed 'General case' 0 C--N 1.345 0.396 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.506 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.46 38.0 0.67 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.441 -178.596 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.6 tt 54.36 52.27 12.79 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.771 -179.738 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.433 ' N ' ' OD2' ' A' ' 18' ' ' ASP . 1.0 OUTLIER 56.1 -80.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.947 179.927 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -160.95 48.68 0.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.362 -179.939 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.038 -179.896 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.52 ' C ' ' H ' ' A' ' 3' ' ' ARG . 67.5 m95 . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 120.606 0.241 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 4' ' ' ARG . 16.4 mt 63.15 -6.9 0.17 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.508 -179.879 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.52 ' H ' ' C ' ' A' ' 1' ' ' TRP . 68.4 mtm180 64.76 -72.31 0.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.917 -179.876 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 2' ' ' LEU . 30.7 ttm180 -59.33 -8.69 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.337 179.934 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.7 pt 34.84 43.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.493 -179.694 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.45 0.96 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.84 -179.999 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -54.82 97.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 0.0 110.468 -179.961 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.66 -105.68 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.016 -0.612 . . . . 0.0 111.83 179.918 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.92 -81.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.616 0.246 . . . . 0.0 110.498 179.925 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -172.14 -25.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.862 0.363 . . . . 0.0 110.284 179.854 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.0 mt -135.72 -50.45 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.831 179.939 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.6 mm -76.53 -96.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.602 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.6 -10.37 0.93 Allowed Glycine 0 C--N 1.346 1.099 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 176.387 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.05 -48.56 6.87 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 113.109 -1.545 . . . . 0.0 110.171 178.082 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.95 29.1 0.84 Allowed 'General case' 0 C--N 1.344 0.337 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.772 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.52 39.74 0.24 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.991 -178.993 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.2 tt 63.09 43.63 6.35 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.966 179.844 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.1 t0 49.0 32.29 3.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.559 -179.977 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 54.79 73.92 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.475 -179.865 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.0 tp . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.52 -179.979 . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 39.5 p90 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.759 0.314 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.5 mt -77.42 -72.58 0.35 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.838 -179.813 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.652 HH12 ' NE ' ' A' ' 4' ' ' ARG . 64.3 ttp85 -172.73 -14.88 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.968 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.652 ' NE ' HH12 ' A' ' 3' ' ' ARG . 11.3 ptp180 -172.79 4.93 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.489 179.612 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mm 53.18 58.2 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.242 -179.888 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.92 25.54 0.02 OUTLIER Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -179.915 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -52.26 -70.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.727 0.298 . . . . 0.0 110.209 -179.929 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . -168.25 48.55 0.23 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.798 179.986 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.445 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 30.4 m -76.72 21.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.783 0.325 . . . . 0.0 110.812 -179.838 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 8' ' ' GLY . 50.2 mtpt -78.7 -14.58 59.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.252 -179.997 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.3 mt -133.15 -38.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.148 -179.789 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.607 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.6 mt -75.58 -89.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.825 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.96 -5.66 4.49 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 107.332 -2.307 . . . . 0.0 107.332 175.385 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.29 -44.73 7.34 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 113.167 -1.516 . . . . 0.0 110.038 178.379 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.69 28.35 1.16 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.889 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.55 38.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.596 -178.766 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 19' ' ' HIS . 3.2 tp 63.22 48.99 3.45 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 53.8 -84.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.754 179.822 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 58.4 m80 -150.36 57.17 0.94 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.353 179.993 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.514 -179.966 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.492 ' O ' ' N ' ' A' ' 3' ' ' ARG . 10.1 t90 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.793 0.33 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.478 ' N ' ' CG ' ' A' ' 1' ' ' TRP . 32.4 tp 53.92 -86.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.292 179.967 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 1' ' ' TRP . 52.0 ttp180 -174.14 -23.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.931 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.407 ' H ' ' H ' ' A' ' 5' ' ' ILE . 54.8 ttt180 -161.55 6.28 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.093 179.743 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' H ' ' H ' ' A' ' 4' ' ' ARG . 34.2 pt 35.43 39.24 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.59 -179.951 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.38 -7.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.0 179.995 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -77.54 73.99 4.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.742 0.305 . . . . 0.0 110.531 -179.929 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.22 122.32 0.6 Allowed Glycine 0 C--N 1.33 0.243 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.973 179.929 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.5 -87.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.401 179.893 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -171.29 -23.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.911 179.891 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.447 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.7 mt -120.69 -47.41 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 120.793 0.33 . . . . 0.0 111.26 -179.163 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.3 mt -91.28 -97.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.128 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.448 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -54.21 -8.93 1.26 Allowed Glycine 0 C--N 1.343 0.933 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 176.524 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.53 -48.96 5.37 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 113.147 -1.526 . . . . 0.0 109.935 177.984 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.507 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.38 28.91 0.91 Allowed 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.723 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.87 48.78 0.13 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.556 -178.724 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.9 mt 65.1 -1.55 0.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.351 -179.427 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 16' ' ' ALA . 26.3 t70 53.9 -83.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.765 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 2.4 t60 -46.98 -37.79 9.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.95 -179.882 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 20' ' ' LEU . 2.0 tt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.068 179.973 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 24.1 m95 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.887 0.375 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 46.2 mt -76.19 -75.89 0.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.514 -179.916 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.411 ' H ' ' H ' ' A' ' 4' ' ' ARG . 86.1 mtt180 -143.42 -18.96 0.62 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.617 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.493 ' C ' ' H ' ' A' ' 6' ' ' GLY . 93.6 mtt180 -149.98 12.02 0.75 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.662 179.675 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mt 70.14 -30.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.96 -179.925 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 4' ' ' ARG . . . -165.59 92.9 0.11 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.882 179.701 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -48.5 153.65 0.74 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.766 0.317 . . . . 0.0 110.683 179.916 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.56 -102.59 0.45 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.798 -179.961 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.5 t -147.27 -73.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.688 0.28 . . . . 0.0 110.29 179.799 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -171.4 -59.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.368 -179.977 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 19.4 pt -78.02 10.79 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.403 180.0 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 14' ' ' GLY . 6.8 mm -74.52 -86.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.515 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.49 -3.15 5.07 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 175.249 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -86.53 -40.77 7.15 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 113.663 -1.269 . . . . 0.0 110.314 178.637 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -90.49 26.21 2.05 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.873 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 79.43 37.16 0.14 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.876 -178.945 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.1 tp 59.24 17.92 6.14 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.546 179.76 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 56.93 6.95 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.794 179.728 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.409 ' H ' ' C ' ' A' ' 17' ' ' LEU . 54.6 t-80 -170.34 -59.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.522 -179.961 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.204 -179.987 . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.776 0.322 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 2' ' ' LEU . 7.8 mp -67.79 -85.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.918 179.922 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -134.11 -15.22 2.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.66 179.664 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 5' ' ' ILE . 20.9 ttm180 -169.94 13.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.578 179.811 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.402 ' O ' ' O ' ' A' ' 4' ' ' ARG . 2.6 tt 34.63 96.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.538 -179.944 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.21 -28.19 0.15 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.811 179.969 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -72.5 159.98 33.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.773 0.321 . . . . 0.0 110.53 179.959 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.05 152.58 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.907 -179.983 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.77 -84.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.474 -179.956 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -171.83 -25.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.816 0.341 . . . . 0.0 110.489 179.908 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.8 mt -139.68 -43.89 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.02 -179.855 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.606 ' C ' ' H ' ' A' ' 14' ' ' GLY . 23.7 mt -84.43 -93.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.771 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.89 -6.25 2.63 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 175.751 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.38 -47.36 5.75 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 113.066 -1.567 . . . . 0.0 110.158 178.265 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -89.32 29.03 1.14 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.726 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.63 47.82 0.12 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.721 -178.821 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.4 mt 63.71 17.81 10.7 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.247 0.342 . . . . 0.0 110.137 -179.596 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 59.56 -76.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.766 179.894 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.513 ' ND1' ' N ' ' A' ' 19' ' ' HIS . 0.0 OUTLIER -154.68 52.56 0.64 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.82 0.343 . . . . 0.0 110.427 -179.991 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.304 -179.967 . . . . . . . . 0 0 . 1 . 068 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 . . . . . 0 N--CA 1.46 0.063 0 CA-C-O 121.001 0.429 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 4' ' ' ARG . 5.8 tp -70.19 -4.41 21.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.013 179.757 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 6' ' ' GLY . 18.5 mmm180 64.03 -74.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.245 -179.63 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 2' ' ' LEU . 69.9 ttt180 -44.48 -25.08 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.025 179.892 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 6' ' ' GLY . 17.6 tt -81.07 -37.48 15.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.776 0.322 . . . . 0.0 110.518 -179.982 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.424 ' N ' HG23 ' A' ' 5' ' ' ILE . . . -68.84 -28.67 72.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.982 179.978 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 6' ' ' GLY . 17.5 mtpp 56.39 116.46 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.095 0.474 . . . . 0.0 111.05 179.871 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.0 119.74 0.9 Allowed Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 179.97 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.8 t -75.93 -94.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.673 -179.769 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -171.33 -23.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.927 0.394 . . . . 0.0 110.406 -179.874 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -138.11 -43.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.332 -179.861 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.61 ' C ' ' H ' ' A' ' 14' ' ' GLY . 76.5 mt -88.0 -93.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.94 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.47 -6.66 3.51 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 175.941 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.73 -47.48 5.9 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 113.046 -1.577 . . . . 0.0 109.939 178.152 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.524 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.88 29.73 0.61 Allowed 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.708 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.47 38.68 0.38 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.773 -178.941 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER 56.39 33.89 23.21 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.969 -179.973 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.7 t0 58.02 -78.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.781 -179.962 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -155.3 62.24 0.63 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.268 179.875 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.373 -179.771 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.895 0.379 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 23.9 mt -69.6 -5.43 24.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.469 179.898 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 77.36 -47.33 0.5 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.592 -179.886 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -70.35 -46.17 64.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.39 . . . . 0.0 110.365 179.838 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mm -83.92 -19.09 9.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.466 179.973 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.24 -30.3 69.59 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.017 -179.97 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -164.22 -80.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.669 0.271 . . . . 0.0 110.386 -179.99 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.89 89.3 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.185 179.905 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' A' ' 11' ' ' ILE . 2.8 t -70.82 0.14 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.924 0.392 . . . . 0.0 110.036 179.881 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.6 mttm 66.47 -13.47 0.17 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.575 179.794 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.483 ' H ' ' C ' ' A' ' 9' ' ' VAL . 17.8 mt -126.4 -45.2 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.832 0.348 . . . . 0.0 110.97 -179.357 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' GLY . 66.1 mt -95.97 -96.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.248 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.38 -7.76 2.18 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 176.434 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.0 -48.75 5.04 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 113.053 -1.573 . . . . 0.0 109.557 177.922 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.2 29.15 0.67 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 177.526 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.06 48.03 0.28 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.451 -178.687 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.0 mt 62.54 22.52 13.34 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.366 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.9 t70 55.73 -82.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.625 -179.875 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 31.9 m-70 -53.66 -33.93 56.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.59 179.973 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.163 -179.985 . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.901 0.382 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 tp -63.77 -16.96 62.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.243 179.907 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 73.93 -64.72 0.38 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.369 -179.764 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 6' ' ' GLY . 77.0 mtp180 -69.57 3.13 2.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.257 179.651 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.1 mm 60.94 -75.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.497 -179.897 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -143.73 56.13 0.56 Allowed Glycine 0 C--N 1.333 0.404 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 179.962 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.2 mttm 59.1 65.63 1.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.806 0.336 . . . . 0.0 110.528 -179.851 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -165.45 163.69 36.75 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.901 -0.48 . . . . 0.0 111.901 -179.999 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -71.89 -81.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.631 0.253 . . . . 0.0 110.567 -179.832 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -171.34 -28.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.249 179.916 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.0 mt -132.06 -48.63 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.343 -179.894 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 14' ' ' GLY . 65.3 mt -78.24 -94.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -179.788 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.11 -8.24 2.25 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 176.241 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.44 -47.53 6.81 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 112.899 -1.651 . . . . 0.0 110.186 178.133 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.82 29.31 0.81 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.757 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.75 39.29 0.33 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.755 -178.928 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 12' ' ' ILE . 0.9 OUTLIER 62.14 27.97 16.83 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.881 179.971 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 t70 50.05 -91.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 179.949 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' LEU . 71.9 m80 -50.19 -25.2 3.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.732 -179.761 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.222 179.994 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.741 0.305 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 4' ' ' ARG . 16.6 mt -72.82 -10.68 60.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.53 179.925 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 73.11 -35.98 0.34 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 -179.898 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.463 ' H ' ' C ' ' A' ' 2' ' ' LEU . 40.6 ttm180 -74.02 -38.94 63.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.275 179.744 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 mt -96.94 -41.97 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.371 179.808 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -52.88 -30.69 37.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.159 -0.543 . . . . 0.0 111.84 179.875 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -75.58 102.14 5.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.772 0.32 . . . . 0.0 110.468 179.996 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.16 126.43 16.5 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.923 -179.936 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.2 -89.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.524 -179.964 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -171.86 -27.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.95 179.824 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.7 mt -123.91 -51.21 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.847 0.356 . . . . 0.0 110.867 -179.563 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 44.3 mm -83.79 -98.34 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.7 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -51.68 -10.89 0.73 Allowed Glycine 0 C--N 1.346 1.121 0 N-CA-C 108.544 -1.823 . . . . 0.0 108.544 176.654 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.57 -49.83 5.97 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 113.136 -1.532 . . . . 0.0 110.058 177.919 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.09 28.42 0.82 Allowed 'General case' 0 C--N 1.345 0.398 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.833 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.43 42.19 0.13 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.084 -179.16 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.1 tp 60.87 44.49 10.72 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.633 179.796 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.9 t70 53.58 47.56 23.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 179.915 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 51.1 53.86 12.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.701 179.818 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 20' ' ' LEU . 7.6 mp . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.261 179.952 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.511 ' C ' ' H ' ' A' ' 3' ' ' ARG . 92.7 m95 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.687 0.28 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 4' ' ' ARG . 17.3 mt 63.66 -8.33 0.16 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.411 -179.992 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.511 ' H ' ' C ' ' A' ' 1' ' ' TRP . 47.7 ttp180 66.28 -14.46 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.478 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.494 ' H ' ' C ' ' A' ' 2' ' ' LEU . 92.6 mtt180 -138.7 -3.79 1.64 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.591 0.234 . . . . 0.0 110.7 -179.68 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 mt 60.53 -77.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.539 179.975 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -78.14 53.65 3.83 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 179.782 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -53.34 -76.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.6 0.238 . . . . 0.0 110.542 -179.705 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.87 113.02 4.03 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 179.82 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.91 -95.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.589 -179.861 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -172.08 -23.56 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.775 0.321 . . . . 0.0 110.469 179.959 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.3 mt -135.41 -44.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.559 -179.486 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 14' ' ' GLY . 27.1 mt -90.34 -95.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.748 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.433 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.44 -8.34 1.76 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 175.976 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.64 -49.15 5.26 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 113.142 -1.529 . . . . 0.0 109.992 177.978 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.94 28.08 0.94 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.808 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.19 48.07 0.1 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.742 -178.877 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.6 mt 64.31 33.97 11.02 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.325 0.391 . . . . 0.0 110.259 -179.773 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 t0 57.0 -78.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.954 179.785 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 17' ' ' LEU . 16.1 p-80 -145.63 51.74 1.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.328 -179.871 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.195 179.986 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 86.1 m95 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.834 0.35 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.477 ' C ' ' H ' ' A' ' 4' ' ' ARG . 15.7 mt -75.95 -15.73 60.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.641 -179.98 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 74.25 -22.42 0.25 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.495 -179.471 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' A' ' 2' ' ' LEU . 13.3 mmt85 -93.51 -15.02 25.95 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.342 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 mt 52.97 54.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.948 -179.898 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 47.01 20.59 0.75 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.202 -179.912 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' CG ' ' H ' ' A' ' 8' ' ' GLY . 1.3 tppp? -170.17 -138.02 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.463 179.966 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.409 ' H ' ' CG ' ' A' ' 7' ' ' LYS . . . 155.18 -173.38 33.44 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -179.951 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -79.63 29.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.817 0.341 . . . . 0.0 110.633 179.929 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 8' ' ' GLY . 19.3 tptm -77.97 -16.98 57.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.289 -179.997 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.409 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.3 mt -138.5 -36.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.539 -179.64 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.6 ' C ' ' H ' ' A' ' 14' ' ' GLY . 85.6 mt -75.03 -88.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.989 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.44 -4.73 5.44 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 175.173 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.6 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.07 -43.87 7.35 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 113.197 -1.502 . . . . 0.0 110.258 178.389 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.06 28.07 1.11 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.702 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.88 39.25 0.42 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.454 -178.626 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.0 tp 60.19 41.26 17.07 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.333 -179.778 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.9 0.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.428 ' H ' ' C ' ' A' ' 17' ' ' LEU . 6.7 t60 -170.79 -65.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 110.65 179.946 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 16' ' ' ALA . 16.7 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.847 0.356 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.5 mt -66.95 -6.12 15.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.278 179.708 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 71.61 -68.5 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.882 179.928 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -48.48 -21.64 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.817 0.341 . . . . 0.0 110.414 -179.81 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.44 62.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.063 179.959 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.68 -42.43 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.849 -179.982 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -70.34 -60.75 2.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.872 0.368 . . . . 0.0 110.401 179.934 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.21 104.1 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.853 -179.98 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.5 t -72.65 -84.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.613 0.244 . . . . 0.0 110.509 -179.942 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -171.43 -29.64 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.538 179.95 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 6.8 mm -131.52 -51.24 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.863 -179.981 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' GLY . 42.6 mm -76.0 -97.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.841 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.01 -11.05 0.88 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 176.766 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -78.34 -48.93 7.09 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 113.029 -1.585 . . . . 0.0 110.128 178.024 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.19 28.8 0.69 Allowed 'General case' 0 C--N 1.343 0.323 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.597 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.93 38.47 0.25 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.899 -179.019 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tt 55.63 45.64 24.34 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.671 179.924 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 54.55 33.19 18.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.379 -179.703 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.0 m80 58.59 45.88 15.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.547 -179.987 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.405 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.137 179.912 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.792 0.33 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 4' ' ' ARG . 17.8 mt -73.55 -6.99 50.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.679 179.934 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 73.33 -36.2 0.34 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.292 -179.54 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.469 ' H ' ' C ' ' A' ' 2' ' ' LEU . 72.9 mtm180 -71.32 -32.12 68.23 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.275 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.4 pt -76.52 -29.72 18.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.357 179.761 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.42 -30.08 60.94 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.293 -0.48 . . . . 0.0 111.996 -179.95 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt 52.07 176.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 110.55 179.963 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.41 137.97 41.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.006 -179.898 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.4 t -76.62 -87.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 -179.991 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -171.29 -25.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.416 179.755 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.2 mp -132.46 -48.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 121.058 0.456 . . . . 0.0 110.341 179.569 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.1 mt -83.67 -94.18 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.667 -179.66 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.03 -8.59 2.38 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 176.1 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.52 -48.74 6.13 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 113.004 -1.598 . . . . 0.0 109.863 178.025 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.69 30.55 0.72 Allowed 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.553 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.21 44.15 0.46 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.527 -178.702 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.7 tp 65.27 21.67 12.04 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.279 -179.711 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.8 t70 56.14 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.998 179.853 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' LEU . 12.5 t-80 -49.32 -29.87 6.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.885 -179.687 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.454 HD23 ' C ' ' A' ' 20' ' ' LEU . 2.8 tt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.15 179.985 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.509 ' C ' ' H ' ' A' ' 3' ' ' ARG . 49.3 m95 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.669 0.271 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' A' ' 4' ' ' ARG . 18.7 mt 63.31 -7.62 0.16 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.472 179.892 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.509 ' H ' ' C ' ' A' ' 1' ' ' TRP . 40.1 mtt-85 66.43 -22.4 0.1 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.855 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.521 ' H ' ' C ' ' A' ' 2' ' ' LEU . 96.9 mtt180 -91.01 -34.35 15.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.854 0.359 . . . . 0.0 110.644 -179.965 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.0 mt 59.27 94.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.654 179.744 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' A' ' 8' ' ' GLY . . . 46.08 18.17 0.26 Allowed Glycine 0 C--N 1.33 0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.458 179.647 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? 52.95 10.04 0.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.703 0.287 . . . . 0.0 110.731 179.904 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 6' ' ' GLY . . . -73.87 105.21 1.76 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.119 -0.562 . . . . 0.0 111.892 179.895 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.36 -95.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.438 -179.801 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -172.64 -24.4 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.823 0.344 . . . . 0.0 110.468 179.831 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.2 mt -137.44 -44.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.416 -179.483 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.598 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.0 mt -87.67 -94.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.849 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.79 -6.23 2.51 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 175.992 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.1 -47.71 5.69 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 113.182 -1.509 . . . . 0.0 109.755 177.987 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.76 27.37 1.15 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.484 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.9 48.19 0.19 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.408 -178.607 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 19' ' ' HIS . 9.6 mt 61.95 35.88 15.98 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.176 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 55.77 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.716 -179.669 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 17' ' ' LEU . 3.8 p-80 -162.27 46.26 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.472 -179.995 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.7 tp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.323 179.974 . . . . . . . . 0 0 . 1 . 077 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.741 0.305 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.97 -9.65 58.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.179 179.845 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 76.51 -49.07 0.57 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.619 179.962 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.3 mtp85 -73.47 -8.1 54.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.861 0.362 . . . . 0.0 110.379 179.895 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.9 mt -142.08 64.77 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.092 179.863 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.17 -35.18 0.2 Allowed Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -179.894 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.3 mttm 55.56 54.08 8.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.754 0.312 . . . . 0.0 110.803 179.689 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.18 107.24 1.71 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.703 179.708 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.35 -87.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.721 -179.693 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -170.86 -27.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.908 0.385 . . . . 0.0 110.247 -179.92 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 14.9 mt -131.71 -50.47 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.898 179.912 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 14' ' ' GLY . 35.1 mm -76.68 -96.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.705 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.39 -9.66 1.1 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 108.379 -1.889 . . . . 0.0 108.379 176.425 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.97 -47.87 6.86 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 113.005 -1.597 . . . . 0.0 110.252 178.249 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.27 27.92 0.88 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.865 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.43 38.6 0.16 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.988 -179.083 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.3 tt 58.21 42.36 22.09 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.691 179.836 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 54.61 -83.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.576 -179.849 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.7 OUTLIER -163.01 52.97 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.36 179.954 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.187 -179.999 . . . . . . . . 0 0 . 1 . 078 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.807 0.337 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 078 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 tp -76.44 -73.01 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.533 -179.869 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.454 ' H ' ' H ' ' A' ' 4' ' ' ARG . 37.4 ttm180 -155.16 -12.31 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.833 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.454 ' H ' ' H ' ' A' ' 3' ' ' ARG . 16.0 ptp180 -153.02 2.47 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.548 179.556 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.0 mt 56.11 91.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.625 179.968 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.22 -24.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.184 -0.531 . . . . 0.0 111.973 -179.998 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt 56.46 106.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.803 0.335 . . . . 0.0 110.51 179.963 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.12 -164.16 54.34 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.191 179.948 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.459 HG23 ' H ' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -145.42 -99.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.882 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.459 ' H ' HG23 ' A' ' 9' ' ' VAL . 32.2 ttmt -164.23 -20.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 110.481 179.785 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 26.7 mm -110.03 -46.83 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.83 -178.959 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 14' ' ' GLY . 47.2 mm -98.36 -101.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.139 -178.695 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -50.47 -11.45 0.47 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 177.252 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.37 -48.09 5.47 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 177.824 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.97 27.13 0.56 Allowed 'General case' 0 C--N 1.342 0.265 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.642 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.35 39.99 0.14 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.968 -179.12 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.5 tp 55.17 22.26 4.52 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.078 -179.983 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 53.56 -86.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.454 -179.742 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -50.21 -37.21 34.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.542 179.94 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.165 179.921 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.421 ' O ' ' CG ' ' A' ' 1' ' ' TRP . 71.7 t-105 . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 121.074 0.464 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.5 tp -178.84 -58.8 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.379 179.901 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 4' ' ' ARG . 76.0 ttt180 -170.73 -21.46 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.774 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 3' ' ' ARG . 14.0 ptm180 -177.38 19.47 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.208 179.456 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.9 mt 61.36 130.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.664 179.962 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.13 -66.46 2.54 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.703 179.438 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -87.31 -178.36 6.17 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.908 0.385 . . . . 0.0 110.944 -179.448 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.43 67.83 0.97 Allowed Glycine 0 C--N 1.335 0.501 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.989 -179.941 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.3 m -156.62 23.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.834 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -75.83 -14.85 60.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.985 0.421 . . . . 0.0 110.337 179.854 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 14.1 mt -138.35 -37.9 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.034 -179.565 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.611 ' C ' ' H ' ' A' ' 14' ' ' GLY . 86.3 mt -73.96 -88.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.577 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.788 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.97 -5.19 5.23 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 175.585 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.02 -43.28 7.66 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 113.091 -1.555 . . . . 0.0 110.189 178.504 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.1 28.4 1.07 Allowed 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.845 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.49 37.06 0.45 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.509 -178.639 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.4 tt 54.2 49.59 18.31 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.838 -179.934 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 49.87 23.8 1.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.609 -179.989 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 54.08 57.59 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.468 -179.912 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.4 tp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.13 -179.838 . . . . . . . . 0 0 . 1 . 080 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 33.2 p90 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.713 0.292 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.5 mt -72.59 -74.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.526 -179.994 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.411 ' H ' ' H ' ' A' ' 4' ' ' ARG . 30.7 mtm105 -148.11 -11.76 0.37 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.711 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.411 ' H ' ' H ' ' A' ' 3' ' ' ARG . 36.8 ttp180 -166.15 7.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.475 179.864 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.7 mt 55.56 48.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.365 179.991 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.05 43.17 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.03 -179.873 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -75.33 -74.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.323 . . . . 0.0 110.597 179.993 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.35 156.42 22.16 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.858 -179.997 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.3 t -74.47 -84.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.64 0.257 . . . . 0.0 110.587 -179.926 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -167.51 -23.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.567 -179.887 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.3 mt -139.71 -46.99 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.039 179.937 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' GLY . 37.5 mt -78.14 -92.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.789 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.01 -8.19 2.95 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 176.121 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.25 -47.67 6.83 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 112.93 -1.635 . . . . 0.0 110.13 178.131 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.96 28.68 0.78 Allowed 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.642 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.51 39.45 0.35 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.715 -178.848 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 12' ' ' ILE . 1.1 tt 60.25 39.14 19.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.945 179.979 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 38.5 t70 47.88 61.38 3.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.5 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 27.0 p80 41.16 51.28 3.41 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.261 -179.98 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 20' ' ' LEU . 7.7 mp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.187 179.975 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 40.2 m95 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.695 0.283 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 2' ' ' LEU . 3.1 mm? -63.12 -88.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.917 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -140.3 -15.73 0.96 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 179.591 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 55.8 mtt85 -154.22 17.18 0.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.503 179.532 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 7' ' ' LYS . 6.7 mt 56.54 43.75 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.949 -179.647 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 41.38 25.47 0.16 Allowed Glycine 0 C--N 1.332 0.348 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.445 -179.89 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 5' ' ' ILE . 52.5 tttm -69.43 -36.53 76.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.644 -179.831 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.38 166.56 29.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.163 179.969 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.2 t -74.47 -83.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.615 0.245 . . . . 0.0 110.421 179.993 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -171.1 -27.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.506 179.963 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.9 mm -133.69 -47.39 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.257 -0.428 . . . . 0.0 109.988 -179.924 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' GLY . 75.8 mt -80.0 -93.39 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.862 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.6 -7.62 3.29 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 176.171 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.64 -47.38 6.79 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 112.799 -1.7 . . . . 0.0 110.008 178.165 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.67 29.35 0.61 Allowed 'General case' 0 C--N 1.343 0.319 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.467 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.5 38.46 0.5 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.444 -178.734 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.6 tt 54.76 50.86 14.85 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.632 -179.746 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t0 55.43 -82.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.695 -179.796 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' LEU . 8.7 t60 -164.39 44.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.524 179.873 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.123 -179.97 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.423 ' CD2' ' O ' ' A' ' 1' ' ' TRP . 42.4 p-90 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.808 0.337 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 2' ' ' LEU . 7.7 mp -65.71 -88.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.255 -179.96 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 4' ' ' ARG . 54.3 ttt-85 -146.44 -11.04 0.47 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.895 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.413 ' H ' ' H ' ' A' ' 5' ' ' ILE . 42.7 ttt85 -163.72 5.0 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.449 179.683 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.413 ' H ' ' H ' ' A' ' 4' ' ' ARG . 17.5 mt 60.57 93.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.393 179.97 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.33 68.79 1.53 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.022 -179.892 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.56 -170.61 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 110.547 180.0 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.27 104.44 0.13 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.993 179.948 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.0 t -77.88 -82.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.656 0.265 . . . . 0.0 110.522 -179.982 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -170.95 -25.46 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.721 -179.858 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 13.5 mt -125.96 -52.62 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.391 -179.672 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.614 ' C ' ' H ' ' A' ' 14' ' ' GLY . 39.8 mm -75.58 -97.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.921 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.23 -10.28 0.8 Allowed Glycine 0 C--N 1.346 1.133 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 176.648 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.28 -48.08 7.07 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.144 -1.528 . . . . 0.0 110.258 178.053 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -88.34 30.36 0.89 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.797 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.44 42.81 0.29 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.802 -178.852 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.6 tp 63.82 51.52 2.36 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.25 -179.827 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.5 t0 69.91 -70.55 0.14 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.591 -179.758 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -159.88 19.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.457 179.934 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.248 179.876 . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.466 ' CD1' ' O ' ' A' ' 1' ' ' TRP . 28.5 p90 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.908 0.385 . . . . 0.0 110.511 . . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 2' ' ' LEU . 9.0 mp -78.06 -76.24 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.932 179.852 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -148.09 -22.72 0.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.744 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -147.79 8.39 0.87 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.36 179.303 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mt 60.53 94.5 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.264 -179.812 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.23 53.76 4.67 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.704 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -60.42 123.24 16.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 110.586 -179.78 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.56 138.14 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.081 179.732 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.47 HG23 ' H ' ' A' ' 10' ' ' LYS . 1.5 m -57.12 -103.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.84 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.47 ' H ' HG23 ' A' ' 9' ' ' VAL . 54.8 tttm -158.2 -22.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.714 0.292 . . . . 0.0 110.731 -179.758 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.0 mt -114.4 -49.1 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.411 -179.207 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.6 mt -91.8 -99.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -178.687 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.424 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.58 -10.74 1.01 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 176.931 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.83 -49.14 5.81 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 113.126 -1.537 . . . . 0.0 109.764 177.881 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.73 29.49 0.7 Allowed 'General case' 0 C--N 1.344 0.342 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.597 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.16 43.48 0.29 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.647 -178.853 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.6 tp 65.7 -1.19 1.09 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.231 -179.725 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 16' ' ' ALA . 19.5 t70 51.35 -85.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.08 179.647 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' LEU . 84.5 m-70 -49.02 -17.96 0.25 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.931 -179.708 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.341 -179.976 . . . . . . . . 0 0 . 1 . 084 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 61.6 m95 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.754 0.311 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 18.2 tp -59.52 -81.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.09 0.472 . . . . 0.0 110.059 179.932 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.42 ' H ' ' H ' ' A' ' 4' ' ' ARG . 52.0 ttt85 -173.64 -18.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.754 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.42 ' H ' ' H ' ' A' ' 3' ' ' ARG . 68.5 mtp180 -149.87 6.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.35 179.413 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 mt 61.82 76.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.438 -179.877 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 56.95 82.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.069 179.871 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -53.36 -31.47 44.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 110.24 179.803 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 49.67 99.99 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.208 179.839 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.463 HG23 ' H ' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -66.75 -101.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.739 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.463 ' H ' HG23 ' A' ' 9' ' ' VAL . 72.3 tttt -162.52 -17.65 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.885 0.374 . . . . 0.0 110.48 -179.924 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' H ' ' H ' ' A' ' 10' ' ' LYS . 7.0 mm -119.38 -43.73 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.569 -178.946 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' GLY . 58.4 mt -96.73 -97.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.645 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.18 -7.44 1.87 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 176.493 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -85.05 -46.77 5.51 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 113.306 -1.447 . . . . 0.0 109.845 178.124 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.93 29.06 0.47 Allowed 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.62 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 75.91 38.38 0.35 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.779 -178.91 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.4 tp 53.2 41.31 32.14 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.234 -179.731 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 55.48 31.46 17.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.321 -179.76 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.3 m80 53.23 69.02 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.378 -179.877 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.18 -179.849 . . . . . . . . 0 0 . 1 . 085 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.772 0.32 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 2' ' ' LEU . 7.7 mp -64.14 -88.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.072 179.957 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -142.3 -15.52 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.776 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -171.31 11.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.312 179.687 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.2 mt 59.86 85.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.355 -179.904 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.01 73.85 0.8 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.002 179.933 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -70.92 -3.14 17.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 0.0 110.473 179.943 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.66 -126.64 0.87 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.011 179.986 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.463 ' C ' ' H ' ' A' ' 11' ' ' ILE . 51.2 t -64.51 -14.49 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.651 0.262 . . . . 0.0 110.433 179.959 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.7 tttm 72.08 -20.0 0.26 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.396 179.845 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.463 ' H ' ' C ' ' A' ' 9' ' ' VAL . 12.9 mt -122.39 -44.69 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 120.737 0.303 . . . . 0.0 111.301 -179.189 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.579 ' C ' ' H ' ' A' ' 14' ' ' GLY . 69.9 mt -95.0 -95.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.935 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.95 -7.72 2.57 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 176.367 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.11 -48.02 5.29 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 113.08 -1.56 . . . . 0.0 110.001 178.193 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -83.25 27.86 0.56 Allowed 'General case' 0 C--N 1.341 0.207 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.834 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.77 39.88 0.16 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.936 -179.005 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.2 tp 54.22 39.46 30.81 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.255 -179.939 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 57.14 -79.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.752 179.996 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 17' ' ' LEU . 38.6 t-80 -63.58 -60.94 2.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 0.0 110.583 -179.999 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.206 -179.969 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.825 0.345 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.5 mt -70.56 -7.29 42.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.484 -179.958 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 76.06 -45.19 0.52 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -73.04 -35.67 66.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.363 . . . . 0.0 110.322 179.855 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 6' ' ' GLY . 8.8 tp -70.18 -36.71 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.094 179.895 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 5' ' ' ILE . . . -63.74 -33.78 88.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.079 -0.582 . . . . 0.0 111.825 179.943 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -167.03 139.95 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.78 0.324 . . . . 0.0 110.479 179.914 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . -178.04 -135.57 2.31 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.015 -179.985 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.444 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 35.6 m -77.32 26.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.728 0.299 . . . . 0.0 110.813 -179.905 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -80.47 -17.33 52.0 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.741 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.0 mt -131.57 -38.86 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.434 -179.542 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.609 ' C ' ' H ' ' A' ' 14' ' ' GLY . 86.5 mt -76.36 -88.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.8 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.25 -4.06 4.45 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 175.343 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.609 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.69 -45.35 6.45 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 113.092 -1.554 . . . . 0.0 110.0 178.357 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -89.22 27.94 1.32 Allowed 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.755 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.28 45.73 0.26 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.437 -178.582 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.8 mt 63.91 28.7 14.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.297 -179.42 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 48.97 27.31 1.61 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.629 -179.905 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.0 m80 53.57 48.46 21.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.332 -179.782 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.279 -179.924 . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.803 0.335 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 37.9 tp -62.29 -14.2 36.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.924 179.843 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 78.65 -50.69 0.46 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.29 179.877 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -78.38 -34.52 48.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.435 179.674 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.8 mt 48.9 51.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.537 179.972 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 166.14 -2.54 0.05 OUTLIER Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.028 -179.934 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt 54.53 176.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.732 0.301 . . . . 0.0 110.639 -179.982 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.07 151.11 11.24 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.235 -0.507 . . . . 0.0 111.835 -179.989 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.9 t -73.54 -83.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.677 -179.883 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -170.89 -20.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.765 -179.885 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.9 mt -135.99 -47.89 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.8 0.333 . . . . 0.0 110.58 -179.731 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.592 ' C ' ' H ' ' A' ' 14' ' ' GLY . 25.2 mt -84.09 -94.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.986 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.417 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -55.21 -9.42 2.08 Favored Glycine 0 C--N 1.345 1.033 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 176.201 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.98 -49.41 6.02 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 112.922 -1.639 . . . . 0.0 110.0 177.956 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.51 29.17 0.79 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.679 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.48 44.01 0.24 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.652 -178.917 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 12' ' ' ILE . 4.5 tp 65.58 22.35 11.74 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.286 -179.908 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.2 t0 55.77 25.24 8.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.286 -179.817 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 53.58 70.25 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.438 -179.8 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.366 -179.902 . . . . . . . . 0 0 . 1 . 088 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 91.4 m95 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.864 0.364 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.529 ' C ' ' H ' ' A' ' 4' ' ' ARG . 18.3 mt -78.53 -10.42 59.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.7 -179.905 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 64.73 -13.92 0.1 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.708 -179.897 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.529 ' H ' ' C ' ' A' ' 2' ' ' LEU . 54.6 mtt85 -109.77 -14.69 14.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.735 0.303 . . . . 0.0 110.534 -179.926 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.9 tt -51.12 -29.66 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.46 179.958 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' GLY . . . 171.04 13.01 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.185 -0.531 . . . . 0.0 111.791 179.954 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' H ' ' H ' ' A' ' 6' ' ' GLY . 83.8 mttt 58.63 -77.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.589 0.233 . . . . 0.0 110.796 179.928 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . 67.93 68.41 1.66 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.763 -179.994 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 m -76.76 32.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 0.0 110.789 -179.747 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 8' ' ' GLY . 26.7 mmtp -82.78 -11.59 58.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 110.332 179.804 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.402 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.7 mt -139.92 -39.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.134 -179.532 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.615 ' C ' ' H ' ' A' ' 14' ' ' GLY . 70.0 mt -75.75 -88.83 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.948 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.44 -5.53 4.98 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 107.276 -2.33 . . . . 0.0 107.276 175.427 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.615 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.93 -44.65 7.04 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.147 -1.526 . . . . 0.0 110.342 178.498 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -87.37 27.04 1.13 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.849 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.05 37.77 0.2 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.818 -178.892 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.8 OUTLIER 55.36 17.84 2.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.911 179.941 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t0 56.24 -80.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.8 -179.962 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 17' ' ' LEU . 18.4 t-80 -50.67 -61.46 2.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.848 0.356 . . . . 0.0 110.611 -179.922 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 9.1 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.463 179.944 . . . . . . . . 0 0 . 1 . 089 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 41.4 m95 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.794 0.33 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 089 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 4' ' ' ARG . 12.2 mt -73.43 -13.91 61.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.414 179.896 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 74.62 -38.83 0.4 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.634 -179.996 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' A' ' 2' ' ' LEU . 73.9 mtt-85 -76.54 -24.12 53.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.917 0.389 . . . . 0.0 110.435 179.881 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.453 HG23 ' N ' ' A' ' 6' ' ' GLY . 7.8 tp -55.32 -39.12 50.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.033 179.895 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' N ' HG23 ' A' ' 5' ' ' ILE . . . -77.28 -12.34 84.68 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 179.888 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -168.83 105.48 0.42 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.725 0.298 . . . . 0.0 110.481 -179.886 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.87 -89.54 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.139 179.974 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 11' ' ' ILE . 14.6 t -146.44 -15.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.808 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 tptp 70.63 -13.8 0.45 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.254 179.798 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.475 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 13.3 mt -123.08 -46.0 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.138 -179.272 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 43.8 mm -97.79 -99.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.034 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.415 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -52.57 -9.4 0.71 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 176.67 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.83 -48.23 5.01 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 113.441 -1.38 . . . . 0.0 110.065 177.953 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.63 25.76 1.2 Allowed 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.923 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.21 48.6 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.864 -178.893 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.7 mt 62.6 1.86 0.84 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.268 -179.686 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 16' ' ' ALA . 27.9 t70 51.08 46.24 26.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.633 -179.938 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.443 ' CG ' ' O ' ' A' ' 19' ' ' HIS . 11.1 t60 55.5 35.68 25.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.583 -179.976 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.067 -179.946 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.799 0.333 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.9 mt -69.47 -68.8 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.222 0.534 . . . . 0.0 110.558 179.984 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -172.02 -16.51 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.988 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -178.63 10.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.215 179.652 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.6 mm 58.71 82.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.229 -179.76 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.413 ' H ' ' H ' ' A' ' 7' ' ' LYS . . . -163.68 -7.2 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 -179.915 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.413 ' H ' ' H ' ' A' ' 6' ' ' GLY . 15.7 mtpp 55.75 -154.17 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.672 0.273 . . . . 0.0 110.308 179.889 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -42.07 144.3 0.96 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.439 -0.41 . . . . 0.0 112.466 -179.751 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.8 t -71.67 -77.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.736 0.303 . . . . 0.0 110.534 -179.925 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.409 ' H ' ' H ' ' A' ' 11' ' ' ILE . 46.6 tptt -172.19 -18.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.02 0.438 . . . . 0.0 109.98 -179.908 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.409 ' H ' ' H ' ' A' ' 10' ' ' LYS . 13.2 mt -142.79 -45.35 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.098 -179.947 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' GLY . 77.9 mt -78.44 -90.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.923 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.73 -7.17 4.24 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 107.546 -2.222 . . . . 0.0 107.546 175.706 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -81.45 -47.13 6.54 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 112.859 -1.671 . . . . 0.0 110.229 178.443 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.535 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -86.07 28.2 0.83 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.75 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.25 40.36 0.25 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.641 -178.801 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 5.1 tp 58.54 36.75 25.38 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 120.126 -0.629 . . . . 0.0 110.218 -179.847 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 54.92 -83.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.703 -179.899 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 28.0 m80 -52.59 -63.7 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.717 -179.929 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.41 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.4 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.193 -179.874 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 74.1 m95 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.906 0.384 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 4' ' ' ARG . 14.9 mt -72.79 -16.84 61.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.413 179.922 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 73.53 -35.87 0.33 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.827 179.946 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.451 ' H ' ' C ' ' A' ' 2' ' ' LEU . 72.2 mtt85 -78.78 -20.14 50.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.562 -179.979 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mt -146.22 68.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.251 179.978 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.04 -48.86 0.18 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.83 179.979 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 53.76 172.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.752 0.31 . . . . 0.0 110.637 179.941 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 170.58 154.13 9.3 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.272 -0.49 . . . . 0.0 111.932 179.929 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 14' ' ' GLY . 29.8 m -74.41 16.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.618 0.247 . . . . 0.0 110.728 -179.946 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 8' ' ' GLY . 49.3 mtpt -77.76 -14.16 59.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.008 0.433 . . . . 0.0 110.026 179.69 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.93 -41.7 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.22 -179.704 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.599 ' C ' ' H ' ' A' ' 14' ' ' GLY . 31.2 mt -75.63 -89.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.379 -179.794 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.21 -5.62 3.45 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 107.631 -2.188 . . . . 0.0 107.631 175.673 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.599 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.84 -45.87 6.54 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 113.03 -1.585 . . . . 0.0 110.097 178.342 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -89.79 28.63 1.3 Allowed 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.813 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 73.28 46.27 0.23 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.54 -178.668 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 12' ' ' ILE . 8.8 mt 64.28 11.66 6.56 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.202 -179.494 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.1 t70 58.45 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 -179.823 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' LEU . 33.6 t-80 -160.16 32.05 0.17 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.618 179.997 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 N--CA 1.468 0.445 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.264 179.806 . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.506 ' C ' ' H ' ' A' ' 3' ' ' ARG . 89.8 m95 . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.759 0.314 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 4' ' ' ARG . 23.2 mt 63.75 -8.84 0.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.62 179.979 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.506 ' H ' ' C ' ' A' ' 1' ' ' TRP . 65.7 mtt180 62.97 -13.65 0.07 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.6 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 2' ' ' LEU . 74.9 mtp180 -135.37 -0.74 2.65 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.717 0.294 . . . . 0.0 110.527 -179.731 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.5 mt 51.47 79.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.227 -179.86 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.68 68.02 1.27 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 111.636 -0.585 . . . . 0.0 111.636 -179.57 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -49.98 -20.18 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.636 0.255 . . . . 0.0 110.936 -179.678 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.07 -108.03 0.26 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.351 179.963 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.44 ' C ' ' H ' ' A' ' 11' ' ' ILE . 30.2 t -140.3 -14.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.77 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.0 tttt 73.27 -18.99 0.34 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.211 179.849 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.44 ' H ' ' C ' ' A' ' 9' ' ' VAL . 11.6 mt -116.68 -47.52 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.545 -179.085 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 14' ' ' GLY . 70.4 mt -94.77 -98.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.728 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.3 -9.4 1.49 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 176.916 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.584 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.59 -48.65 5.48 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 113.105 -1.548 . . . . 0.0 109.857 177.859 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.93 29.88 0.61 Allowed 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.737 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.34 42.92 0.3 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.84 -178.85 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.5 tp 59.47 50.7 7.25 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.286 -179.809 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.7 t0 56.74 35.61 26.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.463 -179.874 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.2 m80 55.91 39.57 30.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.561 179.966 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.194 179.868 . . . . . . . . 0 0 . 1 . 093 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.79 0.328 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.9 mt -69.2 -7.23 34.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.472 -179.947 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 7' ' ' LYS . 27.3 ttm180 73.21 -66.5 0.31 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.758 -179.928 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -57.79 -15.68 8.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.718 -179.845 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 tp -61.4 -30.92 49.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.121 179.964 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.32 -14.65 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 179.971 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 3' ' ' ARG . 68.5 tttt 63.31 -131.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.909 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.44 125.61 7.06 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.365 -0.445 . . . . 0.0 112.077 -179.798 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.466 ' C ' ' H ' ' A' ' 11' ' ' ILE . 25.9 t -60.21 -19.7 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.764 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm 70.96 -23.59 0.17 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.488 179.879 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.466 ' H ' ' C ' ' A' ' 9' ' ' VAL . 10.9 mt -113.3 -48.92 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 120.759 0.314 . . . . 0.0 111.754 -179.094 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.601 ' C ' ' H ' ' A' ' 14' ' ' GLY . 59.8 mt -91.83 -99.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.473 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.82 -8.27 1.3 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 176.915 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.52 -47.91 5.81 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 113.113 -1.544 . . . . 0.0 109.617 177.931 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.55 30.03 0.43 Allowed 'General case' 0 C--N 1.343 0.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.479 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.54 36.68 0.6 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.673 -178.831 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 19' ' ' HIS . 1.1 tt 54.44 38.49 29.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.972 -179.732 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.5 t70 59.19 1.19 0.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.09 179.933 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.476 ' H ' ' C ' ' A' ' 17' ' ' LEU . 47.5 t-80 -172.28 -72.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.879 0.371 . . . . 0.0 110.541 179.923 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 20' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.278 -179.913 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.791 0.329 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 4' ' ' ARG . 14.7 mt -70.63 -6.68 38.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.248 179.799 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 66.58 -13.83 0.17 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.448 -179.941 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' H ' ' C ' ' A' ' 2' ' ' LEU . 59.1 mtt-85 -132.91 1.46 3.59 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.922 0.391 . . . . 0.0 110.068 179.79 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mt 50.19 53.6 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.627 179.759 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.89 -71.58 0.27 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.38 -0.438 . . . . 0.0 112.043 179.937 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -71.01 -158.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.657 0.265 . . . . 0.0 110.415 -179.73 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 83.46 -26.26 4.64 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 -179.967 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 16.7 m -78.04 28.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 110.611 179.962 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 8' ' ' GLY . 18.9 tptm -80.44 -16.25 54.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.169 0.509 . . . . 0.0 109.789 179.808 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.3 mt -132.77 -39.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.501 -179.721 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.61 ' C ' ' H ' ' A' ' 14' ' ' GLY . 84.6 mt -75.49 -89.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.93 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.23 -4.56 3.73 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 175.334 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.78 -45.38 6.79 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 113.128 -1.536 . . . . 0.0 109.855 178.16 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -90.44 29.46 1.28 Allowed 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.573 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 70.08 46.94 0.6 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.221 -178.422 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.5 mt 63.81 12.79 6.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.021 -179.219 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 t0 56.63 46.25 20.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.691 -179.94 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.8 m170 50.15 49.83 19.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.617 179.99 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 11.0 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.519 -179.922 . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 31.5 p90 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.689 0.28 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.92 -71.56 0.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.129 0.49 . . . . 0.0 110.415 -179.995 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -163.15 -16.68 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.827 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 6' ' ' GLY . 57.0 ttt-85 -166.51 9.84 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.933 179.628 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.7 pt 37.32 25.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.498 -179.818 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 4' ' ' ARG . . . -110.86 -67.29 0.55 Allowed Glycine 0 C--N 1.335 0.506 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 179.83 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -77.9 133.84 38.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.723 0.297 . . . . 0.0 110.372 179.906 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.46 135.24 2.58 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.082 -179.996 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.481 ' C ' ' H ' ' A' ' 11' ' ' ILE . 21.8 t -74.2 -14.52 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 179.988 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? 68.49 -13.21 0.32 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.341 179.752 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.481 ' H ' ' C ' ' A' ' 9' ' ' VAL . 18.9 mt -122.73 -44.22 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 120.859 0.361 . . . . 0.0 111.205 -179.113 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.583 ' C ' ' H ' ' A' ' 14' ' ' GLY . 67.6 mt -97.79 -97.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.845 -178.655 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.69 -7.35 2.15 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 176.884 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -84.79 -47.12 5.46 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 113.317 -1.442 . . . . 0.0 109.593 177.915 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.93 30.55 0.44 Allowed 'General case' 0 C--N 1.342 0.273 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.556 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.1 38.43 0.56 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.935 -178.99 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 50.37 29.85 4.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.981 -179.833 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.7 t70 55.1 -82.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.747 -179.903 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' LEU . 19.4 t-80 -48.17 -66.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.696 -179.891 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.411 179.745 . . . . . . . . 0 0 . 1 . 096 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.799 0.333 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 2' ' ' LEU . 6.5 mp -68.9 -11.03 60.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.035 -179.954 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.416 ' C ' ' HE ' ' A' ' 4' ' ' ARG . 28.6 ttt85 75.4 -36.89 0.32 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.379 -179.685 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.563 ' HE ' ' N ' ' A' ' 4' ' ' ARG . 4.7 mmp_? -77.21 -19.65 56.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.3 179.648 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 6' ' ' GLY . 15.8 tt -60.89 -43.64 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.52 179.983 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.53 ' N ' HG23 ' A' ' 5' ' ' ILE . . . -168.38 2.2 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.731 -0.548 . . . . 0.0 111.731 -179.98 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.42 ' H ' ' H ' ' A' ' 6' ' ' GLY . 83.4 tttt 56.88 -80.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.519 0.2 . . . . 0.0 110.94 179.937 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . 54.77 93.4 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.87 -179.787 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.6 t -72.85 -88.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 121.134 -0.227 . . . . 0.0 110.709 -179.856 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -171.87 -26.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.869 0.366 . . . . 0.0 110.58 -179.879 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 15.4 mt -133.08 -50.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.167 -179.964 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.606 ' C ' ' H ' ' A' ' 14' ' ' GLY . 33.0 mm -76.62 -95.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.781 179.876 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.67 -9.53 1.21 Allowed Glycine 0 C--N 1.346 1.12 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 176.313 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -79.77 -48.16 6.79 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 112.978 -1.611 . . . . 0.0 110.204 178.168 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.77 29.02 0.73 Allowed 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.753 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 76.77 38.73 0.25 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.882 -178.917 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 19' ' ' HIS . 4.9 tp 58.03 47.58 14.55 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.186 179.83 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.434 ' O ' ' CG ' ' A' ' 19' ' ' HIS . 12.6 m-20 60.95 -76.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.759 -179.74 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 17' ' ' LEU . 73.0 m80 -155.62 54.6 0.61 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.825 0.345 . . . . 0.0 110.465 -179.951 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 20' ' ' LEU . 7.4 mp . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.221 179.973 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 85.0 m95 . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.769 0.318 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 40.7 tp -51.93 -17.54 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.951 179.802 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.497 ' C ' ' HE ' ' A' ' 4' ' ' ARG . 49.0 ttm-85 76.0 -44.13 0.49 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.603 179.903 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.64 ' HE ' ' N ' ' A' ' 4' ' ' ARG . 4.0 mmp_? -77.58 -19.15 56.1 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.273 179.652 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.3 pt 34.59 37.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.688 179.88 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.0 22.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.232 -0.509 . . . . 0.0 111.865 -179.977 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt 51.12 99.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.858 0.361 . . . . 0.0 110.374 -179.996 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.74 142.16 44.91 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.2 -179.792 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.459 ' C ' ' H ' ' A' ' 11' ' ' ILE . 41.2 t -74.87 -12.52 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.704 0.287 . . . . 0.0 110.265 179.918 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.1 tttp 71.38 -20.5 0.23 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.541 179.745 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.459 ' H ' ' C ' ' A' ' 9' ' ' VAL . 16.4 mt -123.18 -45.66 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 120.802 0.334 . . . . 0.0 111.166 -179.189 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.594 ' C ' ' H ' ' A' ' 14' ' ' GLY . 46.8 mt -92.62 -97.19 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.101 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.17 -7.44 1.86 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 176.219 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.49 -47.46 5.68 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 113.225 -1.487 . . . . 0.0 109.942 177.993 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -82.69 28.94 0.46 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.51 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 14' ' ' GLY . . . 74.78 38.54 0.46 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.41 -178.699 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' ILE . 5.6 tp 57.02 47.79 16.87 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.173 -179.688 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.6 t70 52.22 29.72 6.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.464 -179.964 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 52.06 55.9 8.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.508 -179.986 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 tp . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.359 -179.985 . . . . . . . . 0 0 . 1 . 098 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.454 ' C ' ' H ' ' A' ' 3' ' ' ARG . 23.8 m-90 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.721 0.296 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 tp 67.66 -6.94 0.62 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.83 179.942 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 1' ' ' TRP . 0.5 OUTLIER 72.94 -67.8 0.25 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.18 -179.865 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -69.56 7.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.739 179.848 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.452 ' H ' ' C ' ' A' ' 3' ' ' ARG . 37.2 pt 36.06 46.66 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.733 179.852 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.34 66.83 1.57 Allowed Glycine 0 C--N 1.331 0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.063 179.849 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 53.2 -147.58 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.64 179.87 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.08 112.34 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.952 179.902 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.472 ' C ' ' H ' ' A' ' 11' ' ' ILE . 2.7 t -70.84 -1.41 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.857 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.2 tttm 71.73 -19.58 0.26 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.28 179.829 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' A' ' 9' ' ' VAL . 13.9 mt -117.75 -47.71 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.761 0.315 . . . . 0.0 111.355 -179.098 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.579 ' C ' ' H ' ' A' ' 14' ' ' GLY . 59.1 mt -95.48 -99.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.993 -178.547 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.88 -10.11 0.96 Allowed Glycine 0 C--N 1.345 1.034 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 177.128 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -82.79 -48.89 5.32 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 113.057 -1.571 . . . . 0.0 109.797 177.951 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -84.01 28.54 0.6 Allowed 'General case' 0 C--N 1.342 0.277 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.951 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.95 38.71 0.13 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.356 -179.343 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER 51.82 31.25 7.97 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.174 179.77 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.0 t0 56.64 -79.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.831 -179.954 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 17' ' ' LEU . 17.0 m-70 -49.34 -67.12 0.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.74 179.935 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.173 179.988 . . . . . . . . 0 0 . 1 . 099 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 78.4 m95 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.87 0.367 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 2' ' ' LEU . 9.9 mp -64.44 -81.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.196 0.522 . . . . 0.0 110.037 179.799 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -169.27 -30.86 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.783 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -142.67 0.85 1.29 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.157 179.206 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.1 mt 59.28 83.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.283 -179.9 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.63 75.08 0.41 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.141 -0.552 . . . . 0.0 111.972 -179.967 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -73.19 175.23 6.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.798 0.332 . . . . 0.0 110.651 -179.862 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . 89.12 -0.67 81.98 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.185 179.922 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.425 ' O ' ' CA ' ' A' ' 14' ' ' GLY . 30.2 m -76.35 31.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.625 0.25 . . . . 0.0 110.779 -179.975 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 8' ' ' GLY . 56.3 mttm -83.35 -12.19 56.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.956 0.408 . . . . 0.0 110.224 179.871 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.7 mt -137.65 -40.4 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.19 -179.56 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.634 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.2 mt -76.06 -89.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.928 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.04 -4.87 3.77 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 175.529 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.634 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -83.13 -45.55 6.56 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 113.02 -1.59 . . . . 0.0 110.144 178.365 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -90.62 29.34 1.32 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.832 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 72.64 46.9 0.26 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.425 -178.56 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' ILE . 9.3 mt 65.11 13.48 8.73 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.389 0.431 . . . . 0.0 110.121 -179.393 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 t70 57.28 -78.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.041 179.761 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.498 ' N ' ' O ' ' A' ' 17' ' ' LEU . 97.2 m-70 -50.26 -57.44 7.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.773 -179.801 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.409 ' C ' HD23 ' A' ' 20' ' ' LEU . 1.6 tt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.173 179.974 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 26.9 m95 . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.764 0.316 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 2.4 mm? -68.13 -85.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.063 0.459 . . . . 0.0 110.053 -179.886 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.4 ' H ' ' H ' ' A' ' 4' ' ' ARG . 47.6 ttm-85 -157.82 -15.47 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.82 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.4 ' H ' ' H ' ' A' ' 3' ' ' ARG . 4.4 tpt180 -165.11 6.87 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.355 179.753 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.704 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.9 mp 53.91 93.54 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.166 179.939 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 44.84 43.1 8.11 Favored Glycine 0 CA--C 1.518 0.278 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.723 179.616 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.49 ' N ' ' CD ' ' A' ' 7' ' ' LYS . 3.1 mptp? 50.24 100.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.915 0.388 . . . . 0.0 110.621 179.557 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -49.96 142.21 13.53 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.764 179.736 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.6 -82.39 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 110.624 -179.919 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -171.34 -24.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.29 -179.958 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 12.6 mt -139.44 -48.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.803 179.924 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.608 ' C ' ' H ' ' A' ' 14' ' ' GLY . 41.3 mm -77.58 -94.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.419 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.93 -8.97 1.59 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 176.24 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.608 ' H ' ' C ' ' A' ' 12' ' ' ILE . . . -80.17 -48.02 6.68 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 112.992 -1.604 . . . . 0.0 110.181 178.164 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -85.28 28.66 0.71 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.737 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 77.11 38.04 0.25 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.905 -179.019 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' HIS . 1.4 tt 54.86 46.49 24.36 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.842 179.892 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 54.1 -84.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -179.754 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -162.28 50.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.524 179.876 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 20' ' ' LEU . 7.5 mp . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.251 179.965 . . . . . . . . 1 1 . 1 stop_ save_